pmid|annotator|subject_text_span|subject_label|predicate|object_text_span|object_label
36479494|student_A|polyphenols|dietary supplement|influence|brain health|DDF
36479494|student_A|Dietary supplements|dietary supplement|influence|neurological diseases|DDF
36479494|student_A|Dietary supplements|dietary supplement|influence|brain aging|DDF
36479494|student_A|healthy diet|dietary supplement|influence|neurological diseases|DDF
36479494|student_A|Diet|dietary supplement|influence|neurological diseases|DDF
36479494|student_A|diet|dietary supplement|influence|neurological diseases|DDF
36479494|student_A|B vitamins|dietary supplement|influence|brain health|DDF
36479494|student_A|healthy diet|dietary supplement|influence|brain aging|DDF
36479494|student_A|omega-3 fatty acids|dietary supplement|influence|neurological diseases|DDF
36479494|student_A|Mediterranean diet|dietary supplement|influence|Parkinson's|DDF
36479494|student_A|MedDiet|dietary supplement|influence|Alzheimer's|DDF
36479494|student_A|Mediterranean diet|dietary supplement|influence|Huntington's diseases|DDF
36479494|student_A|polyphenols|dietary supplement|influence|neurological diseases|DDF
36479494|student_A|MedDiet|dietary supplement|influence|neurological diseases|DDF
36479494|student_A|MedDiet|dietary supplement|influence|cognitive decline|DDF
36479494|student_A|Mediterranean diet|dietary supplement|influence|neurodegenerative diseases|DDF
36479494|student_A|unhealthy diet|dietary supplement|influence|neurodegenerative diseases|DDF
36479494|student_A|B vitamins|dietary supplement|influence|neurological diseases|DDF
36479494|student_A|ayurvedic herbs|dietary supplement|influence|brain health|DDF
36479494|student_A|MedDiet|dietary supplement|impact|gut microbiota|microbiome
36479494|student_A|MedDiet|dietary supplement|influence|Parkinson's|DDF
36479494|student_A|Mediterranean diet|dietary supplement|influence|Alzheimer's|DDF
36479494|student_A|ayurvedic herbs|dietary supplement|influence|neurological diseases|DDF
36479494|student_A|MedDiet|dietary supplement|influence|Huntington's diseases|DDF
36479494|student_A|Diet|dietary supplement|influence|mental health|DDF
36479494|student_A|omega-3 fatty acids|dietary supplement|influence|brain health|DDF
36479494|student_A|diet|dietary supplement|influence|brain health|DDF
36479494|student_A|Mediterranean diet|dietary supplement|influence|neurological diseases|DDF
36479494|student_A|MedDiet|dietary supplement|influence|neurodegenerative diseases|DDF
36479494|student_A|Mediterranean diet|dietary supplement|influence|cognitive decline|DDF
36479494|student_A|healthy diet|dietary supplement|influence|brain health|DDF
38891970|student_A|Depression|DDF|target|patients|human
38891970|student_A|depressive disorder|DDF|target|patients|human
38891970|student_A|depression|DDF|target|patients|human
33381005|student_A|uncultured_bacterium_g_Bacillus|bacteria|part of|MPTP group gut microbiota|microbiome
33381005|student_A|Gut Microbiota|microbiome|is linked to|Parkinson's Disease|DDF
33381005|student_A|fisetin|drug|change effect|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurodegeneration|DDF
33381005|student_A|Fisetin|drug|impact|Gut Microbiota|microbiome
33381005|student_A|group|animal|used by|16S rRNA (V3 and V4 regions) sequencing|biomedical technique
33381005|student_A|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurodegeneration|DDF|target|mice|animal
33381005|student_A|fisetin|drug|change effect|PD|DDF
33381005|student_A|uncultured_bacterium_g_Escherichia-Shigella|bacteria|part of|fisetin intervented MPTP group gut microbiota|microbiome
33381005|student_A|Lachnospiraceae|bacteria|part of|MPTP group gut microbiota|microbiome
33381005|student_A|uncultured_bacterium_g_Bacillus|bacteria|part of|fisetin intervented MPTP group gut microbiota|microbiome
33381005|student_A|gut microbiota|microbiome|is linked to|neurodegeneration|DDF
33381005|student_A|Fisetin|drug|change effect|Parkinson's Disease|DDF
33381005|student_A|uncultured_bacterium_g_Escherichia-Shigella|bacteria|part of|MPTP group gut microbiota|microbiome
33381005|student_A|fisetin|drug|change effect|Parkinson's disease|DDF
33381005|student_A|mice|animal|used by|16S rRNA (V3 and V4 regions) sequencing|biomedical technique
33381005|student_A|gut microbiota|microbiome|is linked to|PD|DDF
33381005|student_A|Lachnospiraceae|bacteria|part of|fisetin intervented MPTP group gut microbiota|microbiome
33381005|student_A|fisetin|drug|impact|gut microbiota|microbiome
33381005|student_A|fisetin|drug|change effect|neurodegeneration|DDF
38173790|student_A|prebiotics|dietary supplement|influence|PD|DDF
38173790|student_A|gut microbiota|microbiome|located in|human gastrointestinal tract|anatomical location
38173790|student_A|Parkinson's disease|DDF|target|patients|human
38173790|student_A|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
38173790|student_A|gut microbiota|microbiome|is linked to|PD|DDF
38173790|student_A|probiotics|dietary supplement|influence|PD|DDF
35263739|student_A|gut microbiota|microbiome|is linked to|dementia|DDF
35263739|student_A|Proteobacteria|bacteria|part of|gut microbiota|microbiome
35263739|student_A|Firmicutes|bacteria|part of|gut microbiota|microbiome
35263739|student_A|Parkinson's disease|DDF|target|patients|human
35263739|student_A|Cognitive Impairment|DDF|change abundance|Gut Microbiota|microbiome
35263739|student_A|Bifidobacteria|bacteria|part of|gut microbiota|microbiome
35263739|student_A|gut microbiota|microbiome|is linked to|psychiatric conditions|DDF
35263739|student_A|AD|DDF|target|patients with mild to severe cognitive impairment|human
35263739|student_A|gut microbiota|microbiome|located in|brain|anatomical location
35263739|student_A|AD|DDF|target|poststroke cognitive impairment patients|human
36406865|student_A|general paresis|DDF|target|NS patients|human
36406865|student_A|Coprobacter|bacteria|located in|NS group and GP group|human
36406865|student_A|Bacilli|bacteria|located in|GP patients|human
36406865|student_A|neurosyphilis|DDF|target|patients|human
36406865|student_A|SC-I-84|bacteria|located in|NS patients|human
36406865|student_A|Alloprevotella|bacteria|located in|GP patients|human
36406865|student_A|gut microbiota|microbiome|is linked to|NS|DDF
36406865|student_A|Akkermansia|bacteria|influence|neuropsychiatric disorders|DDF
36406865|student_A|Coprobacter|bacteria|influence|neuropsychiatric disorders|DDF
36406865|student_A|Akkermansia|bacteria|located in|GP Patients|human
36406865|student_A|gut microbiota|microbiome|located in|NS patients|human
36406865|student_A|NS|DDF|target|patients|human
36406865|student_A|GP|DDF|target|NS patients|human
36406865|student_A|gut microbiota|microbiome|is linked to|neurological disorders|DDF
36406865|student_A|Clostridia_UCG-014|bacteria|located in|NS patients|human
33099131|student_A|healthy people|human|used by|16S rRNA sequencing|biomedical technique
33099131|student_A|HP|human|used by|16S rRNA sequencing|biomedical technique
33099131|student_A|healthy spouses|human|used by|16S rRNA sequencing|biomedical technique
33099131|student_A|Altered gut microbiota|microbiome|located in|Parkinson's disease patients|human
33099131|student_A|PD patients|human|used by|16S rRNA sequencing|biomedical technique
33099131|student_A|gut microbiota|microbiome|used by|Disease-associated metagenomics studies|biomedical technique
33099131|student_A|Parkinson's disease|DDF|target|PD patients|human
33099131|student_A|inflammation-associated microbial genera|bacteria|influence|PD|DDF
33099131|student_A|PD|DDF|target|PD patients|human
33099131|student_A|HS|human|used by|16S rRNA sequencing|biomedical technique
33099131|student_A|gut microbiota|microbiome|located in|PD patients|human
33099131|student_A|inflammation-associated microbial genera|bacteria|influence|PD progression|DDF
33099131|student_A|PD patients|human|used by|Disease-associated metagenomics studies|biomedical technique
33099131|student_A|inflammation-associated microbial genera|bacteria|influence|deterioration|DDF
33099131|student_A|Altered gut microbiota|microbiome|located in|healthy spouses|human
33099131|student_A|gut microbiota|microbiome|used by|16S rRNA sequencing|biomedical technique
33099131|student_A|gut microbiota dysbiosis|DDF|target|PD patients|human
32941730|student_B|bacterial taxa|bacteria|located in|groups|animal
32941730|student_B|distinct clustering|DDF|target|groups|animal
32941730|student_B|different microbiota dynamics|DDF|target|treated mice|animal
32941730|student_B|groups|animal|used by|UniFrac|biomedical technique
32733812|student_A|gut microbes|microbiome|is linked to|neurodegenerative disorders|DDF
32733812|student_A|Human Gut-Microbiota|microbiome|is linked to|Neurodegenerative Disorders|DDF
32733812|student_A|gut microbiota|microbiome|is linked to|neurodegenerative disorders|DDF
32733812|student_A|gut microbiota|microbiome|is linked to|neurodegenerative diseases|DDF
32733812|student_A|gut microbiota|microbiome|is linked to|Alzheimer's and Parkinson's diseases|DDF
32733812|student_A|microbial-derived neurochemicals|chemical|influence|neurodegeneration|DDF
32733812|student_A|gut bacteria|bacteria|part of|gut microbes|microbiome
32733812|student_A|gut microbes|microbiome|is linked to|neurodegeneration|DDF
39237483|student_B|Faecalibacterium|bacteria|influence|stress response|DDF
39237483|student_B|Eggerthella|bacteria|part of|Gut microbiota|microbiome
39237483|student_B|Eggerthella|bacteria|influence|reward-seeking|DDF
39237483|student_B|Eggerthella|bacteria|influence|stress response|DDF
39237483|student_B|gut microbiota diversity|microbiome|is linked to|extraversion|DDF
39237483|student_B|gut microbiota diversity|microbiome|is linked to|temperament|DDF
39237483|student_B|anti-inflammatory bacteria|bacteria|part of|Gut microbiota|microbiome
39237483|student_B|Faecalibacterium|bacteria|influence|reward-seeking|DDF
39237483|student_B|gut microbiota diversity|microbiome|is linked to|response initiation|DDF
39237483|student_B|gut microbiota|microbiome|located in|preschool children|human
39237483|student_B|pro-inflammatory bacteria|bacteria|influence|stress response|DDF
39237483|student_B|pro-inflammatory bacteria|bacteria|part of|Gut microbiota|microbiome
39237483|student_B|Flavonifractor|bacteria|influence|stress response|DDF
39237483|student_B|Eggerthella|bacteria|influence|negative emotionality|DDF
39237483|student_B|Flavonifractor|bacteria|influence|reward-seeking|DDF
39237483|student_B|anti-inflammatory bacteria|bacteria|influence|stress response|DDF
39237483|student_B|Eggerthella|bacteria|influence|positive emotionality|DDF
39237483|student_B|Faecalibacterium|bacteria|influence|negative affectivity|DDF
39237483|student_B|Child temperament|DDF|change abundance|Gut microbiota|microbiome
39237483|student_B|Gut Microbiota Composition and Diversity|microbiome|located in|Early Childhood|human
39237483|student_B|Faecalibacterium|bacteria|influence|positive emotionality|DDF
39237483|student_B|pro-inflammatory bacteria|bacteria|influence|reward-seeking|DDF
39237483|student_B|Eggerthella|bacteria|influence|negative affectivity|DDF
39237483|student_B|gut microbiome|microbiome|located in|infancy|human
39237483|student_B|Flavonifractor|bacteria|part of|Gut microbiota|microbiome
39237483|student_B|anti-inflammatory bacteria|bacteria|influence|reward-seeking|DDF
39237483|student_B|pro-inflammatory bacteria|bacteria|influence|positive emotionality|DDF
39237483|student_B|Flavonifractor|bacteria|influence|positive emotionality|DDF
39237483|student_B|Faecalibacterium|bacteria|influence|negative emotionality|DDF
39237483|student_B|temperament|DDF|target|preschool children|human
39237483|student_B|gut microbiota diversity|microbiome|is linked to|psychological/emotional risk|DDF
39237483|student_B|Gut microbiota|microbiome|used by|16S rRNA sequencing|biomedical technique
39237483|student_B|Flavonifractor|bacteria|influence|negative affectivity|DDF
39237483|student_B|pro-inflammatory bacteria|bacteria|influence|negative emotionality|DDF
39237483|student_B|Temperament|DDF|target|Early Childhood|human
39237483|student_B|human fear behavior|DDF|target|infancy|human
39237483|student_B|anti-inflammatory bacteria|bacteria|influence|negative affectivity|DDF
39237483|student_B|Flavonifractor|bacteria|influence|negative emotionality|DDF
39237483|student_B|gut microbiota diversity|microbiome|is linked to|surgency|DDF
39237483|student_B|anti-inflammatory bacteria|bacteria|influence|negative emotionality|DDF
39237483|student_B|gut microbiota diversity|microbiome|is linked to|impulsivity|DDF
39237483|student_B|anti-inflammatory bacteria|bacteria|influence|positive emotionality|DDF
39237483|student_B|pro-inflammatory bacteria|bacteria|influence|negative affectivity|DDF
39237483|student_B|Faecalibacterium|bacteria|part of|Gut microbiota|microbiome
34769091|student_A|microbial gases|chemical|located in|intestine|anatomical location
35411052|student_A|bacterial taxa|bacteria|interact|lipid|chemical
35411052|student_A|serum metabolites|chemical|located in|healthy control subjects|human
35411052|student_A|gut bacterial community composition|microbiome|is linked to|Parkinson's disease|DDF
35411052|student_A|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
35411052|student_A|serum metabolites|chemical|influence|PD|DDF
35411052|student_A|serum metabolite profiles|chemical|influence|PD|DDF
35411052|student_A|energy metabolism|chemical|influence|Parkinson's disease|DDF
35411052|student_A|serum metabolites|chemical|influence|Parkinson's disease|DDF
35411052|student_A|serum metabolites|chemical|located in|HC|human
35411052|student_A|lipid|chemical|influence|Parkinson's disease|DDF
35411052|student_A|gut bacterial community composition|microbiome|is linked to|PD|DDF
35411052|student_A|metabolite features|DDF|change abundance|bacterial taxa|bacteria
35411052|student_A|bacterial taxa|bacteria|interact|energy metabolism|chemical
32733199|student_A|gut microbiota|microbiome|is linked to|microbial dysbiosis|DDF
32733199|student_A|human microbiota|microbiome|is linked to|Neurodegenerative diseases|DDF
32733199|student_A|microbiota|microbiome|is linked to|Alzheimer's|DDF
32733199|student_A|microbiota|microbiome|is linked to|Neurodegenerative Diseases|DDF
32733199|student_A|gut microbiota|microbiome|is linked to|Neurodegenerative diseases|DDF
32733199|student_A|microbiota|microbiome|is linked to|neurological disorders|DDF
32733199|student_A|microbiota|microbiome|is linked to|Parkinson's diseases|DDF
32733199|student_A|microbiota|microbiome|is linked to|microbial dysbiosis|DDF
32733199|student_A|microbiota|microbiome|is linked to|Neurodegenerative diseases|DDF
32733199|student_A|microbiota|microbiome|is linked to|NDDs|DDF
32733199|student_A|human microbiota|microbiome|is linked to|neurological disorders|DDF
32733199|student_A|human microbiota|microbiome|is linked to|Parkinson's diseases|DDF
32733199|student_A|human microbiota|microbiome|is linked to|microbial dysbiosis|DDF
32733199|student_A|human microbiota|microbiome|is linked to|Alzheimer's|DDF
32733199|student_A|human microbiota|microbiome|is linked to|Neurodegenerative Diseases|DDF
32733199|student_A|human microbiota|microbiome|is linked to|NDDs|DDF
32733199|student_A|gut microbiota|microbiome|is linked to|NDDs|DDF
32733199|student_A|gut microbiota|microbiome|is linked to|Alzheimer's|DDF
32733199|student_A|gut microbiota|microbiome|is linked to|Neurodegenerative Diseases|DDF
32733199|student_A|gut microbiota|microbiome|is linked to|neurological disorders|DDF
32733199|student_A|gut microbiota|microbiome|is linked to|Parkinson's diseases|DDF
31576631|student_A|glial pathology|DDF|target|rats|animal
31576631|student_A|Gastrointestinal (GI) symptoms and pathology|DDF|affect|glial pathology|DDF
31576631|student_A|α-synuclein protein|chemical|impact|gut microbiota|microbiome
31576631|student_A|α-synuclein|chemical|impact|gut microbiome|microbiome
31576631|student_A|Gastrointestinal (GI) symptoms and pathology|DDF|target|rats|animal
31576631|student_A|modified gut microbiome composition|DDF|affect|Gastrointestinal (GI) symptoms and pathology|DDF
31576631|student_A|Parkinson's disease|DDF|target|rats|animal
31576631|student_A|PD|DDF|target|rats|animal
31576631|student_A|alterations to gut microbiota composition|DDF|affect|Gastrointestinal (GI) symptoms and pathology|DDF
31576631|student_A|brain|anatomical location|located in|rats|animal
31576631|student_A|constipation|DDF|target|rats|animal
31576631|student_A|alterations to gut microbiota composition|DDF|target|rats|animal
31576631|student_A|α-synuclein|chemical|influence|neuronal loss|DDF
31576631|student_A|α-synuclein|chemical|influence|α-synuclein pathology|DDF
31576631|student_A|Gastrointestinal (GI) symptoms and pathology|DDF|affect|PD|DDF
31576631|student_A|α-synuclein|chemical|located in|brain|anatomical location
31576631|student_A|myenteric plexus|anatomical location|located in|rats|animal
31576631|student_A|rats|animal|used by|bilateral nigral injection of adeno-associated virus (AAV)-α-synuclein|biomedical technique
31576631|student_A|α-synuclein|chemical|influence|nigral α-synuclein pathology|DDF
31576631|student_A|PD pathology|DDF|target|rats|animal
31576631|student_A|neuronal loss|DDF|target|rats|animal
31576631|student_A|gut microbiome|microbiome|located in|rats|animal
31576631|student_A|gut microbiota|microbiome|located in|gut|anatomical location
31576631|student_A|gut|anatomical location|located in|rats|animal
31576631|student_A|α-synuclein protein|chemical|influence|α-synuclein pathology|DDF
31576631|student_A|α-synuclein protein|chemical|impact|gut microbiome|microbiome
31576631|student_A|modified gut microbiome composition|DDF|target|rats|animal
31576631|student_A|nigral α-synuclein pathology|DDF|target|rats|animal
31576631|student_A|α-synuclein protein|chemical|influence|nigral α-synuclein pathology|DDF
31576631|student_A|α-synuclein|chemical|impact|gut microbiota|microbiome
31576631|student_A|gut microbiome|microbiome|located in|gut|anatomical location
31576631|student_A|increased enteric glial expression|DDF|affect|Gastrointestinal (GI) symptoms and pathology|DDF
31576631|student_A|increased enteric glial expression|DDF|target|rats|animal
31576631|student_A|α-synuclein protein|chemical|influence|neuronal loss|DDF
31576631|student_A|α-synuclein protein|chemical|located in|brain|anatomical location
31576631|student_A|α-synuclein pathology|DDF|target|rats|animal
31576631|student_A|ileal submucosal plexus|anatomical location|located in|rats|animal
33327916|student_B|probiotics|dietary supplement|impact|gut microbiota|microbiome
33327916|student_B|probiotics|dietary supplement|influence|depression|DDF
33327916|student_B|gut microbiota|microbiome|is linked to|depression|DDF
33327916|student_B|gut microbiota|microbiome|located in|brain|anatomical location
33327916|student_B|prebiotics|dietary supplement|impact|gut microbiota|microbiome
33643026|student_A|PD|DDF|change abundance|Prevotellaceae|bacteria
33643026|student_A|SCFAs|chemical|produced by|Gut Microbiota|microbiome
33643026|student_A|Parkinson's Disease|DDF|target|Patients|human
33643026|student_A|Gut Microbiota|microbiome|is linked to|Parkinson's Disease|DDF
33643026|student_A|PD|DDF|change abundance|Bifidobacteriaceae|bacteria
33643026|student_A|Parkinson's Disease|DDF|change abundance|Bifidobacteriaceae|bacteria
33643026|student_A|Parkinson's Disease|DDF|target|patients|human
33643026|student_A|short-chain fatty acids|chemical|produced by|gut microbiota|microbiome
33643026|student_A|impairment|DDF|interact|SCFAs|chemical
33643026|student_A|SCFAs|chemical|produced by|gut microbiota|microbiome
33643026|student_A|Parkinson's Disease|DDF|change abundance|Faecalibacterium|bacteria
33643026|student_A|Parkinson's disease|DDF|target|Patients|human
33643026|student_A|Parkinson's disease|DDF|change abundance|Lachnospiraceae|bacteria
33643026|student_A|Parkinson's disease|DDF|change abundance|Christensenellaceae|bacteria
33643026|student_A|Gut Microbiota|microbiome|is linked to|PD-related gut microbiota dysbiosis|DDF
33643026|student_A|gut microbiota|microbiome|located in|Patients|human
33643026|student_A|Parkinson's disease|DDF|target|patients|human
33643026|student_A|PD|DDF|target|Patients|human
33643026|student_A|gastrointestinal symptoms|DDF|target|Patients|human
33643026|student_A|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
33643026|student_A|Parkinson's disease|DDF|change abundance|Ruminococcaceae|bacteria
33643026|student_A|Gut Microbiota|microbiome|is linked to|PD-related alterations|DDF
33643026|student_A|Gut Microbiota|microbiome|is linked to|PD|DDF
33643026|student_A|Parkinson's Disease|DDF|change abundance|Prevotellaceae|bacteria
33643026|student_A|gut microbiota|microbiome|located in|patients|human
33643026|student_A|Gut Microbiota|microbiome|located in|patients|human
33643026|student_A|Parkinson's disease|DDF|change abundance|Verrucomicrobiaceae|bacteria
33643026|student_A|PD-related gut microbiota dysbiosis|DDF|affect|impairment|DDF
33643026|student_A|Gut Microbiota|microbiome|located in|Patients|human
33643026|student_A|PD|DDF|target|patients|human
33643026|student_A|gastrointestinal symptoms|DDF|target|patients|human
33643026|student_A|PD|DDF|change abundance|Lachnospiraceae|bacteria
33643026|student_A|PD|DDF|change abundance|Ruminococcaceae|bacteria
33643026|student_A|PD|DDF|change abundance|Verrucomicrobiaceae|bacteria
33643026|student_A|Gut Microbiota|microbiome|located in|HCs|human
33643026|student_A|Gut Microbiota|microbiome|located in|healthy controls|human
33643026|student_A|PD-related alterations|DDF|target|patients|human
33643026|student_A|PD|DDF|change abundance|Christensenellaceae|bacteria
33643026|student_A|gut microbiota|microbiome|located in|healthy controls|human
33643026|student_A|gut microbiota|microbiome|located in|HCs|human
33643026|student_A|PD-related alterations|DDF|target|Patients|human
33643026|student_A|gut microbiota|microbiome|is linked to|Parkinson's Disease|DDF
33643026|student_A|Parkinson's disease|DDF|change abundance|Bifidobacteriaceae|bacteria
33643026|student_A|gut microbiota|microbiome|is linked to|PD-related gut microbiota dysbiosis|DDF
33643026|student_A|Parkinson's disease|DDF|change abundance|Faecalibacterium|bacteria
33643026|student_A|Parkinson's Disease|DDF|change abundance|Lachnospiraceae|bacteria
33643026|student_A|motor symptoms|DDF|target|Patients|human
33643026|student_A|impairment|DDF|interact|short-chain fatty acids|chemical
33643026|student_A|PD|DDF|change abundance|Faecalibacterium|bacteria
33643026|student_A|Gut Microbiota|microbiome|is linked to|Parkinson's disease|DDF
33643026|student_A|Parkinson's Disease|DDF|change abundance|Christensenellaceae|bacteria
33643026|student_A|motor symptoms|DDF|target|patients|human
33643026|student_A|short-chain fatty acids|chemical|produced by|Gut Microbiota|microbiome
33643026|student_A|Parkinson's Disease|DDF|change abundance|Ruminococcaceae|bacteria
33643026|student_A|gut microbiota|microbiome|is linked to|PD-related alterations|DDF
33643026|student_A|gut microbiota|microbiome|is linked to|PD|DDF
33643026|student_A|Parkinson's disease|DDF|change abundance|Prevotellaceae|bacteria
33643026|student_A|Parkinson's Disease|DDF|change abundance|Verrucomicrobiaceae|bacteria
33070123|student_A|gut microbiome|microbiome|is linked to|neurologic disorders|DDF
33070123|student_A|KD|food|influence|depression|DDF
33070123|student_A|ketogenic diet|food|influence|ASDs|DDF
33070123|student_A|KD|food|influence|AD|DDF
33070123|student_A|gut microbiota|microbiome|is linked to|Alzheimer's disease|DDF
33070123|student_A|stress|DDF|change abundance|gut microbiome|microbiome
33070123|student_A|probiotics|dietary supplement|influence|neurologic disorders|DDF
33070123|student_A|stress|DDF|change abundance|gut microbes|microbiome
33070123|student_A|gut microbiome|microbiome|is linked to|anxiety|DDF
33070123|student_A|adequate protein|dietary supplement|influence|MS|DDF
33070123|student_A|gut microbes|microbiome|is linked to|multiple sclerosis|DDF
33070123|student_A|KD|food|influence|ALS|DDF
33070123|student_A|probiotics|dietary supplement|influence|AD|DDF
33070123|student_A|KD|food|influence|CNS disorders|DDF
33070123|student_A|ketogenic diet|food|influence|anxiety|DDF
33070123|student_A|gut microbes|microbiome|is linked to|MS|DDF
33070123|student_A|ketogenic diet|food|impact|Gut microbes|microbiome
33070123|student_A|low carbohydrate|dietary supplement|influence|autism spectrum disorders|DDF
33070123|student_A|microbes|chemical|influence|MS|DDF
33070123|student_A|Gut microbes|microbiome|is linked to|epilepsy|DDF
33070123|student_A|Gut microbes|microbiome|is linked to|amyotrophic lateral sclerosis|DDF
33070123|student_A|adequate protein|dietary supplement|influence|PD|DDF
33070123|student_A|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
33070123|student_A|microbiota|microbiome|is linked to|PD|DDF
33070123|student_A|probiotics|dietary supplement|influence|CNS disorders|DDF
33070123|student_A|stress|DDF|change abundance|gut microbiota|microbiome
33070123|student_A|low carbohydrate|dietary supplement|impact|Gut microbes|microbiome
33070123|student_A|microbiota|microbiome|is linked to|neurological diseases|DDF
33070123|student_A|gut microbiota|microbiome|is linked to|ALS|DDF
33070123|student_A|adequate protein|dietary supplement|influence|neurologic disorders|DDF
33070123|student_A|gut microbes|microbiome|is linked to|ASDs|DDF
33070123|student_A|gut microbes|microbiome|is linked to|epilepsy|DDF
33070123|student_A|gut microbes|microbiome|is linked to|amyotrophic lateral sclerosis|DDF
33070123|student_A|Gut microbes|microbiome|is linked to|ASDs|DDF
33070123|student_A|gut microbes|microbiome|is linked to|stress|DDF
33070123|student_A|KD|food|influence|PD|DDF
33070123|student_A|gut microbiome|microbiome|is linked to|multiple sclerosis|DDF
33070123|student_A|adequate protein|dietary supplement|influence|anxiety|DDF
33070123|student_A|microbes|chemical|influence|neurologic disorders|DDF
33070123|student_A|microbiota|microbiome|is linked to|neurologic disorders|DDF
33070123|student_A|microbes|chemical|influence|stress|DDF
33070123|student_A|Gut microbes|microbiome|is linked to|central nervous system (CNS) disorders|DDF
33070123|student_A|Gut microbes|microbiome|is linked to|autism spectrum disorders|DDF
33070123|student_A|adequate protein|dietary supplement|influence|central nervous system (CNS) disorders|DDF
33070123|student_A|ketogenic diet|food|impact|gut microbiota|microbiome
33070123|student_A|microbiota|microbiome|is linked to|depression|DDF
33070123|student_A|microbiota|microbiome|is linked to|AD|DDF
33070123|student_A|gut microbiota|microbiome|is linked to|PD|DDF
33070123|student_A|low carbohydrate|dietary supplement|impact|gut microbiota|microbiome
33070123|student_A|gut microbiota|microbiome|is linked to|neurological diseases|DDF
33070123|student_A|gut microbiome|microbiome|is linked to|epilepsy|DDF
33070123|student_A|ketogenic diet|food|influence|Parkinson's disease|DDF
33070123|student_A|microbiota|microbiome|is linked to|CNS disorders|DDF
33070123|student_A|gut microbiome|microbiome|is linked to|amyotrophic lateral sclerosis|DDF
33070123|student_A|microbes|chemical|influence|central nervous system (CNS) disorders|DDF
33070123|student_A|gut microbiome|microbiome|is linked to|stress|DDF
33070123|student_A|probiotics|dietary supplement|influence|amyotrophic lateral sclerosis|DDF
33070123|student_A|adequate protein|dietary supplement|influence|multiple sclerosis|DDF
33070123|student_A|ketogenic diet|food|influence|depression|DDF
33070123|student_A|ketogenic diet|food|influence|AD|DDF
33070123|student_A|low carbohydrate|dietary supplement|influence|Parkinson's disease|DDF
33070123|student_A|Gut microbes|microbiome|is linked to|MS|DDF
33070123|student_A|gut microbes|microbiome|is linked to|Alzheimer's disease|DDF
33070123|student_A|probiotics|dietary supplement|influence|stress|DDF
33070123|student_A|Gut microbes|microbiome|is linked to|Alzheimer's disease|DDF
33070123|student_A|gut microbiota|microbiome|is linked to|neurologic disorders|DDF
33070123|student_A|low carbohydrate|dietary supplement|influence|depression|DDF
33070123|student_A|microbes|chemical|influence|multiple sclerosis|DDF
33070123|student_A|gut microbiota|microbiome|is linked to|central nervous system (CNS) disorders|DDF
33070123|student_A|ketogenic diet|food|impact|gut microbiome|microbiome
33070123|student_A|probiotics|dietary supplement|influence|anxiety|DDF
33070123|student_A|gut microbiota|microbiome|is linked to|depression|DDF
33070123|student_A|KD|food|influence|multiple sclerosis|DDF
33070123|student_A|ketogenic diet|food|impact|gut microbes|microbiome
33070123|student_A|gut microbiota|microbiome|is linked to|AD|DDF
33070123|student_A|gut microbiota|microbiome|is linked to|anxiety|DDF
33070123|student_A|gut microbiome|microbiome|is linked to|central nervous system (CNS) disorders|DDF
33070123|student_A|antibiotic therapy|drug|impact|gut microbiome|microbiome
33070123|student_A|antibiotic therapy|drug|impact|Gut microbes|microbiome
33070123|student_A|low carbohydrate|dietary supplement|impact|gut microbiome|microbiome
33070123|student_A|adequate protein|dietary supplement|impact|microbiota|microbiome
33070123|student_A|antibiotic therapy|drug|impact|gut microbes|microbiome
33070123|student_A|adequate protein|dietary supplement|influence|ASDs|DDF
33070123|student_A|low carbohydrate|dietary supplement|impact|gut microbes|microbiome
33070123|student_A|adequate protein|dietary supplement|influence|epilepsy|DDF
33070123|student_A|adequate protein|dietary supplement|influence|amyotrophic lateral sclerosis|DDF
33070123|student_A|probiotics|dietary supplement|influence|multiple sclerosis|DDF
33070123|student_A|gut microbiota|microbiome|is linked to|CNS disorders|DDF
33070123|student_A|adequate protein|dietary supplement|influence|stress|DDF
33070123|student_A|Gut microbes|microbiome|is linked to|Parkinson's disease|DDF
33070123|student_A|ketogenic diet|food|influence|neurological diseases|DDF
33070123|student_A|KD|food|impact|microbiota|microbiome
33070123|student_A|ketogenic diet|food|influence|Alzheimer's disease|DDF
33070123|student_A|microbes|chemical|influence|epilepsy|DDF
33070123|student_A|microbes|chemical|influence|amyotrophic lateral sclerosis|DDF
33070123|student_A|gut microbiota|microbiome|is linked to|MS|DDF
33070123|student_A|ketogenic diet|food|influence|PD|DDF
33070123|student_A|microbes|chemical|influence|ASDs|DDF
33070123|student_A|low carbohydrate|dietary supplement|influence|neurological diseases|DDF
33070123|student_A|KD|food|influence|amyotrophic lateral sclerosis|DDF
33070123|student_A|microbiota|microbiome|is linked to|stress|DDF
33070123|student_A|KD|food|influence|neurologic disorders|DDF
33070123|student_A|gut microbes|microbiome|is linked to|autism spectrum disorders|DDF
33070123|student_A|KD|food|influence|stress|DDF
33070123|student_A|gut microbes|microbiome|is linked to|CNS disorders|DDF
33070123|student_A|low carbohydrate|dietary supplement|influence|PD|DDF
33070123|student_A|probiotics|dietary supplement|influence|MS|DDF
33070123|student_A|gut microbiome|microbiome|is linked to|Alzheimer's disease|DDF
33070123|student_A|microbes|chemical|influence|autism spectrum disorders|DDF
33070123|student_A|microbes|chemical|influence|anxiety|DDF
33070123|student_A|antibiotic therapy|drug|impact|microbiota|microbiome
33070123|student_A|low carbohydrate|dietary supplement|influence|neurologic disorders|DDF
33070123|student_A|adequate protein|dietary supplement|impact|Gut microbes|microbiome
33070123|student_A|gut microbiome|microbiome|is linked to|ASDs|DDF
33070123|student_A|adequate protein|dietary supplement|influence|Alzheimer's disease|DDF
33070123|student_A|low carbohydrate|dietary supplement|influence|anxiety|DDF
33070123|student_A|KD|food|influence|central nervous system (CNS) disorders|DDF
33070123|student_A|microbiota|microbiome|is linked to|multiple sclerosis|DDF
33070123|student_A|ketogenic diet|food|influence|CNS disorders|DDF
33070123|student_A|Gut microbes|microbiome|is linked to|neurological diseases|DDF
33070123|student_A|probiotics|dietary supplement|influence|ASDs|DDF
33070123|student_A|gut microbiota|microbiome|is linked to|ASDs|DDF
33070123|student_A|gut microbes|microbiome|is linked to|PD|DDF
33070123|student_A|low carbohydrate|dietary supplement|influence|central nervous system (CNS) disorders|DDF
33070123|student_A|gut microbiome|microbiome|is linked to|autism spectrum disorders|DDF
33070123|student_A|low carbohydrate|dietary supplement|influence|ALS|DDF
33070123|student_A|gut microbiota|microbiome|is linked to|stress|DDF
33070123|student_A|low carbohydrate|dietary supplement|influence|CNS disorders|DDF
33070123|student_A|microbiota|microbiome|is linked to|MS|DDF
33070123|student_A|probiotics|dietary supplement|influence|central nervous system (CNS) disorders|DDF
33070123|student_A|probiotics|dietary supplement|influence|autism spectrum disorders|DDF
33070123|student_A|ketogenic diet|food|influence|autism spectrum disorders|DDF
33070123|student_A|gut microbes|microbiome|is linked to|neurological diseases|DDF
33070123|student_A|stress|DDF|change abundance|microbiota|microbiome
33070123|student_A|Gut microbes|microbiome|is linked to|neurologic disorders|DDF
33070123|student_A|microbes|chemical|influence|neurological diseases|DDF
33070123|student_A|KD|food|influence|MS|DDF
33070123|student_A|microbiota|microbiome|is linked to|epilepsy|DDF
33070123|student_A|Gut microbes|microbiome|is linked to|AD|DDF
33070123|student_A|Gut microbes|microbiome|is linked to|depression|DDF
33070123|student_A|microbiota|microbiome|is linked to|amyotrophic lateral sclerosis|DDF
33070123|student_A|gut microbes|microbiome|is linked to|Parkinson's disease|DDF
33070123|student_A|low carbohydrate|dietary supplement|influence|MS|DDF
33070123|student_A|gut microbiota|microbiome|is linked to|multiple sclerosis|DDF
33070123|student_A|Gut microbes|microbiome|is linked to|ALS|DDF
33070123|student_A|gut microbes|microbiome|is linked to|ALS|DDF
33070123|student_A|Gut microbes|microbiome|is linked to|CNS disorders|DDF
33070123|student_A|gut microbes|microbiome|is linked to|depression|DDF
33070123|student_A|gut microbes|microbiome|is linked to|AD|DDF
33070123|student_A|microbes|chemical|influence|Parkinson's disease|DDF
33070123|student_A|adequate protein|dietary supplement|influence|autism spectrum disorders|DDF
33070123|student_A|KD|food|influence|epilepsy|DDF
33070123|student_A|ketogenic diet|food|impact|microbiota|microbiome
33070123|student_A|microbiota|microbiome|is linked to|anxiety|DDF
33070123|student_A|microbiota|microbiome|is linked to|ASDs|DDF
33070123|student_A|probiotics|dietary supplement|influence|Alzheimer's disease|DDF
33070123|student_A|KD|food|influence|ASDs|DDF
33070123|student_A|gut microbiome|microbiome|is linked to|neurological diseases|DDF
33070123|student_A|microbes|chemical|influence|depression|DDF
33070123|student_A|microbes|chemical|influence|AD|DDF
33070123|student_A|ketogenic diet|food|influence|amyotrophic lateral sclerosis|DDF
33070123|student_A|ketogenic diet|food|influence|neurologic disorders|DDF
33070123|student_A|ketogenic diet|food|influence|stress|DDF
33070123|student_A|microbiota|microbiome|is linked to|central nervous system (CNS) disorders|DDF
33070123|student_A|stress|DDF|change abundance|Gut microbes|microbiome
33070123|student_A|microbiota|microbiome|is linked to|autism spectrum disorders|DDF
33070123|student_A|low carbohydrate|dietary supplement|influence|ASDs|DDF
33070123|student_A|KD|food|influence|autism spectrum disorders|DDF
33070123|student_A|low carbohydrate|dietary supplement|influence|amyotrophic lateral sclerosis|DDF
33070123|student_A|KD|food|influence|anxiety|DDF
33070123|student_A|microbes|chemical|influence|CNS disorders|DDF
33070123|student_A|adequate protein|dietary supplement|impact|gut microbiome|microbiome
33070123|student_A|low carbohydrate|dietary supplement|influence|stress|DDF
33070123|student_A|gut microbiota|microbiome|is linked to|epilepsy|DDF
33070123|student_A|antibiotic therapy|drug|impact|gut microbiota|microbiome
33070123|student_A|adequate protein|dietary supplement|impact|gut microbes|microbiome
33070123|student_A|gut microbiota|microbiome|is linked to|amyotrophic lateral sclerosis|DDF
33070123|student_A|gut microbiome|microbiome|is linked to|Parkinson's disease|DDF
33070123|student_A|Gut microbes|microbiome|is linked to|PD|DDF
33070123|student_A|probiotics|dietary supplement|influence|Parkinson's disease|DDF
33070123|student_A|gut microbiome|microbiome|is linked to|depression|DDF
33070123|student_A|gut microbiome|microbiome|is linked to|AD|DDF
33070123|student_A|ketogenic diet|food|influence|central nervous system (CNS) disorders|DDF
33070123|student_A|probiotics|dietary supplement|influence|ALS|DDF
33070123|student_A|ketogenic diet|food|influence|ALS|DDF
33070123|student_A|probiotics|dietary supplement|influence|depression|DDF
33070123|student_A|KD|food|impact|gut microbiome|microbiome
33070123|student_A|KD|food|impact|Gut microbes|microbiome
33070123|student_A|ketogenic diet|food|influence|multiple sclerosis|DDF
33070123|student_A|KD|food|impact|gut microbes|microbiome
33070123|student_A|adequate protein|dietary supplement|influence|neurological diseases|DDF
33070123|student_A|gut microbiome|microbiome|is linked to|ALS|DDF
33070123|student_A|adequate protein|dietary supplement|impact|gut microbiota|microbiome
33070123|student_A|gut microbiome|microbiome|is linked to|CNS disorders|DDF
33070123|student_A|microbes|chemical|influence|Alzheimer's disease|DDF
33070123|student_A|microbiota|microbiome|is linked to|Alzheimer's disease|DDF
33070123|student_A|microbes|chemical|influence|PD|DDF
33070123|student_A|low carbohydrate|dietary supplement|influence|multiple sclerosis|DDF
33070123|student_A|gut microbes|microbiome|is linked to|neurologic disorders|DDF
33070123|student_A|Gut microbes|microbiome|is linked to|stress|DDF
33070123|student_A|gut microbiota|microbiome|is linked to|autism spectrum disorders|DDF
33070123|student_A|gut microbiome|microbiome|is linked to|MS|DDF
33070123|student_A|KD|food|influence|neurological diseases|DDF
33070123|student_A|low carbohydrate|dietary supplement|influence|Alzheimer's disease|DDF
33070123|student_A|adequate protein|dietary supplement|influence|Parkinson's disease|DDF
33070123|student_A|gut microbes|microbiome|is linked to|anxiety|DDF
33070123|student_A|KD|food|impact|gut microbiota|microbiome
33070123|student_A|ketogenic diet|food|influence|MS|DDF
33070123|student_A|KD|food|influence|Alzheimer's disease|DDF
33070123|student_A|Gut microbes|microbiome|is linked to|anxiety|DDF
33070123|student_A|adequate protein|dietary supplement|influence|ALS|DDF
33070123|student_A|adequate protein|dietary supplement|influence|depression|DDF
33070123|student_A|adequate protein|dietary supplement|influence|AD|DDF
33070123|student_A|gut microbes|microbiome|is linked to|central nervous system (CNS) disorders|DDF
33070123|student_A|probiotics|dietary supplement|influence|neurological diseases|DDF
33070123|student_A|low carbohydrate|dietary supplement|impact|microbiota|microbiome
33070123|student_A|microbiota|microbiome|is linked to|Parkinson's disease|DDF
33070123|student_A|gut microbiome|microbiome|is linked to|PD|DDF
33070123|student_A|KD|food|influence|Parkinson's disease|DDF
33070123|student_A|low carbohydrate|dietary supplement|influence|epilepsy|DDF
33070123|student_A|microbes|chemical|influence|ALS|DDF
33070123|student_A|probiotics|dietary supplement|influence|PD|DDF
33070123|student_A|microbiota|microbiome|is linked to|ALS|DDF
33070123|student_A|Gut microbes|microbiome|is linked to|multiple sclerosis|DDF
33070123|student_A|ketogenic diet|food|influence|epilepsy|DDF
33070123|student_A|adequate protein|dietary supplement|influence|CNS disorders|DDF
35931717|student_A|Ruminococcus|bacteria|influence|ET|DDF
35931717|student_A|gut microbiota alterations|DDF|affect|essential tremor|DDF
35931717|student_A|Aeromonas|bacteria|influence|ET|DDF
35931717|student_A|Klebsiella|bacteria|influence|depression|DDF
35931717|student_A|depression|DDF|affect|ET|DDF
35931717|student_A|gut dysbiosis|DDF|affect|ET|DDF
35931717|student_A|gastrointestinal disorders|DDF|affect|ET|DDF
35931717|student_A|Proteus|bacteria|influence|ET|DDF
35931717|student_A|Klebsiella|bacteria|influence|ET|DDF
35931717|student_A|Phascolarctobacterium|bacteria|influence|ET|DDF
35931717|student_A|Fusobacterium|bacteria|influence|ET|DDF
35931717|student_A|Ruminococcus-dominant enterotype|microbiome|is linked to|PD|DDF
35931717|student_A|Romboutsia|bacteria|influence|ET|DDF
35931717|student_A|gut microbiota|microbiome|is linked to|ET|DDF
35931717|student_A|Mucispirillum|bacteria|influence|ET|DDF
35931717|student_A|Lachnospira|bacteria|influence|ET|DDF
35931717|student_A|Bacteroides|bacteria|influence|ET|DDF
35931717|student_A|anxiety|DDF|affect|ET|DDF
35931717|student_A|Bacteroides-dominant enterotype|microbiome|is linked to|ET|DDF
35931717|student_A|Klebsiella|bacteria|influence|anxiety|DDF
35052575|student_A|environmental heavy metals|chemical|impact|host-associated microbiome|microbiome
35052575|student_A|metals|chemical|impact|microbiota|microbiome
35730414|student_A|dopaminergic neuron degeneration|DDF|affect|classic motor symptoms|DDF
35730414|student_A|microbiota|microbiome|is linked to|PD incidence and progression|DDF
35730414|student_A|dairy products|food|influence|PD incidence and progression|DDF
35730414|student_A|polyphenols|dietary supplement|influence|PD|DDF
35730414|student_A|coffee|food|influence|PD incidence and progression|DDF
35730414|student_A|alcohol intake|food|influence|PD incidence and progression|DDF
35730414|student_A|polyunsaturated fatty acids|dietary supplement|influence|PD|DDF
35730414|student_A|Parkinson's disease|DDF|target|elderly patients|human
35730414|student_A|PD|DDF|target|elderly patients|human
35730414|student_A|polyphenols|dietary supplement|influence|PD incidence and progression|DDF
35730414|student_A|coffee intake|food|influence|PD|DDF
35730414|student_A|vitamins|dietary supplement|influence|PD incidence and progression|DDF
35730414|student_A|dopaminergic neuron degeneration|DDF|affect|Oxidative stress|DDF
35730414|student_A|PD|DDF|change abundance|gut microbiota|microbiome
35730414|student_A|neurodegenerative disease|DDF|target|elderly patients|human
35730414|student_A|PD|DDF|affect|dopaminergic neuron degeneration|DDF
36613586|student_B|probiotics|bacteria|influence|central nervous system diseases|DDF
36613586|student_B|Lactobacillus|bacteria|influence|multiple sclerosis|DDF
36613586|student_B|Lactobacillus|bacteria|influence|Parkinson's disease|DDF
36613586|student_B|probiotics-based products|dietary supplement|influence|central nervous system diseases|DDF
36613586|student_B|Lactobacillus|bacteria|influence|neurological disorders|DDF
36613586|student_B|Probiotics|bacteria|part of|gut microbiota|microbiome
36613586|student_B|gut microbiota|microbiome|located in|gut|anatomical location
36613586|student_B|Lactobacillus|bacteria|influence|Alzheimer's|DDF
36613586|student_B|Lactobacillus|bacteria|influence|depression|DDF
38914414|student_A|Psychobiotics|dietary supplement|influence|anorexia nervosa|DDF
38914414|student_A|Psychobiotics|dietary supplement|influence|Huntington's disease|DDF
38914414|student_A|Psychobiotics|dietary supplement|influence|attention deficit hyperactivity disorder|DDF
38914414|student_A|Psychobiotics|dietary supplement|influence|multiple sclerosis|DDF
38914414|student_A|Psychobiotics|dietary supplement|influence|mental health|DDF
38914414|student_A|Psychobiotics|dietary supplement|influence|anxiety|DDF
38914414|student_A|Psychobiotics|dietary supplement|influence|Parkinson's disease|DDF
38914414|student_A|Psychobiotics|dietary supplement|influence|Alzheimer's disease|DDF
38914414|student_A|Psychobiotics|dietary supplement|influence|schizophrenia|DDF
38914414|student_A|gut microbiota|microbiome|is linked to|neurological|DDF
38914414|student_A|gut microbiota|microbiome|is linked to|neurodegenerative disorders|DDF
38914414|student_A|Psychobiotics|dietary supplement|influence|neurodegenerative and neurodevelopmental disorders|DDF
38914414|student_A|Psychobiotics|dietary supplement|influence|depression|DDF
38914414|student_A|Psychobiotics|dietary supplement|influence|autism|DDF
35362965|student_A|gut|anatomical location|located in|host|human
35362965|student_A|L. lactis|bacteria|influence|Parkinson's disease|DDF
35362965|student_A|L. lactis|bacteria|influence|anxiety behavior|DDF
32557853|student_A|α-synuclein fibrils|chemical|influence|gut dysbiosis|DDF
32557853|student_A|PD|DDF|change abundance|decreased genera Roseburia and Faecalibacterium|bacteria
32557853|student_A|gut microbiota|microbiome|located in|controls|human
32557853|student_A|patients|human|used by|16S ribosomal RNA gene sequencing analysis|biomedical technique
32557853|student_A|α-synuclein fibrils|chemical|influence|PD|DDF
32557853|student_A|PD|DDF|change abundance|genera Akkermansia and Catabacter|bacteria
32557853|student_A|gut microbiota|microbiome|is linked to|shared gut dysbiosis|DDF
32557853|student_A|PD|DDF|change abundance|short-chain fatty acid-producing Roseburia and Faecalibacterium|bacteria
32557853|student_A|PD|DDF|change abundance|increased genus Akkermansia|bacteria
32557853|student_A|PD|DDF|change abundance|intestinal mucin layer-degrading Akkermansia|bacteria
32557853|student_A|PD|DDF|change abundance|genera Roseburia, Faecalibacterium, and Lachnospiraceae ND3007 group|bacteria
32557853|student_A|gut microbiota|microbiome|located in|patients|human
32557853|student_A|PD|DDF|change abundance|family Lactobacillaceae|bacteria
32557853|student_A|PD|DDF|change abundance|families Akkermansiaceae|bacteria
32557853|student_A|PD|DDF|target|patients|human
32557853|student_A|gut microbiota|microbiome|used by|16S ribosomal RNA gene sequencing analysis|biomedical technique
35666299|student_B|lipopolysaccharide|chemical|change expression|Iba1|gene
35666299|student_B|gut microbiota|microbiome|is linked to|microglial activation|DDF
35666299|student_B|LPS|chemical|change expression|ionized calcium-binding adapter molecule 1|gene
35666299|student_B|lipopolysaccharide|chemical|change expression|ionized calcium-binding adapter molecule 1|gene
35666299|student_B|WIN55,212-2|chemical|impact|gut microbiota|microbiome
35666299|student_B|WIN55,212-2|chemical|influence|psychosis|DDF
35666299|student_B|cannabis|chemical|influence|psychosis|DDF
35666299|student_B|mPFC|anatomical location|located in|adult mice|animal
35666299|student_B|microbiota|microbiome|located in|NAc|anatomical location
35666299|student_B|medial prefrontal cortex|anatomical location|located in|adult mice|animal
35666299|student_B|gut microbiota|microbiome|is linked to|pathogenesis|DDF
35666299|student_B|gut microbiota|microbiome|is linked to|psychiatric disorders|DDF
35666299|student_B|microbes|bacteria|part of|gut microbiota|microbiome
35666299|student_B|nucleus accumbens|anatomical location|located in|adult mice|animal
35666299|student_B|WIN55,212-2|chemical|change expression|Iba1|gene
35666299|student_B|psychosis|DDF|target|adult|human
35666299|student_B|WIN55,212-2|chemical|change expression|ionized calcium-binding adapter molecule 1|gene
35666299|student_B|NAc|anatomical location|located in|adult mice|animal
35666299|student_B|psychosis|DDF|target|adults|human
35666299|student_B|LPS|chemical|change expression|Iba1|gene
35666299|student_B|gut microbiota|microbiome|is linked to|psychosis|DDF
35666299|student_B|microbiota|microbiome|located in|mPFC|anatomical location
38868440|student_A|obesity|DDF|target|SZ patients|human
38868440|student_A|Schizophrenia|DDF|affect|death|DDF
39247907|student_A|Sleep deprivation|DDF|change abundance|gut microbiota|microbiome
39247907|student_A|SD|DDF|change abundance|mammalian gut microbiota|microbiome
39247907|student_A|chronic SD|DDF|change abundance|gut microbiome|microbiome
39247907|student_A|chronic SD|DDF|change abundance|p_Firmicutes|bacteria
39247907|student_A|mental disorders|DDF|change abundance|gut microbiota|microbiome
39247907|student_A|SD|DDF|target|rats|animal
39247907|student_A|chronic SD|DDF|change abundance|p_Bacteroidetes|bacteria
39247907|student_A|chronic SD|DDF|change abundance|g_Akkermansia|bacteria
39247907|student_A|Sleep deprivation|DDF|change abundance|mammalian gut microbiota|microbiome
39247907|student_A|SD|DDF|change abundance|Bacteroidetes|bacteria
39247907|student_A|SD|DDF|target|SD groups|animal
39247907|student_A|Chronic Sleep Deprivation|DDF|change abundance|Gut Microbiota|microbiome
39247907|student_A|chronic SD|DDF|change abundance|p_Verrucomicrobia|bacteria
39247907|student_A|pre-SD|DDF|target|rats|animal
39247907|student_A|gut microbiota|microbiome|is linked to|SD|DDF
39247907|student_A|mental health|DDF|change abundance|mammalian gut microbiota|microbiome
39247907|student_A|chronic SD|DDF|change abundance|g_Cetobacterium|bacteria
39247907|student_A|SD|DDF|change abundance|Firmicutes|bacteria
39247907|student_A|Mental Disorders|DDF|target|Rats|animal
39247907|student_A|gut microbiota|microbiome|located in|rats|animal
39247907|student_A|Chronic Sleep Deprivation|DDF|target|Rats|animal
39247907|student_A|Gut Microbiota|microbiome|located in|Rats|animal
39247907|student_A|gut microbiota|microbiome|is linked to|mental health|DDF
39247907|student_A|chronic SD|DDF|change abundance|g_Romboutsia|bacteria
39247907|student_A|SD|DDF|target|Male specific-pathogen-free Wistar rats|animal
39247907|student_A|SD|DDF|change abundance|gut microbiota|microbiome
39247907|student_A|chronic SD|DDF|change abundance|p_Fusobacteria|bacteria
39247907|student_A|Mental Disorders|DDF|change abundance|Gut Microbiota|microbiome
39247907|student_A|chronic SD|DDF|target|rats|animal
39247907|student_A|chronic SD|DDF|change abundance|g_Enterococcus|bacteria
36289839|student_B|neurological and psychiatric disorders|DDF|target|patients|human
36289839|student_B|intestinal microbiota|microbiome|located in|host|human
36289839|student_B|intestinal microbiota|microbiome|is linked to|neurological and psychiatric disorders|DDF
36289839|student_B|intestinal microbiota|microbiome|located in|intestine|anatomical location
36289839|student_B|intestine|anatomical location|located in|host|human
36289839|student_B|microbial metabolites|chemical|produced by|luminal microorganisms|microbiome
38975363|student_A|Actinobacteria phylum|bacteria|influence|anhedonia|DDF
38975363|student_A|GM|microbiome|is linked to|depression|DDF
38975363|student_A|gut microbiota|microbiome|is linked to|depressive symptoms|DDF
38975363|student_A|gut microbiota|microbiome|is linked to|depression|DDF
38975363|student_A|Actinobacteria phylum|bacteria|influence|appetite changes|DDF
38975363|student_A|Bifidobacteriaceae|bacteria|influence|suicidality|DDF
38975363|student_A|Actinobacteria|bacteria|influence|depression|DDF
38975363|student_A|Bifidobacterium|bacteria|influence|depression|DDF
38975363|student_A|Actinobacteria phylum|bacteria|influence|suicidality|DDF
38975363|student_A|Bifidobacterium|bacteria|influence|depressed mood|DDF
38975363|student_A|Actinobacteria|bacteria|influence|obesity|DDF
38975363|student_A|GM|microbiome|is linked to|depressive symptoms|DDF
38975363|student_A|Bifidobacterium|bacteria|influence|obesity|DDF
38975363|student_A|Actinobacteria phylum|bacteria|influence|depressed mood|DDF
38975363|student_A|Bifidobacterium|bacteria|influence|anhedonia|DDF
39375584|student_A|Animal and plant protein|food|impact|gut microbiota|microbiome
39375584|student_A|plant protein|food|impact|Firmicutes|bacteria
39375584|student_A|gut microbiota|microbiome|used by|qPCR|biomedical technique
39375584|student_A|higher animal protein|food|influence|psychological stress|DDF
39375584|student_A|gut microbiota|microbiome|used by|ELISA|biomedical technique
39375584|student_A|gut microbiota|microbiome|located in|healthy females aged 18-50|human
39375584|student_A|gut microbiota|microbiome|used by|enzyme-linked immune sorbent assay|biomedical technique
39375584|student_A|dietary animal protein|food|impact|Prevotella|bacteria
39375584|student_A|gut microbiota|microbiome|located in|healthy women|human
39375584|student_A|gut microbiota|microbiome|used by|Real-time quantitative polymerase chain reaction|biomedical technique
39375584|student_A|plant protein|food|influence|depression|DDF
39375584|student_A|plant protein|food|impact|Bacteriodetes|bacteria
39375584|student_A|plant protein|food|influence|mental disorders|DDF
39375584|student_A|plant protein|food|impact|Bacteroidetes|bacteria
39375584|student_A|psychological stress|DDF|target|women|human
39375584|student_A|Higher dietary animal protein intake|dietary supplement|influence|psychological distress|DDF
36155528|student_A|locomotor function|DDF|strike|brain regions|anatomical location
36155528|student_A|gut microbiota|microbiome|is linked to|dysbiosis|DDF
36155528|student_A|gut microbiomes|microbiome|is linked to|PD|DDF
36155528|student_A|neuronal integrity|DDF|strike|brain regions|anatomical location
36155528|student_A|Human fecal microbiota communities|microbiome|used by|metagenomic sequencing|biomedical technique
36155528|student_A|gut microbiota|microbiome|located in|SNCA p.A53T mice|animal
36155528|student_A|motor deficits|DDF|change abundance|gut microbiota|microbiome
36155528|student_A|Parabateroides Merdae|bacteria|part of|gut microbiota|microbiome
36155528|student_A|Ruminococcus torques|bacteria|part of|gut microbiota|microbiome
36155528|student_A|gut microbiota communities|microbiome|is linked to|motor dysfunction|DDF
36155528|student_A|gut microbiota communities|microbiome|is linked to|neuropathy|DDF
36155528|student_A|gut microbiomes|microbiome|is linked to|Parkinson's disease|DDF
36087572|student_A|constipation symptoms|DDF|target|PD patients|human
36087572|student_A|constipation|DDF|target|PD patients|human
36087572|student_A|intestinal flora disorders|DDF|target|PD patients|human
36087572|student_A|Probiotics|dietary supplement|influence|constipation|DDF
36087572|student_A|Probiotics|dietary supplement|impact|gut microbiota|microbiome
36087572|student_A|PD patients|human|used by|randomized controlled study|biomedical technique
36087572|student_A|Parkinson's disease|DDF|affect|Constipation|DDF
36087572|student_A|subjects|human|used by|16s rRNA gene V3-V4 region sequencing|biomedical technique
36087572|student_A|healthy controls|human|used by|16s rRNA gene V3-V4 region sequencing|biomedical technique
36087572|student_A|constipation|DDF|target|probiotics group|human
36087572|student_A|gut microbiota|microbiome|located in|PD patients|human
36087572|student_A|constipation|DDF|target|control group|human
36087572|student_A|Parkinson's disease|DDF|change abundance|gut microbiota|microbiome
33704660|student_A|Neurodegeneration-associated dementia disorders|DDF|target|elderly population|human
33704660|student_A|human gut microbiota|microbiome|is linked to|NADDs|DDF
32266160|student_A|Tourette syndrome|DDF|target|patients|human
32266160|student_A|diabetic neuropathy|DDF|target|patients|human
32266160|student_A|Guillain-Barré|DDF|target|patients|human
32266160|student_A|amyotrophic lateral sclerosis|DDF|target|patients|human
32266160|student_A|gut microbiota|microbiome|located in|patients|human
32266160|student_A|neurological disorders|DDF|target|patients|human
32266160|student_A|multiple sclerosis|DDF|target|patients|human
32266160|student_A|autism spectrum disorder|DDF|target|patients|human
32266160|student_A|neurological symptoms|DDF|target|patients|human
32266160|student_A|Parkinson's disease|DDF|target|patients|human
32266160|student_A|human diseases|DDF|target|patients|human
32266160|student_A|Alzheimer's disease|DDF|target|patients|human
32266160|student_A|epilepsy|DDF|target|patients|human
32266160|student_A|Guillain-Barré syndrome|DDF|target|patients|human
32266160|student_A|<i>Clostridioides difficile</i> infections|DDF|target|patients|human
32266160|student_A|stroke|DDF|target|patients|human
32266160|student_A|gut microbiota|microbiome|is linked to|neurological disorders|DDF
32266160|student_A|gut microbiota|microbiome|is linked to|Neurological Disorders|DDF
35917710|student_A|LC-3B|chemical|located in|hippocampus|anatomical location
35917710|student_A|Manganese|chemical|influence|Parkinson's disease|DDF
35917710|student_A|Manganese|chemical|influence|neurodegenerative diseases|DDF
35917710|student_A|Mn|chemical|influence|neurodegenerative diseases|DDF
35917710|student_A|PINK1|chemical|located in|hippocampus|anatomical location
35917710|student_A|Beclin-1|chemical|located in|hippocampus|anatomical location
35917710|student_A|Mn-induced neurotoxicity|DDF|strike|brain|anatomical location
35917710|student_A|Mn|chemical|influence|Parkinson's disease|DDF
32088434|student_A|DEHP|chemical|influence|increasing body weight gain|DDF
32088434|student_A|highest Th1 inflammatory response|DDF|target|SD rats|animal
32088434|student_A|Di-(2-ethylhexyl) phthalate|chemical|influence|abundance of potential pathogens and microbial genes|DDF
32088434|student_A|plasticizer|chemical|influence|issue and functional damages|DDF
32088434|student_A|plasticizer|chemical|influence|obesity|DDF
32088434|student_A|body weight gain|DDF|target|SD rats|animal
32088434|student_A|plasticizer|chemical|influence|colorectal cancer|DDF
32088434|student_A|DEHP|chemical|influence|abundance of potential pathogens and microbial genes|DDF
32088434|student_A|colorectal cancer|DDF|target|Sprague-Dawley (SD) rats|animal
32088434|student_A|plasticizer|chemical|influence|Parkinson's disease|DDF
32088434|student_A|highest Th1 inflammatory response|DDF|target|Sprague-Dawley (SD) rats|animal
32088434|student_A|Gut microbiota dysbiosis|DDF|affect|toxicity|DDF
32088434|student_A|Di-(2-ethylhexyl) phthalate|chemical|influence|damage to different tissues|DDF
32088434|student_A|reproductive toxicity|DDF|target|rodent|animal
32088434|student_A|Parkinson's disease|DDF|target|Sprague-Dawley (SD) rats|animal
32088434|student_A|Di-(2-ethylhexyl) phthalate|chemical|influence|toxicity|DDF
32088434|student_A|abundance of potential pathogens and microbial genes|DDF|target|Sprague-Dawley (SD) rats|animal
32088434|student_A|type 2 diabetes|DDF|target|SD rats|animal
32088434|student_A|issue and functional damages|DDF|target|SD rats|animal
32088434|student_A|DEHP|chemical|influence|damage to different tissues|DDF
32088434|student_A|butyrate|chemical|produced by|gut microbiota|microbiome
32088434|student_A|plasticizer|chemical|influence|increasing body weight gain|DDF
32088434|student_A|obesity|DDF|target|Sprague-Dawley (SD) rats|animal
32088434|student_A|DEHP|chemical|influence|toxicity|DDF
32088434|student_A|reproductive toxicity|DDF|target|rodents|animal
32088434|student_A|Di-(2-ethylhexyl) phthalate|chemical|influence|diabetes|DDF
32088434|student_A|gut microbiota|microbiome|located in|BALB/c|animal
32088434|student_A|Di-(2-ethylhexyl) phthalate|chemical|influence|reproductive toxicity|DDF
32088434|student_A|Di-(2-ethylhexyl) phthalate|chemical|influence|type 2 diabetes|DDF
32088434|student_A|Di-(2-ethylhexyl) phthalate|chemical|influence|liver toxicity|DDF
32088434|student_A|Proteobacteria abundance in the fecal samples|DDF|target|SD rats|animal
32088434|student_A|reproductive toxicity|DDF|target|male rodents|animal
32088434|student_A|DEHP|chemical|influence|diabetes|DDF
32088434|student_A|plasticizer|chemical|influence|Th1 inflammatory response|DDF
32088434|student_A|DEHP|chemical|influence|reproductive toxicity|DDF
32088434|student_A|DEHP|chemical|influence|type 2 diabetes|DDF
32088434|student_A|DEHP|chemical|influence|liver toxicity|DDF
32088434|student_A|Di-(2-ethylhexyl) phthalate|chemical|influence|colorectal cancer|DDF
32088434|student_A|gut microbiota|microbiome|located in|SD rats|animal
32088434|student_A|obesity|DDF|target|SD rats|animal
32088434|student_A|Gut microbiota dysbiosis|DDF|target|murine rodents|animal
32088434|student_A|plasticizer|chemical|influence|severe organ damage|DDF
32088434|student_A|plasticizer|chemical|influence|damage to different tissues|DDF
32088434|student_A|increasing body weight gain|DDF|target|Sprague-Dawley (SD) rats|animal
32088434|student_A|Di-(2-ethylhexyl) phthalate|chemical|influence|Parkinson's disease|DDF
32088434|student_A|DEHP|chemical|influence|colorectal cancer|DDF
32088434|student_A|severe organ damage|DDF|target|Sprague-Dawley (SD) rats|animal
32088434|student_A|glucose metabolism disorder|DDF|target|rodent|animal
32088434|student_A|Th1 inflammatory response|DDF|target|Sprague-Dawley (SD) rats|animal
32088434|student_A|DEHP|chemical|influence|Parkinson's disease|DDF
32088434|student_A|Di-(2-ethylhexyl) phthalate|chemical|influence|highest Th1 inflammatory response|DDF
32088434|student_A|gut microbiota|microbiome|located in|male rodents|animal
32088434|student_A|DEHP|chemical|influence|highest Th1 inflammatory response|DDF
32088434|student_A|Di-(2-ethylhexyl) phthalate|chemical|influence|Proteobacteria abundance in the fecal samples|DDF
32088434|student_A|type 2 diabetes|DDF|target|Sprague-Dawley (SD) rats|animal
32088434|student_A|liver toxicity|DDF|target|SD rats|animal
32088434|student_A|gut microbiota|microbiome|located in|C57BL/6J mice|animal
32088434|student_A|diabetes|DDF|target|SD rats|animal
32088434|student_A|plasticizer|chemical|influence|abundance of potential pathogens and microbial genes|DDF
32088434|student_A|DEHP|chemical|influence|Proteobacteria abundance in the fecal samples|DDF
32088434|student_A|issue and functional damages|DDF|target|Sprague-Dawley (SD) rats|animal
32088434|student_A|Parkinson's disease|DDF|target|SD rats|animal
32088434|student_A|Di-(2-ethylhexyl) phthalate|chemical|influence|obesity|DDF
32088434|student_A|abundance of potential pathogens and microbial genes|DDF|target|SD rats|animal
32088434|student_A|plasticizer|chemical|influence|body weight gain|DDF
32088434|student_A|gut microbiota|microbiome|located in|rodent|animal
32088434|student_A|Di-(2-ethylhexyl) phthalate|chemical|influence|issue and functional damages|DDF
32088434|student_A|DEHP|chemical|influence|obesity|DDF
32088434|student_A|DEHP|chemical|impact|gut microbiota|microbiome
32088434|student_A|plasticizer|chemical|influence|highest Th1 inflammatory response|DDF
32088434|student_A|plasticizer|chemical|influence|toxicity|DDF
32088434|student_A|DEHP|chemical|influence|issue and functional damages|DDF
32088434|student_A|gut microbiota|microbiome|located in|rodents|animal
32088434|student_A|body weight gain|DDF|target|Sprague-Dawley (SD) rats|animal
32088434|student_A|Di-(2-ethylhexyl) phthalate|chemical|influence|glucose metabolism disorder|DDF
32088434|student_A|plasticizer|chemical|influence|diabetes|DDF
32088434|student_A|gut microbiota|microbiome|located in|Sprague-Dawley (SD) rats|animal
32088434|student_A|plasticizer|chemical|influence|liver toxicity|DDF
32088434|student_A|damage to different tissues|DDF|target|rodent|animal
32088434|student_A|increasing body weight gain|DDF|target|SD rats|animal
32088434|student_A|DEHP|chemical|influence|glucose metabolism disorder|DDF
32088434|student_A|plasticizer|chemical|influence|reproductive toxicity|DDF
32088434|student_A|liver toxicity|DDF|target|rodent|animal
32088434|student_A|glucose metabolism disorder|DDF|target|rodents|animal
32088434|student_A|colorectal cancer|DDF|target|SD rats|animal
32088434|student_A|severe organ damage|DDF|target|SD rats|animal
32088434|student_A|Th1 inflammatory response|DDF|target|SD rats|animal
32088434|student_A|Di-(2-ethylhexyl) phthalate|chemical|influence|body weight gain|DDF
32088434|student_A|glucose metabolism disorder|DDF|target|male rodents|animal
32088434|student_A|diabetes|DDF|target|Sprague-Dawley (SD) rats|animal
32088434|student_A|toxicity|DDF|target|murine rodents|animal
32088434|student_A|liver toxicity|DDF|target|rodents|animal
32088434|student_A|Di-(2-ethylhexyl) phthalate|chemical|influence|Th1 inflammatory response|DDF
32088434|student_A|Di-(2-ethylhexyl) phthalate|chemical|influence|severe organ damage|DDF
32088434|student_A|DEHP|chemical|influence|body weight gain|DDF
32088434|student_A|damage to different tissues|DDF|target|male rodents|animal
32088434|student_A|plasticizer|chemical|influence|glucose metabolism disorder|DDF
32088434|student_A|DEHP|chemical|influence|Th1 inflammatory response|DDF
32088434|student_A|liver toxicity|DDF|target|male rodents|animal
32088434|student_A|Proteobacteria abundance in the fecal samples|DDF|target|Sprague-Dawley (SD) rats|animal
32088434|student_A|DEHP|chemical|influence|severe organ damage|DDF
32088434|student_A|plasticizer|chemical|influence|type 2 diabetes|DDF
32088434|student_A|plasticizer|chemical|influence|Proteobacteria abundance in the fecal samples|DDF
32088434|student_A|Di-(2-ethylhexyl) phthalate|chemical|influence|increasing body weight gain|DDF
32088434|student_A|gut microbiota|microbiome|located in|Wistar rats|animal
35352107|student_A|psychoactive metabolites|chemical|produced by|gut microbiota|microbiome
35352107|student_A|psychoactive compounds|chemical|produced by|gut microbiota|microbiome
35352107|student_A|probiotic microorganisms|bacteria|influence|mental health-related disorders|DDF
35352107|student_A|gut microbiota|microbiome|located in|host|human
35352107|student_A|gut microbiota|microbiome|is linked to|mental health-related disorders|DDF
35352107|student_A|probiotic bacteria|bacteria|influence|mental health-related disorders|DDF
35352107|student_A|psychobiotics|dietary supplement|influence|mental health-related disorders|DDF
35352107|student_A|gut|anatomical location|located in|individual|human
35352107|student_A|brain|anatomical location|located in|individual|human
35352107|student_A|probiotic microorganisms|bacteria|part of|gut microbiota|microbiome
35352107|student_A|brain|anatomical location|located in|host|human
35352107|student_A|psychobiotics|dietary supplement|impact|gut microbiota|microbiome
39452233|student_A|probiotics|dietary supplement|influence|gastrointestinal tract problems|DDF
39452233|student_A|probiotics|dietary supplement|influence|cardiovascular benefits|DDF
36458229|student_B|gut microbiota|microbiome|is linked to|neurodegeneration and mental health conditions|DDF
35956395|student_B|PCOS|DDF|target|women|human
35956395|student_B|α-LA|chemical|influence|polycystic ovary syndrome|DDF
35956395|student_B|α-LA|chemical|influence|obesity|DDF
35956395|student_B|α-LA|chemical|influence|intestinal inflammation|DDF
35956395|student_B|gastrointestinal dysbiosis|DDF|target|women|human
35956395|student_B|altered microbiota|microbiome|located in|offspring|human
35956395|student_B|α-LA|chemical|influence|insulin resistance|DDF
35956395|student_B|α-Lactalbumin|chemical|influence|Polycystic Ovary Syndrome|DDF
35956395|student_B|α-Lactalbumin|chemical|influence|PCOS|DDF
35956395|student_B|α-LA|chemical|influence|PCOS|DDF
35956395|student_B|α-LA|chemical|influence|dysbiosis|DDF
35956395|student_B|α-Lactalbumin|chemical|influence|polycystic ovary syndrome|DDF
39291634|student_B|Inulin|dietary supplement|influence|depression|DDF
39291634|student_B|inulin supplementation|dietary supplement|influence|migraine|DDF
39291634|student_B|women|human|used by|placebo supplement|biomedical technique
39291634|student_B|Inulin|dietary supplement|influence|stress|DDF
39291634|student_B|inulin supplementation|dietary supplement|influence|mental health symptoms|DDF
39291634|student_B|Inulin|dietary supplement|influence|anxiety|DDF
39291634|student_B|inulin|dietary supplement|influence|mental health|DDF
39291634|student_B|gut microbiota|microbiome|is linked to|migraines|DDF
39291634|student_B|migraine|DDF|target|women|human
39291634|student_B|Inulin|dietary supplement|influence|mental health|DDF
39291634|student_B|inulin supplementation|dietary supplement|influence|mental health|DDF
39291634|student_B|inulin supplementation|dietary supplement|influence|migraine headache|DDF
39291634|student_B|inulin|dietary supplement|influence|migraine|DDF
39291634|student_B|migraines|DDF|target|women|human
32643435|student_A|Gut microbiota|microbiome|is linked to|neurodegenerative diseases|DDF
32643435|student_A|gut microbiome|microbiome|is linked to|Alzheimer's|DDF
32643435|student_A|gut microbiome|microbiome|is linked to|neurodegenerative diseases|DDF
32643435|student_A|fecal microbiome|microbiome|is linked to|risk for earlier death|DDF
32643435|student_A|fecal microbiota|microbiome|is linked to|risk for earlier death|DDF
32643435|student_A|motor neuron disease|DDF|target|patients|human
32643435|student_A|Gut microbiota|microbiome|is linked to|Alzheimer's|DDF
32643435|student_A|Motor Neuron Disease|DDF|target|patients|human
32643435|student_A|gut microbiota|microbiome|is linked to|Alzheimer's|DDF
32643435|student_A|Gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
32643435|student_A|gut microbiome|microbiome|is linked to|Parkinson's disease|DDF
32643435|student_A|risk for earlier death|DDF|target|patients|human
32643435|student_A|gut microbiota|microbiome|is linked to|neurodegenerative diseases|DDF
32643435|student_A|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
32643435|student_A|MND|DDF|target|patients|human
33803607|student_B|cooked soybean|food|impact|Bacillus|bacteria
33803607|student_B|fermented soy foods|food|influence|Alzheimer's|DDF
33803607|student_B|fermented soy foods|food|influence|Parkinson's diseases|DDF
33803607|student_B|fermented soy foods|food|influence|neurodegenerative diseases|DDF
33803607|student_B|Fermented Soy Products|food|influence|Neurodegenerative Diseases|DDF
33803607|student_B|cooked soybean|food|impact|Aspergillus|bacteria
33803607|student_B|cooked soybean|food|impact|Rhizopus|bacteria
32735929|student_B|natural polysaccharides|dietary supplement|impact|intestinal flora|microbiome
32735929|student_B|plant polysaccharides|dietary supplement|impact|gut flora|microbiome
32735929|student_B|plant polysaccharides|dietary supplement|influence|neurodegenerative diseases|DDF
32735929|student_B|gut flora|microbiome|is linked to|neurodegenerative diseases|DDF
32735929|student_B|Intestinal flora disorders|DDF|affect|metabolic diseases|DDF
32735929|student_B|gut microbiota|microbiome|located in|brain|anatomical location
35594949|student_A|(R)-ketamine|drug|change effect|reduced cortical BMD and total BMD|DDF
35594949|student_A|saline|chemical|influence|reduced BMD|DDF
35594949|student_A|genera Turicibacter|bacteria|influence|reduced cortical BMD and total BMD|DDF
35594949|student_A|(R)-ketamine|drug|change effect|osteoporosis|DDF
35594949|student_A|reduced BMD|DDF|target|OVX mice|animal
35594949|student_A|novel antidepressant (R)-ketamine|drug|change effect|reduced BMD|DDF
35594949|student_A|saline|chemical|impact|gut microbiota|microbiome
35594949|student_A|(R)-ketamine|drug|change effect|reduced BMD|DDF
35594949|student_A|therapeutic drug|drug|change effect|osteoporosis|DDF
35594949|student_A|depression|DDF|affect|low bone mineral density|DDF
35594949|student_A|genera Turicibacter|bacteria|part of|gut microbiota|microbiome
35594949|student_A|gut microbiota|microbiome|is linked to|depression|DDF
35594949|student_A|(R)-ketamine|drug|impact|gut microbiota|microbiome
35594949|student_A|female mice|animal|used by|OVX|biomedical technique
35594949|student_A|(R)-ketamine|drug|change effect|low BMD|DDF
35594949|student_A|osteoporosis|DDF|target|patients|human
35594949|student_A|female mice|animal|used by|sham|biomedical technique
35594949|student_A|postmenopausal osteoporosis|DDF|target|ovariectomized (OVX) mice|animal
35594949|student_A|gut microbiota|microbiome|located in|ovariectomized mice|animal
35594949|student_A|reduced bone mineral density|DDF|target|ovariectomized mice|animal
35594949|student_A|therapeutic drug|drug|change effect|low BMD|DDF
35594949|student_A|(R)-ketamine|drug|change effect|reduced bone mineral density|DDF
35594949|student_A|reduced BMD|DDF|target|ovariectomized (OVX) mice|animal
35594949|student_A|gut microbiota|microbiome|located in|OVX mice|animal
35594949|student_A|reduced cortical BMD and total BMD|DDF|target|OVX mice|animal
35594949|student_A|gut microbiota|microbiome|is linked to|reduced BMD|DDF
35594949|student_A|low BMD|DDF|target|depressed patients|human
35594949|student_A|Depression|DDF|affect|osteoporosis|DDF
34128115|student_B|oral medication|drug|change effect|PD|DDF
34128115|student_B|PD patients|human|used by|deep brain stimulation|biomedical technique
34128115|student_B|oral medication|drug|impact|GM|microbiome
34128115|student_B|GM|microbiome|used by|DATs|biomedical technique
34128115|student_B|PD-associated GM|microbiome|used by|DAT|biomedical technique
34128115|student_B|PD patients|human|used by|DBS|biomedical technique
34128115|student_B|GM|microbiome|used by|PD device-assisted therapies|biomedical technique
34128115|student_B|oral medication|drug|impact|gut microbiome|microbiome
34128115|student_B|GM|microbiome|is linked to|PD|DDF
36263629|student_A|collagen fibres|chemical|influence|enteric glial activation|DDF
36263629|student_A|neurological and gastrointestinal symptoms|DDF|target|Parkinson's disease (PD) patients|human
36263629|student_A|Epithelial mucins|chemical|influence|enteric glial activation|DDF
36263629|student_A|collagen fibres|chemical|influence|mucosal remodelling|DDF
36263629|student_A|PD patients|human|used by|Faecal microbiota analysis|biomedical technique
36263629|student_A|enteric inflammation|DDF|target|Parkinson's disease patients|human
36263629|student_A|Parkinson's disease|DDF|target|patients|human
36263629|student_A|enteric inflammation|DDF|target|Parkinson's disease (PD) patients|human
36263629|student_A|Intestinal histomorphological and molecular alterations|DDF|target|patients|human
36263629|student_A|neuroplastic changes|DDF|target|Parkinson's disease (PD) patients|human
36263629|student_A|morphofunctional alterations|DDF|target|PD patients|human
36263629|student_A|controls|human|used by|Faecal microbiota analysis|biomedical technique
36263629|student_A|Epithelial mucins|chemical|influence|mucosal remodelling|DDF
36263629|student_A|increased intestinal epithelial barrier permeability|DDF|target|Parkinson's disease patients|human
36263629|student_A|colonic mucosal barrier remodelling|DDF|target|Parkinson's disease patients|human
38959253|student_A|gut microbiota|microbiome|is linked to|schizophrenia|DDF
38959253|student_A|Gut microbes|microbiome|is linked to|complex and long-term psychiatric disorder|DDF
38959253|student_A|phosphonates|chemical|influence|schizophrenia|DDF
38959253|student_A|Gut microbes|microbiome|located in|central nervous system|anatomical location
38959253|student_A|schizophrenia|DDF|target|patients|human
38959253|student_A|phosphinates|chemical|influence|schizophrenia|DDF
38959253|student_A|gut microbiota|microbiome|located in|patients|human
38959253|student_A|gut microbes|microbiome|is linked to|complex and long-term psychiatric disorder|DDF
38959253|student_A|Clostridium|bacteria|located in|patients|human
38959253|student_A|Megasphaera|bacteria|influence|schizophrenia|DDF
38959253|student_A|gut microbes|microbiome|is linked to|schizophrenia|DDF
38959253|student_A|Megasphaera|bacteria|located in|patients|human
38959253|student_A|sphingolipid|chemical|influence|schizophrenia|DDF
38959253|student_A|Gut microbes|microbiome|is linked to|Schizophrenia|DDF
38959253|student_A|gut microbes|microbiome|is linked to|Schizophrenia|DDF
38959253|student_A|Clostridium|bacteria|influence|schizophrenia|DDF
35812394|student_B|prebiotics|dietary supplement|influence|PD|DDF
35812394|student_B|gut dysbiosis|DDF|interact|α-synuclein fibrils|chemical
35812394|student_B|synbiotics|dietary supplement|influence|PD|DDF
35812394|student_B|probiotics|dietary supplement|influence|PD|DDF
35812394|student_B|psychobiotics|dietary supplement|influence|PD|DDF
35812394|student_B|postbiotics|dietary supplement|influence|PD|DDF
32066253|student_A|probiotics|dietary supplement|impact|gut microbiota|microbiome
32066253|student_A|Stenotrophomonas|bacteria|located in|AD-induced <i>Drosophila</i>|animal
32066253|student_A|probiotics|dietary supplement|influence|neurological and psychological changes|DDF
32066253|student_A|Wolbachia|bacteria|part of|gut microbiota|microbiome
32066253|student_A|Stenotrophomonas|bacteria|part of|gut microbiota|microbiome
32066253|student_A|<i>Lactobacillus plantarum</i> DR7|bacteria|located in|AD-induced <i>Drosophila</i>|animal
32066253|student_A|Wolbachia|bacteria|influence|neurodegenerative disorders|DDF
32066253|student_A|gut microbiota|microbiome|is linked to|neurological and psychological changes|DDF
32066253|student_A|Wolbachia|bacteria|influence|Huntington's|DDF
32066253|student_A|Acetobacter|bacteria|located in|AD-induced <i>Drosophila</i>|animal
32066253|student_A|Wolbachia|bacteria|located in|AD-induced <i>Drosophila</i>|animal
32066253|student_A|DR7|bacteria|part of|gut microbiota|microbiome
32066253|student_A|gut microbiota|microbiome|located in|AD-induced <i>Drosophila</i>|animal
32066253|student_A|Wolbachia|bacteria|influence|Parkinson's|DDF
32066253|student_A|Stenotrophomonas|bacteria|influence|neurodegenerative disorders|DDF
32066253|student_A|Wolbachia|bacteria|influence|Alzheimer's diseases|DDF
32066253|student_A|Alzheimer's diseases|DDF|target|AD-induced <i>Drosophila</i>|animal
32066253|student_A|<i>Lactobacillus</i> probiotics|dietary supplement|influence|alleviated neurodegeneration|DDF
32066253|student_A|Acetobacter|bacteria|part of|gut microbiota|microbiome
32066253|student_A|<i>Lactobacillus</i> strains|bacteria|located in|AD-induced <i>Drosophila</i>|animal
32066253|student_A|Wolbachia|bacteria|influence|AD|DDF
32066253|student_A|DR7|bacteria|located in|AD-induced <i>Drosophila</i>|animal
32066253|student_A|alleviated neurodegeneration|DDF|strike|eye|anatomical location
33153085|student_B|human microbiota|microbiome|located in|reproductive organs|anatomical location
33153085|student_B|human microbiota|microbiome|located in|gastrointestinal (GI) tract|anatomical location
33153085|student_B|AD|DDF|interact|neurofibrillary tangles|chemical
33153085|student_B|human microbiota|microbiome|located in|skin|anatomical location
33153085|student_B|AD|DDF|interact|amyloid-β plaques|chemical
33153085|student_B|human microbiota|microbiome|located in|airways|anatomical location
33153085|student_B|gut microbiota|microbiome|located in|brain|anatomical location
33153085|student_B|human microbiota|microbiome|located in|oral cavity|anatomical location
33153085|student_B|Gut Microbiota|microbiome|is linked to|Alzheimer's Disease|DDF
39063241|student_A|gut microbiota|microbiome|is linked to|constipation|DDF
39063241|student_A|Gut dysbiosis|DDF|target|cancer patients|human
39063241|student_A|gut microbiota|microbiome|is linked to|opioid-mediated analgesia and tolerability|DDF
39063241|student_A|analgesia|DDF|target|cancer patients|human
39063241|student_A|Gut Dysbiosis|DDF|target|Cancer Pain Patients|human
39063241|student_A|chemokines|chemical|influence|neuroinflammation|DDF
39063241|student_A|well-known pharmacological effects|DDF|affect|analgesia|DDF
39063241|student_A|specific gut bacteria|bacteria|influence|analgesia|DDF
39063241|student_A|well-known pharmacological effects|DDF|affect|opioid-induced constipation|DDF
39063241|student_A|well-known pharmacological effects|DDF|affect|OIC|DDF
39063241|student_A|Opioid Use|drug|administered|Cancer Pain Patients|human
39063241|student_A|gut dysbiosis|DDF|affect|addictive behavior|DDF
39063241|student_A|opioid-induced gut dysbiosis|DDF|target|cancer patients|human
39063241|student_A|Opioids|drug|change effect|well-known pharmacological effects|DDF
39063241|student_A|Opioids|drug|change effect|management of severe chronic cancer pain|DDF
39063241|student_A|specific gut bacteria|bacteria|influence|promising therapeutic option|DDF
39063241|student_A|inflammatory cytokines|chemical|influence|neuroinflammation|DDF
39063241|student_A|specific gut bacteria|bacteria|influence|gastrointestinal symptoms|DDF
39063241|student_A|gastrointestinal symptoms|DDF|target|cancer patients|human
32282304|student_A|gut microbiota|microbiome|is linked to|Alzheimer's disease|DDF
32282304|student_A|Gut Microbiome|microbiome|is linked to|CNS disorders|DDF
32282304|student_A|Gut Microbiome|microbiome|is linked to|Neurodegenerative Disorders|DDF
32282304|student_A|Gut Microbiome|microbiome|is linked to|ALS|DDF
32282304|student_A|Gut Microbiome|microbiome|is linked to|Huntington's disease|DDF
32282304|student_A|gut microbiota|microbiome|located in|Gut|anatomical location
32282304|student_A|gut microbiota|microbiome|is linked to|amyotrophic lateral sclerosis|DDF
32282304|student_A|intestinal microbiota|microbiome|is linked to|PD|DDF
32282304|student_A|Gut Microbiome|microbiome|is linked to|HD|DDF
32282304|student_A|Gut Microbiome|microbiome|is linked to|pathogenesis|DDF
32282304|student_A|intestinal microbiota|microbiome|is linked to|Alzheimer's disease|DDF
32282304|student_A|Gut Microbiome|microbiome|is linked to|neurodegenerative disorders|DDF
32282304|student_A|intestinal microbiota|microbiome|is linked to|amyotrophic lateral sclerosis|DDF
32282304|student_A|intestinal microbiota|microbiome|located in|Gut|anatomical location
32282304|student_A|gut microbiota|microbiome|is linked to|AD|DDF
32282304|student_A|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
32282304|student_A|Gut Microbiome|microbiome|is linked to|multiple sclerosis|DDF
32282304|student_A|Gut Microbiome|microbiome|is linked to|MS|DDF
32282304|student_A|gut microbiota|microbiome|is linked to|Neurodegenerative Disorders|DDF
32282304|student_A|gut microbiota|microbiome|is linked to|pathogenesis|DDF
32282304|student_A|gut microbiota|microbiome|is linked to|ALS|DDF
32282304|student_A|Gut Microbiome|microbiome|is linked to|Alzheimer's disease|DDF
32282304|student_A|gut microbiota|microbiome|is linked to|HD|DDF
32282304|student_A|intestinal microbiota|microbiome|is linked to|multiple sclerosis|DDF
32282304|student_A|gut microbiota|microbiome|is linked to|CNS disorders|DDF
32282304|student_A|Gut Microbiome|microbiome|is linked to|PD|DDF
32282304|student_A|intestinal microbiota|microbiome|is linked to|Parkinson's disease|DDF
32282304|student_A|intestinal microbiota|microbiome|is linked to|Neurodegenerative Disorders|DDF
32282304|student_A|intestinal microbiota|microbiome|is linked to|AD|DDF
32282304|student_A|gut microbiota|microbiome|is linked to|neurodegenerative disorders|DDF
32282304|student_A|intestinal microbiota|microbiome|is linked to|pathogenesis|DDF
32282304|student_A|gut microbiota|microbiome|is linked to|Huntington's disease|DDF
32282304|student_A|intestinal microbiota|microbiome|is linked to|ALS|DDF
32282304|student_A|gut microbiota|microbiome|is linked to|multiple sclerosis|DDF
32282304|student_A|gut microbiota|microbiome|is linked to|MS|DDF
32282304|student_A|intestinal microbiota|microbiome|is linked to|HD|DDF
32282304|student_A|intestinal microbiota|microbiome|is linked to|CNS disorders|DDF
32282304|student_A|intestinal microbiota|microbiome|is linked to|neurodegenerative disorders|DDF
32282304|student_A|Gut Microbiome|microbiome|located in|Gut|anatomical location
32282304|student_A|intestinal microbiota|microbiome|is linked to|Huntington's disease|DDF
32282304|student_A|gut microbiota|microbiome|is linked to|PD|DDF
32282304|student_A|intestinal microbiota|microbiome|is linked to|MS|DDF
32282304|student_A|Gut Microbiome|microbiome|is linked to|amyotrophic lateral sclerosis|DDF
32282304|student_A|Gut Microbiome|microbiome|is linked to|AD|DDF
32282304|student_A|Gut Microbiome|microbiome|is linked to|Parkinson's disease|DDF
32039674|student_A|probiotics|dietary supplement|impact|gut microbiota|microbiome
32039674|student_A|bacterial cells|bacteria|interact|hydrogel|chemical
32039674|student_A|chemically modified alginate hydrogel|chemical|impact|bacterial cells|bacteria
34413194|student_A|gut microbiota|microbiome|is linked to|neurodegenerative diseases|DDF
34413194|student_A|curli amyloid fibril|bacteria|influence|host neurodegeneration|DDF
35309241|student_B|biomarkers|chemical|influence|schizophrenia|DDF
35309241|student_B|Schizophrenia|DDF|target|individuals|human
32516966|student_A|gut microbiota|microbiome|is linked to|Alzheimer's disease|DDF
32516966|student_A|microbial community|microbiome|located in|human gut|anatomical location
32516966|student_A|human-associated microbiota|microbiome|is linked to|Neurodegeneration|DDF
32516966|student_A|gut microbiota|microbiome|is linked to|amyotrophic lateral sclerosis|DDF
32516966|student_A|microbial community|microbiome|located in|host|human
32516966|student_A|gut microbiota|microbiome|used by|metaproteomics|biomedical technique
32516966|student_A|gut microbiota|microbiome|used by|metatranscriptomics|biomedical technique
32516966|student_A|gut microbiota|microbiome|is linked to|AD|DDF
32516966|student_A|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
32516966|student_A|gut microbiota|microbiome|used by|metagenomics|biomedical technique
32516966|student_A|gut microbiota|microbiome|is linked to|ALS|DDF
32516966|student_A|gut microbiota|microbiome|is linked to|neurodegeneration|DDF
32516966|student_A|gut microbiota|microbiome|used by|metabolomics|biomedical technique
32516966|student_A|gut microbiota|microbiome|is linked to|neurodegenerative diseases|DDF
32516966|student_A|gut microbiota|microbiome|is linked to|multiple sclerosis|DDF
32516966|student_A|gut microbiota|microbiome|is linked to|MS|DDF
32516966|student_A|gut microbiota|microbiome|is linked to|human diseases|DDF
32516966|student_A|gastrointestinal tract|anatomical location|located in|host|human
32516966|student_A|human gut|anatomical location|located in|host|human
32516966|student_A|gut microbiota|microbiome|is linked to|PD|DDF
35276981|student_A|probiotics|dietary supplement|influence|depression|DDF
35276981|student_A|probiotics|dietary supplement|influence|anxiety|DDF
35276981|student_A|probiotics|dietary supplement|influence|psychiatric distress|DDF
35276981|student_A|probiotics|dietary supplement|influence|stress|DDF
35276981|student_A|probiotics|dietary supplement|influence|mental health|DDF
35276981|student_A|Probiotics|dietary supplement|influence|Psychiatric Symptoms|DDF
35276981|student_A|probiotics|dietary supplement|influence|psychiatric symptoms|DDF
32473843|student_B|gut microbiota|microbiome|is linked to|neurodegeneration|DDF
32473843|student_B|altered gut microbiota|DDF|affect|CNS disorders|DDF
32473843|student_B|NLRP3 activation|DDF|affect|CNS disorders|DDF
32473843|student_B|gut microbiota|microbiome|is linked to|neuroinflammation|DDF
32473843|student_B|the nucleotide-binding oligomerization domain leucine rich repeat and pyrin domain-containing protein 3 (NLRP3) inflammasome|chemical|influence|CNS diseases|DDF
32473843|student_B|enteric bacteria|bacteria|influence|CNS diseases|DDF
32819577|student_B|Prevotellaceae_UCG-001|bacteria|located in|KO and WT mice|animal
32819577|student_B|anxiety|DDF|target|KO mice|animal
32819577|student_B|KO mice|animal|used by|Y-maze|biomedical technique
32819577|student_B|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
32819577|student_B|gut microbiota|microbiome|located in|mice|animal
32819577|student_B|Dcf1<sup>-/-</sup>|DDF|target|mice|animal
32819577|student_B|Helicobacter_ganmani|bacteria|located in|KO and WT mice|animal
32819577|student_B|inflammatory lesions|DDF|target|KO mice|animal
32819577|student_B|memory deficits|DDF|target|KO mice|animal
32819577|student_B|Dcf1<sup>-/-</sup>|DDF|change abundance|gut microbiota|microbiome
32819577|student_B|Prevotellaceae_UCG-001|bacteria|influence|inflammatory lesions|DDF
32819577|student_B|Prevotellaceae|bacteria|located in|PD patients|human
32819577|student_B|slowness of movement|DDF|target|KO mice|animal
32819577|student_B|Dcf1 deletion|DDF|change abundance|gut microbiota|microbiome
32819577|student_B|Prevotellaceae|bacteria|located in|Dcf1<sup>-/-</sup> (KO) mice|animal
32819577|student_B|glycolipid metabolism disorders|DDF|target|KO mice|animal
32819577|student_B|Helicobacter_ganmani|bacteria|influence|glycolipid metabolism disorders|DDF
32819577|student_B|Dcf1 deletion|DDF|target|mice|animal
32819577|student_B|Proteobacteria|bacteria|located in|Dcf1<sup>-/-</sup> (KO) mice|animal
32819577|student_B|Prevotellaceae_UCG-001|bacteria|influence|glycolipid metabolism disorders|DDF
32819577|student_B|Helicobacter_ganmani|bacteria|influence|inflammatory lesions|DDF
32819577|student_B|Proteobacteria|bacteria|located in|PD patients|human
32819577|student_B|gut microbiota|microbiome|is linked to|PD|DDF
32819577|student_B|KO mice|animal|used by|Open field test|biomedical technique
35650202|student_A|depression-like behaviors|DDF|target|collagen-induced arthritis (CIA) mice|animal
35650202|student_A|rheumatoid arthritis|DDF|change abundance|gut microbiota|microbiome
35650202|student_A|rheumatoid arthritis|DDF|target|patients|human
35650202|student_A|gut microbiota|microbiome|located in|CIA mice|animal
35650202|student_A|depression|DDF|affect|RA|DDF
35650202|student_A|gut microbiota|microbiome|is linked to|systemic inflammation|DDF
35650202|student_A|gut microbiota|microbiome|is linked to|depression|DDF
35650202|student_A|RA patients|human|used by|FMT|biomedical technique
35650202|student_A|gut microbiota|microbiome|is linked to|depression-like behaviors|DDF
35650202|student_A|prefrontal cortex|anatomical location|located in|CIA mice|animal
35650202|student_A|gut microbiota|microbiome|located in|collagen-induced arthritis (CIA) mice|animal
35650202|student_A|PFC|anatomical location|located in|CIA mice|animal
35650202|student_A|depression-like behaviors|DDF|target|ABX-treated mice|animal
35650202|student_A|systemic inflammation|DDF|target|CIA mice|animal
35650202|student_A|gut microbiota|microbiome|located in|RA patients|human
35650202|student_A|depression-like behaviors|DDF|target|CIA mice|animal
35650202|student_A|RA|DDF|change abundance|gut microbiota|microbiome
35650202|student_A|healthy controls|animal|used by|FMT|biomedical technique
35650202|student_A|spleen|anatomical location|located in|mice|animal
35650202|student_A|RA|DDF|target|patients|human
35650202|student_A|Peyer's patches|anatomical location|located in|mice|animal
35650202|student_A|depression-like behaviors|DDF|target|mice|animal
35650202|student_A|depression-like phenotypes|DDF|target|antibiotic cocktail (ABX)-treated mice|animal
35650202|student_A|abnormal T cells activation|DDF|target|mice|animal
35650202|student_A|PFC|anatomical location|located in|antibiotic cocktail (ABX)-treated mice|animal
35650202|student_A|plasma cytokines|chemical|impact|gut microbiota|microbiome
35650202|student_A|depression|DDF|target|RA patients|human
35650202|student_A|Depression|DDF|target|patients|human
35002935|student_B|Roseburia|bacteria|influence|PD|DDF
35002935|student_B|Bilophila|bacteria|influence|PD|DDF
35002935|student_B|PD|DDF|target|people|human
35002935|student_B|PD|DDF|target|individuals|human
35002935|student_B|Parkinson's Disease|DDF|target|People|human
35002935|student_B|PD|DDF|target|participants|human
35002935|student_B|Mediterranean diet|food|influence|PD|DDF
35002935|student_B|PD|DDF|target|Participants|human
33417221|student_A|neurodegenerative diseases|DDF|target|COVID-19 survivors|human
33417221|student_A|neurodegenerative diseases|DDF|target|survived patients|human
34112355|student_A|zinc|chemical|influence|Zn deficiency|DDF
34112355|student_A|Zinc|chemical|influence|COVID-19|DDF
34112355|student_A|Zn2+|chemical|influence|neurodegeneration|DDF
34112355|student_A|Alzheimer's and Parkinson's disease|DDF|interact|Zinc|chemical
34112355|student_A|zinc|chemical|influence|COVID-19|DDF
34112355|student_A|Alzheimer's and Parkinson's disease|DDF|interact|Zn|chemical
34112355|student_A|Zn|chemical|influence|obesity|DDF
34112355|student_A|Zn|chemical|influence|Zn deficiency|DDF
34112355|student_A|Alzheimer's and Parkinson's disease|DDF|interact|zinc|chemical
34112355|student_A|Zn<sup>2+</sup>|chemical|influence|novel coronavirus infection|DDF
34112355|student_A|Zn2+|chemical|influence|novel coronavirus infection|DDF
34112355|student_A|zinc|chemical|influence|diabetes|DDF
34112355|student_A|Zinc|chemical|influence|neurodegenerative and neurodevelopmental disorders|DDF
34112355|student_A|Zinc|chemical|influence|diabetes|DDF
34112355|student_A|zinc|chemical|influence|novel coronavirus infection|DDF
34112355|student_A|Zn<sup>2+</sup>|chemical|influence|diabetes mellitus type 2|DDF
34112355|student_A|Zn2+|chemical|influence|obesity|DDF
34112355|student_A|Zn|chemical|influence|COVID-19|DDF
34112355|student_A|Zn<sup>2+</sup>|chemical|influence|obesity|DDF
34112355|student_A|zinc|chemical|influence|neurodegenerative and neurodevelopmental disorders|DDF
34112355|student_A|Zn2+|chemical|influence|diabetes mellitus type 2|DDF
34112355|student_A|Zinc|chemical|influence|novel coronavirus infection|DDF
34112355|student_A|ProSAP/Shank scaffold|chemical|impact|gut microbiota|microbiome
34112355|student_A|Zinc|chemical|influence|obesity|DDF
34112355|student_A|Zn<sup>2+</sup>|chemical|influence|COVID-19|DDF
34112355|student_A|Zn|chemical|influence|diabetes|DDF
34112355|student_A|Zn2+|chemical|influence|COVID-19|DDF
34112355|student_A|zinc|chemical|influence|obesity|DDF
34112355|student_A|Zinc|chemical|influence|Zn deficiency|DDF
34112355|student_A|Zn|chemical|influence|neurodegenerative and neurodevelopmental disorders|DDF
34112355|student_A|Zn<sup>2+</sup>|chemical|influence|neurodegeneration|DDF
34112355|student_A|Zn|chemical|influence|novel coronavirus infection|DDF
38922485|student_B|GM|microbiome|located in|Macaca mulatta|animal
38922485|student_B|Male Sprague-Dawley rats|animal|used by|16S rRNA sequencing|biomedical technique
38922485|student_B|GM|microbiome|located in|rats|animal
38922485|student_B|GM|microbiome|located in|animals|animal
38922485|student_B|addiction|DDF|target|animals|animal
38922485|student_B|Gut Microbiota|microbiome|located in|Rhesus Monkeys|animal
38922485|student_B|MA|drug|change effect|addiction|DDF
38922485|student_B|GM|microbiome|is linked to|addiction|DDF
38922485|student_B|gut microbiota|microbiome|is linked to|addiction|DDF
38922485|student_B|MA|drug|impact|Clostridia_vadinBB60_group|bacteria
38922485|student_B|GM|microbiome|located in|mammals|animal
38922485|student_B|MA|drug|impact|GM|microbiome
38922485|student_B|Gut Microbiota|microbiome|located in|Rats|animal
38922485|student_B|Lactobacillus|dietary supplement|impact|GM|microbiome
38922485|student_B|Methamphetamine|drug|change effect|addiction|DDF
38922485|student_B|male rhesus monkeys|animal|used by|16S rRNA sequencing|biomedical technique
38922485|student_B|Lactobacillus|dietary supplement|influence|addiction|DDF
38922485|student_B|Clostridia_vadinBB60_group|bacteria|part of|GM|microbiome
38922485|student_B|GM|microbiome|located in|rhesus monkeys|animal
39267834|student_B|esophageal cancer|DDF|change abundance|gut microbiome|microbiome
39267834|student_B|esophageal carcinoma patients|DDF|change abundance|gut microbiota|microbiome
39267834|student_B|gut microbiota|microbiome|used by|sequencing|biomedical technique
39267834|student_B|ESCC|DDF|change abundance|Proteobacteria|bacteria
39267834|student_B|esophageal cancer|DDF|target|patients|human
39267834|student_B|esophageal carcinoma|DDF|target|patients|human
39267834|student_B|ESCC|DDF|change abundance|Bacteroidetes|bacteria
36104346|student_A|ASD|DDF|target|females|human
36104346|student_A|females|human|used by|preclinical studies|biomedical technique
36104346|student_A|neuroinflammation|DDF|target|mouse offspring|animal
36104346|student_A|gut microbiota|microbiome|located in|mouse offspring|animal
36104346|student_A|ASD|DDF|target|males|human
36104346|student_A|males|human|used by|preclinical studies|biomedical technique
32946938|student_A|Clostridium bacteria|bacteria|influence|PD|DDF
32946938|student_A|PD|DDF|target|39 PD patients|human
32946938|student_A|TAS2R38 bitter taste receptor|chemical|influence|PD|DDF
32946938|student_A|taste receptors|chemical|influence|alteration in gut microbiota composition|DDF
32946938|student_A|Parkinson's disease|DDF|target|PD patients|human
32946938|student_A|TAS2R38 bitter taste receptor|chemical|influence|Parkinson's disease|DDF
32946938|student_A|6-n-propylthiouracil|chemical|located in|PD patients|human
32946938|student_A|PROP|chemical|located in|PD patients|human
32946938|student_A|PROP|chemical|located in|39 PD patients|human
32946938|student_A|Clostridium genus|bacteria|influence|PD|DDF
32946938|student_A|Clostridium bacteria|bacteria|influence|Parkinson's disease|DDF
32946938|student_A|PD|DDF|target|PD patients|human
32946938|student_A|taste receptors|chemical|located in|lower gastrointestinal tract|anatomical location
32946938|student_A|taste receptors|chemical|impact|bacterial molecules|bacteria
32946938|student_A|6-n-propylthiouracil|chemical|located in|39 PD patients|human
32946938|student_A|Parkinson's disease|DDF|target|39 PD patients|human
32946938|student_A|Clostridium genus|bacteria|influence|Parkinson's disease|DDF
32946938|student_A|reduced sensitivity to PROP|DDF|change abundance|bacteria|bacteria
35308282|student_A|psychological stress|DDF|target|psychiatrically healthy medical students|human
35308282|student_A|psychological stress|DDF|target|medical students|human
35308282|student_A|Psychological Stress|DDF|target|Psychiatrically Healthy Medical Students|human
36494405|student_A|Collinsella|bacteria|influence|Alzheimer's disease|DDF
36494405|student_A|Theraeutic intervention|drug|impact|Bifidobacteirum|bacteria
36494405|student_A|Bifidobacterium|bacteria|influence|Alzheimer's disease|DDF
36494405|student_A|UDCA|chemical|influence|neuroinflammation|DDF
36494405|student_A|ursodeoxycholic acid|chemical|influence|DLB|DDF
36494405|student_A|UDCA|chemical|influence|DLB|DDF
36494405|student_A|Ruminococcus torques|bacteria|influence|DLB|DDF
36494405|student_A|Collinsella|bacteria|influence|DLB|DDF
36494405|student_A|Ruminococcus torques|bacteria|influence|Alzheimer's disease|DDF
35304983|student_B|beneficial metabolites|chemical|produced by|microbiota|microbiome
35304983|student_B|bioactive polyphenols|chemical|influence|neurotransmitter dysfunction|DDF
35304983|student_B|dietary components|dietary supplement|influence|neurodegenerative diseases|DDF
35304983|student_B|bioactive polyphenols|chemical|influence|oxidative stress|DDF
35304983|student_B|bioactive polyphenols|chemical|influence|neuroinflammation|DDF
35304983|student_B|gut microbiota|microbiome|is linked to|neurodegenerative diseases|DDF
35304983|student_B|beneficial metabolites|chemical|produced by|healthy enterotype|microbiome
35304983|student_B|dietary components|dietary supplement|impact|bacterial communities|bacteria
35304983|student_B|bioactive polyphenols|chemical|influence|neuronal death|DDF
38866914|student_A|fecal calprotectin|chemical|influence|gut microbial dysbiosis|DDF
38866914|student_A|Fecal calprotectin|chemical|influence|IBD|DDF
38866914|student_A|fecal calprotectin|chemical|impact|pro-inflammatory gut microbial genera|bacteria
38866914|student_A|fecal calprotectin|chemical|influence|gut dysbiosis|DDF
38866914|student_A|Fecal calprotectin|chemical|influence|gut inflammation|DDF
38866914|student_A|gut microbial dysbiosis|DDF|target|older individuals|human
38866914|student_A|Fecal calprotectin|chemical|influence|inflammatory bowel disease|DDF
38866914|student_A|gut dysbiosis|DDF|target|older individuals|human
38866914|student_A|fecal calprotectin|chemical|impact|short-chain fatty acid producing genera|bacteria
38866914|student_A|IL-17C|chemical|impact|gut microbiota|microbiome
38866914|student_A|CCL19|chemical|impact|gut microbiota|microbiome
38866914|student_A|serum inflammation|DDF|target|older individuals|human
35275534|student_B|Ruminococcus|bacteria|influence|ALS|DDF
35275534|student_B|gut microbiota|microbiome|is linked to|Alzheimer's disease|DDF
35275534|student_B|gut microbiome-dependent metabolites|chemical|influence|neurodegenerative diseases|DDF
35275534|student_B|gut microbiota|microbiome|is linked to|AD|DDF
35275534|student_B|gut microbiota|microbiome|is linked to|neurodegenerative diseases|DDF
35275534|student_B|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
35275534|student_B|gut microbiota|microbiome|is linked to|amyotrophic lateral sclerosis|DDF
35275534|student_B|gut microbiota|microbiome|is linked to|PD|DDF
35275534|student_B|gut microbiota|microbiome|is linked to|ALS|DDF
35967810|student_B|microbial communities|microbiome|located in|gut|anatomical location
35967810|student_B|honey|food|impact|Escherichia coli|bacteria
35967810|student_B|honey|food|impact|infection-causing bacteria|bacteria
35967810|student_B|Honey|food|influence|digestive ailments|DDF
35967810|student_B|honey|food|impact|Lactobacillus|bacteria
35967810|student_B|honey|food|impact|Clostridiodes difficile|bacteria
35967810|student_B|honey|food|impact|microbial communities|microbiome
35967810|student_B|honey|food|impact|Bifidobacteria|bacteria
35967810|student_B|honey|food|influence|infection|DDF
35967810|student_B|honey|food|impact|Salmonella|bacteria
35967810|student_B|Honey|food|impact|Gut Microbiome|microbiome
35967810|student_B|honey|food|influence|inflammation|DDF
35967810|student_B|Prebiotics|dietary supplement|impact|gut microbiota|microbiome
35967810|student_B|honey|food|impact|healthy gut microbiome|microbiome
35085752|student_A|(R)-ketamine|drug|impact|gut-microbiota|microbiome
35085752|student_A|demyelination|DDF|target|MS patients|human
35085752|student_A|(R)-ketamine|drug|change effect|demyelination|DDF
35085752|student_A|demyelination|DDF|strike|brain|anatomical location
35085752|student_A|(R)-ketamine|drug|interact|lactic acid|chemical
35085752|student_A|Multiple sclerosis|DDF|strike|central nervous system|anatomical location
35085752|student_A|Cuprizone|drug|change effect|demyelination|DDF
35085752|student_A|gut microbiota|microbiome|located in|brain|anatomical location
36370535|student_B|Gut mycobiota dysbiosis|DDF|target|drug-naïve|human
36370535|student_B|first-episode schizophrenia|DDF|target|drug-naïve|human
36370535|student_B|schizophrenia|DDF|target|patients|human
36370535|student_B|clinical manifestations|DDF|target|SCH patients|human
36370535|student_B|psychiatric symptoms|DDF|target|SCH patients|human
36370535|student_B|SCH|DDF|target|patients|human
36370535|student_B|first episode SCH|DDF|target|drug-naïve|human
36370535|student_B|Bacterial dysbiosis|DDF|target|patients|human
36370535|student_B|mycobiota|microbiome|is linked to|SCH|DDF
36648872|student_B|unbalanced nutrition|dietary supplement|influence|inflammation|DDF
36648872|student_B|insulin resistance|DDF|target|host|human
36648872|student_B|therapeutic approaches|drug|change effect|obesity|DDF
36648872|student_B|chronic multifactorial disease|DDF|target|host|human
36648872|student_B|gut microbiota|microbiome|located in|host|human
36648872|student_B|low-grade chronic inflammation|DDF|target|host|human
36648872|student_B|malignant tumors|DDF|target|host|human
36648872|student_B|alterations in reproductive function|DDF|target|host|human
36648872|student_B|type 2 diabetes|DDF|target|host|human
36648872|student_B|therapeutic approaches|drug|impact|intestinal microbial ecosystem|microbiome
36648872|student_B|microbiota|microbiome|is linked to|obesity|DDF
36648872|student_B|Obesity|DDF|target|host|human
36648872|student_B|inflammation|DDF|target|host|human
36648872|student_B|pro-inflammatory mediators|chemical|influence|obesity|DDF
36648872|student_B|systemic inflammation|DDF|target|host|human
36648872|student_B|pro-inflammatory mediators|chemical|influence|low-grade chronic inflammation|DDF
36648872|student_B|intestinal microbial ecosystem|microbiome|is linked to|obesity|DDF
36648872|student_B|cardiovascular|DDF|target|host|human
36648872|student_B|neurodegenerative diseases|DDF|target|host|human
38979127|student_A|sleep disorder (SD) patients|human|used by|WMT|biomedical technique
38979127|student_A|sleep disorders|DDF|target|patients|human
38979127|student_A|patients|human|used by|WMT|biomedical technique
38979127|student_A|gut microbiota|microbiome|is linked to|sleep disorders|DDF
38979127|student_A|patients|human|used by|amplicon sequencing|biomedical technique
38979127|student_A|SD patients|human|used by|WMT|biomedical technique
38979127|student_A|gut microbiota|microbiome|located in|patients|human
38979127|student_A|gut microbiota|microbiome|used by|WMT|biomedical technique
38979127|student_A|sleep disorder|DDF|target|patients|human
31843492|student_A|antibiotic-treated animals|animal|used by|paw-rearing measurements|biomedical technique
31843492|student_A|gut microbiota|microbiome|is linked to|dopamine neuron loss|DDF
31843492|student_A|motor symptoms|DDF|target|PD patients|human
31843492|student_A|6-OHDA|chemical|influence|motor dysfunction|DDF
31843492|student_A|gut microbiota|microbiome|is linked to|motor dysfunction|DDF
31843492|student_A|psychiatric and neurological conditions|DDF|change abundance|gut microbiota|microbiome
31843492|student_A|antibiotic-treated animals|animal|used by|forepaw stepping test|biomedical technique
31843492|student_A|antibiotic-treated animals|animal|used by|cylinder test|biomedical technique
31843492|student_A|gut microbiota|microbiome|is linked to|psychiatric and neurological conditions|DDF
31843492|student_A|antibiotic treated animals|animal|used by|immunohistochemistry|biomedical technique
31843492|student_A|gut dysbiosis|DDF|change abundance|gut microbiota|microbiome
31843492|student_A|motor and non-motor symptoms|DDF|target|people|human
31843492|student_A|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
31843492|student_A|gut microbiota|microbiome|is linked to|motor deficits|DDF
31843492|student_A|Parkinson's disease|DDF|target|people|human
31843492|student_A|6-OHDA|chemical|influence|6-OHDA-induced dopaminergic neuron loss|DDF
31843492|student_A|antibiotics|drug|change effect|dopamine neuron loss|DDF
31843492|student_A|gut dysbiosis|DDF|target|PD patients|human
31843492|student_A|striatum of antibiotic-treated animals|anatomical location|located in|antibiotic treated animals|animal
31843492|student_A|control animals|animal|used by|immunohistochemistry|biomedical technique
31843492|student_A|PD|DDF|target|people|human
31843492|student_A|antibiotics|drug|impact|gut microbiota|microbiome
31843492|student_A|gut microbiota|microbiome|is linked to|gut dysbiosis|DDF
31843492|student_A|gut microbiota|microbiome|located in|PD patients|human
31843492|student_A|gut microbiota|microbiome|is linked to|dopaminergic neuron loss|DDF
31843492|student_A|antibiotics|drug|change effect|Parkinson's disease|DDF
31843492|student_A|cardinal PD motor symptoms|DDF|target|PD patients|human
31843492|student_A|antibiotics|drug|change effect|motor deficits|DDF
31843492|student_A|6-hydroxydopamine|chemical|influence|6-OHDA-induced dopaminergic neuron loss|DDF
31843492|student_A|bacterial species|bacteria|part of|gut microbiota|microbiome
31843492|student_A|gastrointestinal dysfunction|DDF|target|PD patients|human
31843492|student_A|gut microbiota|microbiome|is linked to|PD|DDF
31843492|student_A|antibiotic-treated animals|animal|used by|amphetamine-induced rotation test|biomedical technique
31843492|student_A|PD|DDF|change abundance|gut microbiota|microbiome
36144449|student_A|AGEs|chemical|influence|TBI|DDF
36144449|student_A|Dietary AGEs|dietary supplement|impact|gut microbiota|microbiome
36144449|student_A|AGEs|chemical|influence|diabetes|DDF
36144449|student_A|AGE inhibitor|drug|change effect|neurodegenerative diseases|DDF
36144449|student_A|AGE breaker compounds|drug|change effect|diabetes|DDF
36144449|student_A|Dietary AGEs|dietary supplement|influence|endothelial dysfunction|DDF
36144449|student_A|AGEs|chemical|interact|side-chain amino groups|chemical
36144449|student_A|PD|DDF|change abundance|gut bacterial species|bacteria
36144449|student_A|AGE inhibitor|drug|change effect|diabetes|DDF
36144449|student_A|AD|DDF|change abundance|gut bacterial species|bacteria
36144449|student_A|AGEs|chemical|influence|atherosclerosis|DDF
36144449|student_A|AGEs|chemical|influence|AD|DDF
36144449|student_A|AGE breaker compounds|drug|change effect|neurodegenerative diseases|DDF
36144449|student_A|AGEs|chemical|part of|sugars|chemical
35463646|student_A|entacapone|drug|change effect|fatigue|DDF
35463646|student_A|Gut Microbiota|microbiome|located in|Patients With Parkinson's Disease|human
35463646|student_A|levodopa|drug|change effect|GI|DDF
35463646|student_A|Entacapone|drug|impact|Gut Microbiota|microbiome
35463646|student_A|catechol-O-methyltransferase (COMT) inhibitor|drug|change effect|GI|DDF
35463646|student_A|entacapone|drug|change expression|16S rRNA|gene
35463646|student_A|entacapone|drug|change effect|auditory hallucinations|DDF
35463646|student_A|entacapone|drug|change effect|GI|DDF
35463646|student_A|entacapone|drug|change effect|nightmare|DDF
36037991|student_B|gut microbiota|microbiome|is linked to|inflammation-related depression|DDF
36037991|student_B|LPS|chemical|influence|splenomegaly|DDF
36037991|student_B|gut microbiota|microbiome|used by|splenic nerve denervation|biomedical technique
36037991|student_B|lipopolysaccharide|chemical|influence|depression-like phenotype|DDF
36037991|student_B|gut microbiota|microbiome|used by|spleen nerve denervation|biomedical technique
36037991|student_B|systemic inflammation|DDF|change abundance|gut microbiota|microbiome
36037991|student_B|LPS|chemical|influence|abnormal composition|DDF
36037991|student_B|abnormal expressions|DDF|target|SND-operated mice|animal
36037991|student_B|LPS|chemical|influence|systemic inflammation|DDF
36037991|student_B|mice|animal|used by|SND|biomedical technique
36037991|student_B|gut microbiota|microbiome|is linked to|systemic inflammation|DDF
36037991|student_B|depression-like phenotype|DDF|target|sham-operated mice|animal
36037991|student_B|gut microbiota|microbiome|located in|mice|animal
36037991|student_B|lipopolysaccharide|chemical|impact|gut microbiota|microbiome
36037991|student_B|depression-like phenotype|DDF|target|SND-operated mice|animal
36037991|student_B|microbiota|microbiome|change expression|Iba1|gene
36037991|student_B|LPS|chemical|influence|LPS-induced splenomegaly|DDF
36037991|student_B|abnormal composition|DDF|target|mice|animal
36037991|student_B|depression-like phenotype|DDF|target|mice|animal
36037991|student_B|lipopolysaccharide|chemical|influence|abnormal composition|DDF
36037991|student_B|abnormal composition|DDF|change abundance|gut microbiota|microbiome
36037991|student_B|LPS-induced splenomegaly|DDF|target|mice|animal
36037991|student_B|depression-like phenotype|DDF|target|adult mice|animal
36037991|student_B|microbiota|microbiome|change expression|PSD-95|gene
36037991|student_B|depression-like phenotype|DDF|change abundance|gut microbiota|microbiome
36037991|student_B|systemic inflammation|DDF|target|sham-operated mice|animal
36037991|student_B|mice|animal|used by|spleen nerve denervation|biomedical technique
36037991|student_B|systemic inflammation|DDF|target|mice|animal
36037991|student_B|gut microbiota|microbiome|used by|SND|biomedical technique
36037991|student_B|hippocampus|anatomical location|located in|mice|animal
36037991|student_B|splenomegaly|DDF|target|sham-operated mice|animal
36037991|student_B|anti-inflammatory effects|drug|change effect|inflammation-related depression|DDF
36037991|student_B|lipopolysaccharide|chemical|influence|systemic inflammation|DDF
36037991|student_B|LPS|chemical|influence|depression-like phenotype|DDF
36037991|student_B|hippocampus|anatomical location|located in|SND-operated mice|animal
36037991|student_B|microbiota|microbiome|located in|mice|animal
36037991|student_B|gut microbiota|microbiome|is linked to|depression-like phenotype|DDF
36037991|student_B|hippocampus|anatomical location|located in|sham-operated mice|animal
36037991|student_B|abnormal composition|DDF|target|adult mice|animal
36037991|student_B|gut microbiota|microbiome|located in|adult mice|animal
36037991|student_B|LPS|chemical|impact|gut microbiota|microbiome
36037991|student_B|systemic inflammation|DDF|target|adult mice|animal
35144237|student_A|genera|bacteria|influence|PD|DDF
35144237|student_A|gut microbiota|microbiome|is linked to|neurodegeneration|DDF
35144237|student_A|MeDi|dietary supplement|influence|PD|DDF
35144237|student_A|Mediterranean diet|dietary supplement|impact|gut microbiota|microbiome
35144237|student_A|MeDi|dietary supplement|impact|genera|bacteria
35144237|student_A|genera|bacteria|influence|AD|DDF
35144237|student_A|MeDi|dietary supplement|influence|neurodegeneration|DDF
35144237|student_A|MeDi|dietary supplement|influence|AD|DDF
35144237|student_A|MeDi|dietary supplement|impact|gut microbiota|microbiome
39271063|student_A|LP299v|bacteria|interact|N-acyl taurines|chemical
39271063|student_A|Observed metabolic changes|DDF|affect|gut microbiota disruption|DDF
39271063|student_A|major depression|DDF|target|patients|human
39271063|student_A|LP299v|bacteria|influence|improved mitochondrial function|DDF
39271063|student_A|LP299v|bacteria|interact|long-chain acylcarnitines|chemical
34839011|student_A|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
34839011|student_A|Gut Microbiota|microbiome|is linked to|Parkinson'sDisease|DDF
34839011|student_A|Resistant Starch|dietary supplement|influence|Parkinson'sDisease|DDF
34839011|student_A|gut microbiota|microbiome|is linked to|PD|DDF
35449203|student_A|Disturbances of circulating amino acids|DDF|target|patients|human
35449203|student_A|plasma BCAAs|chemical|located in|PD patients|human
35449203|student_A|AAA|chemical|located in|PD patients|human
35449203|student_A|AAAs|chemical|influence|Hoehn and Yahr stage|DDF
35449203|student_A|Plasma branched-chain and aromatic amino acids|chemical|produced by|gut microbiota|microbiome
35449203|student_A|disturbances of plasma BCAAs and AAAs|DDF|affect|PD severity|DDF
35449203|student_A|valine|chemical|located in|PD patients|human
35449203|student_A|isoleucine|chemical|located in|PD patients|human
35449203|student_A|phenylalanine|chemical|located in|PD patients|human
35449203|student_A|BCAAs|chemical|produced by|microbial taxa|microbiome
35449203|student_A|Parkinson's disease|DDF|target|patients|human
35449203|student_A|microbial composition|microbiome|located in|advanced PD patients|human
35449203|student_A|PD patients|human|used by|microbiota sequencing|biomedical technique
35449203|student_A|PD|DDF|target|patients|human
35449203|student_A|leucine|chemical|located in|PD patients|human
35449203|student_A|fecal BCAA|chemical|located in|advanced PD patients|human
35449203|student_A|gut microbiota|microbiome|located in|PD patients|human
35449203|student_A|BCAAs|chemical|influence|Hoehn and Yahr stage|DDF
35449203|student_A|Plasma BCAA|chemical|located in|PD patients|human
35449203|student_A|Plasma branched-chain and aromatic amino acids|chemical|influence|Parkinson's disease|DDF
35449203|student_A|AAAs|chemical|produced by|microbial taxa|microbiome
35449203|student_A|BCAA|chemical|located in|early PD patients|human
35449203|student_A|AAA|chemical|located in|early PD patients|human
35449203|student_A|PD patients|human|used by|functional analysis|biomedical technique
35449203|student_A|tyrosine|chemical|located in|PD patients|human
35449203|student_A|disturbances of plasma BCAAs and AAAs|DDF|target|PD patients|human
35449203|student_A|plasma BCAA and AAA|chemical|located in|PD patients|human
35886849|student_A|Parkinson's disease|DDF|affect|dopaminergic neuron degeneration|DDF
35886849|student_A|gut microbiota|microbiome|is linked to|PD|DDF
35886849|student_A|gut microbiota|microbiome|is linked to|dopamine-related pathologies|DDF
35886849|student_A|PD|DDF|affect|dopaminergic neuron degeneration|DDF
33417973|student_A|misfolded protein α-syn|chemical|located in|olfactory bulb|anatomical location
33417973|student_A|Parkinson's disease|DDF|strike|brain|anatomical location
33417973|student_A|gut microbial dysbiosis|DDF|interact|pathogenic microbial metabolites|chemical
33417973|student_A|gut microbiota|microbiome|is linked to|PD|DDF
33417973|student_A|pathogenic microbial metabolites|chemical|influence|neuroinflammation|DDF
33417973|student_A|microbial gut dysbiosis|DDF|interact|pathogenic microbial metabolites|chemical
33417973|student_A|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
33417973|student_A|misfolded protein α-syn|chemical|located in|gut|anatomical location
33417973|student_A|PD|DDF|strike|brain|anatomical location
33417973|student_A|Parkinson's disease|DDF|strike|gut|anatomical location
33417973|student_A|misfolded protein α-syn|chemical|influence|PD|DDF
33417973|student_A|misfolded protein α-syn|chemical|located in|vagus nerve|anatomical location
33417973|student_A|inflammation|DDF|strike|gut|anatomical location
33417973|student_A|PD|DDF|strike|gut|anatomical location
33417973|student_A|misfolded protein α-syn|chemical|influence|Parkinson's disease|DDF
36329546|student_A|Gut microbes|microbiome|is linked to|eating disorders|DDF
36329546|student_A|Gut microbes|microbiome|is linked to|depression|DDF
36329546|student_A|gut microbiota|microbiome|is linked to|eating disorders|DDF
36329546|student_A|Gut microbes|microbiome|is linked to|obesity|DDF
36329546|student_A|gut microbiome|microbiome|is linked to|EDs|DDF
36329546|student_A|microbiome-directed supplemental foods|food|influence|EDs|DDF
36329546|student_A|gut microbes|microbiome|is linked to|EDs|DDF
36329546|student_A|Gut microbes|microbiome|is linked to|mental health disorders|DDF
36329546|student_A|probiotics|dietary supplement|influence|EDs|DDF
36329546|student_A|Gut microbes|microbiome|is linked to|EDs|DDF
36329546|student_A|gut microbiome|microbiome|is linked to|eating disorders|DDF
36329546|student_A|Gut microbes|microbiome|is linked to|anxiety|DDF
38737108|student_A|Cucurbitacin E|chemical|influence|Inflammation Response|DDF
38737108|student_A|cucurbitacin E|chemical|influence|DSS-induced alterations|DDF
38737108|student_A|cucurbitacin E|chemical|influence|microbiota composition|DDF
38737108|student_A|cucurbitacin E|chemical|influence|host gene expression|DDF
38737108|student_A|Muribaculaceae|bacteria|change expression|DEGs|gene
38737108|student_A|Cucurbitacin E|chemical|influence|Colonic Barrier Function Impairment|DDF
38737108|student_A|cucurbitacin E|chemical|influence|colitis|DDF
38737108|student_A|Escherichia-Shigella|bacteria|change expression|DEGs|gene
38737108|student_A|cucurbitacin E|chemical|influence|inflammatory response|DDF
38737108|student_A|cucurbitacin E|chemical|influence|impaired colonic morphology|DDF
38737108|student_A|cucurbitacin E|chemical|influence|Intestinal tight junction|DDF
38737108|student_A|cucurbitacin E|chemical|influence|DSS-induced body weight loss|DDF
38737108|student_A|Cucurbitacin E|chemical|interact|inflammatory cytokines|chemical
38737108|student_A|Cucurbitacin E|chemical|influence|inflammatory response|DDF
35779869|student_A|gut microbiota|microbiome|is linked to|neurological diseases|DDF
35779869|student_A|gut microbiota|microbiome|is linked to|Alzheimer disease|DDF
35779869|student_A|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
35779869|student_A|gut microbiota|microbiome|is linked to|amyotrophic lateral sclerosis|DDF
35779869|student_A|gut microbiota|microbiome|is linked to|neuromyelitis optica|DDF
35779869|student_A|gut microbiota|microbiome|is linked to|multiple sclerosis|DDF
35873830|student_A|probiotics|dietary supplement|influence|PD|DDF
35873830|student_A|GI motility agents|drug|change effect|PD|DDF
35873830|student_A|antibiotics|drug|change effect|PD|DDF
35873830|student_A|GI peptides|drug|change effect|PD|DDF
35302147|student_B|dysbiosis of mouse gut microbiota|DDF|change abundance|Lachnospiraceae|bacteria
35302147|student_B|dysbiosis of mouse gut microbiota|DDF|change abundance|NK4A136|bacteria
35302147|student_B|probiotics|dietary supplement|influence|chronic stress|DDF
35302147|student_B|Lactobacillus rhamnosus|bacteria|influence|depression|DDF
35302147|student_B|L. rhamnosus|bacteria|influence|intestinal inflammation|DDF
35302147|student_B|Lactobacillus rhamnosus|bacteria|influence|chronic unpredictable mild stress-induced depression|DDF
35302147|student_B|L. rhamnosus|bacteria|influence|dysbiosis of mouse gut microbiota|DDF
35302147|student_B|intestinal microenvironment|microbiome|located in|mice|animal
35302147|student_B|intestinal microenvironment|microbiome|is linked to|chronic unpredictable mild stress-induced depression|DDF
35302147|student_B|probiotics|dietary supplement|influence|depression|DDF
35302147|student_B|intestinal damage|DDF|target|mice|animal
35302147|student_B|intestinal inflammation|DDF|target|mice|animal
35302147|student_B|L. rhamnosus|bacteria|influence|intestinal damage|DDF
35302147|student_B|L. rhamnosus|bacteria|influence|depression|DDF
35302147|student_B|sucrose|chemical|influence|CUMS-induced depression-like behaviors|DDF
35302147|student_B|gut microenvironment|microbiome|is linked to|stress-related psychiatric disorders|DDF
35302147|student_B|L. rhamnosus|bacteria|influence|CUMS-induced depression-like behaviors|DDF
35302147|student_B|dysbiosis of mouse gut microbiota|DDF|change abundance|Bacteroides|bacteria
35302147|student_B|chronic unpredictable mild stress-induced depression|DDF|target|mice|animal
35302147|student_B|dysbiosis of mouse gut microbiota|DDF|change abundance|Muribaculum|bacteria
36160716|student_A|psychobiotics|drug|change effect|neuropsychiatric diseases|DDF
36160716|student_A|psychotherapeutic treatments|drug|change effect|depressive mood|DDF
36160716|student_A|gut microbiota|microbiome|located in|intestinal tract|anatomical location
34795270|student_A|micronutrients|dietary supplement|influence|child malnutrition|DDF
34795270|student_A|micronutrients|dietary supplement|impact|gut microbiota|microbiome
35704960|student_A|Irritable bowel syndrome|DDF|target|patients|human
35704960|student_A|food supplement|dietary supplement|influence|Irritable bowel syndrome|DDF
35704960|student_A|limonene|chemical|influence|irritable bowel syndrome|DDF
35704960|student_A|menthol|chemical|influence|IBS|DDF
35704960|student_A|gingerol|chemical|influence|Irritable bowel syndrome|DDF
35704960|student_A|gingerol|chemical|influence|IBS/functional dyspepsia|DDF
35704960|student_A|Group 1|human|used by|double-blind, randomized, placebo-controlled trial|biomedical technique
35704960|student_A|group 2|human|used by|double-blind, randomized, placebo-controlled trial|biomedical technique
35704960|student_A|limonene|chemical|influence|IBS/FD|DDF
35704960|student_A|IBS/functional dyspepsia|DDF|target|human participants|human
35704960|student_A|antidiarrheals|drug|change effect|Irritable bowel syndrome|DDF
35704960|student_A|intestinal microbiota|microbiome|used by|16S rRNA gene sequencing|biomedical technique
35704960|student_A|limonene|chemical|influence|IBS/functional dyspepsia|DDF
35704960|student_A|spasmolytics|drug|change effect|IBS|DDF
35704960|student_A|laxatives|drug|change effect|IBS|DDF
35704960|student_A|food supplement|dietary supplement|influence|IBS|DDF
35704960|student_A|limonene|chemical|influence|FD|DDF
35704960|student_A|control group|human|used by|double-blind, randomized, placebo-controlled trial|biomedical technique
35704960|student_A|limonene|chemical|influence|Irritable bowel syndrome|DDF
35704960|student_A|IBS|DDF|target|human participants|human
35704960|student_A|antidiarrheals|drug|change effect|IBS|DDF
35704960|student_A|menthol|chemical|influence|irritable bowel syndrome|DDF
35704960|student_A|patients|human|used by|double-blind, randomized, placebo-controlled trial|biomedical technique
35704960|student_A|gingerol|chemical|influence|IBS|DDF
35704960|student_A|Group 2|human|used by|double-blind, randomized, placebo-controlled trial|biomedical technique
35704960|student_A|irritable bowel syndrome|DDF|target|patients|human
35704960|student_A|menthol|chemical|influence|IBS/FD|DDF
35704960|student_A|menthol|chemical|influence|FD|DDF
35704960|student_A|IBS|DDF|target|patients|human
35704960|student_A|menthol|chemical|influence|IBS/functional dyspepsia|DDF
35704960|student_A|group 1|human|used by|double-blind, randomized, placebo-controlled trial|biomedical technique
35704960|student_A|laxatives|drug|change effect|irritable bowel syndrome|DDF
35704960|student_A|spasmolytics|drug|change effect|irritable bowel syndrome|DDF
35704960|student_A|gingerol|chemical|influence|IBS/FD|DDF
35704960|student_A|food supplement|dietary supplement|influence|irritable bowel syndrome|DDF
35704960|student_A|menthol|chemical|influence|Irritable bowel syndrome|DDF
35704960|student_A|intervention group|human|used by|double-blind, randomized, placebo-controlled trial|biomedical technique
35704960|student_A|IBS/FD|DDF|target|human participants|human
35704960|student_A|gingerol|chemical|influence|irritable bowel syndrome|DDF
35704960|student_A|antidiarrheals|drug|change effect|irritable bowel syndrome|DDF
35704960|student_A|limonene|chemical|influence|IBS|DDF
35704960|student_A|food supplement|dietary supplement|influence|IBS/functional dyspepsia|DDF
35704960|student_A|FD|DDF|target|human participants|human
35704960|student_A|food supplement|dietary supplement|influence|IBS/FD|DDF
35704960|student_A|gingerol|chemical|influence|FD|DDF
35704960|student_A|laxatives|drug|change effect|Irritable bowel syndrome|DDF
35704960|student_A|spasmolytics|drug|change effect|Irritable bowel syndrome|DDF
35704960|student_A|food supplement|dietary supplement|influence|FD|DDF
39134099|student_A|lurasidone|drug|change effect|significant food effect|DDF
39134099|student_A|gut microbiota interactions|DDF|interact|commonly employed formulations|chemical
39134099|student_A|pharmaceutical excipients|chemical|impact|gut microbiota|microbiome
39134099|student_A|gut microbiota|microbiome|is linked to|mood|DDF
39134099|student_A|poorly soluble antipsychotic|drug|change effect|rate-limiting dissolution|DDF
39134099|student_A|rats|animal|used by|oral pharmacokinetics|biomedical technique
39134099|student_A|effective solubility-enhancing formulations|drug|impact|gut microbiota|microbiome
39134099|student_A|contrasting effects|DDF|change abundance|gut microbiota|microbiome
39134099|student_A|lurasidone|drug|change effect|poor oral bioavailability|DDF
39134099|student_A|poorly soluble antipsychotic|drug|change effect|significant food effect|DDF
39134099|student_A|poorly soluble antipsychotic|drug|change effect|poor oral bioavailability|DDF
39134099|student_A|lurasidone|drug|change effect|rate-limiting dissolution|DDF
39134099|student_A|schizophrenia|DDF|is a|mental health disorders|DDF
39134099|student_A|oral drugs|drug|impact|gut microbiota|microbiome
39134099|student_A|pharmacokinetic performance|DDF|interact|commonly employed formulations|chemical
39134099|student_A|gut microbiota|microbiome|is linked to|cognition|DDF
39134099|student_A|oral formulations|drug|change effect|contrasting effects|DDF
35889348|student_B|QUR|chemical|impact|gut microbiota|microbiome
35889348|student_B|Polycystic ovary syndrome|DDF|target|women of childbearing age|human
35889348|student_B|QUR|chemical|influence|ovulation disorder|DDF
35889348|student_B|QUR|chemical|influence|PCOS|DDF
35889348|student_B|QUR|chemical|interact|androgen|chemical
35889348|student_B|QUR|chemical|influence|Insulin resistance|DDF
35889348|student_B|QUR|chemical|influence|IR|DDF
35889348|student_B|PCOS|DDF|target|women of childbearing age|human
35889348|student_B|Quercetin|chemical|influence|Polycystic Ovary Syndrome|DDF
35889348|student_B|Quercetin|chemical|influence|PCOS|DDF
35806985|student_B|neurodegenerative diseases|DDF|target|patients|human
35806985|student_B|gut microbiota|microbiome|is linked to|Parkinson’s disease|DDF
35806985|student_B|Crohn’s disease|DDF|target|patients|human
35806985|student_B|Parkinson's Disease|DDF|target|Patients|human
35806985|student_B|gut microbiota|microbiome|is linked to|Alzheimer’s disease|DDF
35806985|student_B|gut microbiota|microbiome|is linked to|central nervous system diseases|DDF
35806985|student_B|ulcerative colitis|DDF|target|patients|human
35806985|student_B|Alzheimer's Disease|DDF|target|Patients|human
35806985|student_B|Inflammatory Bowel Disease|DDF|target|Patients|human
36422338|student_B|Probiotics|dietary supplement|influence|Autism spectrum disorders|DDF
36422338|student_B|gut microbiota|microbiome|is linked to|Autism spectrum disorders|DDF
36422338|student_B|Gut microbiota|microbiome|is linked to|gut disorders|DDF
36422338|student_B|Probiotics|dietary supplement|impact|Gut microbiota|microbiome
36422338|student_B|Probiotics|dietary supplement|influence|Neurological Diseases|DDF
36422338|student_B|Probiotics|dietary supplement|impact|Lactobacillus|bacteria
36422338|student_B|gut microbiota|microbiome|is linked to|Neurological Diseases|DDF
36422338|student_B|Probiotics|dietary supplement|influence|cognitive impairment|DDF
36422338|student_B|Probiotics|dietary supplement|influence|psychiatric diseases|DDF
36422338|student_B|gut microbiota|microbiome|is linked to|cognitive impairment|DDF
36422338|student_B|diet|dietary supplement|impact|gut microbiota|microbiome
36422338|student_B|gut microbiota|microbiome|is linked to|depression|DDF
36422338|student_B|gut microbiota|microbiome|is linked to|anxiety|DDF
36422338|student_B|Probiotics|dietary supplement|influence|depression|DDF
36422338|student_B|Probiotics|dietary supplement|influence|anxiety|DDF
36422338|student_B|brain|anatomical location|located in|host|human
36422338|student_B|Gut microbiota|microbiome|is linked to|psychiatric disorders|DDF
36422338|student_B|brain-derived neurotrophic factors|chemical|impact|gut microbiota|microbiome
36422338|student_B|Probiotics|dietary supplement|impact|Bifidobacterium|bacteria
36422338|student_B|gut|anatomical location|located in|host|human
36422338|student_B|gut microbiota|microbiome|located in|gut|anatomical location
36422338|student_B|Probiotics|dietary supplement|influence|Alzheimer's|DDF
36422338|student_B|Probiotics|dietary supplement|influence|metabolic|DDF
36422338|student_B|gut microbiota|microbiome|is linked to|Alzheimer's|DDF
36422338|student_B|Probiotics|dietary supplement|influence|neurological disorders|DDF
36422338|student_B|Probiotics|dietary supplement|influence|Parkinson's diseases|DDF
36422338|student_B|Gut microbiota|microbiome|is linked to|neurocognitive|DDF
36422338|student_B|gut microbiota|microbiome|is linked to|neurological disorders|DDF
36422338|student_B|gut microbiota|microbiome|is linked to|Parkinson's diseases|DDF
34783227|student_A|H<sub>2</sub>|chemical|impact|butyrate-producing bacteria|bacteria
34783227|student_A|exogenous H<sub>2</sub>|chemical|impact|gut microbiota|microbiome
32712266|student_A|severe parkinsonism|DDF|target|male cases|animal
32712266|student_A|MPTP|chemical|influence|clinical motor symptoms|DDF
32712266|student_A|inflammation|DDF|affect|prodromal/pre-motor features|DDF
32712266|student_A|Inflammation|DDF|affect|nonmotor symptoms|DDF
32712266|student_A|XPro1595|drug|change effect|PD|DDF
32712266|student_A|XPro1595|drug|administered|monkeys|animal
32712266|student_A|inflammation|DDF|affect|PD-like degeneration|DDF
32712266|student_A|inflammation|DDF|target|non-human primates|animal
32712266|student_A|inflammation|DDF|target|female cases|animal
32712266|student_A|MPTP|chemical|influence|inflammation|DDF
32712266|student_A|XPro1595|drug|change effect|inflammation|DDF
32712266|student_A|severe parkinsonism|DDF|target|female cases|animal
32712266|student_A|MPTP-induced central and peripheral inflammatory dysfunction|DDF|target|non-human primates|animal
32712266|student_A|TNF inhibitor XPro1595|drug|change effect|PD|DDF
32712266|student_A|progressive parkinsonism|DDF|target|non-human primates|animal
32712266|student_A|TNF inhibitor XPro1595|drug|administered|monkeys|animal
32712266|student_A|PD-like degeneration|DDF|target|non-human primates|animal
32712266|student_A|TNF inhibitor XPro1595|drug|change effect|inflammation|DDF
32712266|student_A|prodromal/pre-motor features|DDF|target|non-human primates|animal
32712266|student_A|microbiota|microbiome|is linked to|MPTP-induced progressive central and peripheral inflammation|DDF
32712266|student_A|MPTP|chemical|influence|nigrostriatal dopaminergic loss|DDF
32712266|student_A|microbiota|microbiome|is linked to|nonmotor symptoms|DDF
32712266|student_A|MPTP|chemical|influence|PD|DDF
32712266|student_A|Monkeys|animal|used by|FEPPA PET scans|biomedical technique
32712266|student_A|inflammation|DDF|target|male cases|animal
39187187|student_A|chronic unpredictable mild stress|DDF|target|depressed mother|animal
39187187|student_A|gut microbiota|microbiome|located in|depressed/normal mother rats|animal
39187187|student_A|milder anxiety|DDF|target|depressed father rats|animal
39187187|student_A|intestinal microbiota|microbiome|located in|mothers|human
39187187|student_A|depression|DDF|target|Depressed mother rats|animal
39187187|student_A|chronic unpredictable mild stress|DDF|target|father rats|animal
39187187|student_A|CUMS|DDF|target|Offspring rats|animal
39187187|student_A|anxiety/depression|DDF|target|depressed mothers|animal
39187187|student_A|intestinal microbiota|microbiome|is linked to|childhood anxiety|DDF
39187187|student_A|gut microbiota|microbiome|located in|pups|animal
39187187|student_A|depression|DDF|target|mothers|human
39187187|student_A|CUMS|DDF|target|depressed mother|animal
39187187|student_A|gut microbiota|microbiome|used by|FMT|biomedical technique
39187187|student_A|anxiety/depression|DDF|target|offspring|animal
39187187|student_A|CUMS|DDF|target|father rats|animal
39187187|student_A|childhood anxiety|DDF|target|mothers|human
39187187|student_A|fecal microbiota|microbiome|located in|pups|animal
39187187|student_A|anxiety|DDF|target|Depressed mother rats|animal
39187187|student_A|depressed/normal mother rats|animal|used by|FMT|biomedical technique
39187187|student_A|gut microbiota|microbiome|located in|offspring rats|animal
39187187|student_A|offspring rats|animal|used by|FMT|biomedical technique
39187187|student_A|fecal microbiota|microbiome|used by|FMT|biomedical technique
39187187|student_A|anxiety- and depression-like behaviors|DDF|target|pups|animal
39187187|student_A|depression|DDF|target|children|human
39187187|student_A|intestinal microbiota|microbiome|is linked to|depression|DDF
39187187|student_A|intestinal microbiota|microbiome|is linked to|anxiety/depression|DDF
39187187|student_A|maternal depression|DDF|target|offspring|animal
39187187|student_A|depression|DDF|target|cohabited rat pups|animal
39187187|student_A|depression|DDF|target|depressed father rats|animal
39187187|student_A|anxiety|DDF|target|cohabited rat pups|animal
39187187|student_A|anxiety/depression|DDF|target|depressed mother rats|animal
39187187|student_A|anxiety/depression|DDF|target|pups|animal
39187187|student_A|childhood anxiety|DDF|target|children|human
39187187|student_A|anxiety/depression|DDF|target|children|human
39187187|student_A|anxiety- and depression-like behaviors|DDF|target|mother|animal
39187187|student_A|anxiety- and depression-like behaviors|DDF|target|father|animal
39187187|student_A|anxiety/depression|DDF|target|cohabited offspring|animal
39187187|student_A|chronic unpredictable mild stress|DDF|target|Offspring rats|animal
35788394|student_A|sulforaphane glucosinolate|chemical|impact|gut microbiota|microbiome
35788394|student_A|SGS|chemical|impact|gut microbiota|microbiome
35788394|student_A|behavioral abnormalities|DDF|target|offspring|animal
35788394|student_A|gut microbiota|microbiome|located in|adult offspring|animal
35788394|student_A|IL-6|chemical|impact|genus Blautia|bacteria
35788394|student_A|stress-related psychiatric disorders|DDF|target|offspring|animal
35788394|student_A|lipopolysaccharide|chemical|impact|gut microbiota|microbiome
35788394|student_A|gut microbiota|microbiome|located in|3-week-old offspring|animal
35788394|student_A|gut microbiota|microbiome|located in|offspring|animal
35788394|student_A|sulforaphane glucosinolate|chemical|influence|behavioral abnormalities|DDF
35788394|student_A|gut microbiota|microbiome|located in|SGS-10W group|animal
35788394|student_A|TNF-α|chemical|impact|genus Blautia|bacteria
35788394|student_A|gut microbiota|microbiome|is linked to|stress-related psychiatric disorders|DDF
35788394|student_A|SGS|chemical|influence|behavioral abnormalities|DDF
35788394|student_A|gut microbiota|microbiome|located in|10-week-old offspring|animal
35788394|student_A|gut microbiota|microbiome|located in|SGS-3W group|animal
35788394|student_A|SGS|chemical|influence|stress-related psychiatric disorders|DDF
35788394|student_A|LPS|chemical|impact|gut microbiota|microbiome
35788394|student_A|genus Blautia|bacteria|part of|gut microbiota|microbiome
38960582|student_A|IS|chemical|influence|gut microbiota depletion|DDF
38960582|student_A|indoxyl sulfate|chemical|influence|RIA|DDF
38960582|student_A|UIA|DDF|target|patients|human
38960582|student_A|stage-specific gut-microbiome-derived metabolites|chemical|influence|intracranial aneurysms|DDF
38960582|student_A|ruptured IA|DDF|target|patients|human
38960582|student_A|antibiotics|drug|change effect|Gut microbiota depletion|DDF
38960582|student_A|metabolites|chemical|produced by|gut microbiota|microbiome
38960582|student_A|tryptophan metabolites|chemical|influence|RIA|DDF
38960582|student_A|gut microbiota|microbiome|is linked to|intracranial aneurysms|DDF
38960582|student_A|RIA|DDF|target|patients|human
38960582|student_A|indole-producing microbiota|bacteria|part of|gut microbiome|microbiome
38960582|student_A|IS|chemical|influence|RIA|DDF
38960582|student_A|IA|DDF|target|mice|animal
38960582|student_A|IS|chemical|influence|elastin degradation|DDF
38960582|student_A|gut microbiota|microbiome|is linked to|IA|DDF
38960582|student_A|unruptured IA|DDF|target|patients|human
36558556|student_B|infants’ SCFAs|microbiome|located in|breastfeeding group|human
36558556|student_B|breast milk microbiota|microbiome|located in|breastfeeding group|human
36558556|student_B|breast milk microbiota|microbiome|compared to|gut microbiota|microbiome
36558556|student_B|breast milk microbiota|microbiome|compared to|infants’ SCFAs|microbiome
36558556|student_B|breast milk microbiota|microbiome|located in|mixed feeding group|human
36558556|student_B|Actinobacteriota|bacteria|part of|dominated breast milk gut microbiota|microbiome
36558556|student_B|breast milk microbiota|microbiome|compared to|infant gut microbiota|microbiome
36558556|student_B|breast milk microbiota|microbiome|compared to|infant’s gut microbiota|microbiome
36558556|student_B|SCFAs|chemical|produced by|infant gut microbiota|microbiome
36558556|student_B|SCFAs|chemical|produced by|breast milk microbiota|microbiome
36558556|student_B|Bifidobacterium|bacteria|part of|infant gut microbiota|microbiome
36558556|student_B|breast milk microbiota|microbiome|located in|newborns|human
36558556|student_B|key strains|bacteria|part of|infant gut microbiota|microbiome
36558556|student_B|gut microbiota|microbiome|located in|newborns|human
36558556|student_B|Lactobacillus|bacteria|part of|infant gut microbiota|microbiome
36558556|student_B|newborns|human|used by|SCFA detection|biomedical technique
36558556|student_B|Proteobacteria|bacteria|part of|dominated breast milk gut microbiota|microbiome
36558556|student_B|newborns|human|used by|16S rRNA second-generation sequencing|biomedical technique
36558556|student_B|Firmicutes|bacteria|part of|dominated breast milk gut microbiota|microbiome
36558556|student_B|Breast Milk Microbiota|microbiome|compared to|Infant Gut Microbiota|microbiome
36558556|student_B|infants’ SCFAs|microbiome|located in|mixed feeding group|human
36558556|student_B|Enterobacter|bacteria|part of|infant gut microbiota|microbiome
35956326|student_A|oxidative stress|DDF|change abundance|maternal microbiota|microbiome
35956326|student_A|maternal microbiota|microbiome|is linked to|mental disorders|DDF
35956326|student_A|Maternal Microbiota|microbiome|is linked to|Neurodevelopmental Disorders|DDF
35956326|student_A|maternal obesity-related gut dysbiosis|DDF|change abundance|maternal microbiota|microbiome
35956326|student_A|inflamed womb|DDF|affect|dysbiosis|DDF
35956326|student_A|Obesity|DDF|affect|low-grade chronic systemic inflammation|DDF
35956326|student_A|Maternal Obesity|DDF|change abundance|Maternal Microbiota|microbiome
35956326|student_A|inflammation|DDF|change abundance|maternal microbiota|microbiome
35956326|student_A|maternal obesity|DDF|change abundance|maternal microbiota|microbiome
39139979|student_A|PCOS|DDF|target|women|human
39139979|student_A|Polycystic Ovary Syndrome|DDF|target|women|human
39139979|student_A|Kefir|food|impact|microbiota|microbiome
39139979|student_A|kefir|food|impact|class Bacilli|bacteria
39139979|student_A|kefir|food|impact|microbiota|microbiome
39139979|student_A|polycystic ovary syndrome|DDF|target|women|human
39139979|student_A|Kefir|food|impact|class Bacilli|bacteria
39139979|student_A|polycystic ovary syndrome|DDF|target|women of reproductive age|human
39139979|student_A|PCOS|DDF|target|women of reproductive age|human
39139979|student_A|kefir|food|impact|genus <i>Holdemania</i>|bacteria
39139979|student_A|Kefir|food|impact|genus <i>Holdemania</i>|bacteria
39139979|student_A|Kefir|food|impact|genus <i>Lactococcus</i>|bacteria
39139979|student_A|kefir|food|impact|genus <i>Lactococcus</i>|bacteria
39139979|student_A|Polycystic Ovary Syndrome|DDF|target|women of reproductive age|human
35562885|student_B|MDD|DDF|change abundance|gut microbiome|microbiome
35562885|student_B|Gut Microbiome|microbiome|is linked to|Depression|DDF
35562885|student_B|Probiotic and synbiotic, but not prebiotic, treatment|dietary supplement|influence|MDD|DDF
35562885|student_B|gut microbiome|microbiome|located in|patients with major depressive disorder|human
35562885|student_B|MDD|DDF|target|patients with major depressive disorder|human
35562885|student_B|GMB|microbiome|located in|patients with major depressive disorder|human
35562885|student_B|MDD|DDF|change abundance|GMB|microbiome
33293403|student_A|Early-stage gut dysbiosis|DDF|affect|iRBD|DDF
33293403|student_A|SCFA-producing bacteria|bacteria|influence|PD|DDF
33293403|student_A|iRBD patients|human|used by|16S rRNA sequencing|biomedical technique
33293403|student_A|α-synuclein fibrils|chemical|influence|PD|DDF
33293403|student_A|controls|human|used by|16S rRNA-seq|biomedical technique
33293403|student_A|PD|DDF|change abundance|Genus <i>Akkermansia</i>|bacteria
33293403|student_A|Gut dysbiosis|DDF|affect|iRBD|DDF
33293403|student_A|PD|DDF|target|iRBD patients|human
33293403|student_A|iRBD|DDF|change abundance|mucin-layer-degrading genus <i>Akkermansia</i>|bacteria
33293403|student_A|Short-chain fatty acid (SCFA)-producing bacteria|bacteria|influence|PD|DDF
33293403|student_A|α-synucleinopathy|DDF|change abundance|mucin-layer-degrading genus <i>Akkermansia</i>|bacteria
33293403|student_A|gut microbiota|microbiome|located in|iRBD patients|human
33293403|student_A|gut microbiota|microbiome|located in|controls|human
33293403|student_A|iRBD patients|human|used by|16S rRNA-seq|biomedical technique
33293403|student_A|PD|DDF|change abundance|SCFA-producing genera|bacteria
33293403|student_A|intestinal SCFA|chemical|influence|PD|DDF
33293403|student_A|abnormal aggregation|DDF|strike|intestine|anatomical location
33293403|student_A|PD|DDF|change abundance|family <i>Akkermansiaceae</i>|bacteria
33293403|student_A|gut microbiota|microbiome|is linked to|PD|DDF
33293403|student_A|prion-like α-synuclein fibrils|chemical|influence|abnormal aggregation|DDF
33293403|student_A|prion-like α-synuclein fibrils|chemical|located in|intestine|anatomical location
33293403|student_A|Gut dysbiosis|DDF|affect|idiopathic rapid-eye-movement sleep behavior disorder|DDF
33293403|student_A|gut microbiota|microbiome|located in|PD patients|human
33293403|student_A|Short-Chain Fatty Acid-Producing Gut Microbiota|chemical|influence|Parkinson's Disease|DDF
33293403|student_A|iRBD|DDF|change abundance|Genus <i>Akkermansia</i>|bacteria
33293403|student_A|iRBD|DDF|change abundance|Short-chain fatty acid (SCFA)-producing bacteria|bacteria
33293403|student_A|Short-Chain Fatty Acid-Producing Gut Microbiota|chemical|influence|Rapid-Eye-Movement Sleep Behavior Disorder|DDF
33293403|student_A|intestinal SCFA|chemical|influence|iRBD|DDF
33293403|student_A|controls|human|used by|single-cell RNA sequencing (RNA-seq) analysis|biomedical technique
33293403|student_A|controls|human|used by|16S rRNA sequencing|biomedical technique
33293403|student_A|Short-chain fatty acid (SCFA)-producing bacteria|bacteria|located in|controls|human
33293403|student_A|iRBD|DDF|change abundance|family <i>Akkermansiaceae</i>|bacteria
38792361|student_B|gut microbiota|microbiome|is linked to|schizophrenia|DDF
38792361|student_B|KD|dietary supplement|influence|mental disorders|DDF
38792361|student_B|KD|dietary supplement|influence|inflammation|DDF
38792361|student_B|KD|dietary supplement|influence|disease-related symptoms|DDF
38792361|student_B|KD|dietary supplement|influence|oxidative stress|DDF
38792361|student_B|Ketogenic Diet|dietary supplement|influence|Serious Mental Illness|DDF
38792361|student_B|gut microbiota|microbiome|is linked to|serious mental illness|DDF
38792361|student_B|KD|dietary supplement|influence|weight gain reduction|DDF
38792361|student_B|gut microbiota|microbiome|is linked to|major depressive disorder|DDF
38792361|student_B|KD|dietary supplement|influence|SMI|DDF
38792361|student_B|KD|dietary supplement|influence|carbohydrate and lipid metabolism|DDF
38792361|student_B|KD|dietary supplement|impact|gut microbiota|microbiome
38792361|student_B|gut microbiota|microbiome|is linked to|bipolar disorder|DDF
38792361|student_B|gut microbiota|microbiome|is linked to|SMI|DDF
33459114|student_A|gut microbiota|microbiome|is linked to|motor symptoms|DDF
33459114|student_A|epithelial barrier dysfunction|DDF|affect|motor symptom generation|DDF
33459114|student_A|gut microbiota|microbiome|is linked to|motor symptom generation|DDF
33459114|student_A|gut microbiota|microbiome|is linked to|motor deficits|DDF
33459114|student_A|gut microbiota|microbiome|is linked to|gastrointestinal dysfunction|DDF
33459114|student_A|gut microbiota|microbiome|is linked to|barrier dysfunction|DDF
36278467|student_B|levodopa|drug|impact|Clostridium sporogenes|bacteria
36278467|student_B|levodopa|drug|impact|intestinal bacteria|bacteria
36278467|student_B|levodopa|drug|impact|Eggerthella lenta|bacteria
36278467|student_B|Levodopa|drug|change effect|PD|DDF
36278467|student_B|levodopa|drug|impact|Enterococcus faecalis|bacteria
38960388|student_A|GABA|chemical|influence|major depression|DDF
38960388|student_A|GABA|chemical|influence|anxiety|DDF
38960388|student_A|LPB145|bacteria|influence|antidepressive-like behaviour|DDF
38960388|student_A|GABA|chemical|influence|mental health disorders|DDF
36467550|student_A|curcumin|dietary supplement|influence|cell survival|DDF
36467550|student_A|Curcumin|dietary supplement|influence|Neuroprotective Effect|DDF
36467550|student_A|MPTP|chemical|impact|gut microbiota|microbiome
36467550|student_A|Curcumin|dietary supplement|influence|Parkinson's Disease|DDF
36467550|student_A|mice|animal|used by|open-field test|biomedical technique
36467550|student_A|striatal tissue cells|anatomical location|located in|mice|animal
36467550|student_A|curcumin|dietary supplement|influence|vacuolar degeneration|DDF
36467550|student_A|mice|animal|used by|pole text|biomedical technique
36467550|student_A|Proteobacteria|bacteria|interact|MPTP group|chemical
36467550|student_A|curcumin|dietary supplement|influence|cell wrinkling|DDF
36467550|student_A|curcumin|dietary supplement|change expression|TH|gene
36467550|student_A|Patescibacteria|bacteria|interact|MPTP group|chemical
36467550|student_A|curcumin|dietary supplement|influence|N-acetylneuraminate degradation|DDF
36467550|student_A|Curcumin|dietary supplement|impact|gut microbiota|microbiome
36467550|student_A|Curcumin|dietary supplement|impact|Gut Microbiota|microbiome
36467550|student_A|mice|animal|used by|hanging test|biomedical technique
36467550|student_A|curcumin|dietary supplement|impact|gut microbiota|microbiome
36467550|student_A|curcumin|dietary supplement|influence|motor impairment|DDF
36467550|student_A|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|chemical|impact|gut microbiota|microbiome
36467550|student_A|Verrucomicrobia|bacteria|interact|MPTP group|chemical
36467550|student_A|curcumin|dietary supplement|influence|Parkinson's disease|DDF
35127957|student_A|Piperine|chemical|influence|diabetes|DDF
35127957|student_A|Piperine|chemical|influence|inflammatory diseases|DDF
35127957|student_A|Piperine|chemical|influence|cerebral stroke|DDF
35127957|student_A|piperine|chemical|interact|anti-apoptotic proteins|chemical
35127957|student_A|piperine|chemical|interact|cytochrome P450 3A4|chemical
35127957|student_A|Piperine|chemical|interact|Akt/mTOR/MMP-9|chemical
35127957|student_A|Piperine|chemical|interact|kinase-activated NLR family pyrin domain containing-3 inflammasome|chemical
35127957|student_A|Piperine|chemical|influence|Alzheimer's disease|DDF
35127957|student_A|piperine|chemical|interact|nuclear factor-κB|chemical
35127957|student_A|piperine|chemical|change expression|MicroRNA|gene
35127957|student_A|piperine|chemical|interact|multidrug resistance protein 1|chemical
35127957|student_A|piperine|chemical|interact|activation transcription factor-2|chemical
35127957|student_A|piperine|chemical|interact|P-glycoprotein|chemical
35127957|student_A|Piperine|chemical|interact|5'-AMP-activated protein|chemical
35127957|student_A|piperine|chemical|interact|cell cycle proteins|chemical
35127957|student_A|Piperine|chemical|interact|PKCα/ERK1/2|chemical
35127957|student_A|Piperine|chemical|influence|obesity|DDF
35127957|student_A|Piperine|chemical|influence|arthritis|DDF
35127957|student_A|Piperine|chemical|influence|gastrointestinal disorders|DDF
35127957|student_A|Piperine|chemical|influence|metabolic syndrome|DDF
35127957|student_A|Piperine|chemical|influence|Parkinson's disease|DDF
35127957|student_A|Piperine|chemical|interact|JNK/P38 MAPK|chemical
35127957|student_A|Piperine|chemical|interact|NF-κB/AP-1/MMP-9|chemical
35127957|student_A|piperine|chemical|interact|c-Fos|chemical
35127957|student_A|piperine|chemical|interact|peroxisome proliferator-activated receptor-gamma|chemical
35127957|student_A|Piperine|chemical|influence|breast cancer|DDF
35127957|student_A|piperine|chemical|interact|breast cancer resistance protein|chemical
35127957|student_A|Piperine|chemical|influence|oral cancer|DDF
35127957|student_A|piperine|chemical|change expression|Human G-quadruplex DNA|gene
35127957|student_A|piperine|chemical|interact|cAMP response element-binding protein|chemical
35127957|student_A|Piperine|chemical|part of|drug-metabolizing enzymes|chemical
35127957|student_A|piperine|chemical|interact|Cyclooxygenase-2|chemical
35127957|student_A|Piperine|chemical|influence|kidney diseases|DDF
35127957|student_A|Piperine|chemical|influence|multiple myeloma|DDF
35127957|student_A|piperine|chemical|influence|coronaviruses|DDF
35127957|student_A|Piperine|chemical|impact|gut microbiota|microbiome
35127957|student_A|Piperine|chemical|influence|hypertension|DDF
35127957|student_A|Piperine|chemical|influence|cardiovascular diseases|DDF
35127957|student_A|piperine|chemical|interact|transient receptor potential vanilloid 1 proinflammatory cytokine|chemical
35127957|student_A|Piperine|chemical|influence|rhinopharyngitis|DDF
35127957|student_A|Piperine|chemical|interact|Wnt/β-catenin|chemical
35127957|student_A|piperine|chemical|interact|Nitric oxide synthases-2|chemical
35127957|student_A|Piperine|chemical|interact|voltage-gated K+ current|chemical
35563197|student_A|endogenous host proteins|chemical|interact|bacteria-derived protein aggregates|chemical
35563197|student_A|antibiotics|drug|change effect|Parkinson's disease|DDF
35563197|student_A|antibiotics|drug|change effect|neurodegenerative diseases|DDF
35563197|student_A|antibiotics|drug|impact|gut microbiota|microbiome
35563197|student_A|Neurodegenerative protein conformational diseases|DDF|interact|metastable proteins|chemical
35563197|student_A|endogenous host proteins|chemical|interact|BDPAs|chemical
35563197|student_A|antibiotics|drug|change effect|amyotrophic lateral sclerosis|DDF
35279596|student_B|ICH|DDF|change abundance|Firmicutes|bacteria
35279596|student_B|intracerebral hemorrhage|DDF|target|mice|animal
35279596|student_B|Paenibacillus|bacteria|part of|gut flora|microbiome
35279596|student_B|inhibition|drug|change expression|NLRP3 inflammasome|gene
35279596|student_B|MCC950|drug|impact|Bifidobacterium|bacteria
35279596|student_B|ICH|DDF|change abundance|Campilobacterota|bacteria
35279596|student_B|ICH|DDF|change abundance|Dubosiella|bacteria
35279596|student_B|gut flora|microbiome|located in|mice|animal
35279596|student_B|corticospinal tract injury|DDF|target|mice|animal
35279596|student_B|ICH|DDF|change abundance|Proteobacteria|bacteria
35279596|student_B|inhibition|drug|change effect|CST injury|DDF
35279596|student_B|inhibitor|drug|change effect|CST injury|DDF
35279596|student_B|gut microbiota|microbiome|located in|mice|animal
35279596|student_B|ICH|DDF|change abundance|Faecalibaculum|bacteria
35279596|student_B|MCC950|drug|impact|Bacteroides|bacteria
35279596|student_B|gut microbiota|microbiome|is linked to|CST injury|DDF
35279596|student_B|Bifidobacterium|bacteria|part of|gut flora|microbiome
35279596|student_B|MCC950|drug|change effect|neurological deficits|DDF
35279596|student_B|ICH|DDF|target|Vehicle group|animal
35279596|student_B|inhibitor|drug|impact|gut microbiota|microbiome
35279596|student_B|MCC950|drug|impact|Paenibacillus|bacteria
35279596|student_B|neurobehavioral deficits|DDF|target|mice|animal
35279596|student_B|Bacteroides|bacteria|part of|gut flora|microbiome
35279596|student_B|ICH|DDF|change abundance|Helicobacter|bacteria
35279596|student_B|MCC950|drug|change effect|CST injury|DDF
35279596|student_B|ICH|DDF|target|sham group|animal
35279596|student_B|MCC950|drug|impact|gut microbiota|microbiome
35279596|student_B|ICH|DDF|change abundance|Enterobacter|bacteria
35370947|student_A|gut microbiota|microbiome|located in|ADHD patients|human
35370947|student_A|gut microbiota|microbiome|is linked to|neurodevelopmental disorders|DDF
36058421|student_B|Altered gut microbiota|microbiome|located in|individuals|human
36058421|student_B|autistic symptoms|DDF|affect|ASD|DDF
36058421|student_B|ASD|DDF|target|Participants|human
36058421|student_B|gastrointestinal symptoms|DDF|target|individuals|human
36058421|student_B|ASD|DDF|affect|somatic complaints|DDF
36058421|student_B|altered microbiome|microbiome|is linked to|immune dysregulation|DDF
36058421|student_B|gut microbiota|microbiome|is linked to|GI symptoms|DDF
36058421|student_B|ASD|DDF|target|young men|human
36058421|student_B|molecular biomarkers|chemical|influence|ASD|DDF
36058421|student_B|autism|DDF|target|individuals|human
36058421|student_B|microbial micro-environment|microbiome|is linked to|ASD|DDF
36058421|student_B|gut microbiota|microbiome|is linked to|clinical symptoms|DDF
36058421|student_B|all participants|human|used by|16S V3-V4 rRNA sequencing|biomedical technique
36058421|student_B|altered microbiome|microbiome|is linked to|ASD|DDF
36058421|student_B|altered microbiota|microbiome|is linked to|behavioral phenotypes|DDF
36058421|student_B|ASD|DDF|target|boys|human
36058421|student_B|GI symptoms|DDF|target|Autistic individuals|human
36058421|student_B|gut microbiota|microbiome|is linked to|ASD|DDF
36058421|student_B|microbial micro-environment|microbiome|is linked to|autism spectrum disorder|DDF
38903788|student_A|murine gut microbiota|microbiome|used by|T cell depletion|biomedical technique
38903788|student_A|gut microbiota|microbiome|used by|radiation|biomedical technique
38903788|student_A|Akkermansia|bacteria|part of|microbial symbionts|microbiome
38903788|student_A|caecum|anatomical location|located in|host|human
38903788|student_A|microbiota|microbiome|located in|intestinal regions|anatomical location
38903788|student_A|murine gut microbiota|microbiome|used by|radiation|biomedical technique
38903788|student_A|non-T-cell-depleted group|human|used by|radiation|biomedical technique
38903788|student_A|microbiota|microbiome|used by|radiation|biomedical technique
38903788|student_A|microbiota|microbiome|located in|caecum|anatomical location
38903788|student_A|caecal microbiota|microbiome|used by|radiation|biomedical technique
38903788|student_A|microbial symbionts|microbiome|located in|host|human
38903788|student_A|microbiota|microbiome|located in|ileum|anatomical location
38903788|student_A|caecal microbiota|microbiome|located in|non-T-cell-depleted group|human
38903788|student_A|T-cell-depleted group|human|used by|radiation|biomedical technique
38903788|student_A|gut microbiota|microbiome|located in|intestinal regions|anatomical location
38903788|student_A|Faecalibaculum|bacteria|part of|microbial symbionts|microbiome
38903788|student_A|intestinal regions|anatomical location|located in|host|human
38903788|student_A|bacterial taxa|bacteria|part of|microbial symbionts|microbiome
38903788|student_A|caecal microbiota|microbiome|located in|T-cell-depleted group|human
38903788|student_A|microbiota|microbiome|used by|T cell depletion|biomedical technique
36191374|student_A|CMUS group|animal|used by|MS and CUMS paradigms|biomedical technique
36191374|student_A|CMUS group|animal|used by|tail suspension test|biomedical technique
36191374|student_A|5-hydroxytryptamine|chemical|impact|gut microbiota|microbiome
36191374|student_A|MS group|animal|used by|MS and CUMS paradigms|biomedical technique
36191374|student_A|PPD|DDF|target|mothers|human
36191374|student_A|MS group|animal|used by|TST|biomedical technique
36191374|student_A|5-HT|chemical|impact|gut microbiota|microbiome
36191374|student_A|CMUS group|animal|used by|forced swim test|biomedical technique
36191374|student_A|MS group|animal|used by|tail suspension test|biomedical technique
36191374|student_A|Proteobacteria|bacteria|part of|gut microbiota|microbiome
36191374|student_A|gut microbiota|microbiome|located in|MS and CUMS groups|animal
36191374|student_A|Firmicutes|bacteria|part of|gut microbiota|microbiome
36191374|student_A|MS group|animal|used by|forced swim test|biomedical technique
36191374|student_A|Bacteroidetes|bacteria|part of|gut microbiota|microbiome
36191374|student_A|gut microbiota|microbiome|is linked to|PPD|DDF
36191374|student_A|MS and CUMS groups|animal|used by|maternal separation (MS) and chronic unpredictable mild stress (CUMS) modeling approaches|biomedical technique
36191374|student_A|PPD|DDF|target|CMUS group|animal
36191374|student_A|CMUS group|animal|used by|CUMS|biomedical technique
36191374|student_A|CMUS group|animal|used by|TST|biomedical technique
36191374|student_A|Postpartum depression|DDF|target|mothers|human
35091889|student_A|vancomycin pretreatment|drug|change effect|neuroinflammation|DDF
35091889|student_A|vancomycin pretreatment|drug|impact|gut microbiota|microbiome
35091889|student_A|gut microbiota|microbiome|is linked to|PD|DDF
35091889|student_A|motor dysfunction|DDF|target|mice|animal
35091889|student_A|Vancomycin Pretreatment|drug|change effect|Inflammation|DDF
35091889|student_A|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
35091889|student_A|vancomycin pretreatment|drug|change expression|TLR4/MyD88/NF-κB/TNF-α|gene
35091889|student_A|vancomycin pretreatment|drug|impact|Akkermansia|bacteria
35091889|student_A|vancomycin pretreatment|drug|change effect|motor dysfunction|DDF
35091889|student_A|vancomycin pretreatment|drug|impact|Blautia|bacteria
35091889|student_A|gut microbiota|microbiome|is linked to|pathogenesis|DDF
35091889|student_A|vancomycin pretreatment|drug|change effect|inflammation|DDF
35091889|student_A|mice|animal|used by|pole and traction tests|biomedical technique
39158758|student_B|behavioral dysfunction|DDF|change abundance|Desulfovibrio|bacteria
39158758|student_B|behavioral dysfunction|DDF|change abundance|Lactobacillus johnsonii|bacteria
39158758|student_B|CNS|anatomical location|located in|mice|animal
39158758|student_B|reduced synaptic plasticity|DDF|target|mice|animal
39158758|student_B|neuroinflammation|DDF|target|mice|animal
39158758|student_B|behavioral dysfunction|DDF|target|mice|animal
39158758|student_B|gut microbiota|microbiome|is linked to|behavioral dysfunction|DDF
39158758|student_B|immune cell infiltration|DDF|target|mice|animal
39158758|student_B|dysfunction|DDF|target|mice|animal
39158758|student_B|inflammation|DDF|target|mice|animal
39158758|student_B|behavioral dysfunction|DDF|change abundance|Erysipelotrichaceae|bacteria
39158758|student_B|behavioral dysfunction|DDF|change abundance|Firmicutes|bacteria
39158758|student_B|behavioral dysfunction|DDF|change abundance|Desulfovibrionaceae|bacteria
39158758|student_B|blood-brain barrier|anatomical location|located in|mice|animal
39158758|student_B|mice|animal|used by|Experimental Autoimmune Encephalomyelitis|biomedical technique
39158758|student_B|mice|animal|used by|EAE|biomedical technique
39158758|student_B|behavioral dysfunction|DDF|change abundance|Saccharibacteria|bacteria
39158758|student_B|distal colon|anatomical location|located in|mice|animal
39158758|student_B|Phosphodiesterase Type-5 Inhibitor Tadalafil|drug|change effect|CNS Autoimmunity|DDF
39158758|student_B|behavioral dysfunction|DDF|change abundance|Proteobacteria|bacteria
39158758|student_B|increased intestinal permeability|DDF|target|mice|animal
39158758|student_B|behavioral dysfunction|DDF|change abundance|Parabacteroides|bacteria
36552604|student_A|MP extract|food|impact|gut microbiota|microbiome
36552604|student_A|Gut Microbiota|microbiome|is linked to|Motor Deficit|DDF
36552604|student_A|Gut Microbiota|microbiome|is linked to|6-OHDA-Induced Parkinson's Disease|DDF
36552604|student_A|MP extract|food|influence|PD|DDF
36552604|student_A|HMP|food|influence|inflammation|DDF
36552604|student_A|MP extract|food|influence|motor deficit|DDF
36552604|student_A|MP extract|food|influence|inflammation|DDF
39295905|student_A|delayed language development|DDF|target|children|human
39295905|student_A|genus <i>Coprococcus</i>|bacteria|influence|neuropsychological and neurodegenerative disorders|DDF
39295905|student_A|delayed language development|DDF|change abundance|Coprococcus eutactus|bacteria
39295905|student_A|<i>Coprococcus</i> spp.|bacteria|influence|neurological disorders|DDF
39295905|student_A|Parkinson's disease|DDF|change abundance|Coprococcus eutactus|bacteria
39295905|student_A|<i>Coprococcus</i> spp.|bacteria|influence|neuropsychological and neurodegenerative disorders|DDF
39295905|student_A|Coprococcus|bacteria|influence|neuropsychological and neurodegenerative disorders|DDF
39295905|student_A|Parkinson's disease|DDF|target|adults|human
39295905|student_A|Coprococcus|bacteria|influence|neurological disorders|DDF
39295905|student_A|genus <i>Coprococcus</i>|bacteria|influence|neurological disorders|DDF
32865266|student_A|Bifidobacterium|bacteria|located in|control|human
32865266|student_A|Bifidobacterium|bacteria|located in|Parkinson's disease patients|human
32865266|student_A|intestinal microbiota|microbiome|located in|Parkinson's patients|human
32865266|student_A|Parkinson's disease|DDF|target|patients|human
32865266|student_A|gut microbiome|microbiome|is linked to|Parkinson's disease|DDF
32865266|student_A|Clostridium|bacteria|located in|Parkinson's disease patients|human
32865266|student_A|Clostridium|bacteria|located in|control|human
32865266|student_A|gut microbiota|microbiome|located in|patients|human
36099873|student_B|sleep disorders comorbid with neuropsychiatric disorders|DDF|change abundance|gut bacteria|bacteria
36099873|student_B|sleep disorders|DDF|change abundance|gut microbiota|microbiome
36099873|student_B|gut microbiota|microbiome|is linked to|sleep disorders|DDF
36099873|student_B|sleep disturbances|DDF|change abundance|gut bacteria|bacteria
36099873|student_B|sleep disorders|DDF|change abundance|gut bacteria|bacteria
37515687|student_A|gut microbiota|microbiome|is linked to|disorders|DDF
37515687|student_A|gut flora|microbiome|is linked to|disorders|DDF
37515687|student_A|gut microbes|bacteria|influence|disorders|DDF
37515687|student_A|secondary metabolites|chemical|produced by|gut microbiota|microbiome
37515687|student_A|gut microbes|bacteria|influence|dysbiosis of gut microbiota|DDF
37515687|student_A|Iron|chemical|impact|bacteria|bacteria
37515687|student_A|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
37515687|student_A|gut microbiota|microbiome|is linked to|obesity|DDF
37515687|student_A|gut microbes|bacteria|influence|metabolic and chronic diseases|DDF
37515687|student_A|gut microbiota|microbiome|is linked to|fatty liver|DDF
37515687|student_A|gut microbes|bacteria|influence|dysregulation of iron metabolism|DDF
35611932|student_A|gut microbiome dysbiosis|DDF|target|Parkinson's disease patients|human
35611932|student_A|Hoehn and Yahr disease|DDF|target|urolithin non-producers|human
35611932|student_A|Urolithins|chemical|produced by|gut microbial ecologies|microbiome
35611932|student_A|gut dysbiosis|DDF|target|Parkinson's patients|human
35611932|student_A|Parkinson's disease patients|human|used by|microbiota sequencing|biomedical technique
35611932|student_A|dietary polyphenols|chemical|produced by|gut microbial ecologies|microbiome
35611932|student_A|Gut dysbiosis biomarkers|chemical|influence|Parkinson's disease|DDF
35611932|student_A|anti-inflammatory metabolites|chemical|produced by|gut microbial ecologies|microbiome
35611932|student_A|medication|drug|change effect|Hoehn and Yahr disease|DDF
35611932|student_A|Hoehn and Yahr disease|DDF|target|metabotype-0|human
35611932|student_A|gut microbiome|microbiome|located in|metabotype-0 patients|human
35611932|student_A|urolithin metabotypes|chemical|produced by|gut microbial ecologies|microbiome
35611932|student_A|intestinal inflammation|DDF|target|Parkinson's disease patients|human
35611932|student_A|biomarkers|chemical|influence|gut dysbiosis|DDF
35611932|student_A|gut dysbiosis|DDF|target|Parkinson's disease patients|human
36280322|student_A|medications|drug|change effect|PD|DDF
36280322|student_A|Human gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
36280322|student_A|α-synuclein|chemical|located in|vagus nerve|anatomical location
36280322|student_A|pathogens|bacteria|influence|neuroinflammation|DDF
36280322|student_A|PD|DDF|affect|gastrointestinal issues|DDF
36280322|student_A|α-synuclein|chemical|influence|PD neuropathology|DDF
36280322|student_A|Inflammation|DDF|strike|gut|anatomical location
36280322|student_A|α-synuclein|chemical|located in|olfactory bulb|anatomical location
36280322|student_A|pathogens|bacteria|influence|gut inflammation|DDF
36280322|student_A|α-synuclein|chemical|located in|gut|anatomical location
36280322|student_A|gut microbiota|microbiome|is linked to|PD|DDF
36280322|student_A|PD|DDF|interact|microbial metabolites|chemical
35337376|student_A|neuropsychiatric disorders|DDF|target|Women|human
35337376|student_A|bulimia nervosa|DDF|affect|eating disorders|DDF
35337376|student_A|gut microbiota|microbiome|is linked to|neuropsychiatric disorders|DDF
35337376|student_A|schizophrenia|DDF|affect|neuropsychiatric disorders|DDF
35337376|student_A|anorexia nervosa|DDF|affect|eating disorders|DDF
35337376|student_A|neuropsychiatric disorders|DDF|target|men|human
35631252|student_B|medicinal plants|drug|impact|gut microbiome|microbiome
35631252|student_B|herbal preparations|drug|impact|health-beneficial microorganisms|microbiome
35631252|student_B|medicinal plants|drug|impact|gut microbiota|microbiome
35631252|student_B|Panax ginseng|drug|impact|gut microbiota|microbiome
35631252|student_B|Salvia rosmarinus|drug|impact|gut microbiota|microbiome
35631252|student_B|gut microbiome|microbiome|is linked to|neurocognitive and mental health-related conditions|DDF
35631252|student_B|Schisandra chinensis|drug|impact|gut microbiota|microbiome
35631252|student_B|medicinal plants|drug|change effect|mental disorders|DDF
35631252|student_B|Medicinal Plants|drug|impact|Gut Microbiome|microbiome
36516809|student_B|male|human|used by|enzyme-linked immunosorbent assay|biomedical technique
36516809|student_B|Parkinson's Disease|DDF|target|Patients|human
36516809|student_B|female|human|used by|enzyme-linked immunosorbent assay|biomedical technique
36516809|student_B|NTS|chemical|produced by|gut microbiota|microbiome
36516809|student_B|amantadine|drug|change effect|PD|DDF
36516809|student_B|Neurotensin|chemical|located in|brain|anatomical location
36516809|student_B|gut microbiota|microbiome|is linked to|PD|DDF
36516809|student_B|NTS-binding IgG|chemical|influence|Parkinson's disease|DDF
36516809|student_B|levodopa|drug|change effect|PD|DDF
35246670|student_A|neuroinflammation|DDF|target|patients|human
35246670|student_A|pesticides|chemical|influence|PD|DDF
35246670|student_A|Inflammation|DDF|affect|Parkinson disease|DDF
35246670|student_A|inflammation|DDF|target|patients|human
35246670|student_A|immune dysfunction|DDF|affect|Parkinson disease|DDF
35246670|student_A|PD|DDF|change abundance|gut microbiota|microbiome
35246670|student_A|PD|DDF|target|patients|human
35840611|student_A|probiotics|dietary supplement|administered|participants|human
35840611|student_A|gut microbiota|microbiome|used by|lesion studies|biomedical technique
35840611|student_A|gut microbiota|microbiome|located in|brain regions|anatomical location
35840611|student_A|gut microbiota|microbiome|located in|healthy humans|human
39065244|student_A|<i>Lachnospiranaceae</i> genus|bacteria|part of|gut microbiome|microbiome
39065244|student_A|MS|DDF|change abundance|microbial communities|microbiome
39065244|student_A|multiple sclerosis|DDF|change abundance|microbial communities|microbiome
39065244|student_A|<i>Actinobacteria</i> class|bacteria|part of|gut microbiome|microbiome
39065244|student_A|Ruminococcus Torques|bacteria|part of|gut microbiome|microbiome
39065244|student_A|<i>Bifidobacteriaceae</i> family|bacteria|part of|gut microbiome|microbiome
39065244|student_A|gut microbiome|microbiome|is linked to|multiple sclerosis|DDF
39065244|student_A|gut microbiome|microbiome|is linked to|MS|DDF
39065244|student_A|<i>Negativibacillus</i> genus|bacteria|part of|gut microbiome|microbiome
39065244|student_A|Akkermansia municiphila|bacteria|part of|gut microbiome|microbiome
39065244|student_A|<i>Prevotella</i> spp.|bacteria|part of|gut microbiome|microbiome
39065244|student_A|microbial communities|microbiome|located in|gut|anatomical location
39065244|student_A|<i>Lactobacillus</i> genus|bacteria|part of|gut microbiome|microbiome
35013099|student_B|gut microbiome|microbiome|is linked to|major depressive disorders|DDF
35013099|student_B|24 drug-naïve MDD patients|human|used by|MRI scanning|biomedical technique
35013099|student_B|carbohydrate metabolism disorder|DDF|target|MDD patients|human
35013099|student_B|gut microbiome|microbiome|is linked to|MDD|DDF
35013099|student_B|26 healthy controls|human|used by|MRI scanning|biomedical technique
35013099|student_B|HCs|human|used by|MRI scanning|biomedical technique
35923300|student_B|gut microbiota imbalance|DDF|target|patients|human
35923300|student_B|Parkinson's disease|DDF|target|patients|human
35923300|student_B|PD|DDF|target|patients|human
39339649|student_A|butyrate-producer bacteria|bacteria|part of|gut microbiota|microbiome
39339649|student_A|LL1 + silymarin capsule supplementation|dietary supplement|influence|mood disorders|DDF
39339649|student_A|LL1 + silymarin capsule supplementation|dietary supplement|administered|overweight adults|human
39339649|student_A|mood disorders|DDF|target|overweight adults|human
39339649|student_A|minerals|chemical|influence|mood disorders|DDF
39339649|student_A|microbiota-derived short-chain fatty acids|chemical|produced by|gut microbiota|microbiome
39339649|student_A|fecal gut microbiota|microbiome|change expression|16S rRNA sequences|gene
39339649|student_A|prebiotics|chemical|influence|mood disorders|DDF
39339649|student_A|nutraceutical formulation|dietary supplement|influence|mood disorders|DDF
39339649|student_A|fecal gut microbiota|microbiome|located in|overweight adults|human
36228569|student_A|Bacteroides xylanisolvens|bacteria|influence|MCI|DDF
36228569|student_A|Bacteroides thetaiotaomicron|bacteria|influence|MCI|DDF
36228569|student_A|Prevotella ruminicola|bacteria|influence|MCI|DDF
36228569|student_A|Psychobiotics|dietary supplement|influence|aging brain|DDF
36228569|student_A|gut microbiota|microbiome|located in|middle-aged and older adults|human
34785689|student_B|gut microbiota|microbiome|used by|cholecystectomy|biomedical technique
34785689|student_B|BAs|chemical|impact|intestinal microbiota|microbiome
34785689|student_B|PD|DDF|target|control group|human
34785689|student_B|PD|DDF|target|cholecystectomy group|human
34785689|student_B|women|human|used by|cholecystectomy|biomedical technique
34785689|student_B|patients|human|used by|cholecystectomy|biomedical technique
34785689|student_B|men|human|used by|cholecystectomy|biomedical technique
34785689|student_B|bile acids|chemical|impact|intestinal microbiota|microbiome
35194166|student_B|bipolar disorder|DDF|target|people with the major psychiatric disorders|human
35194166|student_B|gut microbiota|microbiome|is linked to|mental and brain health|DDF
35194166|student_B|gut microbiota|microbiome|is linked to|mental disorders|DDF
35194166|student_B|schizophrenia|DDF|target|people with the major psychiatric disorders|human
35194166|student_B|major depressive disorder|DDF|target|people with the major psychiatric disorders|human
35194166|student_B|MDD|DDF|target|people with the major psychiatric disorders|human
35194166|student_B|SZ|DDF|target|people with the major psychiatric disorders|human
35194166|student_B|mental disorders|DDF|change abundance|bacteria associated with glutamate and GABA metabolism|bacteria
35194166|student_B|mental disorders|DDF|change abundance|lactic acid-producing bacteria|bacteria
35194166|student_B|BD|DDF|target|people with the major psychiatric disorders|human
35194166|student_B|mental disorders|DDF|change abundance|bacterial genera that produce short-chain fatty acids|bacteria
33279302|student_A|Gut microbiota|microbiome|is linked to|depression|DDF
33279302|student_A|Gut microbiota|microbiome|is linked to|autism spectrum disorder|DDF
33279302|student_A|Gut microbiota|microbiome|used by|Metabolomics analysis|biomedical technique
33279302|student_A|Gut microbiota|microbiome|is linked to|oxidative stress|DDF
33279302|student_A|Gut microbiota|microbiome|is linked to|posttraumatic stress disorder|DDF
33279302|student_A|Gut microbiota|microbiome|is linked to|Alzheimer's disease|DDF
33279302|student_A|Gut microbiota|microbiome|is linked to|Huntington's disease|DDF
33279302|student_A|Gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
33279302|student_A|Gut microbiota|microbiome|is linked to|schizophrenia|DDF
33279302|student_A|Gut microbiota|microbiome|is linked to|inflammation|DDF
33279302|student_A|Gut microbiota|microbiome|is linked to|gut permeability|DDF
33279302|student_A|gut microbiota|microbiome|is linked to|brain-related diseases|DDF
33279302|student_A|Gut microbiota|microbiome|is linked to|bipolar disorder|DDF
33279302|student_A|Gut microbiota|microbiome|is linked to|neurodegenerative and neuropsychiatric disorders|DDF
32112917|student_A|microbiota-produced substances|chemical|influence|permeability of the intestinal ("leaky gut") and the blood brain barrier|DDF
32112917|student_A|endotoxins|chemical|influence|altered gut microbiota|DDF
32112917|student_A|endotoxins|chemical|influence|dysbiosis|DDF
32112917|student_A|lipopolysaccharide|chemical|influence|dysbiosis|DDF
32112917|student_A|metabolic products|chemical|influence|altered gut microbiota|DDF
32112917|student_A|lipopolysaccharide|chemical|influence|altered gut microbiota|DDF
32112917|student_A|metabolic products|chemical|influence|dysbiosis|DDF
32112917|student_A|Gut Dysbiosis|DDF|affect|Neuroinflammation|DDF
35276927|student_A|gut microbiota|microbiome|is linked to|Alzheimer's disease|DDF
35276927|student_A|gut microbiota|microbiome|is linked to|neurodegenerative disorders|DDF
35276927|student_A|gut microbiota|microbiome|is linked to|depression|DDF
35276927|student_A|gut microbiota|microbiome|is linked to|mood disorders|DDF
35276927|student_A|gut microbiota|microbiome|is linked to|anxiety|DDF
35276927|student_A|probiotics|dietary supplement|influence|mood disorders|DDF
35276927|student_A|gut microbiota|microbiome|is linked to|neurodevelopmental disorders|DDF
36034698|student_B|CUR|chemical|influence|neurological disorders|DDF
36034698|student_B|tyrosine|chemical|impact|Aerococcaceae|bacteria
36034698|student_B|MPTP-treated mice|animal|used by|16S rRNA sequencing|biomedical technique
36034698|student_B|Lactobacillaceae|bacteria|interact|tyrosine|chemical
36034698|student_B|Lactobacillaceae|bacteria|interact|dopa|chemical
36034698|student_B|Aerococcaceae|bacteria|interact|dopa|chemical
36034698|student_B|CUR|chemical|impact|Muribaculaceae|bacteria
36034698|student_B|Lactobacillaceae|bacteria|interact|levodopa|chemical
36034698|student_B|CUR|chemical|impact|Aerococcaceae|bacteria
36034698|student_B|CUR|chemical|impact|Staphylococcaceae|bacteria
36034698|student_B|CUR|chemical|impact|gut flora|microbiome
36034698|student_B|CUR|chemical|impact|Eggerthellaceae|bacteria
36034698|student_B|gut microbiota|microbiome|is linked to|motor deficits|DDF
36034698|student_B|CUR-treated mice|animal|used by|16S rRNA sequencing|biomedical technique
36034698|student_B|gut microbiota|microbiome|is linked to|PD|DDF
36034698|student_B|Curcumin|chemical|impact|gut flora|microbiome
36034698|student_B|gut microbiota|microbiome|is linked to|neuroinflammation|DDF
36034698|student_B|CUR|chemical|impact|Lactobacillaceae|bacteria
36034698|student_B|Curcumin|chemical|influence|neurological disorders|DDF
36034698|student_B|CUR|chemical|impact|Lachnospiraceae|bacteria
36034698|student_B|CUR|chemical|influence|PD|DDF
32032654|student_A|Parkinson's disease|DDF|target|PD individuals|human
32032654|student_A|butyrate producing bacteria|bacteria|part of|butyrate producing gut microbiota|microbiome
32032654|student_A|PD|DDF|target|PD individuals|human
32032654|student_A|gastrointestinal symptoms|DDF|target|PD individuals|human
32032654|student_A|gut microbiota|microbiome|located in|PD|human
32032654|student_A|gut microbiota|microbiome|located in|controls|human
32032654|student_A|PD|DDF|target|PD|human
32032654|student_A|butyrate producing gut microbiota|microbiome|located in|controls|human
32032654|student_A|PD|DDF|target|PD groups|human
32032654|student_A|gut|anatomical location|located in|PD individuals|human
32032654|student_A|PD|DDF|change abundance|butyrate producing bacteria|bacteria
32032654|student_A|gut|anatomical location|located in|controls|human
32032654|student_A|butyrate producing gut microbiota|microbiome|located in|PD|human
32032654|student_A|gut|anatomical location|located in|PD groups|human
32032654|student_A|butyrate producing bacteria|bacteria|part of|gut microbiota|microbiome
32032654|student_A|microbiota abundance and diversity|DDF|target|PD|human
32032654|student_A|microbiota abundance and diversity|DDF|target|PD groups|human
32032654|student_A|gut microbiota|microbiome|is linked to|microbiota abundance and diversity|DDF
32032654|student_A|gut microbiota|microbiome|is linked to|PD|DDF
32032654|student_A|Parkinson's disease|DDF|target|individuals|human
35286767|student_A|probiotics|dietary supplement|administered|MDD patients|human
35286767|student_A|gut microbiota|microbiome|is linked to|MDD|DDF
35286767|student_A|prebiotics|dietary supplement|administered|MDD patients|human
35286767|student_A|postbiotics|dietary supplement|administered|MDD patients|human
35286767|student_A|Probiotics|dietary supplement|influence|Major Depressive Disorder|DDF
35286767|student_A|probiotics|dietary supplement|influence|MDD|DDF
35286767|student_A|Major depressive disorder|DDF|target|patient|human
35286767|student_A|probiotic|dietary supplement|influence|MDD|DDF
35286767|student_A|gut microbiota|microbiome|is linked to|Major depressive disorder|DDF
35286767|student_A|MDD|DDF|target|patient|human
35286767|student_A|Major Depressive Disorder|DDF|target|Patients|human
35286767|student_A|MDD|DDF|target|patients|human
35257836|student_A|PD|DDF|interact|dopaminergic (DA) neurons|chemical
35257836|student_A|dopaminergic (DA) neurons|chemical|located in|substantia nigra|anatomical location
35257836|student_A|Parkinson's disease|DDF|interact|dopaminergic (DA) neurons|chemical
32154946|student_A|Short-chain fatty acids|chemical|produced by|gut microbiota|microbiome
32154946|student_A|Plasma short-chain fatty acids|chemical|influence|PD|DDF
32154946|student_A|gut dysbiosis|DDF|interact|plasma short-chain fatty acids|chemical
32154946|student_A|inflammation|DDF|interact|plasma short-chain fatty acids|chemical
32154946|student_A|Parkinson's Disease|DDF|target|Patients|human
32154946|student_A|Parkinson's disease|DDF|target|patients|human
32154946|student_A|PD|DDF|target|patients|human
34430117|student_B|amyloid|chemical|located in|blood-brain barrier|anatomical location
34430117|student_B|lipopolysaccharides|chemical|located in|intestine|anatomical location
34430117|student_B|gut microbiota|microbiome|is linked to|AD|DDF
34430117|student_B|amyloid|chemical|influence|dysbiosis|DDF
34430117|student_B|lipopolysaccharides|chemical|influence|dysbiosis|DDF
34430117|student_B|personalized diet|food|influence|AD|DDF
34430117|student_B|AD|DDF|strike|brain|anatomical location
34430117|student_B|probiotics|dietary supplement|influence|AD|DDF
37492530|student_A|Akkermansia muciniphila|bacteria|influence|neuropsychiatric disorders|DDF
37492530|student_A|A. muciniphila|bacteria|influence|neuropsychiatric disorders|DDF
37492530|student_A|A. muciniphila|bacteria|influence|autism spectrum disorders|DDF
37492530|student_A|A. muciniphila|bacteria|influence|multiple sclerosis|DDF
37492530|student_A|A. muciniphila|bacteria|influence|depression|DDF
37492530|student_A|A. muciniphila|bacteria|influence|anxiety|DDF
37492530|student_A|A. muciniphila|bacteria|influence|Parkinson's disease|DDF
37492530|student_A|A. muciniphila|bacteria|part of|gut microbiota|microbiome
37492530|student_A|metabolic substances|chemical|impact|A. muciniphila|bacteria
37492530|student_A|A. muciniphila|bacteria|influence|Alzheimer's disease|DDF
37492530|student_A|A. muciniphila|bacteria|influence|strokes|DDF
37492530|student_A|A. muciniphila|bacteria|influence|neurological and psychiatric disorders|DDF
39360283|student_A|major depressive disorder|DDF|target|individuals|human
39360283|student_A|irritable bowel syndrome|DDF|target|patients|human
39360283|student_A|irritable bowel syndrome|DDF|target|individuals|human
39360283|student_A|probiotics|dietary supplement|influence|major depressive disorder|DDF
39360283|student_A|major depressive disorder|DDF|target|patients|human
39360283|student_A|individuals|human|used by|task-based fMRI studies|biomedical technique
39360283|student_A|probiotics|dietary supplement|influence|irritable bowel syndrome|DDF
34012926|student_B|<i>Desulfovibrio</i> species|bacteria|influence|PD|DDF
34012926|student_B|<i>Desulfovibrio</i> bacteria|bacteria|part of|gut microbiota|microbiome
34012926|student_B|<i>Desulfovibrio</i> bacteria|bacteria|located in|PD patients|human
34012926|student_B|hydrogen sulfide|chemical|impact|<i>Desulfovibrio</i> bacteria|bacteria
34012926|student_B|lipopolysaccharide|chemical|impact|<i>Desulfovibrio</i> bacteria|bacteria
34012926|student_B|magnetite|chemical|impact|<i>Desulfovibrio</i> bacteria|bacteria
34012926|student_B|Gram-negative sulfate-reducing bacteria|bacteria|interact|genus <i>Desulfovibrio</i>|bacteria
34012926|student_B|<i>Desulfovibrio</i> bacteria|bacteria|interact|hydrogen sulfide|chemical
34012926|student_B|PD|DDF|change abundance|Gram-negative sulfate-reducing bacteria|bacteria
38806681|student_A|stress|DDF|target|mice|animal
34371014|student_A|microglia activation|DDF|target|human PD cases|human
34371014|student_A|gut microbiota|microbiome|is linked to|microglial activation|DDF
34371014|student_A|α-synuclein pathology|DDF|target|human PD cases|human
34371014|student_A|microglia activation|DDF|target|patients|human
34371014|student_A|α-synuclein pathology|DDF|target|patients|human
34371014|student_A|Parkinson's Disease|DDF|target|human case-control studies|human
34371014|student_A|microglial activation|DDF|target|human case-control studies|human
34371014|student_A|microglia activation|DDF|target|human case-control studies|human
34371014|student_A|microglial activation|DDF|target|patients|human
34371014|student_A|Parkinson's Disease|DDF|target|human PD cases|human
34371014|student_A|human PD cases|human|used by|oral LPS|biomedical technique
34371014|student_A|Parkinson's Disease|DDF|target|patients|human
34371014|student_A|gut dysbiosis|DDF|target|human case-control studies|human
34371014|student_A|patients|human|used by|oral LPS|biomedical technique
34371014|student_A|gut dysbiosis|DDF|target|human PD cases|human
34371014|student_A|altered gut microbiota|microbiome|is linked to|Parkinson's Disease|DDF
34371014|student_A|functional dysbiosis|DDF|target|human PD cases|human
34371014|student_A|functional dysbiosis|DDF|target|patients|human
34371014|student_A|altered gut microbiota|microbiome|used by|oral LPS|biomedical technique
34371014|student_A|gut dysbiosis|DDF|target|patients|human
34371014|student_A|PD|DDF|target|human case-control studies|human
34371014|student_A|functional dysbiosis|DDF|target|human case-control studies|human
34371014|student_A|α-synuclein|chemical|influence|Parkinson's Disease|DDF
34371014|student_A|brain|anatomical location|located in|human PD cases|human
34371014|student_A|gut microbiota|microbiome|located in|human PD cases|human
34371014|student_A|gut microbiota|microbiome|is linked to|motor deficits|DDF
34371014|student_A|brain|anatomical location|located in|healthy controls|human
34371014|student_A|gut microbiota|microbiome|located in|patients|human
34371014|student_A|brain|anatomical location|located in|patients|human
34371014|student_A|PD|DDF|target|human PD cases|human
34371014|student_A|gut microbiota|microbiome|used by|oral LPS|biomedical technique
34371014|student_A|phosphorylated α-synuclein|chemical|influence|Parkinson's Disease|DDF
34371014|student_A|PD|DDF|target|patients|human
34371014|student_A|gut microbiota|microbiome|located in|human case-control studies|human
34371014|student_A|phosphorylated α-synuclein|chemical|influence|α-synuclein pathology|DDF
34371014|student_A|motor deficits|DDF|target|human PD cases|human
34371014|student_A|α-synuclein|chemical|influence|α-synuclein pathology|DDF
34371014|student_A|motor deficits|DDF|target|patients|human
34371014|student_A|gut|anatomical location|located in|human PD cases|human
34371014|student_A|neuroinflammation|DDF|target|patients|human
34371014|student_A|gut microbiota|microbiome|located in|healthy controls|human
34371014|student_A|gut microbiota|microbiome|is linked to|Parkinson's Disease|DDF
34371014|student_A|motor deficits|DDF|target|human case-control studies|human
34371014|student_A|brain|anatomical location|located in|human case-control studies|human
34371014|student_A|loss of dopaminergic neurons|DDF|target|human case-control studies|human
34371014|student_A|gut|anatomical location|located in|patients|human
34371014|student_A|gut|anatomical location|located in|human case-control studies|human
34371014|student_A|neuroinflammation|DDF|target|human case-control studies|human
34371014|student_A|gastrointestinal dysfunction|DDF|target|human PD cases|human
34371014|student_A|loss of dopaminergic neurons|DDF|target|human PD cases|human
34371014|student_A|α-synuclein|chemical|influence|PD|DDF
34371014|student_A|gut microbiota|microbiome|located in|gut|anatomical location
34371014|student_A|neuroinflammation|DDF|target|human PD cases|human
34371014|student_A|motor symptoms|DDF|target|human case-control studies|human
34371014|student_A|altered gut microbiota|microbiome|located in|human PD cases|human
34371014|student_A|altered gut microbiota|microbiome|is linked to|PD|DDF
34371014|student_A|gastrointestinal dysfunction|DDF|target|patients|human
34371014|student_A|gastrointestinal dysfunction|DDF|target|human case-control studies|human
34371014|student_A|gut microbiota|microbiome|is linked to|α-synuclein pathology|DDF
34371014|student_A|gut|anatomical location|located in|healthy controls|human
34371014|student_A|altered gut microbiota|microbiome|located in|patients|human
34371014|student_A|phosphorylated α-synuclein|chemical|influence|PD|DDF
34371014|student_A|loss of dopaminergic neurons|DDF|target|patients|human
34371014|student_A|motor symptoms|DDF|target|human PD cases|human
34371014|student_A|human case-control studies|human|used by|oral LPS|biomedical technique
34371014|student_A|gut microbiota|microbiome|is linked to|microglia activation|DDF
34371014|student_A|altered gut microbiota|microbiome|located in|human case-control studies|human
34371014|student_A|motor symptoms|DDF|target|patients|human
34371014|student_A|altered gut microbiota|microbiome|located in|gut|anatomical location
34371014|student_A|gut microbiota|microbiome|is linked to|PD|DDF
34371014|student_A|microglial activation|DDF|target|human PD cases|human
34371014|student_A|α-synuclein pathology|DDF|target|human case-control studies|human
38852801|student_A|L. brevis SG031|bacteria|influence|anxiety|DDF
38852801|student_A|SG031|bacteria|influence|mental health|DDF
38852801|student_A|Levilactobacillus brevis SG031|bacteria|influence|stress-related sleep disturbance|DDF
38852801|student_A|L. brevis|bacteria|influence|stress-related sleep disturbances|DDF
38852801|student_A|SCFAs|chemical|located in|gut|anatomical location
38852801|student_A|Levilactobacillus brevis|bacteria|influence|mood disorders|DDF
38852801|student_A|L. brevis|bacteria|influence|mood disorders|DDF
38852801|student_A|Levilactobacillus brevis SG031|bacteria|influence|autonomic dysfunction|DDF
38852801|student_A|L. brevis SG031|bacteria|influence|depression|DDF
38852801|student_A|SG031|bacteria|influence|autonomic dysfunction|DDF
38852801|student_A|SG031|bacteria|part of|gut microbiota|microbiome
38852801|student_A|gut microbiota|microbiome|is linked to|mental health|DDF
38852801|student_A|Levilactobacillus brevis|bacteria|influence|stress-related sleep disturbances|DDF
38852801|student_A|L. brevis SG031 supplementation|dietary supplement|influence|anxiety/depression-like behaviors|DDF
38852801|student_A|SG031|bacteria|influence|stress-induced sleep disturbance|DDF
38852801|student_A|Levilactobacillus brevis SG031|bacteria|located in|Wistar-Kyoto rats|animal
34032647|student_B|gamma-aminobutyric acid|chemical|located in|human gut|anatomical location
34032647|student_B|Psychoactive Metabolites|chemical|impact|Gut Bacteria|bacteria
34032647|student_B|psychoactive metabolites|chemical|produced by|gut microbiome|microbiome
34032647|student_B|psychoactive metabolites|chemical|influence|stress-related disorders|DDF
34032647|student_B|acetylcholine|chemical|located in|human gut|anatomical location
34032647|student_B|psychoactive metabolites|chemical|impact|gut bacteria|bacteria
34032647|student_B|gut microbiota|microbiome|is linked to|metabolic diseases|DDF
34032647|student_B|gut microbiota|microbiome|is linked to|stress-related disorders|DDF
34032647|student_B|serotonin|chemical|located in|human gut|anatomical location
34032647|student_B|catecholamines|chemical|located in|human gut|anatomical location
31790727|student_A|dopaminergic (DAergic) neuron injury and inflammation|DDF|target|PD mice|animal
31790727|student_A|PD-related injuries|DDF|target|PD mice|animal
31790727|student_A|GM|microbiome|is linked to|local immune disorders of the intestine|DDF
31790727|student_A|time-dependent dopaminergic neurodegeneration|DDF|target|PD mice|animal
31790727|student_A|midbrain|anatomical location|located in|PD mice|animal
31790727|student_A|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|drug|impact|gut microbiota|microbiome
31790727|student_A|MPTP|drug|change effect|GM disorders|DDF
31790727|student_A|GM disorders|DDF|target|PD mice|animal
31790727|student_A|pathological state|DDF|target|PD mice|animal
31790727|student_A|GM|microbiome|is linked to|gut microbiota disorders|DDF
31790727|student_A|gut microbiota|microbiome|is linked to|gut microbiota disorders|DDF
31790727|student_A|PD-related injury|DDF|target|PD mice|animal
31790727|student_A|PD|DDF|target|PD mice|animal
31790727|student_A|MPTP|drug|change effect|pathological state|DDF
31790727|student_A|intestine|anatomical location|located in|PD mice|animal
31790727|student_A|MPTP|drug|change effect|PD-related injuries|DDF
31790727|student_A|Parkinson's disease|DDF|target|PD mice|animal
31790727|student_A|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|drug|impact|GM|microbiome
31790727|student_A|GM|microbiome|is linked to|disturbances|DDF
31790727|student_A|local immune disorders of the intestine|DDF|target|PD mice|animal
31790727|student_A|gut microbiota|microbiome|is linked to|disturbances|DDF
31790727|student_A|intestinal pathology|DDF|target|PD mice|animal
31790727|student_A|MPTP|drug|change effect|dopaminergic (DAergic) neuron injury and inflammation|DDF
31790727|student_A|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|drug|change effect|PD-related injuries|DDF
31790727|student_A|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|drug|change effect|GM disorders|DDF
31790727|student_A|inflammation|DDF|target|PD mice|animal
31790727|student_A|MPTP|drug|change effect|PD-related injury|DDF
31790727|student_A|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|drug|change effect|pathological state|DDF
31790727|student_A|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|drug|change effect|dopaminergic (DAergic) neuron injury and inflammation|DDF
31790727|student_A|MPTP|drug|impact|gut microbiota|microbiome
31790727|student_A|MPTP|drug|change effect|intestinal pathology|DDF
31790727|student_A|Parkinson's disease|DDF|change abundance|gut microbiota|microbiome
31790727|student_A|GM|microbiome|is linked to|GM disorders|DDF
31790727|student_A|disturbances|DDF|target|PD mice|animal
31790727|student_A|ileum|anatomical location|located in|PD mice|animal
31790727|student_A|MPTP|drug|impact|GM|microbiome
31790727|student_A|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|drug|change effect|PD-related injury|DDF
31790727|student_A|gut microbiota disorders|DDF|target|PD mice|animal
31790727|student_A|progressive neurodegenerative disease|DDF|target|PD mice|animal
31790727|student_A|Parkinson's disease|DDF|change abundance|GM|microbiome
31790727|student_A|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|drug|change effect|intestinal pathology|DDF
31790727|student_A|gut microbiota|microbiome|is linked to|GM disorders|DDF
31790727|student_A|intestinal tract|anatomical location|located in|PD mice|animal
31790727|student_A|progressive neurodegenerative disease|DDF|change abundance|GM|microbiome
31790727|student_A|PD|DDF|change abundance|gut microbiota|microbiome
31790727|student_A|PD|DDF|change abundance|GM|microbiome
35275538|student_A|Streptococcaceae|bacteria|part of|AD oral microbiota|microbiome
35275538|student_A|Actinomycetaceae|bacteria|part of|AD oral microbiota|microbiome
35275538|student_A|clinical variables|DDF|target|AD population|human
35275538|student_A|gut microbiota|microbiome|located in|AD patients|human
35275538|student_A|mood disorders|DDF|affect|BMI|DDF
35275538|student_A|Weeksellaceae|bacteria|part of|AD oral microbiota|microbiome
35275538|student_A|Alphaproteobacteria|bacteria|influence|depression score|DDF
35741624|student_A|HC|human|used by|fecal sampling|biomedical technique
35741624|student_A|PD patients|human|used by|fecal sampling|biomedical technique
39426041|student_A|microbiota|microbiome|is linked to|psychiatric disorders|DDF
39426041|student_A|bacteria|bacteria|interact|SCFA|chemical
39426041|student_A|gut microbiota|microbiome|is linked to|SCZ|DDF
39426041|student_A|unique patterns|DDF|target|SCZ|human
39426041|student_A|Erysipelotrichaceae UCG-003|bacteria|influence|MDD|DDF
39426041|student_A|unique patterns|DDF|target|MDD|human
39426041|student_A|Lachnospiraceae genus CAG-56|bacteria|influence|MDD|DDF
39426041|student_A|observed differences|DDF|change abundance|bacteria|bacteria
39426041|student_A|lactic acid|chemical|part of|metabolites|chemical
39426041|student_A|microbiota|microbiome|located in|MDD and SCZ patients|human
39426041|student_A|bacteria|bacteria|interact|metabolites|chemical
39426041|student_A|GABA|chemical|part of|metabolites|chemical
39426041|student_A|significant differences|DDF|target|MDD and SCZ patients|human
39426041|student_A|unique patterns|DDF|change abundance|Anaerostipes|bacteria
39426041|student_A|Suturella|bacteria|influence|SZC|DDF
39426041|student_A|unique patterns|DDF|change abundance|Sutterella|bacteria
39426041|student_A|gamma-aminobutyric acid|chemical|part of|metabolites|chemical
39426041|student_A|Lachnospiraceae UCG-001|bacteria|influence|SCZ|DDF
39426041|student_A|Lachnospiraceae UCG-001|bacteria|influence|MDD|DDF
39426041|student_A|gut microbiota|microbiome|is linked to|schizophrenia|DDF
39426041|student_A|Holdemania|bacteria|influence|SZC|DDF
39426041|student_A|gut microbiota|microbiome|is linked to|MDD|DDF
39426041|student_A|bacteria|bacteria|influence|inflammation|DDF
39426041|student_A|Ruminococcus torques group|bacteria|influence|SCZ|DDF
39426041|student_A|common patterns|DDF|change abundance|Streptococcus|bacteria
39426041|student_A|conditions|DDF|target|inpatients|human
39426041|student_A|common patterns|DDF|change abundance|Lachnospiraceae ND3007 group|bacteria
39426041|student_A|distinct microbial patterns|microbiome|located in|group|human
39426041|student_A|SCZ|DDF|target|Individuals|human
39426041|student_A|Ruminococcus torques group|bacteria|influence|MDD|DDF
39426041|student_A|distinct microbial patterns|microbiome|located in|HC|human
39426041|student_A|Anaerostipes|bacteria|influence|MDD|DDF
39426041|student_A|gut microbiota|microbiome|is linked to|major depressive disorder|DDF
39426041|student_A|common patterns|DDF|change abundance|Erysipelotrichaceae UCG-003|bacteria
39426041|student_A|Erysipelotrichaceae UCG-003|bacteria|influence|SCZ|DDF
39426041|student_A|bacteria|bacteria|interact|short chain fatty acids|chemical
39426041|student_A|unique patterns|DDF|change abundance|Clostridium sensu stricto 1|bacteria
39426041|student_A|differentially abundant taxa|DDF|affect|influential features|DDF
36240098|student_B|levodopa|drug|change expression|tyrosine decarboxylase gene|gene
36240098|student_B|Gut microbiota|microbiome|is linked to|Parkinson disease|DDF
36240098|student_B|Gut microbiota|microbiome|change expression|tyrosine decarboxylase gene|gene
36240098|student_B|Parkinson Disease|DDF|target|Patients|human
36240098|student_B|Enterococcus faecalis|bacteria|part of|Gut microbiota|microbiome
36240098|student_B|Enterococcus faecalis|bacteria|influence|PD|DDF
36240098|student_B|patients|human|used by|liquid chromatography-tandem mass spectrometry analysis|biomedical technique
36240098|student_B|Enterococcus faecalis|bacteria|change expression|tyrDC|gene
36240098|student_B|Levodopa|drug|change expression|Microbial Tyrosine Decarboxylase Gene|gene
36240098|student_B|levodopa|drug|change effect|Parkinson disease|DDF
36240098|student_B|patients|human|used by|levodopa challenge test|biomedical technique
36240098|student_B|patients|human|used by|quantitative real-time PCR|biomedical technique
36240098|student_B|levodopa|drug|impact|Enterococcus faecalis|bacteria
35400445|student_B|prebiotic|dietary supplement|influence|Parkinson's disease|DDF
35400445|student_B|LGG|bacteria|interact|Lactobacillus genus|bacteria
35400445|student_B|Polymannuronic acid prebiotic|dietary supplement|impact|GM|microbiome
35400445|student_B|probiotic|dietary supplement|impact|Lactobacillus genus|bacteria
35400445|student_B|prebiotic PM|dietary supplement|impact|GM|microbiome
35400445|student_B|polymannuronic acid|chemical|interact|short chain fatty acids|chemical
35400445|student_B|GM|microbiome|is linked to|Parkinson's disease|DDF
35400445|student_B|Parkinson's disease|DDF|target|mice|animal
35400445|student_B|Parkinson's disease|DDF|change abundance|LGG|bacteria
35400445|student_B|Gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
35400445|student_B|synbiotic|dietary supplement|influence|neuroprotection|DDF
35400445|student_B|agents|drug|impact|Gut microbiota|microbiome
35400445|student_B|synbiotic|dietary supplement|impact|Gut microbiota|microbiome
35400445|student_B|Gut microbiota|microbiome|located in|striatum|anatomical location
35400445|student_B|polymannuronic acid|chemical|interact|brain-derived neurotrophic factor|chemical
35400445|student_B|prebiotic|dietary supplement|influence|PD|DDF
35400445|student_B|prebiotic|dietary supplement|impact|Lactobacillus genus|bacteria
35400445|student_B|polymannuronic acid|chemical|influence|PD|DDF
35400445|student_B|GM|microbiome|located in|midbrain|anatomical location
35400445|student_B|synbiotic|dietary supplement|influence|Parkinson's disease|DDF
35400445|student_B|polymannuronic acid|chemical|interact|BDNF|chemical
35400445|student_B|brain-derived neurotrophic factor|chemical|located in|striatum|anatomical location
35400445|student_B|probiotic|dietary supplement|influence|neuroprotection|DDF
35400445|student_B|prebiotic|dietary supplement|impact|Bacilli class|bacteria
35400445|student_B|GM|microbiome|is linked to|PD|DDF
35400445|student_B|PM|chemical|interact|brain-derived neurotrophic factor|chemical
35400445|student_B|Lacticaseibacillus rhamnosus GG|bacteria|interact|brain-derived neurotrophic factor|chemical
35400445|student_B|PD|DDF|strike|midbrain|anatomical location
35400445|student_B|Gut microbiota|microbiome|is linked to|PD|DDF
35400445|student_B|Lacticaseibacillus rhamnosus GG|bacteria|interact|Lactobacillus genus|bacteria
35400445|student_B|PD|DDF|affect|PD|DDF
35400445|student_B|PM|chemical|interact|BDNF|chemical
35400445|student_B|LGG|bacteria|interact|Bacilli class|bacteria
35400445|student_B|LGG|bacteria|influence|Parkinson's disease|DDF
35400445|student_B|probiotic|dietary supplement|influence|Parkinson's disease|DDF
35400445|student_B|PD|DDF|change abundance|Lacticaseibacillus rhamnosus GG|bacteria
35400445|student_B|probiotic|dietary supplement|impact|Bacilli class|bacteria
35400445|student_B|Lacticaseibacillus rhamnosus GG|bacteria|interact|short chain fatty acids|chemical
35400445|student_B|synbiotic|dietary supplement|influence|PD|DDF
35400445|student_B|Gut microbiota|microbiome|is linked to|dopaminergic neuronal loss|DDF
35400445|student_B|PM|chemical|influence|Parkinson's disease|DDF
35400445|student_B|Parkinson's disease|DDF|strike|striatum|anatomical location
35400445|student_B|dopaminergic neuronal loss|DDF|affect|Parkinson's disease|DDF
35400445|student_B|prebiotic|dietary supplement|impact|Gut microbiota|microbiome
35400445|student_B|Lactobacillus genus|bacteria|interact|Bacilli class|bacteria
35400445|student_B|prebiotic PM|dietary supplement|influence|PD|DDF
35400445|student_B|probiotic|dietary supplement|influence|PD|DDF
35400445|student_B|Gut microbiota|microbiome|located in|midbrain|anatomical location
35400445|student_B|short chain fatty acids|chemical|located in|striatum|anatomical location
35400445|student_B|prebiotic|dietary supplement|impact|GM|microbiome
35400445|student_B|Lacticaseibacillus rhamnosus GG|bacteria|interact|Bacilli class|bacteria
35400445|student_B|oral agents|drug|change effect|Parkinson's disease|DDF
35400445|student_B|short chain fatty acids|chemical|produced by|Gut microbiota|microbiome
35400445|student_B|PM|chemical|influence|PD|DDF
35400445|student_B|prebiotic PM|dietary supplement|influence|Parkinson's disease|DDF
35400445|student_B|probiotic|dietary supplement|impact|Gut microbiota|microbiome
35400445|student_B|brain-derived neurotrophic factor|chemical|impact|LGG|bacteria
35400445|student_B|SCFAs|chemical|influence|Parkinson's disease|DDF
35400445|student_B|GM|microbiome|is linked to|dopaminergic neuronal loss|DDF
35400445|student_B|short chain fatty acids|chemical|influence|PD|DDF
35400445|student_B|short chain fatty acids|chemical|produced by|GM|microbiome
35400445|student_B|probiotic|dietary supplement|impact|GM|microbiome
35400445|student_B|PD|DDF|strike|striatum|anatomical location
35400445|student_B|oral agents|drug|change effect|PD|DDF
35400445|student_B|polymannuronic acid|chemical|influence|Parkinson's disease|DDF
35400445|student_B|short chain fatty acids|chemical|influence|Parkinson's disease|DDF
35400445|student_B|Parkinson's disease|DDF|change abundance|Lacticaseibacillus rhamnosus GG|bacteria
35400445|student_B|SCFAs|chemical|produced by|GM|microbiome
35400445|student_B|Parkinson's disease|DDF|strike|midbrain|anatomical location
35400445|student_B|polymannuronic acid|chemical|located in|blood brain barrier|anatomical location
35400445|student_B|SCFAs|chemical|influence|PD|DDF
35400445|student_B|GM|microbiome|located in|striatum|anatomical location
35400445|student_B|PD|DDF|target|mice|animal
35400445|student_B|polymannuronic acid|chemical|impact|Gut microbiota|microbiome
35400445|student_B|synbiotic|dietary supplement|impact|GM|microbiome
35400445|student_B|prebiotic PM|dietary supplement|impact|Gut microbiota|microbiome
35400445|student_B|BDNF|chemical|located in|striatum|anatomical location
35400445|student_B|SCFAs|chemical|produced by|Gut microbiota|microbiome
35400445|student_B|agents|drug|impact|GM|microbiome
35731901|student_A|bile acids|chemical|influence|depression|DDF
35731901|student_A|BAs|chemical|influence|depression|DDF
35731901|student_A|BAs|chemical|influence|neurological and neuropsychiatric diseases|DDF
35731901|student_A|BAs|chemical|influence|Alzheimer's disease|DDF
35731901|student_A|BAs|chemical|influence|inflammation|DDF
35731901|student_A|neurological and neuropsychiatric disorders|DDF|change abundance|gut microbiota|microbiome
35731901|student_A|BAs|chemical|influence|neurological and neuropsychiatric disorders|DDF
35731901|student_A|bile acids|chemical|influence|neurological and neuropsychiatric diseases|DDF
35731901|student_A|bile acids|chemical|influence|Alzheimer's disease|DDF
35731901|student_A|BAs|chemical|influence|brain disorders|DDF
35731901|student_A|bile acids|chemical|influence|stroke|DDF
35731901|student_A|BAs|chemical|influence|stroke|DDF
35405323|student_A|gut dysbiosis|DDF|affect|aging-associated neurodegenerative diseases|DDF
39078446|student_A|prebiotics|dietary supplement|influence|MDD|DDF
39078446|student_A|probiotics|dietary supplement|influence|MDD|DDF
39078446|student_A|Prebiotics|dietary supplement|influence|Major Depression|DDF
39078446|student_A|Probiotics|dietary supplement|influence|Major Depression|DDF
39110402|student_A|gut microbiota|microbiome|is linked to|inflammaging|DDF
39110402|student_A|Gut microbiota|microbiome|is linked to|inflammaging|DDF
39110402|student_A|gut microbiota|microbiome|is linked to|age-related diseases|DDF
39110402|student_A|Gut microbiota|microbiome|is linked to|age-related diseases|DDF
32290475|student_A|N-methyl-d-aspartate glutamate receptor (NMDAR)-enhancing agents|drug|change effect|cognition|DDF
32290475|student_A|gut microbiota|microbiome|located in|AD patients|human
32290475|student_A|d-form glutamate|chemical|influence|cognitive function|DDF
32290475|student_A|d-form glutamate|chemical|impact|gut bacteria|bacteria
32290475|student_A|Bacteroides vulgatus|bacteria|part of|Gut microbiota|microbiome
32290475|student_A|Bacteroides vulgatus|bacteria|interact|2-keto-glutaramic acid|chemical
32290475|student_A|d-glutamate|chemical|influence|cognitive function|DDF
32290475|student_A|glutamate|chemical|influence|dementia|DDF
32290475|student_A|gut microbiota|microbiome|located in|patients|human
32290475|student_A|d-glutamate|chemical|influence|Alzheimer's Disease|DDF
32290475|student_A|other neurodegenerative dementias|DDF|target|patients|human
32290475|student_A|Campylobacter jejuni|bacteria|part of|Gut microbiota|microbiome
32290475|student_A|AD|DDF|target|patients|human
32290475|student_A|Gut Microbiota|microbiome|is linked to|Alzheimer's Disease|DDF
32290475|student_A|gut microbiota|microbiome|is linked to|dementia|DDF
32290475|student_A|Gut microbiota|microbiome|is linked to|dementia|DDF
32290475|student_A|d-glutamate|chemical|impact|gut bacteria|bacteria
32290475|student_A|impaired memory and learning|DDF|interact|glutamate|chemical
32290475|student_A|Campylobacter jejuni|bacteria|interact|2-keto-glutaramic acid|chemical
32290475|student_A|glutamate|chemical|located in|brain|anatomical location
32089785|student_A|lipopolysaccharide|chemical|influence|ND|DDF
32089785|student_A|amyotrophic lateral sclerosis|DDF|target|ND patients|human
32089785|student_A|gut microbiota|microbiome|is linked to|inflammation|DDF
32089785|student_A|LPS|chemical|influence|amyotrophic lateral sclerosis|DDF
32089785|student_A|Neurodegenerative diseases|DDF|target|patients|human
32089785|student_A|LPS|chemical|influence|Parkinson's disease|DDF
32089785|student_A|amyotrophic lateral sclerosis|DDF|target|patients|human
32089785|student_A|NOX2|chemical|influence|ND|DDF
32089785|student_A|NOX2|chemical|influence|neuroinflammation|DDF
32089785|student_A|Parkinson's disease|DDF|target|ND patients|human
32089785|student_A|Gram-negative bacteria|bacteria|part of|gut microbiota|microbiome
32089785|student_A|NADPH oxidase 2|chemical|influence|amyotrophic lateral sclerosis|DDF
32089785|student_A|NOX2|chemical|influence|Alzheimer's disease|DDF
32089785|student_A|Alzheimer's disease|DDF|target|ND patients|human
32089785|student_A|LPS|chemical|influence|Neurodegenerative diseases|DDF
32089785|student_A|lipopolysaccharide|chemical|influence|Alzheimer's disease|DDF
32089785|student_A|NADPH oxidase 2|chemical|influence|Parkinson's disease|DDF
32089785|student_A|Gram-negative bacteria|bacteria|influence|Alzheimer's disease|DDF
32089785|student_A|Parkinson's disease|DDF|target|patients|human
32089785|student_A|NADPH oxidase 2|chemical|influence|Neurodegenerative diseases|DDF
32089785|student_A|gut microbiota|microbiome|is linked to|oxidative stress|DDF
32089785|student_A|LPS|chemical|influence|disability|DDF
32089785|student_A|Alzheimer's disease|DDF|target|patients|human
32089785|student_A|lipopolysaccharide|chemical|influence|amyotrophic lateral sclerosis|DDF
32089785|student_A|gut microbiota|microbiome|located in|patients|human
32089785|student_A|oxidative stress|DDF|affect|ND|DDF
32089785|student_A|gut microbiota|microbiome|located in|ND patients|human
32089785|student_A|Gut-Derived Lipopolysaccharides|chemical|influence|Neurodegenerative Disease|DDF
32089785|student_A|Gram-negative bacteria|bacteria|influence|amyotrophic lateral sclerosis|DDF
32089785|student_A|Oxidative Stress|DDF|affect|Neurodegenerative Disease|DDF
32089785|student_A|NOX2|chemical|influence|Neurodegenerative diseases|DDF
32089785|student_A|NOX2|chemical|influence|Neurodegenerative Disease|DDF
32089785|student_A|neuroinflammation|DDF|target|patients|human
32089785|student_A|Neurodegenerative Disease|DDF|target|patients|human
32089785|student_A|NADPH oxidase 2|chemical|influence|ND|DDF
32089785|student_A|NADPH oxidase 2|chemical|influence|neuroinflammation|DDF
32089785|student_A|neuroinflammation|DDF|target|ND patients|human
32089785|student_A|Neurodegenerative Disease|DDF|target|ND patients|human
32089785|student_A|lipopolysaccharide|chemical|influence|Parkinson's disease|DDF
32089785|student_A|LPS|chemical|influence|ND|DDF
32089785|student_A|Gram-negative bacteria|bacteria|influence|Parkinson's disease|DDF
32089785|student_A|LPS|chemical|influence|Alzheimer's disease|DDF
32089785|student_A|gut microbiota|microbiome|is linked to|neuroinflammation|DDF
32089785|student_A|NOX2|chemical|influence|amyotrophic lateral sclerosis|DDF
32089785|student_A|ND|DDF|target|ND patients|human
32089785|student_A|gut microbiota|microbiome|located in|gut|anatomical location
32089785|student_A|Gram-negative bacteria|bacteria|influence|Neurodegenerative diseases|DDF
32089785|student_A|NOX2|chemical|influence|Parkinson's disease|DDF
32089785|student_A|lipopolysaccharide|chemical|influence|Neurodegenerative diseases|DDF
32089785|student_A|lipopolysaccharide|chemical|influence|disability|DDF
32089785|student_A|NADPH oxidase 2|chemical|influence|Alzheimer's disease|DDF
32089785|student_A|ND|DDF|target|patients|human
32089785|student_A|Gram-negative bacteria|bacteria|influence|disability|DDF
32089785|student_A|Gram-negative bacteria|bacteria|influence|ND|DDF
32089785|student_A|Neurodegenerative diseases|DDF|target|ND patients|human
39121711|student_A|ADHD|DDF|target|adults|human
39121711|student_A|ADHD|DDF|change abundance|Eubacterium_xylanophilum_group|bacteria
39121711|student_A|Ruminococcus_torques_group|bacteria|influence|ADHD|DDF
39121711|student_A|Eisenbergiella|bacteria|influence|ADHD|DDF
39121711|student_A|gut-microbiome|microbiome|is linked to|adult Attention-deficit/hyperactivity disorder|DDF
39121711|student_A|gut-microbiome|microbiome|is linked to|ADHD|DDF
39121711|student_A|ADHD|DDF|change abundance|Ruminococcus_torques_group|bacteria
39121711|student_A|Attention-deficit/hyperactivity disorder|DDF|target|individuals|human
39121711|student_A|ADHD|DDF|target|individuals|human
39335452|student_B|colon|anatomical location|located in|adults|human
39335452|student_B|Gut microbiota composition|microbiome|used by|16S rRNA sequencing|biomedical technique
39335452|student_B|bacterial genera|bacteria|part of|gut microbiota|microbiome
39335452|student_B|gut microbiota|microbiome|located in|adults|human
39335452|student_B|gut microbiota composition|microbiome|used by|16S rRNA sequencing|biomedical technique
39335452|student_B|human vermiform appendix|anatomical location|located in|adults|human
39335452|student_B|Gut microbiota composition|microbiome|located in|adults|human
39335452|student_B|bacterial genera|bacteria|part of|gut microbiota richness|microbiome
39335452|student_B|appendix|anatomical location|located in|adults|human
32252363|student_A|IL-22|chemical|impact|gut microbiota|microbiome
32252363|student_A|GFLs|chemical|located in|heart|anatomical location
32252363|student_A|neurturin|chemical|influence|neurodegenerative diseases|DDF
32252363|student_A|NRTN|chemical|influence|inflammatory airway diseases|DDF
32252363|student_A|cytokines|chemical|impact|gut microbiota|microbiome
32252363|student_A|NRTN|chemical|influence|hyperglycemia|DDF
32252363|student_A|Glial cell-derived neurotrophic factor|chemical|influence|neurodegenerative diseases|DDF
32252363|student_A|GDNF|chemical|influence|neurodegenerative diseases|DDF
32252363|student_A|NRTN|chemical|influence|neurodegenerative diseases|DDF
35743087|student_B|mental health concerns|DDF|target|emerging adult|human
35743087|student_B|GM|microbiome|is linked to|mental health issues|DDF
35743087|student_B|mental health issues|DDF|target|emerging adults|human
35743087|student_B|GM|microbiome|located in|emerging adults|human
35743087|student_B|Gut Microbiota|microbiome|located in|Emerging Adults|human
36293176|student_A|antibiotics|drug|change effect|PD|DDF
36293176|student_A|neurodegenerative diseases|DDF|change abundance|GM|microbiome
36293176|student_A|leaky gut|DDF|target|PD patients|human
36293176|student_A|prebiotics|dietary supplement|influence|PD|DDF
36293176|student_A|nasal and oral microbiota|microbiome|is linked to|PD pathology|DDF
36293176|student_A|Parkinson's disease|DDF|affect|motor and non-motor manifestations|DDF
36293176|student_A|GM|microbiome|is linked to|neurodegenerative diseases|DDF
36293176|student_A|neurodegenerative diseases|DDF|change abundance|gut microbiota|microbiome
36293176|student_A|Gut Microbiota|microbiome|is linked to|Parkinson's Disease|DDF
36293176|student_A|Parkinson's Disease|DDF|change abundance|Gut Microbiota|microbiome
36293176|student_A|gastrointestinal symptoms|DDF|affect|Parkinson's disease|DDF
36293176|student_A|gut microbiota|microbiome|is linked to|neurodegenerative diseases|DDF
36293176|student_A|PD|DDF|affect|gastrointestinal symptoms|DDF
36293176|student_A|PD medications|drug|impact|gut-microbiota|microbiome
36293176|student_A|PD|DDF|affect|motor and non-motor manifestations|DDF
36293176|student_A|probiotics|dietary supplement|influence|PD|DDF
36293176|student_A|motor and non-motor manifestations|DDF|affect|gastrointestinal symptoms|DDF
38901183|student_A|bacteria|bacteria|influence|inflammation|DDF
38901183|student_A|Nitrates|chemical|located in|gut|anatomical location
38901183|student_A|chemical pollutants|chemical|influence|gut dysbiosis|DDF
38901183|student_A|nitrites|chemical|located in|gut|anatomical location
38901183|student_A|chemical pollutant|chemical|impact|gut microbiota|microbiome
38901183|student_A|microbiota|microbiome|is linked to|gut dysbiosis|DDF
38901183|student_A|lead|chemical|impact|bacteria|bacteria
38901183|student_A|secondary and tertiary metabolites|chemical|impact|gut bacteria|bacteria
38901183|student_A|Arsenic|chemical|impact|bacteria|bacteria
38901183|student_A|chemical pollutant|chemical|influence|inflammation|DDF
38901183|student_A|cadmium|chemical|impact|bacteria|bacteria
38901183|student_A|microbiota|microbiome|located in|gut|anatomical location
38901183|student_A|heavy metals|chemical|impact|bacteria|bacteria
38901183|student_A|pollutants|chemical|impact|gut microbiome|microbiome
38901183|student_A|chemical pollutants|chemical|impact|microbiota|microbiome
35607987|student_A|Short-chain fatty acids|chemical|produced by|gut microbiota|microbiome
35607987|student_A|patients|human|used by|liquid and gas chromatography mass spectrometry|biomedical technique
35607987|student_A|impaired GBB|DDF|target|patients|human
35607987|student_A|healthy control subjects|human|used by|liquid and gas chromatography mass spectrometry|biomedical technique
35607987|student_A|constipation|DDF|target|patients|human
35607987|student_A|Constipation|DDF|target|patients|human
35607987|student_A|Parkinson's disease|DDF|target|patients|human
35607987|student_A|intestinal wall leakage|DDF|target|patients|human
35607987|student_A|PD|DDF|target|Patients|human
35607987|student_A|Impaired Gut-Blood Barrier|DDF|affect|Parkinson's Disease|DDF
35607987|student_A|SCFAs|chemical|produced by|gut microbiota|microbiome
35607987|student_A|PD|DDF|target|patients|human
34909657|student_A|ND|DDF|affect|Cognitive decline|DDF
34909657|student_A|Neurodegenerative diseases|DDF|affect|gradual progressive loss of neurons|DDF
34909657|student_A|ND|DDF|affect|hyperkinetic, and hypokinetic movements disorder|DDF
38732043|student_B|nutraceuticals|dietary supplement|influence|bipolar disorder|DDF
38732043|student_B|nutraceuticals|dietary supplement|influence|schizophrenia|DDF
38732043|student_B|omega-3 fatty acids|chemical|influence|mental disorders|DDF
38732043|student_B|nutraceuticals|dietary supplement|influence|personality disorders|DDF
38732043|student_B|nutraceuticals|dietary supplement|influence|mental disorders|DDF
38732043|student_B|gut microbiota composition|microbiome|located in|immune system|anatomical location
38732043|student_B|nutraceuticals|dietary supplement|influence|major depression|DDF
38732043|student_B|phytochemicals|chemical|located in|nervous system|anatomical location
38732043|student_B|probiotics|dietary supplement|influence|mental disorders|DDF
38732043|student_B|short-chain fatty acids|chemical|located in|nervous system|anatomical location
38732043|student_B|Nutraceuticals|dietary supplement|influence|Psychiatric Disorders|DDF
38732043|student_B|omega-3 fatty acids|chemical|located in|nervous system|anatomical location
38732043|student_B|nutraceuticals|dietary supplement|influence|autism spectrum disorders|DDF
35157987|student_A|splenomegaly|DDF|target|CSDS-susceptible mice|animal
35157987|student_A|splenomegaly|DDF|target|rodents|animal
35157987|student_A|antidepressant arketamine|drug|change effect|depression-like behaviors|DDF
35157987|student_A|antidepressant arketamine|drug|change effect|splenomegaly|DDF
35157987|student_A|depression-like behaviors|DDF|target|CSDS-susceptible mice|animal
34243604|student_A|metabolites|chemical|influence|Parkinson's disease|DDF
34243604|student_A|succinate|chemical|influence|amyotrophic lateral sclerosis|DDF
34243604|student_A|metabolites|chemical|influence|neuromyelitis optica spectrum disorders|DDF
34243604|student_A|butyrate|chemical|influence|multiple sclerosis|DDF
34243604|student_A|short-chain fatty acids|chemical|influence|stress|DDF
34243604|student_A|acetate|chemical|influence|amyotrophic lateral sclerosis|DDF
34243604|student_A|SCFAs|chemical|influence|stroke|DDF
34243604|student_A|metabolites|chemical|influence|depression|DDF
34243604|student_A|microbiota-derived metabolites|chemical|influence|amyotrophic lateral sclerosis|DDF
34243604|student_A|succinate|chemical|influence|nervous system disorders|DDF
34243604|student_A|short-chain fatty acids|chemical|influence|nervous system disorders|DDF
34243604|student_A|metabolites|chemical|influence|schizophrenia|DDF
34243604|student_A|succinate|chemical|influence|anxiety|DDF
34243604|student_A|short-chain fatty acids|chemical|influence|anxiety|DDF
34243604|student_A|succinate|chemical|located in|gut|anatomical location
34243604|student_A|gut microbiota metabolites|chemical|influence|nervous system disorders|DDF
34243604|student_A|microbiota-derived metabolites|chemical|influence|anxiety|DDF
34243604|student_A|acetate|chemical|located in|gut|anatomical location
34243604|student_A|gut microbiota metabolites|chemical|produced by|human gut microbiota|microbiome
34243604|student_A|gut microbiota metabolites|chemical|influence|anxiety|DDF
34243604|student_A|microbiota-derived metabolites|chemical|located in|gut|anatomical location
34243604|student_A|acetate|chemical|influence|vascular dementia|DDF
34243604|student_A|short-chain fatty acids|chemical|influence|multiple sclerosis|DDF
34243604|student_A|butyrate|chemical|influence|amyotrophic lateral sclerosis|DDF
34243604|student_A|succinate|chemical|produced by|human gut microbiota|microbiome
34243604|student_A|metabolites|chemical|influence|stroke|DDF
34243604|student_A|SCFAs|chemical|produced by|human gut microbiota|microbiome
34243604|student_A|gut bacterial dysbiosis|DDF|interact|metabolites|chemical
34243604|student_A|metabolites|chemical|located in|gut|anatomical location
34243604|student_A|succinate|chemical|influence|neurological disorders|DDF
34243604|student_A|short-chain fatty acids|chemical|influence|stroke|DDF
34243604|student_A|acetate|chemical|influence|autism|DDF
34243604|student_A|microbiota-derived metabolites|chemical|influence|autism|DDF
34243604|student_A|acetate|chemical|produced by|human gut microbiota|microbiome
34243604|student_A|SCFAs|chemical|influence|nervous system disorders|DDF
34243604|student_A|butyrate|chemical|located in|gut|anatomical location
34243604|student_A|microbiota-derived metabolites|chemical|produced by|human gut microbiota|microbiome
34243604|student_A|gut bacterial dysbiosis|DDF|interact|gut microbiota metabolites|chemical
34243604|student_A|butyrate|chemical|influence|vascular dementia|DDF
34243604|student_A|acetate|chemical|influence|neurological disorders|DDF
34243604|student_A|short-chain fatty acids|chemical|influence|amyotrophic lateral sclerosis|DDF
34243604|student_A|microbiota-derived short-chain fatty acids|chemical|produced by|human gut microbiota|microbiome
34243604|student_A|microbiota-derived metabolites|chemical|influence|neurological disorders|DDF
34243604|student_A|acetate|chemical|influence|Alzheimer's disease|DDF
34243604|student_A|metabolites|chemical|produced by|human gut microbiota|microbiome
34243604|student_A|microbiota-derived short-chain fatty acids|chemical|influence|neuromyelitis optica spectrum disorders|DDF
34243604|student_A|microbiota-derived short-chain fatty acids|chemical|influence|depression|DDF
34243604|student_A|butyrate|chemical|produced by|human gut microbiota|microbiome
34243604|student_A|gut bacterial dysbiosis|DDF|interact|short-chain fatty acids|chemical
34243604|student_A|succinate|chemical|influence|depression|DDF
34243604|student_A|metabolites|chemical|influence|nervous system disorders|DDF
34243604|student_A|microbiota-derived short-chain fatty acids|chemical|influence|schizophrenia|DDF
34243604|student_A|short-chain fatty acids|chemical|located in|gut|anatomical location
34243604|student_A|succinate|chemical|influence|vascular dementia|DDF
34243604|student_A|short-chain fatty acids|chemical|influence|vascular dementia|DDF
34243604|student_A|butyrate|chemical|influence|neurological disorders|DDF
34243604|student_A|microbiota-derived short-chain fatty acids|chemical|influence|stroke|DDF
34243604|student_A|acetate|chemical|influence|Parkinson's disease|DDF
34243604|student_A|gut microbiota metabolites|chemical|influence|amyotrophic lateral sclerosis|DDF
34243604|student_A|acetate|chemical|influence|neuromyelitis optica spectrum disorders|DDF
34243604|student_A|gut bacterial dysbiosis|DDF|interact|butyrate|chemical
34243604|student_A|butyrate|chemical|influence|Alzheimer's disease|DDF
34243604|student_A|microbiota-derived metabolites|chemical|influence|Parkinson's disease|DDF
34243604|student_A|gut microbiota metabolites|chemical|influence|stress|DDF
34243604|student_A|microbiota-derived metabolites|chemical|influence|neuromyelitis optica spectrum disorders|DDF
34243604|student_A|gut bacterial dysbiosis|DDF|interact|microbiota-derived metabolites|chemical
34243604|student_A|gut microbiota metabolites|chemical|influence|vascular dementia|DDF
34243604|student_A|SCFAs|chemical|influence|amyotrophic lateral sclerosis|DDF
34243604|student_A|gut bacterial dysbiosis|DDF|interact|microbiota-derived short-chain fatty acids|chemical
34243604|student_A|succinate|chemical|influence|autism|DDF
34243604|student_A|short-chain fatty acids|chemical|influence|autism|DDF
34243604|student_A|SCFAs|chemical|influence|stress|DDF
34243604|student_A|butyrate|chemical|influence|Parkinson's disease|DDF
34243604|student_A|microbiota-derived metabolites|chemical|influence|vascular dementia|DDF
34243604|student_A|acetate|chemical|influence|schizophrenia|DDF
34243604|student_A|short-chain fatty acids|chemical|produced by|human gut microbiota|microbiome
34243604|student_A|gut bacterial dysbiosis|DDF|interact|SCFAs|chemical
34243604|student_A|gut microbiota metabolites|chemical|influence|autism|DDF
34243604|student_A|SCFAs|chemical|influence|anxiety|DDF
34243604|student_A|short-chain fatty acids|chemical|influence|neurological disorders|DDF
34243604|student_A|butyrate|chemical|influence|neuromyelitis optica spectrum disorders|DDF
34243604|student_A|succinate|chemical|influence|Alzheimer's disease|DDF
34243604|student_A|gut bacterial dysbiosis|DDF|interact|succinate|chemical
34243604|student_A|short-chain fatty acids|chemical|influence|Alzheimer's disease|DDF
34243604|student_A|gut microbiota metabolites|chemical|influence|multiple sclerosis|DDF
34243604|student_A|SCFAs|chemical|influence|vascular dementia|DDF
34243604|student_A|gut microbiota metabolites|chemical|influence|neurological disorders|DDF
34243604|student_A|metabolites|chemical|influence|amyotrophic lateral sclerosis|DDF
34243604|student_A|gut microbiota metabolites|chemical|influence|Alzheimer's disease|DDF
34243604|student_A|SCFAs|chemical|influence|multiple sclerosis|DDF
34243604|student_A|metabolites|chemical|influence|stress|DDF
34243604|student_A|microbiota-derived short-chain fatty acids|chemical|influence|anxiety|DDF
34243604|student_A|butyrate|chemical|influence|autism|DDF
34243604|student_A|microbiota-derived metabolites|chemical|influence|Alzheimer's disease|DDF
34243604|student_A|short-chain fatty acids|chemical|influence|depression|DDF
34243604|student_A|metabolites|chemical|influence|anxiety|DDF
34243604|student_A|succinate|chemical|influence|neuromyelitis optica spectrum disorders|DDF
34243604|student_A|short-chain fatty acids|chemical|influence|neuromyelitis optica spectrum disorders|DDF
34243604|student_A|succinate|chemical|influence|Parkinson's disease|DDF
34243604|student_A|acetate|chemical|influence|depression|DDF
34243604|student_A|gut microbiota metabolites|chemical|influence|neuromyelitis optica spectrum disorders|DDF
34243604|student_A|microbiota-derived short-chain fatty acids|chemical|influence|neurological disorders|DDF
34243604|student_A|metabolites|chemical|influence|multiple sclerosis|DDF
34243604|student_A|microbiota-derived metabolites|chemical|influence|depression|DDF
34243604|student_A|succinate|chemical|influence|schizophrenia|DDF
34243604|student_A|short-chain fatty acids|chemical|influence|schizophrenia|DDF
34243604|student_A|microbiota-derived metabolites|chemical|influence|schizophrenia|DDF
34243604|student_A|SCFAs|chemical|influence|Parkinson's disease|DDF
34243604|student_A|butyrate|chemical|influence|depression|DDF
34243604|student_A|acetate|chemical|influence|stroke|DDF
34243604|student_A|microbiota-derived metabolites|chemical|influence|stroke|DDF
34243604|student_A|butyrate|chemical|influence|schizophrenia|DDF
34243604|student_A|microbiota-derived short-chain fatty acids|chemical|influence|amyotrophic lateral sclerosis|DDF
34243604|student_A|gut microbiota metabolites|chemical|located in|gut|anatomical location
34243604|student_A|microbiota-derived short-chain fatty acids|chemical|influence|stress|DDF
34243604|student_A|microbiota-derived short-chain fatty acids|chemical|influence|vascular dementia|DDF
34243604|student_A|SCFAs|chemical|influence|autism|DDF
34243604|student_A|succinate|chemical|influence|stress|DDF
34243604|student_A|microbiota-derived short-chain fatty acids|chemical|influence|nervous system disorders|DDF
34243604|student_A|butyrate|chemical|influence|stroke|DDF
34243604|student_A|SCFAs|chemical|influence|neurological disorders|DDF
34243604|student_A|microbiota-derived short-chain fatty acids|chemical|influence|autism|DDF
34243604|student_A|SCFAs|chemical|influence|Alzheimer's disease|DDF
34243604|student_A|acetate|chemical|influence|stress|DDF
34243604|student_A|short-chain fatty acids|chemical|influence|Parkinson's disease|DDF
34243604|student_A|SCFAs|chemical|located in|gut|anatomical location
34243604|student_A|microbiota-derived metabolites|chemical|influence|stress|DDF
34243604|student_A|microbiota-derived short-chain fatty acids|chemical|influence|multiple sclerosis|DDF
34243604|student_A|metabolites|chemical|influence|vascular dementia|DDF
34243604|student_A|acetate|chemical|influence|nervous system disorders|DDF
34243604|student_A|metabolites|chemical|influence|autism|DDF
34243604|student_A|succinate|chemical|influence|multiple sclerosis|DDF
34243604|student_A|microbiota-derived metabolites|chemical|influence|nervous system disorders|DDF
34243604|student_A|gut microbiota metabolites|chemical|influence|Parkinson's disease|DDF
34243604|student_A|acetate|chemical|influence|anxiety|DDF
34243604|student_A|microbiota-derived short-chain fatty acids|chemical|influence|Alzheimer's disease|DDF
34243604|student_A|gut bacterial dysbiosis|DDF|interact|acetate|chemical
34243604|student_A|gut microbiota metabolites|chemical|influence|depression|DDF
34243604|student_A|metabolites|chemical|influence|neurological disorders|DDF
34243604|student_A|butyrate|chemical|influence|anxiety|DDF
34243604|student_A|SCFAs|chemical|influence|neuromyelitis optica spectrum disorders|DDF
34243604|student_A|metabolites|chemical|influence|Alzheimer's disease|DDF
34243604|student_A|butyrate|chemical|influence|stress|DDF
34243604|student_A|acetate|chemical|influence|multiple sclerosis|DDF
34243604|student_A|microbiota-derived short-chain fatty acids|chemical|located in|gut|anatomical location
34243604|student_A|SCFAs|chemical|influence|depression|DDF
34243604|student_A|gut microbiota metabolites|chemical|influence|schizophrenia|DDF
34243604|student_A|microbiota-derived metabolites|chemical|influence|multiple sclerosis|DDF
34243604|student_A|gut microbiota metabolites|chemical|influence|stroke|DDF
34243604|student_A|butyrate|chemical|influence|nervous system disorders|DDF
34243604|student_A|succinate|chemical|influence|stroke|DDF
34243604|student_A|SCFAs|chemical|influence|schizophrenia|DDF
34243604|student_A|microbiota-derived short-chain fatty acids|chemical|influence|Parkinson's disease|DDF
38801922|student_B|c_Actinobacteria|bacteria|influence|IBS|DDF
38801922|student_B|c_Clostridia|bacteria|influence|IBS|DDF
38801922|student_B|c_Actinobacteria|bacteria|part of|gut microbiota|microbiome
38801922|student_B|c_Clostridia|bacteria|part of|gut microbiota|microbiome
38801922|student_B|g_Streptococcus|bacteria|part of|gut microbiota|microbiome
38801922|student_B|o_Clostridiales|bacteria|influence|depression|DDF
38801922|student_B|gut microbiota|microbiome|is linked to|irritable bowel syndrome|DDF
38801922|student_B|gut microbiota|microbiome|is linked to|depression|DDF
38801922|student_B|p_Actinobacteria|bacteria|influence|IBS|DDF
38801922|student_B|s_Desulfovibrio_piger|bacteria|influence|IBS|DDF
38801922|student_B|p_Actinobacteria|bacteria|part of|gut microbiota|microbiome
38801922|student_B|c_Clostridia|bacteria|influence|depression|DDF
38801922|student_B|depression|DDF|change abundance|gut bacteria|microbiome
38801922|student_B|depression-mediated gut microbiota composition|microbiome|is linked to|Irritable Bowel Syndrome|DDF
38801922|student_B|o_Clostridiales|bacteria|influence|IBS|DDF
38801922|student_B|gut microbiota|microbiome|used by|two-sample Mendelian randomization (MR) analysis|biomedical technique
38801922|student_B|gut microbiota|microbiome|used by|two-sample MR methods|biomedical technique
38801922|student_B|g_Streptococcus|bacteria|influence|IBS|DDF
38801922|student_B|gut microbiota|microbiome|used by|Two-sample MR analysis|biomedical technique
38801922|student_B|gut microbiota|microbiome|is linked to|IBS|DDF
38801922|student_B|s_Desulfovibrio_piger|bacteria|part of|gut microbiota|microbiome
33262001|student_B|dysregulated microbiota-gut-brain axis|DDF|affect|neuroimmune-mediated disorders|DDF
33262001|student_B|dysregulated microbiota-gut-brain axis|DDF|affect|multiple sclerosis|DDF
33262001|student_B|dysregulated microbiota-gut-brain axis|DDF|affect|Alzheimer's and Parkinson's disease|DDF
33262001|student_B|PET tracers|chemical|influence|sterile or pathogen-mediated infection|DDF
33262001|student_B|Gut microbiota|microbiome|located in|host|human
32105745|student_A|70W|drug|change effect|disturbance of gut microbiota|DDF
32105745|student_A|α-HgS-containing Hua-Feng-Dan|drug|impact|Pronicromonosporaceae|bacteria
32105745|student_A|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|chemical|influence|Parkinson's disease|DDF
32105745|student_A|Hua-Feng-Dan|drug|impact|Verrucomicrobiaceae|bacteria
32105745|student_A|lipopolysaccharide|chemical|influence|chronic neuroinflammation|DDF
32105745|student_A|Mercury sulfides|chemical|impact|gut microbiomes|microbiome
32105745|student_A|Parkinson's disease|DDF|target|mice|animal
32105745|student_A|LPS plus MPTP-induced neurotoxicity|DDF|target|mice|animal
32105745|student_A|Hua-Feng-Dan|drug|change effect|Parkinson's disease|DDF
32105745|student_A|α-HgS-containing Hua-Feng-Dan|drug|impact|Clostridaceae species|bacteria
32105745|student_A|α-HgS-containing Hua-Feng-Dan|drug|impact|Verrucomicrobiaceae|bacteria
32105745|student_A|Rannasangpei|drug|change effect|Parkinson's disease|DDF
32105745|student_A|Mercury sulfides|chemical|impact|gut microbiota|microbiome
32105745|student_A|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|chemical|impact|Clostridaceae species|bacteria
32105745|student_A|HgS-containing traditional medicines|drug|impact|gut microbiomes|microbiome
32105745|student_A|α-HgS-containing Hua-Feng-Dan|drug|change effect|chronic LPS plus MPTP-induced toxicity to the brain and gut|DDF
32105745|student_A|HgS-containing traditional medicines|drug|impact|gut microbiota|microbiome
32105745|student_A|MPTP|chemical|impact|Clostridaceae species|bacteria
32105745|student_A|MPTP|chemical|impact|Verrucomicrobiaceae|bacteria
32105745|student_A|Rannasangpei|drug|impact|Methanobacteriaceae|bacteria
32105745|student_A|β-HgS-containing 70 Wei-Zhen-Zhu-Wan|drug|change effect|Parkinson's disease|DDF
32105745|student_A|Hua-Feng-Dan|drug|impact|Pronicromonosporaceae|bacteria
32105745|student_A|α-HgS-containing Hua-Feng-Dan|drug|change effect|pathological lesions in the brain|DDF
32105745|student_A|Rannasangpei|drug|impact|Pronicromonosporaceae|bacteria
32105745|student_A|Verrucomicrobiaceae|bacteria|part of|gut microbiota|microbiome
32105745|student_A|microglia activation|DDF|affect|MPTP neurotoxicity|DDF
32105745|student_A|β-HgS-containing 70W|drug|change effect|chronic LPS plus MPTP-induced toxicity to the brain and gut|DDF
32105745|student_A|Mercury sulfide-containing Hua-Feng-Dan|drug|change effect|disturbance of gut microbiota|DDF
32105745|student_A|MPTP|chemical|impact|gut microbiomes|microbiome
32105745|student_A|Hua-Feng-Dan|drug|impact|Clostridaceae species|bacteria
32105745|student_A|70W|drug|change effect|Parkinson's disease|DDF
32105745|student_A|MPTP|chemical|impact|gut microbiota|microbiome
32105745|student_A|Verrucomicrobiaceae|bacteria|part of|gut microbiomes|microbiome
32105745|student_A|70W|drug|impact|Pronicromonosporaceae|bacteria
32105745|student_A|Rannasangpei|drug|change effect|disturbance of gut microbiota|DDF
32105745|student_A|lipopolysaccharide|chemical|impact|gut microbiota|microbiome
32105745|student_A|MPTP|chemical|influence|Parkinson's disease|DDF
32105745|student_A|brain|anatomical location|located in|mice|animal
32105745|student_A|β-HgS-containing 70W|drug|change effect|pathological lesions in the brain|DDF
32105745|student_A|lipopolysaccharide|chemical|influence|Parkinson's disease|DDF
32105745|student_A|lipopolysaccharide|chemical|impact|Methanobacteriaceae|bacteria
32105745|student_A|Parkinson's disease|DDF|target|C57BL/6 mice|animal
32105745|student_A|brain|anatomical location|located in|C57BL/6 mice|animal
32105745|student_A|β-HgS-containing 70 Wei-Zhen-Zhu-Wan|drug|change effect|chronic LPS plus MPTP-induced toxicity to the brain and gut|DDF
32105745|student_A|chronic neuroinflammation|DDF|affect|MPTP neurotoxicity|DDF
32105745|student_A|Hua-Feng-Dan|drug|change effect|pathological lesions in the brain|DDF
32105745|student_A|LPS|chemical|influence|chronic neuroinflammation|DDF
32105745|student_A|lipopolysaccharide|chemical|impact|Pronicromonosporaceae|bacteria
32105745|student_A|lipopolysaccharide|chemical|impact|Verrucomicrobiaceae|bacteria
32105745|student_A|Rannasangpei|drug|impact|Clostridaceae species|bacteria
32105745|student_A|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|chemical|impact|Methanobacteriaceae|bacteria
32105745|student_A|HgS|chemical|impact|gut microbiota|microbiome
32105745|student_A|LPS|chemical|impact|Methanobacteriaceae|bacteria
32105745|student_A|substantia nigra|anatomical location|located in|mice|animal
32105745|student_A|Mercury sulfide-containing Hua-Feng-Dan|drug|change effect|Parkinson's disease|DDF
32105745|student_A|LPS|chemical|impact|Pronicromonosporaceae|bacteria
32105745|student_A|chronic LPS plus MPTP-induced toxicity to the brain and gut|DDF|target|mice|animal
32105745|student_A|HgS|chemical|impact|gut microbiomes|microbiome
32105745|student_A|Mercury sulfide-containing Hua-Feng-Dan|drug|impact|Pronicromonosporaceae|bacteria
32105745|student_A|70W|drug|impact|Clostridaceae species|bacteria
32105745|student_A|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|chemical|impact|Verrucomicrobiaceae|bacteria
32105745|student_A|LPS|chemical|impact|Clostridaceae species|bacteria
32105745|student_A|LPS|chemical|impact|Verrucomicrobiaceae|bacteria
32105745|student_A|Mercury sulfide-containing Hua-Feng-Dan|drug|impact|Clostridaceae species|bacteria
32105745|student_A|70W|drug|change effect|pathological lesions in the brain|DDF
32105745|student_A|disturbance of gut microbiota|DDF|target|mice|animal
32105745|student_A|Mercury sulfide-containing Hua-Feng-Dan|drug|impact|Verrucomicrobiaceae|bacteria
32105745|student_A|70W|drug|change effect|LPS plus MPTP-induced neurotoxicity|DDF
32105745|student_A|Pronicromonosporaceae|bacteria|part of|gut microbiomes|microbiome
32105745|student_A|MPTP neurotoxicity|DDF|affect|decreased motor activity|DDF
32105745|student_A|chronic LPS plus MPTP-induced toxicity to the brain and gut|DDF|target|C57BL/6 mice|animal
32105745|student_A|Methanobacteriaceae|bacteria|part of|gut microbiota|microbiome
32105745|student_A|LPS|chemical|impact|gut microbiota|microbiome
32105745|student_A|β-HgS-containing 70 Wei-Zhen-Zhu-Wan|drug|impact|Methanobacteriaceae|bacteria
32105745|student_A|Rannasangpei|drug|change effect|pathological lesions in the brain|DDF
32105745|student_A|lipopolysaccharide|chemical|impact|Clostridaceae species|bacteria
32105745|student_A|LPS|chemical|impact|gut microbiomes|microbiome
32105745|student_A|Methanobacteriaceae|bacteria|part of|gut microbiomes|microbiome
32105745|student_A|β-HgS-containing 70W|drug|change effect|Parkinson's disease|DDF
32105745|student_A|LPS|chemical|influence|Parkinson's disease|DDF
32105745|student_A|Rannasangpei|drug|impact|Verrucomicrobiaceae|bacteria
32105745|student_A|70W|drug|impact|Methanobacteriaceae|bacteria
32105745|student_A|β-HgS-containing 70 Wei-Zhen-Zhu-Wan|drug|impact|Pronicromonosporaceae|bacteria
32105745|student_A|β-HgS-containing 70 Wei-Zhen-Zhu-Wan|drug|impact|Clostridaceae species|bacteria
32105745|student_A|β-HgS-containing 70 Wei-Zhen-Zhu-Wan|drug|impact|Verrucomicrobiaceae|bacteria
32105745|student_A|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|chemical|impact|Pronicromonosporaceae|bacteria
32105745|student_A|β-HgS-containing 70 Wei-Zhen-Zhu-Wan|drug|change effect|pathological lesions in the brain|DDF
32105745|student_A|MPTP|chemical|impact|Methanobacteriaceae|bacteria
32105745|student_A|Clostridaceae species|bacteria|part of|gut microbiota|microbiome
32105745|student_A|β-HgS-containing 70W|drug|impact|Methanobacteriaceae|bacteria
32105745|student_A|lipopolysaccharide|chemical|impact|gut microbiomes|microbiome
32105745|student_A|MPTP|chemical|impact|Pronicromonosporaceae|bacteria
32105745|student_A|70W|drug|impact|Verrucomicrobiaceae|bacteria
32105745|student_A|substantia nigra|anatomical location|located in|C57BL/6 mice|animal
32105745|student_A|α-HgS-containing Hua-Feng-Dan|drug|change effect|Parkinson's disease|DDF
32105745|student_A|Clostridaceae species|bacteria|part of|gut microbiomes|microbiome
32105745|student_A|Mercury sulfide-containing Hua-Feng-Dan|drug|change effect|LPS plus MPTP-induced neurotoxicity|DDF
32105745|student_A|Pronicromonosporaceae|bacteria|part of|gut microbiota|microbiome
32105745|student_A|loss of dopaminergic neurons|DDF|affect|MPTP neurotoxicity|DDF
32105745|student_A|β-HgS-containing 70W|drug|impact|Pronicromonosporaceae|bacteria
32105745|student_A|Hua-Feng-Dan|drug|impact|Methanobacteriaceae|bacteria
32105745|student_A|β-HgS-containing 70W|drug|impact|Clostridaceae species|bacteria
32105745|student_A|Mercury sulfide-containing Hua-Feng-Dan|drug|change effect|pathological lesions in the brain|DDF
32105745|student_A|β-HgS-containing 70W|drug|impact|Verrucomicrobiaceae|bacteria
32105745|student_A|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|chemical|impact|gut microbiomes|microbiome
32105745|student_A|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|chemical|impact|gut microbiota|microbiome
32105745|student_A|α-HgS-containing Hua-Feng-Dan|drug|impact|Methanobacteriaceae|bacteria
32105745|student_A|Rannasangpei|drug|change effect|LPS plus MPTP-induced neurotoxicity|DDF
32768944|student_A|NLRP3|chemical|located in|normal rats|animal
32768944|student_A|Manganese|chemical|influence|neurodegenerative disorders|DDF
32768944|student_A|gut microbiota|microbiome|located in|gut|anatomical location
32768944|student_A|gut microbiota|microbiome|located in|normal rats|animal
32768944|student_A|cerebral NLRP3 inflammasome|chemical|influence|neuroinflammation|DDF
32768944|student_A|gut microbiota|microbiome|located in|Mn exposure rats|animal
32768944|student_A|NLRP3|chemical|located in|Mn exposure rats|animal
32768944|student_A|Aβ|chemical|influence|Alzheimer's and Parkinson's diseases|DDF
32768944|student_A|cerebral NLRP3 inflammasome|chemical|impact|gut microbiota|microbiome
32768944|student_A|Mn|chemical|influence|neurodegenerative disorders|DDF
32768944|student_A|gut microbiota|microbiome|is linked to|neuroinflammation|DDF
32768944|student_A|β-Amyloid|chemical|influence|Alzheimer's and Parkinson's diseases|DDF
32768944|student_A|hippocampal degeneration|DDF|strike|brain|anatomical location
37960284|student_A|gut microbiota|microbiome|is linked to|gut dysbiosis|DDF
37960284|student_A|gut dysbiosis|DDF|affect|GBA dysfunction|DDF
34370175|student_A|probiotics|dietary supplement|influence|PD|DDF
34370175|student_A|gut microbiota|microbiome|located in|central nervous system|anatomical location
34370175|student_A|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
34370175|student_A|gut microbiota|microbiome|located in|CNS|anatomical location
35308288|student_B|hippocampus|anatomical location|located in|C57BL/6J mice|animal
35308288|student_B|fiber|dietary supplement|impact|microbial ecosystem|microbiome
35308288|student_B|PFC|anatomical location|located in|C57BL/6J mice|animal
35308288|student_B|β-glucan|chemical|impact|gut microbiota|microbiome
35308288|student_B|prefrontal cortex|anatomical location|located in|C57BL/6J mice|animal
35308288|student_B|microglia|anatomical location|located in|C57BL/6J mice|animal
35308288|student_B|β-glucans|chemical|influence|cognitive deficit|DDF
36402501|student_A|gut microbiota|microbiome|is linked to|dysbiosis|DDF
36402501|student_A|gut microbiome|microbiome|is linked to|multiple sclerosis|DDF
36402501|student_A|gut microbiome|microbiome|is linked to|gastrointestinal diseases|DDF
36402501|student_A|gut microbiome|microbiome|is linked to|Parkinson's disease|DDF
36402501|student_A|gut microbiome|microbiome|is linked to|Alzheimer's disease|DDF
36402501|student_A|gut microbiome|microbiome|is linked to|neuropsychiatric diseases|DDF
38963982|student_A|JPJDF|drug|impact|intestinal microbiota|microbiome
38963982|student_A|JPJDF|drug|impact|gut microbiota|microbiome
38963982|student_A|JianpiJiedu decoction|drug|change effect|colorectal cancer|DDF
38963982|student_A|tumourigenesis|DDF|target|AOM/DSS treated mice|animal
38963982|student_A|JPJDF|drug|change effect|CAC|DDF
38963982|student_A|Jianpi Jiedu decoction|drug|change expression|M2|gene
38963982|student_A|JPJDF|drug|change effect|intestinal inflammation|DDF
39458270|student_A|stress|DDF|target|adults|human
39458270|student_A|Gut Microbiota|microbiome|is linked to|Depressive Symptoms|DDF
39458270|student_A|anxiety|DDF|change abundance|gut microbiota|microbiome
39458270|student_A|gut microbiota|microbiome|is linked to|depressive symptoms|DDF
39458270|student_A|depressive symptoms|DDF|change abundance|gut microbiota|microbiome
39458270|student_A|anxiety|DDF|target|adults|human
39458270|student_A|stress|DDF|change abundance|gut microbiota|microbiome
39458270|student_A|gut microbiota|microbiome|is linked to|IBS|DDF
39458270|student_A|Ruminococcaceae UCG-009|bacteria|influence|depressive symptoms|DDF
39458270|student_A|gut microbiota|microbiome|used by|16S rRNA sequencing|biomedical technique
34530073|student_A|PD patients|human|used by|GC-MS|biomedical technique
34530073|student_A|PD patients|human|used by|16S ribosomal RNA (16S rRNA) gene sequencing|biomedical technique
34530073|student_A|Bifidobacterium|bacteria|part of|Gut microbiota|microbiome
34530073|student_A|PD and healthy controls|human|used by|gas chromatography|biomedical technique
34530073|student_A|gut microbiota|microbiome|used by|16S ribosomal RNA (16S rRNA) gene sequencing|biomedical technique
34530073|student_A|Bifidobacterium|bacteria|part of|gut microbiota|microbiome
34530073|student_A|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
34530073|student_A|Gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
34530073|student_A|Parkinson's disease|DDF|change abundance|Alistipes|bacteria
34530073|student_A|controls|human|used by|mass spectrometry|biomedical technique
34530073|student_A|Gut microbiota|microbiome|is linked to|alterations|DDF
34530073|student_A|PD|DDF|change abundance|Rikenellaceae_RC9_gut_group|bacteria
34530073|student_A|Gut microbiota|microbiome|used by|gas chromatography|biomedical technique
34530073|student_A|PD|DDF|target|PD patients|human
34530073|student_A|Parkinson's disease|DDF|change abundance|Parabacteroides|bacteria
34530073|student_A|gut microbiota|microbiome|used by|mass spectrometry|biomedical technique
34530073|student_A|Parabacteroides|bacteria|part of|fecal microbiome|microbiome
34530073|student_A|Parkinson's disease|DDF|change abundance|Faecalibacterium|bacteria
34530073|student_A|gut microbiota|microbiome|located in|PD and healthy controls|human
34530073|student_A|Gut microbiota|microbiome|located in|PD and healthy controls|human
34530073|student_A|PD|DDF|target|PD and healthy controls|human
34530073|student_A|controls|human|used by|gas chromatography|biomedical technique
34530073|student_A|gut microbiota|microbiome|is linked to|PD|DDF
34530073|student_A|Faecalibacterium|bacteria|part of|Gut microbiota|microbiome
34530073|student_A|alteration|DDF|target|PD patients|human
34530073|student_A|BCAAs|chemical|produced by|Gut microbiota|microbiome
34530073|student_A|controls|human|used by|GC-MS|biomedical technique
34530073|student_A|Gut microbiota|microbiome|is linked to|PD|DDF
34530073|student_A|Alistipes|bacteria|part of|Gut microbiota|microbiome
34530073|student_A|PD|DDF|change abundance|Bifidobacterium|bacteria
34530073|student_A|gut microbiota|microbiome|located in|controls|human
34530073|student_A|Gut microbiota|microbiome|located in|controls|human
34530073|student_A|PD and healthy controls|human|used by|GC-MS|biomedical technique
34530073|student_A|gut microbiota|microbiome|used by|GC-MS|biomedical technique
34530073|student_A|PD and healthy controls|human|used by|16S ribosomal RNA (16S rRNA) gene sequencing|biomedical technique
34530073|student_A|gut microbiota|microbiome|is linked to|alterations|DDF
34530073|student_A|alterations|DDF|target|PD patients|human
34530073|student_A|gut microbiota|microbiome|located in|PD patients|human
34530073|student_A|Parkinson's disease|DDF|target|PD and healthy controls|human
34530073|student_A|PD|DDF|change abundance|Faecalibacterium|bacteria
34530073|student_A|Rikenellaceae_RC9_gut_group|bacteria|part of|gut microbiota|microbiome
34530073|student_A|amino acids|chemical|produced by|Gut microbiota|microbiome
34530073|student_A|Parkinson's disease|DDF|change abundance|Bifidobacterium|bacteria
34530073|student_A|Parabacteroides|bacteria|part of|Gut microbiota|microbiome
34530073|student_A|neurodegeneration|DDF|target|PD patients|human
34530073|student_A|amino acids|chemical|influence|neurodegeneration|DDF
34530073|student_A|aromatic amino acids|chemical|produced by|fecal microbiome|microbiome
34530073|student_A|controls|human|used by|16S ribosomal RNA (16S rRNA) gene sequencing|biomedical technique
34530073|student_A|Gut microbiota|microbiome|used by|mass spectrometry|biomedical technique
34530073|student_A|Rikenellaceae_RC9_gut_group|bacteria|part of|fecal microbiome|microbiome
34530073|student_A|PD patients|human|used by|mass spectrometry|biomedical technique
34530073|student_A|neurodegeneration|DDF|target|PD and healthy controls|human
34530073|student_A|alteration|DDF|target|PD and healthy controls|human
34530073|student_A|Faecalibacterium|bacteria|part of|gut microbiota|microbiome
34530073|student_A|BCAAs|chemical|produced by|gut microbiota|microbiome
34530073|student_A|Parkinson's disease|DDF|change abundance|Rikenellaceae_RC9_gut_group|bacteria
34530073|student_A|gut microbiota|microbiome|is linked to|neurodegeneration|DDF
34530073|student_A|Gut microbiota|microbiome|is linked to|neurodegeneration|DDF
34530073|student_A|PD|DDF|change abundance|Alistipes|bacteria
34530073|student_A|Parkinson's disease|DDF|target|PD patients|human
34530073|student_A|PD patients|human|used by|gas chromatography|biomedical technique
34530073|student_A|Alterations|DDF|target|PD and healthy controls|human
34530073|student_A|PD|DDF|change abundance|Parabacteroides|bacteria
34530073|student_A|Bifidobacterium|bacteria|part of|fecal microbiome|microbiome
34530073|student_A|alterations|DDF|target|PD and healthy controls|human
34530073|student_A|gut microbiota|microbiome|used by|gas chromatography|biomedical technique
34530073|student_A|gut microbiota|microbiome|is linked to|alteration|DDF
34530073|student_A|Gut microbiota|microbiome|is linked to|alteration|DDF
34530073|student_A|amino acids|chemical|produced by|gut microbiota|microbiome
34530073|student_A|aromatic amino acids|chemical|produced by|Gut microbiota|microbiome
34530073|student_A|Parabacteroides|bacteria|part of|gut microbiota|microbiome
34530073|student_A|Alistipes|bacteria|part of|gut microbiota|microbiome
34530073|student_A|Rikenellaceae_RC9_gut_group|bacteria|part of|Gut microbiota|microbiome
34530073|student_A|amino acids|chemical|produced by|fecal microbiome|microbiome
34530073|student_A|gut microbiota|microbiome|is linked to|Alterations|DDF
34530073|student_A|Alterations|DDF|target|PD patients|human
34530073|student_A|PD and healthy controls|human|used by|mass spectrometry|biomedical technique
34530073|student_A|Gut microbiota|microbiome|located in|PD patients|human
34530073|student_A|Faecalibacterium|bacteria|part of|fecal microbiome|microbiome
34530073|student_A|aromatic amino acids|chemical|produced by|gut microbiota|microbiome
34530073|student_A|BCAAs|chemical|produced by|fecal microbiome|microbiome
34530073|student_A|Gut microbiota|microbiome|is linked to|Alterations|DDF
34530073|student_A|Alistipes|bacteria|part of|fecal microbiome|microbiome
34530073|student_A|Gut microbiota|microbiome|used by|GC-MS|biomedical technique
34530073|student_A|Gut microbiota|microbiome|used by|16S ribosomal RNA (16S rRNA) gene sequencing|biomedical technique
34569965|student_B|gut microbiota|microbiome|located in|Drosophila|animal
34569965|student_B|dysbiosis|DDF|change abundance|fly microbiota|microbiome
34569965|student_B|gut microbiota|microbiome|located in|mice|animal
34569965|student_B|gut microbiota|microbiome|is linked to|chronic disease|DDF
34569965|student_B|fly's gut microbiota|microbiome|located in|humans|human
34569965|student_B|gut microbiota|microbiome|located in|mammals|animal
36363733|student_B|probiotics|dietary supplement|impact|gut microbiota|microbiome
36363733|student_B|psychobiotics|dietary supplement|influence|anxiety disorders|DDF
36363733|student_B|low mood|DDF|target|people|human
36363733|student_B|psychobiotics|dietary supplement|influence|depression|DDF
36363733|student_B|Probiotics|dietary supplement|impact|gut microbiota|microbiome
36363733|student_B|depression|DDF|target|people|human
36363733|student_B|psychobiotics|dietary supplement|influence|chronic stress|DDF
36363733|student_B|neurochemicals|chemical|impact|gut microbiota|microbiome
36363733|student_B|chronic stress|DDF|target|people|human
36363733|student_B|probiotics|dietary supplement|influence|psycho-related diseases|DDF
36363733|student_B|brain|anatomical location|located in|people|human
36363733|student_B|psychobiotics|dietary supplement|influence|low mood|DDF
36363733|student_B|probiotics|dietary supplement|impact|gut microbial system|microbiome
36363733|student_B|anxiety disorders|DDF|target|people|human
36363733|student_B|psychobiotics|dietary supplement|impact|gut microbiota|microbiome
36363733|student_B|gastrointestinal tract|anatomical location|located in|people|human
35819136|student_B|antibiotics|drug|change effect|altered gut barrier function, activation of the hypothalamic-pituitary-adrenal axis, reducing levels of brain-derived neurotrophic factor or oxytocin and alteration of vagal tone|DDF
35819136|student_B|antibiotics|drug|change effect|depression|DDF
35819136|student_B|antibiotics|drug|change effect|iatrogenic psychiatric disorder|DDF
35819136|student_B|Antibiotics|drug|change effect|depression and anxiety|DDF
35819136|student_B|antibiotics|drug|change effect|mental health problems|DDF
35819136|student_B|short-chain fatty acids or the amino acid tryptophan|chemical|produced by|Microbes in the gut|microbiome
35819136|student_B|isoniazid|drug|change effect|tuberculosis|DDF
35819136|student_B|antibiotics|drug|impact|Microbes in the gut|microbiome
35819136|student_B|iatrogenic psychiatric disorder|DDF|target|patients|human
35572129|student_A|Cyanidin-3-<i>O</i>-Glucoside|chemical|influence|Parkinson's Disease|DDF
35572129|student_A|PD|DDF|change abundance|gut microbiota|microbiome
35572129|student_A|Parkinson's Disease|DDF|target|Mice|animal
35572129|student_A|Parkinson's disease|DDF|target|older adults|human
39092201|student_B|immune response|DDF|strike|blood-brain barrier|anatomical location
39092201|student_B|microbial metabolites|chemical|located in|nervous system|anatomical location
39092201|student_B|gut microbiota|microbiome|located in|BBB|anatomical location
39092201|student_B|gut microbiota|microbiome|is linked to|dysbiosis|DDF
39092201|student_B|stress response|DDF|strike|intestinal|anatomical location
39092201|student_B|immune response|DDF|strike|intestinal|anatomical location
39092201|student_B|microbial metabolites|chemical|located in|molecular signals|anatomical location
39092201|student_B|stress response|DDF|strike|blood-brain barrier|anatomical location
39092201|student_B|tight junction protein expression|chemical|influence|inflammation|DDF
39092201|student_B|stress response|DDF|strike|BBB|anatomical location
39092201|student_B|immune response|DDF|strike|BBB|anatomical location
39092201|student_B|animal studies|animal|used by|probiotic administration|biomedical technique
39092201|student_B|gut microbiota|microbiome|is linked to|anxiety|DDF
39092201|student_B|animal studies|animal|used by|microbiota restoration|biomedical technique
39092201|student_B|gut microbiota|microbiome|is linked to|depressive-like behaviors|DDF
39092201|student_B|cytokines|chemical|influence|inflammation|DDF
33194809|student_A|medication option|drug|change effect|PD|DDF
33194809|student_A|Medications|drug|change effect|PD|DDF
33194809|student_A|Endogenous α-syn|chemical|located in|brain|anatomical location
33194809|student_A|gut microbiota|microbiome|is linked to|PD|DDF
33194809|student_A|medication option|drug|impact|gut microbiota|microbiome
33050862|student_B|Prebiotic Nutraceutical Supplementations|dietary supplement|influence|Non-communicable Disorders|DDF
33050862|student_B|commensal gut microbiota|microbiome|is linked to|non-alcoholic fatty liver disease|DDF
33050862|student_B|nutraceutical supplementations|dietary supplement|influence|Type-II diabetes|DDF
33050862|student_B|commensal gut microbiota|microbiome|is linked to|infant eczema|DDF
33050862|student_B|commensal gut microbiota|microbiome|is linked to|metabolic disorders|DDF
33050862|student_B|nutraceutical supplementations|dietary supplement|influence|non-alcoholic fatty liver disease|DDF
33050862|student_B|commensal gut microbiota|microbiome|is linked to|Multiple sclerosis|DDF
33050862|student_B|nutraceutical supplementations|dietary supplement|influence|obesity|DDF
33050862|student_B|commensal gut microbiota|microbiome|is linked to|bronchopulmonary dysplasia|DDF
33050862|student_B|nutraceutical supplementations|dietary supplement|influence|metabolic disorders|DDF
33050862|student_B|commensal gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
33050862|student_B|bronchopulmonary dysplasia|DDF|target|preterm babies|human
33050862|student_B|nutraceutical supplementations|dietary supplement|influence|bronchopulmonary dysplasia|DDF
33050862|student_B|extra-uterine growth restriction|DDF|target|preterm babies|human
33050862|student_B|nutraceutical supplementations|dietary supplement|influence|infant eczema|DDF
33050862|student_B|nutraceutical supplementations|dietary supplement|influence|chronic non-communicable degenerative diseases|DDF
33050862|student_B|nutraceutical supplementations|dietary supplement|influence|Multiple sclerosis|DDF
33050862|student_B|commensal gut microbiota|microbiome|is linked to|chronic non-communicable degenerative diseases|DDF
33050862|student_B|nutraceutical supplementations|dietary supplement|impact|commensal gut microbiota|microbiome
33050862|student_B|nutraceutical supplementations|dietary supplement|influence|Parkinson's disease|DDF
33050862|student_B|commensal gut microbiota|microbiome|is linked to|Autism Spectrum Disorder|DDF
33050862|student_B|commensal gut microbiota|microbiome|is linked to|necrotizing enterocolitis|DDF
33050862|student_B|necrotizing enterocolitis|DDF|target|preterm babies|human
33050862|student_B|commensal gut microbiota|microbiome|is linked to|neurological disorders|DDF
33050862|student_B|commensal gut microbiota|microbiome|is linked to|Type-II diabetes|DDF
33050862|student_B|infant eczema|DDF|target|preterm babies|human
33050862|student_B|nutraceutical supplementations|dietary supplement|influence|neurological disorders|DDF
33050862|student_B|allergy|DDF|target|preterm babies|human
33050862|student_B|Nutraceuticals|dietary supplement|impact|commensal gut microbiota|microbiome
33050862|student_B|nutraceutical supplementations|dietary supplement|influence|Autism Spectrum Disorder|DDF
33050862|student_B|nutraceutical supplementations|dietary supplement|influence|allergy|DDF
33050862|student_B|commensal gut microbiota|microbiome|is linked to|allergy|DDF
33050862|student_B|Engineered Probiotic|dietary supplement|influence|Non-communicable Disorders|DDF
33050862|student_B|nutraceutical supplementations|dietary supplement|influence|necrotizing enterocolitis|DDF
33050862|student_B|commensal gut microbiota|microbiome|is linked to|obesity|DDF
33050862|student_B|commensal gut microbiota|microbiome|is linked to|extra-uterine growth restriction|DDF
33050862|student_B|nutraceutical supplementations|dietary supplement|influence|non-communicable diseases|DDF
33050862|student_B|nutraceutical supplementations|dietary supplement|influence|extra-uterine growth restriction|DDF
38999739|student_A|Psychobiotic|drug|change effect|Psychosomatic Diarrhea|DDF
38999739|student_A|Diarrhea|DDF|target|college students|human
38999739|student_A|gut microbial|microbiome|is linked to|diarrhea|DDF
38999739|student_A|Bifidobacterium breve|bacteria|influence|Psychosomatic Diarrhea|DDF
38999739|student_A|BB05|dietary supplement|influence|Diarrhea|DDF
38999739|student_A|Diarrhea|DDF|change abundance|Bacteroides|bacteria
38999739|student_A|BB05|dietary supplement|impact|gut microbial|microbiome
38999739|student_A|Diarrhea|DDF|change abundance|Streptococcus|bacteria
38999739|student_A|Diarrhea|DDF|change abundance|Bifidobacterium|bacteria
38999739|student_A|Diarrhea|DDF|change abundance|Collinsella|bacteria
38999739|student_A|Psychosomatic Diarrhea|DDF|target|College Students|human
38999739|student_A|Diarrhea|DDF|change abundance|Prevotella|bacteria
36168204|student_A|PD pathology|DDF|change abundance|gut microbiota|microbiome
36168204|student_A|PD|DDF|strike|midbrain|anatomical location
36168204|student_A|SR79|bacteria|influence|6-OHDA-induced toxicity|DDF
36168204|student_A|SR79|bacteria|interact|d-AMPH|drug
36168204|student_A|SR79|bacteria|influence|PD|DDF
36168204|student_A|Parkinson's disease|DDF|strike|midbrain|anatomical location
36168204|student_A|SR79|bacteria|influence|Alzheimer's disease pathologies|DDF
36168204|student_A|Agathobaculum butyriciproducens|bacteria|influence|Parkinson's Disease|DDF
35076890|student_A|PD|DDF|target|individuals|human
35076890|student_A|PD|DDF|change abundance|gut microbiota|microbiome
35076890|student_A|gut microbiome|microbiome|located in|individuals|human
35076890|student_A|dysbiosis|DDF|change abundance|gut microbiota|microbiome
32317956|student_A|BMAA|chemical|impact|diatoms|bacteria
32317956|student_A|BMAA|chemical|impact|cyanobacteria|bacteria
32317956|student_A|natural non-proteinogenic diamino acid|chemical|impact|cyanobacteria|bacteria
32317956|student_A|β-<i>N</i>-methylamino-L-alanine|chemical|impact|diatoms|bacteria
32317956|student_A|dietary sources|food|influence|chronic low-grade gut inflammation|DDF
32317956|student_A|dietary sources|food|influence|mitochondrial dysfunction|DDF
32317956|student_A|dietary sources|food|influence|Parkinson's disease|DDF
32317956|student_A|non-photosynthetic cyanobacteria|bacteria|part of|human gut microbiota|microbiome
32317956|student_A|β-<i>N</i>-methylamino-L-alanine|chemical|impact|cyanobacteria|bacteria
32317956|student_A|dietary sources|food|influence|protein misfolding|DDF
32317956|student_A|BMAA|chemical|located in|gut|anatomical location
32317956|student_A|Melainabacteria|bacteria|part of|human gut microbiota|microbiome
32317956|student_A|BMAA|chemical|impact|human gut microbiota|microbiome
32317956|student_A|natural non-proteinogenic diamino acid|chemical|impact|dinoflagellates|bacteria
32317956|student_A|Microbial BMAA|chemical|influence|Parkinson's Disease Neurodegeneration|DDF
32317956|student_A|BMAA|chemical|influence|neurodegenerative diseases|DDF
32317956|student_A|natural non-proteinogenic diamino acid|chemical|impact|diatoms|bacteria
32317956|student_A|BMAA|chemical|influence|neuroinflammation|DDF
32317956|student_A|BMAA|chemical|impact|dinoflagellates|bacteria
32317956|student_A|dietary sources|food|influence|PD|DDF
32317956|student_A|β-<i>N</i>-methylamino-L-alanine|chemical|impact|dinoflagellates|bacteria
33418492|student_B|PD-dementia conversion|DDF|interact|TMAO|chemical
33418492|student_B|TMAO|chemical|influence|early Parkinson's disease|DDF
33418492|student_B|gut microbiota-derived metabolite|chemical|influence|early Parkinson's disease|DDF
33418492|student_B|Gut microbiota-derived metabolite trimethylamine N-oxide|chemical|influence|early Parkinson's disease|DDF
33418492|student_B|low plasma TMAO level|DDF|affect|PD-dementia conversion|DDF
33418492|student_B|PD|DDF|interact|TMAO|chemical
33418492|student_B|TMAO|chemical|influence|early stage PD|DDF
33418492|student_B|trimethylamine N-oxide|chemical|influence|early Parkinson's disease|DDF
33418492|student_B|low plasma TMAO level|DDF|target|PD group|human
33418492|student_B|drug-naïve early stage PD|DDF|target|patients|human
33418492|student_B|gut microbiota-derived metabolite|chemical|influence|PD|DDF
33418492|student_B|PD|DDF|target|patients|human
33418492|student_B|high TMAO level|DDF|target|group|human
33418492|student_B|TMAO|chemical|influence|PD|DDF
33418492|student_B|lower baseline plasma TMAO levels|DDF|affect|early stage PD|DDF
33418492|student_B|lower baseline plasma TMAO levels|DDF|affect|PD-dementia conversion|DDF
33418492|student_B|tertile PD groups|human|used by|Cox regression analysis|biomedical technique
33418492|student_B|trimethylamine N-oxide|chemical|influence|PD|DDF
34669122|student_A|late onset neuropathology|DDF|affect|autoimmune diseases|DDF
34669122|student_A|mercury|chemical|influence|Parkinson's disease|DDF
34669122|student_A|aluminum|chemical|influence|late onset neuropathology|DDF
34669122|student_A|transient gut dysbiosis|DDF|affect|Alzheimer's disease|DDF
34669122|student_A|Neurotoxins|chemical|influence|late onset neuropathology|DDF
34669122|student_A|cadmium|chemical|influence|late onset neuropathology|DDF
34669122|student_A|neurotoxins|chemical|influence|late onset neuropathology|DDF
34669122|student_A|selenium|chemical|influence|Alzheimer's disease|DDF
34669122|student_A|organochlorines|chemical|influence|Alzheimer's disease|DDF
34669122|student_A|Antibiotics|drug|change effect|Parkinson's disease|DDF
34669122|student_A|organophosphate pesticides|chemical|influence|Parkinson's disease|DDF
34669122|student_A|transient gut dysbiosis|DDF|affect|late onset neuropathologies|DDF
34669122|student_A|selenium|chemical|influence|late onset neuropathologies|DDF
34669122|student_A|transient gut dysbiosis|DDF|affect|late onset neuropathology|DDF
34669122|student_A|organochlorines|chemical|influence|late onset neuropathologies|DDF
34669122|student_A|Antibiotics|drug|change effect|gut dysbiosis|DDF
34669122|student_A|arsenic|chemical|influence|late onset neuropathologies|DDF
34669122|student_A|organochlorines|chemical|influence|Parkinson's disease|DDF
34669122|student_A|Inflammation|DDF|affect|late onset neuropathology|DDF
34669122|student_A|Inflammation|DDF|affect|Alzheimer's disease|DDF
34669122|student_A|Alzheimer's disease|DDF|is a|autoimmune diseases|DDF
34669122|student_A|Gut dysbiosis|DDF|affect|late onset neuropathologies|DDF
34669122|student_A|manganese|chemical|influence|late onset neuropathology|DDF
34669122|student_A|antibiotic treatments|drug|change effect|gut microbiota dysbiosis|DDF
34669122|student_A|organophosphate pesticides|chemical|influence|Alzheimer's disease|DDF
34669122|student_A|arsenic|chemical|influence|Parkinson's disease|DDF
34669122|student_A|Inflammation|DDF|affect|Parkinson's disease|DDF
34669122|student_A|antibiotic treatments|drug|change effect|transient gut dysbiosis|DDF
34669122|student_A|organophosphate pesticides|chemical|influence|late onset neuropathologies|DDF
34669122|student_A|Neurotoxins|chemical|influence|Alzheimer's disease|DDF
34669122|student_A|cadmium|chemical|influence|Alzheimer's disease|DDF
34669122|student_A|neurotoxins|chemical|influence|Alzheimer's disease|DDF
34669122|student_A|neurotoxins|chemical|influence|late onset neuropathologies|DDF
34669122|student_A|cadmium|chemical|influence|late onset neuropathologies|DDF
34669122|student_A|Gut Microbiota Dysbiosis|DDF|affect|late onset neuropathology|DDF
34669122|student_A|Antibiotics|drug|change effect|Gut Microbiota Dysbiosis|DDF
34669122|student_A|antibiotic treatments|drug|change effect|Gut Microbiota Dysbiosis|DDF
34669122|student_A|transient gut dysbiosis|DDF|affect|Parkinson's disease|DDF
34669122|student_A|selenium|chemical|influence|Parkinson's disease|DDF
34669122|student_A|neurotoxins|chemical|influence|Parkinson's disease|DDF
34669122|student_A|Inflammation|DDF|affect|late onset neuropathologies|DDF
34669122|student_A|lead|chemical|influence|late onset neuropathology|DDF
34669122|student_A|aluminum|chemical|influence|Alzheimer's disease|DDF
34669122|student_A|aluminum|chemical|influence|late onset neuropathologies|DDF
34669122|student_A|Neurotoxins|chemical|influence|late onset neuropathologies|DDF
34669122|student_A|Gut dysbiosis|DDF|affect|Alzheimer's disease|DDF
34669122|student_A|late onset neuropathologies|DDF|affect|Gut dysbiosis|DDF
34669122|student_A|antibiotic treatments|drug|change effect|gut dysbiosis|DDF
34669122|student_A|Gut Microbiota Dysbiosis|DDF|affect|Alzheimer's disease|DDF
34669122|student_A|late onset neuropathologies|DDF|affect|Inflammation|DDF
34669122|student_A|mercury|chemical|influence|Alzheimer's disease|DDF
34669122|student_A|antibiotic treatments|drug|change effect|Gut dysbiosis|DDF
34669122|student_A|cadmium|chemical|influence|Parkinson's disease|DDF
34669122|student_A|Gut dysbiosis|DDF|affect|late onset neuropathology|DDF
34669122|student_A|arsenic|chemical|influence|late onset neuropathology|DDF
34669122|student_A|lead|chemical|influence|Alzheimer's disease|DDF
34669122|student_A|manganese|chemical|influence|Alzheimer's disease|DDF
34669122|student_A|Neurotoxins|chemical|influence|Parkinson's disease|DDF
34669122|student_A|manganese|chemical|influence|late onset neuropathologies|DDF
34669122|student_A|antibiotic treatments|drug|change effect|late onset neuropathology|DDF
34669122|student_A|Gut Microbiota Dysbiosis|DDF|affect|Parkinson's disease|DDF
34669122|student_A|antibiotic treatments|drug|change effect|Alzheimer's disease|DDF
34669122|student_A|lead|chemical|influence|late onset neuropathologies|DDF
34669122|student_A|Antibiotics|drug|change effect|gut microbiota dysbiosis|DDF
34669122|student_A|organophosphate pesticides|chemical|influence|late onset neuropathology|DDF
34669122|student_A|Parkinson's disease|DDF|affect|autoimmune diseases|DDF
34669122|student_A|lead|chemical|influence|Parkinson's disease|DDF
34669122|student_A|late onset neuropathologies|DDF|affect|autoimmune diseases|DDF
34669122|student_A|manganese|chemical|influence|Parkinson's disease|DDF
34669122|student_A|antibiotic treatments|drug|change effect|Parkinson's disease|DDF
34669122|student_A|selenium|chemical|influence|late onset neuropathology|DDF
34669122|student_A|Antibiotics|drug|change effect|transient gut dysbiosis|DDF
34669122|student_A|organochlorines|chemical|influence|late onset neuropathology|DDF
34669122|student_A|Gut Microbiota Dysbiosis|DDF|affect|late onset neuropathologies|DDF
34669122|student_A|aluminum|chemical|influence|Parkinson's disease|DDF
34669122|student_A|arsenic|chemical|influence|Alzheimer's disease|DDF
34669122|student_A|mercury|chemical|influence|late onset neuropathologies|DDF
34669122|student_A|Antibiotics|drug|change effect|Gut dysbiosis|DDF
34669122|student_A|mercury|chemical|influence|late onset neuropathology|DDF
34669122|student_A|Antibiotics|drug|change effect|Alzheimer's disease|DDF
34669122|student_A|Antibiotics|drug|change effect|late onset neuropathologies|DDF
34669122|student_A|Gut dysbiosis|DDF|affect|Parkinson's disease|DDF
34669122|student_A|Antibiotics|drug|change effect|late onset neuropathology|DDF
34669122|student_A|antibiotic treatments|drug|change effect|late onset neuropathologies|DDF
35432048|student_B|probiotics|dietary supplement|influence|depression|DDF
35432048|student_B|probiotics|dietary supplement|influence|anxiety|DDF
35432048|student_B|Probiotics|dietary supplement|influence|Depression|DDF
35432048|student_B|gut microbiota|microbiome|is linked to|depression|DDF
35432048|student_B|gut microbiota|microbiome|is linked to|anxiety|DDF
35432048|student_B|Probiotics|dietary supplement|influence|Anxiety|DDF
36365032|student_B|gut microbiota|microbiome|located in|antipsychotic naïve or quasi-naïve people|human
36365032|student_B|first-episode psychosis|DDF|target|people|human
36365032|student_B|Participants|human|used by|16S rRNA sequencing|biomedical technique
36365032|student_B|established illness|DDF|target|patients|human
36365032|student_B|established schizophrenia|DDF|target|patients|human
36365032|student_B|gut microbiota|microbiome|located in|people|human
36365032|student_B|established schizophrenia|DDF|target|people|human
36365032|student_B|metabolic conditions|DDF|target|people|human
36365032|student_B|gut microbial diversity|microbiome|located in|patients|human
36365032|student_B|Schizophrenia|DDF|target|People|human
36365032|student_B|established illness|DDF|target|people|human
36365032|student_B|first-episode psychosis|DDF|target|antipsychotic naïve or quasi-naïve people|human
36365032|student_B|schizophrenia|DDF|target|people|human
36365032|student_B|Psychoses|DDF|target|People|human
36365032|student_B|psychoses|DDF|target|people|human
35981685|student_B|submandibular gland|anatomical location|located in|NOD mice|animal
35981685|student_B|microbiota|microbiome|is linked to|depression-related phenotypes|DDF
35981685|student_B|gut microbiota|microbiome|is linked to|SS-related symptoms|DDF
35981685|student_B|psychiatric symptom|DDF|target|patients|human
35981685|student_B|gut microbiota|microbiome|located in|NOD mice|animal
35981685|student_B|Sjögren's syndrome|DDF|target|patients|human
35981685|student_B|SMG|anatomical location|located in|NOD mice|animal
35981685|student_B|SS-related symptoms|DDF|target|Eleven-week-old NOD mice|animal
35981685|student_B|gut microbiota|microbiome|located in|non-obese diabetic (NOD) mice|animal
35981685|student_B|depression|DDF|target|general population|human
35981685|student_B|depression-like behaviors|DDF|target|NOD mice|animal
35981685|student_B|depression|DDF|target|SS patients|human
35981685|student_B|PFC|anatomical location|located in|NOD mice|animal
35981685|student_B|microbiota|microbiome|is linked to|SS-related symptoms|DDF
35981685|student_B|gut microbiota|microbiome|is linked to|depression-like phenotypes|DDF
35981685|student_B|prefrontal cortex|anatomical location|located in|NOD mice|animal
35981685|student_B|depression-like phenotypes|DDF|target|NOD mice|animal
35981685|student_B|depression-like phenotypes|DDF|target|non-obese diabetic (NOD) mice|animal
35981685|student_B|SS|DDF|target|non-obese diabetic (NOD) mice|animal
35981685|student_B|Depression|DDF|target|patients|human
35981685|student_B|SS|DDF|target|patients|human
36244970|student_A|amino acid|chemical|influence|fatigue|DDF
36244970|student_A|short-chain fatty acid producers|bacteria|influence|Depression|DDF
36244970|student_A|faecal gut microbiota|microbiome|is linked to|depression|DDF
36244970|student_A|faecal gut microbiota|microbiome|located in|Patients|human
36244970|student_A|glycan|chemical|influence|fatigue|DDF
36244970|student_A|faecal gut microbiota|microbiome|is linked to|fatigue|DDF
36244970|student_A|Clostridiales g.i.s|bacteria|part of|faecal gut microbiota|microbiome
36244970|student_A|depressive symptoms|DDF|target|patients|human
36244970|student_A|glycosaminoglycan|chemical|influence|depression|DDF
36244970|student_A|faecal gut microbiota|microbiome|is linked to|depression and fatigue symptoms|DDF
36244970|student_A|glycan|chemical|influence|Depression|DDF
36244970|student_A|Odoribacter|bacteria|part of|faecal gut microbiota|microbiome
36244970|student_A|bacterial genera|bacteria|part of|faecal gut microbiota|microbiome
36244970|student_A|pectin|chemical|influence|depression|DDF
36244970|student_A|active IBD|DDF|target|patients|human
36244970|student_A|carbohydrate|chemical|influence|fatigue|DDF
36244970|student_A|faecal gut microbiota|microbiome|used by|faecal metagenomics|biomedical technique
36244970|student_A|Intestinimonas|bacteria|part of|faecal gut microbiota|microbiome
36244970|student_A|short-chain fatty acid producers|bacteria|influence|fatigue|DDF
36244970|student_A|depression and fatigue symptoms|DDF|target|Patients|human
36244970|student_A|fatigue|DDF|target|patients|human
36244970|student_A|Anaerotruncus|bacteria|part of|faecal gut microbiota|microbiome
36244970|student_A|carbohydrate|chemical|influence|Depression|DDF
36244970|student_A|Alistipes|bacteria|part of|faecal gut microbiota|microbiome
36244970|student_A|Eubacterium|bacteria|part of|faecal gut microbiota|microbiome
36244970|student_A|IBD|DDF|target|prospectively enrolled patients|human
33889128|student_B|constipation|DDF|target|PD patients|human
33889128|student_B|Parkinson's Disease|DDF|target|Patients|human
33889128|student_B|flora|microbiome|located in|nasal mucosa|anatomical location
33889128|student_B|PD patients|human|used by|DBS|biomedical technique
33889128|student_B|Patients|human|used by|Subthalamic Deep Brain Stimulation|biomedical technique
33889128|student_B|Parkinson patients|human|used by|DBS|biomedical technique
39260135|student_B|antidepressant treatment|drug|impact|GM|microbiome
39260135|student_B|antidepressant medications|drug|change effect|MDD|DDF
39260135|student_B|GM|microbiome|is linked to|neurogenesis|DDF
39260135|student_B|MDD|DDF|change abundance|gut microbiota|microbiome
39260135|student_B|Major depressive disorder|DDF|affect|reduced activity|DDF
39260135|student_B|MDD|DDF|change abundance|GM|microbiome
39260135|student_B|NPs|dietary supplement|influence|MDD|DDF
39260135|student_B|NPs|dietary supplement|impact|GM|microbiome
39260135|student_B|SCAFs|chemical|impact|GM|microbiome
39260135|student_B|saponins|chemical|impact|GM|microbiome
39260135|student_B|GM|microbiome|is linked to|MDD|DDF
39260135|student_B|GM|microbiome|is linked to|neural plasticity|DDF
39260135|student_B|antidepressant treatments|drug|change effect|MDD|DDF
39260135|student_B|flavonoids|chemical|influence|MDD|DDF
39260135|student_B|Natural products|dietary supplement|impact|GM|microbiome
39260135|student_B|5-HT|chemical|impact|GM|microbiome
39260135|student_B|alkaloids|chemical|impact|GM|microbiome
39260135|student_B|antidepressant|drug|change effect|MDD|DDF
39260135|student_B|terpenoids|chemical|impact|GM|microbiome
39260135|student_B|saponins|chemical|influence|MDD|DDF
39260135|student_B|flavonoids|chemical|impact|GM|microbiome
39260135|student_B|Major depressive disorder|DDF|affect|persistent depression|DDF
39260135|student_B|BDNF|chemical|impact|GM|microbiome
39260135|student_B|MDD|DDF|affect|reduced activity|DDF
39260135|student_B|GM|microbiome|is linked to|neuroinflammation|DDF
39260135|student_B|polysaccharides|chemical|impact|GM|microbiome
39260135|student_B|terpenoids|chemical|influence|MDD|DDF
39260135|student_B|GM|microbiome|located in|brain|anatomical location
39260135|student_B|alkaloids|chemical|influence|MDD|DDF
39260135|student_B|MDD|DDF|affect|persistent depression|DDF
39260135|student_B|polysaccharides|chemical|influence|MDD|DDF
33064969|student_A|intestinal microbiota|microbiome|located in|Pink1</i><sup>-/-</sup> mice|animal
33064969|student_A|Citrobacter rodentium|bacteria|influence|PD-like pathology|DDF
33064969|student_A|gut microbiota|microbiome|located in|wild-type littermates|animal
33064969|student_A|intestinal microbiota|microbiome|is linked to|PD|DDF
33064969|student_A|gut microbiota|microbiome|located in|Pink1</i><sup>-/-</sup> and wild-type control littermates|animal
33064969|student_A|intestinal murine pathogen|bacteria|influence|PD-like pathology|DDF
33064969|student_A|PD-like pathology|DDF|target|Pink1</i><sup>-/-</sup> mice|animal
33064969|student_A|intestinal microbiota|microbiome|located in|wild-type littermates|animal
33064969|student_A|repeated infection|DDF|target|Pink1</i><sup>-/-</sup> mice|animal
33064969|student_A|intestinal microbiota|microbiome|located in|Pink1</i><sup>-/-</sup> and wild-type control littermates|animal
33064969|student_A|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
33064969|student_A|gut microbiota|microbiome|is linked to|C. rodentium</i> infection|DDF
33064969|student_A|intestinal microbiota|microbiome|is linked to|Parkinson's disease|DDF
33064969|student_A|gut microbiota|microbiome|located in|PD patients|human
33064969|student_A|intestinal milieu|microbiome|is linked to|PD|DDF
33064969|student_A|gut microbiota|microbiome|located in|Pink1</i><sup>-/-</sup> mice|animal
33064969|student_A|intestinal microbiota|microbiome|located in|PD patients|human
33064969|student_A|gut microbiota|microbiome|is linked to|PD|DDF
33064969|student_A|intestinal milieu|microbiome|is linked to|Parkinson's disease|DDF
38984896|student_A|ED|DDF|target|men|human
38984896|student_A|Gut microbiota|microbiome|is linked to|depression|DDF
38984896|student_A|Gut microbiota|microbiome|is linked to|psychological ED|DDF
38984896|student_A|Gut microbiota|microbiome|is linked to|vascular endothelial dysfunction|DDF
38984896|student_A|Gut microbiota|microbiome|is linked to|organic ED|DDF
38984896|student_A|Gut microbiota|microbiome|is linked to|androgen metabolism disorder|DDF
38984896|student_A|erectile dysfunction|DDF|target|men|human
38984896|student_A|Gut microbiota|microbiome|is linked to|ED|DDF
38984896|student_A|gut microbiota|microbiome|is linked to|erectile dysfunction|DDF
38984896|student_A|Gut microbiota|microbiome|is linked to|anxiety|DDF
38984896|student_A|gut microbiota|microbiome|is linked to|ED|DDF
32157731|student_A|neuronal and behavioral dysfunction|DDF|target|PD flies|animal
32157731|student_A|Lactobacillus plantarum or Acetobacter pomorum strain|bacteria|influence|neuronal and behavioral dysfunction|DDF
32157731|student_A|rotenone|drug|change effect|PD symptoms|DDF
32157731|student_A|EGCG|chemical|change expression|TotM|gene
32157731|student_A|EGCG|chemical|impact|gut microbiota|microbiome
32157731|student_A|dopaminergic, survival, and behavioral deficits|DDF|target|mutant PINK1<sup>B9</sup> flies|animal
32157731|student_A|nutritional intervention|dietary supplement|influence|Parkinson's disease|DDF
32157731|student_A|antibiotics|drug|impact|gut microbiota|microbiome
32157731|student_A|EGCG|chemical|located in|Drosophila melanogaster with PINK1 (PTEN induced putative kinase 1) mutations|animal
32157731|student_A|EGCG|chemical|influence|neuronal and behavioral defects|DDF
32157731|student_A|EGCG|chemical|influence|PD symptoms|DDF
32157731|student_A|PD flies|animal|used by|Transcriptomic analysis|biomedical technique
32157731|student_A|green tea|food|administered|PD patients|human
32157731|student_A|EGCG|chemical|impact|gut microbial compositions|microbiome
32157731|student_A|gut microbial compositions|microbiome|located in|PINK1<sup>B9</sup> flies|animal
32157731|student_A|EGCG|chemical|influence|Parkinson's disease|DDF
36958817|student_A|IBD|DDF|target|patients|human
36958817|student_A|Inflammatory bowel disease|DDF|strike|intestine|anatomical location
36958817|student_A|ulcerative colitis|DDF|strike|intestine|anatomical location
36958817|student_A|bile acid pool|chemical|produced by|dysbiotic microbial communities|microbiome
36958817|student_A|Crohn's disease|DDF|strike|intestine|anatomical location
36958817|student_A|sphingolipid|chemical|influence|IBD|DDF
36958817|student_A|faecal metabolites|chemical|produced by|microbiome|microbiome
36958817|student_A|L-urobilin|chemical|influence|IBD|DDF
36958817|student_A|intestinal inflammation|DDF|change abundance|microbiome|microbiome
36958817|student_A|Faecal metabolome|chemical|influence|inflammatory bowel disease|DDF
36466655|student_A|harmful substances|chemical|located in|central center|anatomical location
36466655|student_A|pathogenic proteins|bacteria|part of|gut microbiota|microbiome
36466655|student_A|pathogenic proteins|bacteria|influence|neurodegenerative diseases|DDF
36466655|student_A|pathogenic proteins|bacteria|part of|GM|microbiome
36466655|student_A|cytokines|chemical|impact|pathogenic proteins|bacteria
36466655|student_A|harmful substances|chemical|produced by|GM|microbiome
36466655|student_A|dietary therapy|dietary supplement|influence|NDs|DDF
36466655|student_A|Gut microbiota|microbiome|is linked to|neurodegenerative diseases|DDF
36466655|student_A|pathogenic proteins|bacteria|influence|central inflammation|DDF
36466655|student_A|GM|microbiome|is linked to|NDs|DDF
36466655|student_A|gut microbiota|microbiome|is linked to|NDs|DDF
36466655|student_A|harmful substances|chemical|located in|peripheral circulation|anatomical location
36466655|student_A|metabolites|chemical|produced by|GM|microbiome
36466655|student_A|harmful substances|chemical|located in|blood-brain barrier|anatomical location
36466655|student_A|dietary therapy|dietary supplement|impact|pathogenic proteins|bacteria
36466655|student_A|harmful substances|chemical|located in|intestinal barrier|anatomical location
36466655|student_A|gut|anatomical location|located in|human|human
36466655|student_A|pathogenic proteins|bacteria|part of|Gut microbiota|microbiome
36466655|student_A|pathogenic proteins|bacteria|influence|NDs|DDF
35526743|student_B|gut microbiome|microbiome|is linked to|epilepsy|DDF
35526743|student_B|focal epilepsy|DDF|target|people|human
35526743|student_B|gut|anatomical location|located in|people|human
35526743|student_B|gut microbiome|microbiome|located in|people|human
35526743|student_B|gut microbiota-regulated|microbiome|is linked to|TLE|DDF
35526743|student_B|gut microbiome|microbiome|is linked to|neuroinflammation|DDF
35526743|student_B|adult hippocampal|anatomical location|located in|people|human
35526743|student_B|Temporal lobe epilepsy|DDF|target|people|human
35526743|student_B|neuroinflammation|DDF|target|people|human
35526743|student_B|gut microbial metabolites|chemical|located in|gut|anatomical location
35526743|student_B|gut microbial metabolites|chemical|produced by|gut microbiome|microbiome
35526743|student_B|gut microbiome|microbiome|is linked to|TLE|DDF
35526743|student_B|brain|anatomical location|located in|people|human
35526743|student_B|neurological disorder|DDF|target|people|human
35526743|student_B|TLE|DDF|target|people|human
39371767|student_A|Nutraceuticals|dietary supplement|influence|CKD|DDF
39371767|student_A|nutraceuticals|dietary supplement|influence|CKD|DDF
39371767|student_A|Bioactive Nutraceuticals|dietary supplement|influence|Chronic Kidney Disease Progression|DDF
39371767|student_A|nutraceuticals|dietary supplement|influence|kidney disease|DDF
39371767|student_A|gut microbiota|microbiome|is linked to|CKD|DDF
35151796|student_B|"depression-related" microbiome|microbiome|located in|rodents|animal
35151796|student_B|vagus nerve|anatomical location|located in|rodents|animal
35151796|student_B|gut microbiota|microbiome|is linked to|depression|DDF
35151796|student_B|"depression-related" microbiome|microbiome|is linked to|depression|DDF
35151796|student_B|depression|DDF|target|rodents|animal
35151796|student_B|stress|DDF|target|rodents|animal
38097625|student_A|AAA metabolites|chemical|impact|Clostridium sp. AF50-3|bacteria
38097625|student_A|constipation|DDF|target|PD patients|human
38097625|student_A|PD patients|human|used by|microbiota shotgun metagenomic sequencing|biomedical technique
38097625|student_A|AAA metabolites|chemical|impact|Bacteroides vulgatus|bacteria
38097625|student_A|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
38097625|student_A|aromatic amino acids|chemical|impact|gut microbiota|microbiome
38097625|student_A|AAA metabolites|chemical|impact|Bacteroides sp. CF01-10NS|bacteria
38097625|student_A|Plasma metabolites|chemical|produced by|gut microbiota|microbiome
39203714|student_A|methyltransferases|chemical|influence|epigenetic mechanisms|DDF
39203714|student_A|Prebiotics|dietary supplement|influence|neuroendocrine response to stress|DDF
39203714|student_A|Dietary Fiber|chemical|influence|Genetic and Epigenetic Aspects|DDF
39203714|student_A|effects|DDF|change abundance|gut microbiota|microbiome
39203714|student_A|plant secondary metabolites|chemical|influence|mental health outcomes|DDF
39203714|student_A|Long-chain <i>n</i>-3 fatty acids|chemical|influence|psychotic and mood disorders|DDF
39203714|student_A|fatty acids|chemical|influence|mental health outcomes|DDF
39203714|student_A|EPA|chemical|part of|Long-chain <i>n</i>-3 fatty acids|chemical
39203714|student_A|phenolic compounds|chemical|influence|mental health outcomes|DDF
39203714|student_A|brain-derived neurotrophic factor|chemical|influence|genetic and epigenetic mechanisms|DDF
39203714|student_A|Prebiotics|dietary supplement|influence|effects|DDF
39203714|student_A|Dietary constituents|chemical|influence|gene expression|DDF
39203714|student_A|mental health outcomes|DDF|affect|genetic and epigenetic aspects|DDF
39203714|student_A|Phenolic Compounds|chemical|influence|Genetic and Epigenetic Aspects|DDF
39203714|student_A|dietary fiber|chemical|influence|mental health outcomes|DDF
39203714|student_A|Fatty Acids|chemical|influence|Genetic and Epigenetic Aspects|DDF
39203714|student_A|Dietary constituents|chemical|influence|mental health conditions|DDF
39203714|student_A|Prebiotics|dietary supplement|influence|facilitation of the processing of positive emotions|DDF
39203714|student_A|histone deacetylases|chemical|influence|genetic and epigenetic mechanisms|DDF
39203714|student_A|DHA|chemical|part of|Long-chain <i>n</i>-3 fatty acids|chemical
35837118|student_A|gut microbiota|microbiome|is linked to|schizophrenia|DDF
35837118|student_A|controls|human|used by|V3-V5 sequencing region|biomedical technique
35837118|student_A|gut microbiota|microbiome|is linked to|neurological diseases|DDF
35837118|student_A|gut microbiota|microbiome|is linked to|MS|DDF
35837118|student_A|biomarker|chemical|influence|MS|DDF
35837118|student_A|patients|human|used by|16S rRNA gene amplified sequencing|biomedical technique
35837118|student_A|controls|human|used by|Illumina HiSeq 2500|biomedical technique
35837118|student_A|neurological diseases|DDF|change abundance|gut microbiota|microbiome
35837118|student_A|biomarker|chemical|influence|schizophrenia|DDF
35837118|student_A|gut microbiota|microbiome|is linked to|AD|DDF
35837118|student_A|biomarker|chemical|influence|AD|DDF
35837118|student_A|controls|human|used by|16S rRNA gene amplified sequencing|biomedical technique
35837118|student_A|Gut Microbiota|microbiome|is linked to|Neurological Diseases|DDF
35837118|student_A|gut microbiota|microbiome|used by|16S rRNA gene amplified sequencing|biomedical technique
35837118|student_A|controls|human|used by|Illumina HiSeq 2000|biomedical technique
36615279|student_A|Anthocyanins|chemical|impact|gut microbiota|microbiome
36615279|student_A|anthocyanins|chemical|influence|chronic disorders|DDF
36615279|student_A|Anthocyanins|chemical|interact|neuropeptides|chemical
36615279|student_A|Anthocyanins|chemical|influence|Chronic Disorders|DDF
36615279|student_A|Anthocyanins|chemical|influence|chronic diseases|DDF
36615279|student_A|Anthocyanins|chemical|interact|insulin-like growth factor-1|chemical
35303781|student_A|Gut microbiome|microbiome|is linked to|AN|DDF
37179826|student_A|Mitochondrial dysfunction|DDF|affect|chronic fatigue syndrome|DDF
37179826|student_A|Mitochondrial dysfunction|DDF|affect|inflammatory disorders|DDF
37179826|student_A|Mitochondrial dysfunction|DDF|affect|amyotrophic lateral sclerosis (ALS)|DDF
37179826|student_A|Mitochondrial dysfunction|DDF|affect|cancer|DDF
37179826|student_A|Mitochondrial dysfunction|DDF|affect|CFS|DDF
37179826|student_A|Mitochondrial dysfunction|DDF|affect|cardiovascular and infectious diseases|DDF
37179826|student_A|Mitochondrial dysfunction|DDF|affect|neuronal diseases|DDF
37179826|student_A|Mitochondrial dysfunction|DDF|affect|chronic pain|DDF
39346901|student_A|Lactobacillus helveticus|bacteria|influence|depression|DDF
39346901|student_A|L. helveticus|bacteria|influence|improve endogenous depression|DDF
39346901|student_A|L. helveticus|bacteria|influence|treatment-resistant depression|DDF
39346901|student_A|drugs|drug|change effect|exogenous depression|DDF
39346901|student_A|NS8|dietary supplement|influence|depression|DDF
39346901|student_A|Wistar-Kyoto rats|animal|used by|forced swimming test|biomedical technique
39346901|student_A|NS8|dietary supplement|influence|improve endogenous depression|DDF
39346901|student_A|gut microbiota|microbiome|is linked to|endogenous depression|DDF
39346901|student_A|Wistar-Kyoto rats|animal|used by|sucrose preference test|biomedical technique
39346901|student_A|NS8|dietary supplement|influence|treatment-resistant depression|DDF
34475403|student_A|early PD|DDF|target|rhesus monkeys|animal
34475403|student_A|PD|DDF|target|rhesus monkeys|animal
34475403|student_A|microbiota|microbiome|located in|A53T monkeys|animal
34475403|student_A|p-Hydroxyphenylacetic acid|chemical|produced by|gut microbiota|microbiome
34475403|student_A|3-Methylindole|chemical|produced by|intestine microbiota|microbiome
34475403|student_A|early PD|DDF|interact|GAPDH|chemical
34475403|student_A|PD|DDF|interact|GAPDH|chemical
34475403|student_A|microbiota|microbiome|located in|control monkeys|animal
34475403|student_A|Parkinson's disease|DDF|interact|Myristic acid|chemical
34475403|student_A|PD|DDF|interact|Myristic acid|chemical
34475403|student_A|Parkinson's disease|DDF|change abundance|Eggerthella lenta|bacteria
34475403|student_A|five compositional different metabolites|chemical|produced by|intestine microbiota|microbiome
34475403|student_A|Gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
34475403|student_A|microbiota|microbiome|is linked to|PD|DDF
34475403|student_A|anxiety|DDF|target|rhesus monkeys|animal
34475403|student_A|microbiota|microbiome|is linked to|neurodegenerative disease|DDF
34475403|student_A|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
34475403|student_A|Eggerthella lenta|bacteria|part of|gut microbiota|microbiome
34475403|student_A|mitochondrial dysfunction|DDF|target|A53T monkeys|animal
34475403|student_A|Prevotella|bacteria|part of|gut microbiota|microbiome
34475403|student_A|intestine microbiota|microbiome|used by|metagenomic sequencing|biomedical technique
34475403|student_A|Parkinson's disease|DDF|change abundance|Sybergistetes|bacteria
34475403|student_A|five compositional different metabolites|chemical|produced by|gut microbiota|microbiome
34475403|student_A|microbiota|microbiome|is linked to|early PD|DDF
34475403|student_A|five compositional different metabolites|chemical|influence|mitochondrial dysfunction|DDF
34475403|student_A|gut microbiota|microbiome|used by|metagenomic sequencing|biomedical technique
34475403|student_A|early PD|DDF|change abundance|Akkermansia|bacteria
34475403|student_A|A53T monkeys|animal|used by|targeted gas chromatography|biomedical technique
34475403|student_A|PD|DDF|change abundance|Akkermansia|bacteria
34475403|student_A|metabolites|chemical|produced by|microbiota|microbiome
34475403|student_A|PD|DDF|target|A53T monkeys|animal
34475403|student_A|gut microbiota|microbiome|located in|control monkeys|animal
34475403|student_A|Myristic acid|chemical|produced by|Gut microbiota|microbiome
34475403|student_A|Parkinson's disease|DDF|target|rhesus monkeys|animal
34475403|student_A|mitochondrial dysfunction|DDF|target|rhesus monkeys|animal
34475403|student_A|gut microbiota|microbiome|is linked to|PD|DDF
34475403|student_A|Gut microbiota|microbiome|is linked to|neurodegenerative disease|DDF
34475403|student_A|early PD|DDF|change abundance|Prevotella|bacteria
34475403|student_A|gut microbiota|microbiome|is linked to|neurodegenerative disease|DDF
34475403|student_A|PD|DDF|change abundance|Prevotella|bacteria
34475403|student_A|Parkinson's disease|DDF|interact|GAPDH|chemical
34475403|student_A|Myristic acid|chemical|produced by|microbiota|microbiome
34475403|student_A|anxiety|DDF|target|A53T monkeys|animal
34475403|student_A|control monkeys|animal|used by|metagenomic sequencing|biomedical technique
34475403|student_A|A53T monkeys|animal|used by|metagenomic sequencing|biomedical technique
34475403|student_A|Gut microbiota|microbiome|is linked to|early PD|DDF
34475403|student_A|gut microbiota|microbiome|is linked to|early PD|DDF
34475403|student_A|Gut microbiota|microbiome|is linked to|PD|DDF
34475403|student_A|early PD|DDF|interact|p-Hydroxyphenylacetic acid|chemical
34475403|student_A|metabolites|chemical|produced by|Gut microbiota|microbiome
34475403|student_A|A53T transgenic monkeys|animal|used by|metagenomic sequencing|biomedical technique
34475403|student_A|five compositional different metabolites|chemical|produced by|Gut microbiota|microbiome
34475403|student_A|Parkinson's disease|DDF|change abundance|Akkermansia|bacteria
34475403|student_A|early PD|DDF|interact|3-Methylindole|chemical
34475403|student_A|anxiety|DDF|target|A53T transgenic monkeys|animal
34475403|student_A|Parkinson's disease|DDF|target|A53T monkeys|animal
34475403|student_A|early Parkinson's symptoms|DDF|target|A53T transgenic monkeys|animal
34475403|student_A|microbiota|microbiome|used by|metagenomic sequencing|biomedical technique
34475403|student_A|intestine microbiota|microbiome|is linked to|early PD|DDF
34475403|student_A|intestine microbiota|microbiome|is linked to|PD|DDF
34475403|student_A|intestine microbiota|microbiome|is linked to|neurodegenerative disease|DDF
34475403|student_A|cognitive impairment|DDF|target|A53T monkeys|animal
34475403|student_A|neurodegenerative disease|DDF|target|A53T transgenic monkeys|animal
34475403|student_A|Parkinson's disease|DDF|interact|Glyceric acid|chemical
34475403|student_A|neurodegenerative disease|DDF|target|rhesus monkeys|animal
34475403|student_A|Akkermansia|bacteria|part of|microbiota|microbiome
34475403|student_A|early PD|DDF|interact|L-Aspartic acid|chemical
34475403|student_A|intestine microbiota|microbiome|located in|control monkeys|animal
34475403|student_A|early PD|DDF|interact|Glyceric acid|chemical
34475403|student_A|intestine microbiota|microbiome|is linked to|Parkinson's disease|DDF
34475403|student_A|Sybergistetes|bacteria|part of|microbiota|microbiome
34475403|student_A|early PD|DDF|interact|Glyceraldehyde-3-phosphate dehydrogenase|chemical
34475403|student_A|PD|DDF|interact|Glyceraldehyde-3-phosphate dehydrogenase|chemical
34475403|student_A|Eggerthella lenta|bacteria|part of|Gut microbiota|microbiome
34475403|student_A|Gut microbiota|microbiome|used by|metagenomic sequencing|biomedical technique
34475403|student_A|PD|DDF|interact|Glyceric acid|chemical
34475403|student_A|Myristic acid|chemical|produced by|gut microbiota|microbiome
34475403|student_A|L-Aspartic acid|chemical|produced by|microbiota|microbiome
34475403|student_A|rhesus monkeys|animal|used by|targeted gas chromatography|biomedical technique
34475403|student_A|PD|DDF|interact|p-Hydroxyphenylacetic acid|chemical
34475403|student_A|cognitive impairment|DDF|target|A53T transgenic monkeys|animal
34475403|student_A|cognitive impairment|DDF|target|rhesus monkeys|animal
34475403|student_A|intestine microbiota|microbiome|located in|rhesus monkeys|animal
34475403|student_A|PD|DDF|change abundance|Eggerthella lenta|bacteria
34475403|student_A|metabolites|chemical|produced by|intestine microbiota|microbiome
34475403|student_A|3-Methylindole|chemical|produced by|microbiota|microbiome
34475403|student_A|Eggerthella lenta|bacteria|part of|microbiota|microbiome
34475403|student_A|Glyceric acid|chemical|produced by|microbiota|microbiome
34475403|student_A|microbiota|microbiome|located in|A53T transgenic monkeys|animal
34475403|student_A|intestine microbiota|microbiome|located in|A53T transgenic monkeys|animal
34475403|student_A|metabolites|chemical|produced by|gut microbiota|microbiome
34475403|student_A|early PD|DDF|change abundance|Sybergistetes|bacteria
34475403|student_A|p-Hydroxyphenylacetic acid|chemical|produced by|Gut microbiota|microbiome
34475403|student_A|PD|DDF|change abundance|Sybergistetes|bacteria
34475403|student_A|Akkermansia|bacteria|part of|Gut microbiota|microbiome
34475403|student_A|Myristic acid|chemical|produced by|intestine microbiota|microbiome
34475403|student_A|Parkinson's disease|DDF|interact|L-Aspartic acid|chemical
34475403|student_A|Parkinson's disease|DDF|change abundance|Prevotella|bacteria
34475403|student_A|L-Aspartic acid|chemical|produced by|intestine microbiota|microbiome
34475403|student_A|PD|DDF|target|A53T transgenic monkeys|animal
34475403|student_A|Parkinson's disease|DDF|interact|Glyceraldehyde-3-phosphate dehydrogenase|chemical
34475403|student_A|p-Hydroxyphenylacetic acid|chemical|produced by|microbiota|microbiome
34475403|student_A|intestine microbiota|microbiome|located in|A53T monkeys|animal
34475403|student_A|Akkermansia|bacteria|part of|gut microbiota|microbiome
34475403|student_A|early Parkinson's symptoms|DDF|target|A53T monkeys|animal
34475403|student_A|Prevotella|bacteria|part of|Gut microbiota|microbiome
34475403|student_A|L-Aspartic acid|chemical|produced by|Gut microbiota|microbiome
34475403|student_A|Gut microbiota|microbiome|located in|A53T transgenic monkeys|animal
34475403|student_A|gut microbiota|microbiome|located in|A53T transgenic monkeys|animal
34475403|student_A|early PD|DDF|target|A53T transgenic monkeys|animal
34475403|student_A|PD|DDF|interact|L-Aspartic acid|chemical
34475403|student_A|Gut microbiota|microbiome|located in|rhesus monkeys|animal
34475403|student_A|Parkinson's disease|DDF|interact|p-Hydroxyphenylacetic acid|chemical
34475403|student_A|Sybergistetes|bacteria|part of|gut microbiota|microbiome
34475403|student_A|3-Methylindole|chemical|produced by|Gut microbiota|microbiome
34475403|student_A|Glyceric acid|chemical|produced by|Gut microbiota|microbiome
34475403|student_A|early PD|DDF|interact|Myristic acid|chemical
34475403|student_A|Glyceric acid|chemical|produced by|intestine microbiota|microbiome
34475403|student_A|L-Aspartic acid|chemical|produced by|gut microbiota|microbiome
34475403|student_A|Prevotella|bacteria|part of|microbiota|microbiome
34475403|student_A|early PD|DDF|change abundance|Eggerthella lenta|bacteria
34475403|student_A|five compositional different metabolites|chemical|produced by|microbiota|microbiome
34475403|student_A|microbiota|microbiome|located in|rhesus monkeys|animal
34475403|student_A|Gut microbiota|microbiome|located in|A53T monkeys|animal
34475403|student_A|gut microbiota|microbiome|located in|A53T monkeys|animal
34475403|student_A|3-Methylindole|chemical|produced by|gut microbiota|microbiome
34475403|student_A|early PD|DDF|target|A53T monkeys|animal
34475403|student_A|Parkinson's disease|DDF|interact|3-Methylindole|chemical
34475403|student_A|PD|DDF|interact|3-Methylindole|chemical
34475403|student_A|early Parkinson's symptoms|DDF|target|rhesus monkeys|animal
34475403|student_A|Glyceric acid|chemical|produced by|gut microbiota|microbiome
34475403|student_A|neurodegenerative disease|DDF|target|A53T monkeys|animal
34475403|student_A|p-Hydroxyphenylacetic acid|chemical|produced by|intestine microbiota|microbiome
34475403|student_A|control monkeys|animal|used by|targeted gas chromatography|biomedical technique
34475403|student_A|Parkinson's disease|DDF|target|A53T transgenic monkeys|animal
34475403|student_A|Gut microbiota|microbiome|located in|control monkeys|animal
34475403|student_A|mitochondrial dysfunction|DDF|target|A53T transgenic monkeys|animal
34475403|student_A|microbiota|microbiome|is linked to|Parkinson's disease|DDF
34475403|student_A|A53T transgenic monkeys|animal|used by|targeted gas chromatography|biomedical technique
34475403|student_A|rhesus monkeys|animal|used by|metagenomic sequencing|biomedical technique
34475403|student_A|Sybergistetes|bacteria|part of|Gut microbiota|microbiome
34475403|student_A|gut microbiota|microbiome|located in|rhesus monkeys|animal
36687704|student_A|leucine rich repeat|chemical|located in|substantia nigra|anatomical location
36687704|student_A|DEPs|chemical|located in|duodenum|anatomical location
36687704|student_A|recombinant tissue inhibitors of metalloproteinase 3|chemical|located in|duodenum|anatomical location
36687704|student_A|pyrin domain containing proteins 6|chemical|located in|duodenum|anatomical location
36687704|student_A|<i>Ping-wei-san plus</i> herbal therapy|dietary supplement|influence|Parkinson's disease|DDF
36687704|student_A|nucleotide-binding oligomerization domain|chemical|located in|substantia nigra|anatomical location
36687704|student_A|Parkinson's disease|DDF|interact|rotenone|chemical
36687704|student_A|gasdermin D|chemical|located in|duodenum|anatomical location
36687704|student_A|leucine rich repeat|chemical|located in|duodenum|anatomical location
36687704|student_A|nucleotide-binding oligomerization domain|chemical|located in|duodenum|anatomical location
36687704|student_A|<i>Ping-wei-san plus</i> herbal decoction|dietary supplement|influence|Parkinson's disease|DDF
36687704|student_A|<i>Ping-wei-san plus</i> Herbal Decoction|dietary supplement|influence|Parkinson's disease|DDF
36687704|student_A|DEPs|chemical|located in|substantia nigra|anatomical location
36687704|student_A|Parkinson's disease|DDF|interact|dopaminergic|chemical
36687704|student_A|differentially expressed proteins|chemical|located in|substantia nigra|anatomical location
36687704|student_A|pyrin domain containing proteins 6|chemical|located in|substantia nigra|anatomical location
36687704|student_A|differentially expressed proteins|chemical|located in|duodenum|anatomical location
36687704|student_A|recombinant tissue inhibitors of metalloproteinase 3|chemical|located in|substantia nigra|anatomical location
36687704|student_A|Ping-wei-san plus|dietary supplement|influence|Parkinson's disease|DDF
36687704|student_A|PWP herbal treatment|dietary supplement|impact|gut microbiota|microbiome
36687704|student_A|parkin|chemical|located in|duodenum|anatomical location
38931307|student_A|Chronic Stress|DDF|target|Growth-Period Mice|animal
38931307|student_A|chronic unpredictable mild stress|DDF|target|C57BL/6 mice|animal
38931307|student_A|SHH|chemical|impact|Bacteroidota|bacteria
38931307|student_A|short-chain fatty acids|chemical|produced by|gut microbiota|microbiome
38931307|student_A|SCFAs|chemical|produced by|gut microbiota|microbiome
38931307|student_A|Shrimp Head Hydrolysate|chemical|influence|Depression-like Behaviour|DDF
38931307|student_A|SHH|chemical|impact|Bacteroides|bacteria
38931307|student_A|Depression-like Behaviour|DDF|target|Growth-Period Mice|animal
38931307|student_A|SHH|chemical|impact|Alistipes|bacteria
38931307|student_A|SHH|chemical|impact|Firmicutes|bacteria
38931307|student_A|SHH|chemical|influence|depression-like behaviour|DDF
38931307|student_A|CS|DDF|target|adolescents|human
38931307|student_A|SHH|chemical|impact|Parabacteroides|bacteria
38931307|student_A|Chronic stress|DDF|target|adolescents|human
38931307|student_A|shrimp head hydrolysate|chemical|impact|gut microbiota|microbiome
38931307|student_A|SHH|chemical|impact|Muribaculaceae|bacteria
38931307|student_A|Microbiome|microbiome|is linked to|Depression-like Behaviour|DDF
38931307|student_A|Microbiome|microbiome|located in|Growth-Period Mice|animal
38931307|student_A|SHH|chemical|influence|CS|DDF
38931307|student_A|SHH|chemical|influence|chronic stress damage|DDF
38931307|student_A|neurotransmitters|chemical|impact|gut microbiota|microbiome
38931307|student_A|CS|DDF|target|Mice|animal
38931307|student_A|gut microbiota|microbiome|located in|C57BL/6 mice|animal
38931307|student_A|SHH|chemical|impact|gut microbiota|microbiome
38931307|student_A|SHH|chemical|impact|Prevotellaceae_UCG-001|bacteria
38896988|student_A|chronic hyperglycemia|DDF|affect|metabolic disorder|DDF
38896988|student_A|insulin|chemical|located in|CNS|anatomical location
38896988|student_A|cognitive impairments|DDF|target|TALLYHO/JngJ mice|animal
38896988|student_A|Hyperglycemia|DDF|target|TALLYHO/JngJ mice|animal
38896988|student_A|T2DM-like phenotype|DDF|target|TH mice|animal
38896988|student_A|type 2 diabetes-like phenotype|DDF|target|TALLYHO/JngJ mice|animal
38896988|student_A|insulin|chemical|located in|central nervous system|anatomical location
38896988|student_A|T2DM|DDF|target|TH|animal
38896988|student_A|insulin|chemical|located in|peripheral nervous system|anatomical location
35599496|student_A|gut microbiota|microbiome|is linked to|GI|DDF
35599496|student_A|antibiotic|drug|impact|gut microbiota|microbiome
35599496|student_A|PD|DDF|affect|classic motor symptoms|DDF
35599496|student_A|gut microbiota|microbiome|change expression|PD-like phenotype|gene
35599496|student_A|increased depression-like|DDF|target|Transgenic mice|animal
35599496|student_A|Parkinson's disease|DDF|is a|multi-system disorder|DDF
35599496|student_A|gut microbiota|microbiome|is linked to|non-motor features|DDF
35599496|student_A|motor symptoms|DDF|target|wild-type control mouse strain|animal
35599496|student_A|behavioral alterations|DDF|target|Transgenic mice|animal
35599496|student_A|gut microbiota|microbiome|is linked to|PD motor|DDF
35599496|student_A|GI dysfunction|DDF|target|Transgenic mice|animal
35599496|student_A|gastrointestinal (GI) dysfunction|DDF|affect|Parkinson's disease|DDF
35599496|student_A|gut microbiota|microbiome|located in|Transgenic mice|animal
35599496|student_A|reduced anxiety-like behavior|DDF|target|Transgenic mice|animal
35599496|student_A|Parkinson's disease|DDF|affect|classic motor symptoms|DDF
35599496|student_A|gut microbial|microbiome|change expression|PD-like phenotype|gene
35599496|student_A|antibiotic|drug|change expression|PD-like phenotype|gene
35599496|student_A|PD|DDF|affect|gastrointestinal (GI) dysfunction|DDF
35599496|student_A|gut microbiota|microbiome|is linked to|motor|DDF
35599496|student_A|PD|DDF|is a|multi-system disorder|DDF
35599496|student_A|apathy-like behavior|DDF|target|Transgenic mice|animal
33571701|student_A|OS|DDF|affect|apoptosis|DDF
33571701|student_A|resveratrol|dietary supplement|influence|Alzheimer's disease pathology|DDF
33571701|student_A|resveratrol|dietary supplement|influence|cognitive decline|DDF
33092396|student_A|Probiotics|dietary supplement|influence|Neurodegenerative Disease|DDF
33092396|student_A|neurodegeneration|DDF|target|disease subpopulations|human
33092396|student_A|Prebiotics|dietary supplement|influence|Neurodegenerative Disease|DDF
33092396|student_A|Medicinal Herbs|dietary supplement|influence|Neurodegenerative Disease|DDF
33092396|student_A|neurodegenerative diseases|DDF|target|disease subpopulations|human
33092396|student_A|probiotics|dietary supplement|influence|neurodegeneration|DDF
33092396|student_A|Parkinson's Disease|DDF|target|disease subpopulations|human
33092396|student_A|neurodegenerative disease|DDF|target|disease subpopulations|human
33092396|student_A|gut microbiota dysbiosis|DDF|target|disease subpopulations|human
33092396|student_A|PD|DDF|target|disease subpopulations|human
33092396|student_A|Alzheimer's Disease|DDF|target|disease subpopulations|human
33092396|student_A|gut microbiota dysbiosis|DDF|affect|Alzheimer's Disease|DDF
33092396|student_A|medicinal herbs|dietary supplement|influence|neurodegeneration|DDF
33092396|student_A|Synbiotics|dietary supplement|influence|Neurodegenerative Disease|DDF
33092396|student_A|neurological disease|DDF|target|disease subpopulations|human
33092396|student_A|prebiotics|dietary supplement|influence|neurodegeneration|DDF
33092396|student_A|vagus nerve|anatomical location|located in|disease subpopulations|human
33092396|student_A|AD|DDF|target|disease subpopulations|human
33092396|student_A|synbiotics|dietary supplement|influence|neurodegeneration|DDF
33092396|student_A|Neurodegenerative Disease|DDF|target|disease subpopulations|human
35203645|student_B|Bifidobacterium|bacteria|part of|gut microbiota|microbiome
35203645|student_B|Lactobacillus|bacteria|part of|gut microbiota|microbiome
35203645|student_B|dopamine|chemical|located in|central nervous system|anatomical location
35203645|student_B|Ruminococcus|bacteria|part of|gut microbiota|microbiome
35203645|student_B|Clostridium|bacteria|part of|gut microbiota|microbiome
35203645|student_B|Enterococcus|bacteria|part of|gut microbiota|microbiome
35203645|student_B|Prevotella|bacteria|part of|gut microbiota|microbiome
35203645|student_B|dopamine|chemical|located in|periphery|anatomical location
35203645|student_B|Bacteroides|bacteria|part of|gut microbiota|microbiome
35203645|student_B|gut dysbiosis|DDF|affect|dopamine-related pathological conditions|DDF
35203645|student_B|dopamine|chemical|impact|gut microbiota|microbiome
35203645|student_B|Dopamine|chemical|influence|neurological diseases|DDF
39126817|student_A|probiotics|dietary supplement|impact|gut microbiota|microbiome
39126817|student_A|probiotics|dietary supplement|influence|irritable bowel syndrome|DDF
39126817|student_A|probiotics|dietary supplement|influence|IBS|DDF
39203794|student_A|bacteria|bacteria|interact|short-chain fatty acids|chemical
39203794|student_A|impact|DDF|target|IBS patients|human
39203794|student_A|bacteria|bacteria|influence|anti-inflammatory properties|DDF
39203794|student_A|IBS patients|human|used by|structured aerobic exercise programs|biomedical technique
39203794|student_A|Bifidobacterium|bacteria|interact|beneficial gut bacteria|bacteria
39203794|student_A|significant improvements|DDF|target|IBS patients|human
39203794|student_A|abdominal pain|DDF|affect|alleviation of symptoms|DDF
39203794|student_A|bloating|DDF|affect|alleviation of symptoms|DDF
39203794|student_A|impact|DDF|change abundance|gut microbiota|microbiome
39203794|student_A|Lactobacillus|bacteria|interact|beneficial gut bacteria|bacteria
39203794|student_A|gut microbiota|microbiome|located in|IBS patients|human
39203794|student_A|Microbiota|microbiome|is linked to|Irritable Bowel Syndrome|DDF
39203794|student_A|gut microbiota|microbiome|is linked to|pathogenesis|DDF
39203794|student_A|IBS symptoms|DDF|change abundance|gut microbiota|microbiome
39203794|student_A|Microbiota|microbiome|used by|Physical Exercise|biomedical technique
36364961|student_B|Non-Digestible Oligosaccharides|dietary supplement|influence|Leaky Gut|DDF
36364961|student_B|microbiota|microbiome|is linked to|inflammatory bowel disease|DDF
36364961|student_B|nutraceuticals|dietary supplement|influence|gut leakiness|DDF
36364961|student_B|microbiota|microbiome|is linked to|neurodegenerative diseases|DDF
36364961|student_B|microbiota|microbiome|is linked to|Parkinson's disease|DDF
36364961|student_B|NDOs|dietary supplement|impact|microbiota|microbiome
35157946|student_A|COVID-19|DDF|change abundance|gut microbiota|microbiome
35157946|student_A|gut microbiota|microbiome|is linked to|stress-induced mental problems|DDF
35157946|student_A|stress|DDF|change abundance|gut microbiome|microbiome
35157946|student_A|depression|DDF|change abundance|gut microbiome|microbiome
35157946|student_A|psychological stress|DDF|target|FHW|human
35157946|student_A|stress|DDF|target|FHWs|human
35157946|student_A|anxiety|DDF|target|FHWs|human
35157946|student_A|depression|DDF|target|FHWs|human
35157946|student_A|anxiety|DDF|change abundance|gut microbiome|microbiome
33662500|student_A|Korean red ginseng|food|impact|gut microbiota|microbiome
33662500|student_A|mice|animal|used by|MPTP injection|biomedical technique
33662500|student_A|KRG|food|impact|Eubacterium|bacteria
33662500|student_A|KRG|food|impact|Verrucomicrobia|bacteria
33662500|student_A|KRG|food|impact|Ruminococcus|bacteria
34571840|student_A|<i>H. pylori</i> infection|DDF|affect|neurological, dermatological, hematologic, ocular, cardiovascular, metabolic, hepatobiliary, or even allergic diseases|DDF
34571840|student_A|<i>H. pylori</i> infection|DDF|affect|extragastric diseases|DDF
34571840|student_A|altered gut microbiota|microbiome|is linked to|Neurological impairments|DDF
34571840|student_A|H. pylori|bacteria|influence|gastrointestinal impairments|DDF
34571840|student_A|<i>H. pylori</i> infection|DDF|affect|Neurological impairments|DDF
34571840|student_A|Helicobacter pylori|bacteria|influence|gastrointestinal impairments|DDF
31737957|student_A|antibiotics|drug|change effect|PD|DDF
31737957|student_A|oral antibiotics|drug|change effect|PD|DDF
31737957|student_A|gut microbiota|microbiome|is linked to|PD|DDF
31737957|student_A|sulfonamides|drug|change effect|PD|DDF
31737957|student_A|antibiotics|drug|impact|gut microbiota|microbiome
31737957|student_A|antianaerobics|drug|change effect|PD|DDF
31737957|student_A|macrolides|drug|change effect|PD|DDF
31737957|student_A|antifungal medications|drug|change effect|PD|DDF
31737957|student_A|lincosamides|drug|change effect|PD|DDF
31737957|student_A|Gut microbiota alterations|DDF|affect|prodromal and established Parkinson's disease|DDF
31737957|student_A|tetracyclines|drug|change effect|PD|DDF
31737957|student_A|trimethoprim|drug|change effect|PD|DDF
31737957|student_A|PD|DDF|target|patients|human
35937875|student_A|gut microbiota|microbiome|located in|responder group|human
35937875|student_A|steroid esters|chemical|produced by|gut microbiome|microbiome
35937875|student_A|gut microbiota|microbiome|used by|16S rRNA sequencing|biomedical technique
35937875|student_A|cholestane steroids|chemical|produced by|gut microbiome|microbiome
35937875|student_A|antidepressants|drug|impact|gut microbiome|microbiome
35937875|student_A|families Christensenellaceae and Eggerthellaceae|bacteria|part of|gut microbiota|microbiome
35937875|student_A|Adlercreutzia|bacteria|part of|gut microbiome|microbiome
35937875|student_A|gut microbiota|microbiome|located in|patients|human
35937875|student_A|genera <i>Adlercreutzia</i> and <i>Christensenellaceae R7 group</i>|bacteria|part of|gut microbiota|microbiome
35937875|student_A|antidepressant treatment|drug|impact|gut microbiome|microbiome
35937875|student_A|gut microbiota|microbiome|is linked to|MDD|DDF
35937875|student_A|gut microbiota|microbiome|located in|non-responder group|human
35937875|student_A|gut microbiota|microbiome|located in|responder and non-responder groups|human
35937875|student_A|gut microbiota|microbiome|used by|metabolomics|biomedical technique
35937875|student_A|phylum Actinobacteria|bacteria|part of|gut microbiota|microbiome
35937875|student_A|MDD|DDF|target|patients|human
35937875|student_A|antidepressant treatment|drug|change effect|MDD|DDF
35937875|student_A|Gut microbiome|microbiome|is linked to|major depressive disorder|DDF
35937875|student_A|antidepressant treatment|drug|impact|gut microbiota|microbiome
35937875|student_A|gut microbiome|microbiome|located in|responder and non-responder groups|human
35937875|student_A|differential metabolites|chemical|produced by|gut microbiome|microbiome
35937875|student_A|Eggerthellaceae|bacteria|part of|gut microbiome|microbiome
36543925|student_A|motor deficits|DDF|target|SNCA mice|animal
36543925|student_A|α-Synuclein pathology|DDF|target|SNCA mice|animal
36543925|student_A|Helicobacter hepaticus|bacteria|influence|motor disorders|DDF
36543925|student_A|Gastrointestinal disturbances|DDF|target|PD patients|human
36543925|student_A|Parkinson's disease|DDF|target|mice|animal
36543925|student_A|antibiotics cocktail|drug|change effect|inflammation|DDF
36543925|student_A|gut microbiota|microbiome|located in|transgenic mice|animal
36543925|student_A|gut microbiota|microbiome|change expression|SNCA|gene
36543925|student_A|Dextran sodium sulfate|chemical|located in|gut|anatomical location
36543925|student_A|gut microbiomes|microbiome|is linked to|PD pathogenesis|DDF
36543925|student_A|H. hepaticus|bacteria|part of|gut microbiota|microbiome
36543925|student_A|gut microbiota|microbiome|located in|PD patients|human
36543925|student_A|Helicobacter hepaticus|bacteria|part of|gut microbiota|microbiome
36543925|student_A|DSS|chemical|located in|gut|anatomical location
36543925|student_A|gut microbiota|microbiome|change expression|α-Synuclein gene|gene
36543925|student_A|intestinal inflammation|DDF|target|PD patients|human
36543925|student_A|antibiotics cocktail|drug|change effect|α-Synuclein pathology|DDF
36543925|student_A|Helicobacter hepaticus|bacteria|part of|PD gut microbiomes|microbiome
36543925|student_A|asparagine endopeptidase|dietary supplement|change expression|α-Synuclein N103|gene
36543925|student_A|Helicobacter hepaticus|bacteria|influence|Dopaminergic degeneration|DDF
36543925|student_A|Helicobacter hepaticus|bacteria|influence|α-Synuclein pathologies|DDF
36543925|student_A|AEP|dietary supplement|change expression|α-Synuclein N103|gene
36543925|student_A|gut leakage|DDF|target|PD patients|human
39360304|student_A|anhedonic behaviors|DDF|affect|intestinal microbial community disturbance|DDF
39360304|student_A|Mice|animal|used by|LF-TMS|biomedical technique
39360304|student_A|chronic unpredictable mild stress|DDF|target|mice|animal
39360304|student_A|Gut Microbiome|microbiome|located in|Mice|animal
39360304|student_A|CUMS|DDF|target|Mice|animal
39360304|student_A|gut microbiota|microbiome|used by|LF-TMS|biomedical technique
39360304|student_A|CUMS|DDF|change abundance|gut microbiotas|microbiome
39360304|student_A|chronic unpredictable mild stress|DDF|target|Mice|animal
39360304|student_A|gut microbiota|microbiome|located in|mice|animal
39360304|student_A|anhedonic behaviors|DDF|affect|CUMS|DDF
39360304|student_A|Chronic Unpredictable Mild Stress|DDF|target|Mice|animal
39360304|student_A|CUMS|DDF|target|mice|animal
39360304|student_A|gut microbiota|microbiome|used by|low-frequency transcranial magnetic stimulation|biomedical technique
39456245|student_A|gut microbiome|microbiome|located in|young children|human
39456245|student_A|Children|human|used by|16S rRNA sequencing|biomedical technique
39456245|student_A|gut microbiota|microbiome|located in|young children|human
32987244|student_A|KD|food|influence|epileptic encephalopathies|DDF
32987244|student_A|KD|food|influence|Febrile Infection-Related Epilepsy Syndrome|DDF
32987244|student_A|dysregulated adaptive and innate immunity|DDF|affect|drug-resistant epilepsy|DDF
32987244|student_A|KD|food|influence|drug-resistant epilepsy|DDF
32987244|student_A|polyunsaturated fatty acids|chemical|influence|inflammation|DDF
32987244|student_A|KD|food|influence|multiple sclerosis|DDF
32987244|student_A|The high-fat, low-carbohydrate ketogenic diet|food|influence|drug-resistant epilepsy|DDF
32987244|student_A|Ketogenic diet|food|influence|Neuroinflammation|DDF
32987244|student_A|Ketones bodies|chemical|influence|inflammation|DDF
32987244|student_A|KD|food|influence|spinal cord injury|DDF
32987244|student_A|dysregulated adaptive and innate immunity|DDF|affect|refractory status epilepticus|DDF
32987244|student_A|KD|food|influence|neurological disorders|DDF
32987244|student_A|KD|food|influence|FIRES|DDF
32987244|student_A|KD|food|influence|inflammation|DDF
32987244|student_A|KD|food|influence|refractory status epilepticus|DDF
32987244|student_A|KD|food|influence|pain|DDF
32987244|student_A|KD|food|influence|epilepsy|DDF
32987244|student_A|KD|food|influence|Parkinson's disease|DDF
32987244|student_A|KD|food|influence|dysregulated adaptive and innate immunity|DDF
38974216|student_B|gut microbiome|microbiome|is linked to|depression|DDF
38974216|student_B|microbiome|microbiome|is linked to|depression|DDF
38974216|student_B|depression|DDF|change abundance|gut microbiome|microbiome
38974216|student_B|vitamins|chemical|influence|Depression|DDF
38974216|student_B|microbiome|microbiome|is linked to|Depression|DDF
32710966|student_A|striatal homovanillic acid|chemical|located in|substantia nigra pars compacta|anatomical location
32710966|student_A|SNpc|anatomical location|located in|PD mice|animal
32710966|student_A|HVA|chemical|located in|SNpc|anatomical location
32710966|student_A|5-hydroxyindole acetic acid|chemical|located in|substantia nigra pars compacta|anatomical location
32710966|student_A|GABA|chemical|located in|SNpc|anatomical location
32710966|student_A|serotonin|chemical|located in|SNpc|anatomical location
32710966|student_A|5-HIAA|chemical|located in|SNpc|anatomical location
32710966|student_A|PM|chemical|influence|neuronal loss|DDF
32710966|student_A|inflammation|DDF|strike|gut|anatomical location
32710966|student_A|tight junction associated proteins|chemical|located in|SNpc|anatomical location
32710966|student_A|GABA|chemical|located in|substantia nigra pars compacta|anatomical location
32710966|student_A|inhibited mitogen-activated protein kinases|chemical|located in|mice colon|anatomical location
32710966|student_A|PM|chemical|influence|inflammation|DDF
32710966|student_A|PM|chemical|located in|mice colon|anatomical location
32710966|student_A|pro-inflammatory cytokines|chemical|located in|mice colon|anatomical location
32710966|student_A|5-HT|chemical|located in|SNpc|anatomical location
32710966|student_A|dopaminergic neuronal loss|DDF|strike|SNpc|anatomical location
32710966|student_A|PM|chemical|interact|gut microbiota derived SCFAs|chemical
32710966|student_A|serotonin|chemical|located in|substantia nigra pars compacta|anatomical location
32710966|student_A|HVA|chemical|located in|substantia nigra pars compacta|anatomical location
32710966|student_A|inflammation|DDF|strike|brain|anatomical location
32710966|student_A|5-HIAA|chemical|located in|substantia nigra pars compacta|anatomical location
32710966|student_A|Polymannuronic acid|chemical|influence|dopaminergic neuronal loss|DDF
32710966|student_A|PM|chemical|located in|SNpc|anatomical location
32710966|student_A|striatal homovanillic acid|chemical|located in|SNpc|anatomical location
32710966|student_A|5-HT|chemical|located in|substantia nigra pars compacta|anatomical location
32710966|student_A|γ-aminobutyric acid|chemical|located in|SNpc|anatomical location
32710966|student_A|fecal short chain fatty acids|chemical|located in|colon|anatomical location
32710966|student_A|colon|anatomical location|located in|PD mice|animal
32710966|student_A|SCFAs|chemical|located in|colon|anatomical location
32710966|student_A|MAPK|chemical|located in|mice colon|anatomical location
32710966|student_A|dietary proteins and fats|chemical|interact|fecal short chain fatty acids|chemical
32710966|student_A|dietary proteins and fats|chemical|interact|SCFAs|chemical
32710966|student_A|5-hydroxyindole acetic acid|chemical|located in|SNpc|anatomical location
32710966|student_A|tight junction associated proteins|chemical|located in|mice colon|anatomical location
32710966|student_A|γ-aminobutyric acid|chemical|located in|substantia nigra pars compacta|anatomical location
32710966|student_A|dopaminergic neuronal loss|DDF|strike|substantia nigra pars compacta|anatomical location
32710966|student_A|substantia nigra pars compacta|anatomical location|located in|PD mice|animal
34896331|student_A|Short-chain fatty acids|chemical|produced by|gut microbiota|microbiome
34896331|student_A|Sodium butyrate|chemical|influence|autophagy|DDF
34896331|student_A|rotenone-induced toxicity|DDF|interact|NaB|chemical
34896331|student_A|rotenone-induced toxicity|DDF|interact|sodium butyrate|chemical
34896331|student_A|rotenone-induced toxicity|DDF|interact|SCFAs|chemical
34896331|student_A|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
34896331|student_A|gut microbiota|microbiome|is linked to|PD|DDF
34896331|student_A|PD|DDF|interact|SCFAs|chemical
34896331|student_A|NaB|chemical|influence|autophagy|DDF
34896331|student_A|SCFAs|chemical|produced by|gut microbiota|microbiome
34896331|student_A|Sodium butyrate|chemical|influence|rotenone-induced toxicity|DDF
34896331|student_A|autophagy|DDF|interact|SCFAs|chemical
34896331|student_A|epigenetic modification|DDF|interact|NaB|chemical
38928361|student_B|Intestinal Microbiota|microbiome|is linked to|Migraine|DDF
38928361|student_B|gut microbiota|microbiome|located in|gut-brain|anatomical location
38928361|student_B|migraine medication|drug|change effect|chronic migraine|DDF
38928361|student_B|gut microbiota|microbiome|is linked to|mental health conditions|DDF
38928361|student_B|gut microbiota|microbiome|is linked to|depression|DDF
38928361|student_B|gut microbiota|microbiome|is linked to|anxiety|DDF
38928361|student_B|migraine medication|drug|change effect|Migraine|DDF
38928361|student_B|gut microbiota|microbiome|is linked to|migraines|DDF
38928361|student_B|Migraine|DDF|affect|mood changes|DDF
38928361|student_B|anxiety|DDF|target|individuals|human
38928361|student_B|Intestinal Microbiota|microbiome|is linked to|Psychopathologies|DDF
38928361|student_B|depression|DDF|target|individuals|human
38928361|student_B|Migraine|DDF|affect|sensitivity to light, sound and smell|DDF
39331265|student_A|lung cancer|DDF|change abundance|gut microbiota|microbiome
39331265|student_A|cytokines|chemical|influence|lung cancer|DDF
39331265|student_A|serum metabolites|chemical|produced by|gut microbiota|microbiome
39331265|student_A|cytokines|chemical|impact|gut microbiota|microbiome
39331265|student_A|gut microbiota-serum metabolites-cytokines|chemical|influence|lung cancer|DDF
39331265|student_A|cytokines|chemical|change expression|SURF4|gene
39331265|student_A|cytokines|chemical|change expression|lncRNA|gene
39331265|student_A|gut microbiota|microbiome|is linked to|lung cancer|DDF
39331265|student_A|Lung cancer|DDF|change abundance|gut microbiota|microbiome
39331265|student_A|gut microbiota-metabolites- cytokines|chemical|influence|lung cancer|DDF
39331265|student_A|cytokines|chemical|change expression|pseudogene-microRNA-SURF4|gene
36075637|student_B|Disruption of the intestinal microbiota|DDF|affect|diseases in the gut|DDF
36075637|student_B|Disruption of the intestinal microbiota|DDF|affect|neurodegenerative and behavioral disorders|DDF
36075637|student_B|Disruption of the intestinal microbiota|DDF|affect|Parkinson disease|DDF
36075637|student_B|Disruption of the intestinal microbiota|DDF|affect|Alzheimer disease|DDF
33573273|student_A|BAs|chemical|located in|intestinal lumen|anatomical location
33573273|student_A|BAs|chemical|impact|gut bacteria|bacteria
33573273|student_A|bile acids|chemical|located in|intestinal lumen|anatomical location
33573273|student_A|cholesterol|chemical|located in|hepatic tissues|anatomical location
33573273|student_A|BAs|chemical|located in|colon|anatomical location
33573273|student_A|BAs|chemical|located in|liver|anatomical location
33573273|student_A|BAs|chemical|located in|terminal ileum|anatomical location
33573273|student_A|BAs|chemical|produced by|intestinal microbiota|microbiome
31854093|student_B|Parkinson's disease|DDF|strike|brain|anatomical location
31854093|student_B|rats|animal|used by|adeno-associated virus (AAV)-alpha-synuclein|biomedical technique
31854093|student_B|swollen tyrosine hydroxylase-positive varicosities|DDF|strike|submucosal plexus|anatomical location
31854093|student_B|glial markers|chemical|influence|Parkinson's disease pathophysiology|DDF
31854093|student_B|gastrointestinal tract|anatomical location|located in|animals|animal
31854093|student_B|animals|animal|used by|AAV-alpha-synuclein|biomedical technique
31854093|student_B|Lachnospiraceae|bacteria|influence|Parkinson's disease pathophysiology|DDF
31854093|student_B|Parkinson's disease|DDF|strike|gut|anatomical location
31854093|student_B|Faecalibacterium|bacteria|influence|Parkinson's disease pathophysiology|DDF
31854093|student_B|swollen tyrosine hydroxylase-positive varicosities|DDF|affect|Parkinson's disease pathophysiology|DDF
35464431|student_A|gut microbiota|microbiome|is linked to|Alzheimer's disease|DDF
35464431|student_A|GM|microbiome|is linked to|immune and chronic systemic inflammation|DDF
35464431|student_A|Gut Microbiota|microbiome|located in|Brain|anatomical location
35464431|student_A|gut microbiota|microbiome|is linked to|psychiatric symptoms|DDF
35464431|student_A|dietary components|dietary supplement|influence|gut mucosal immunity dysregulation|DDF
35464431|student_A|ND|DDF|affect|gut microbiota-induced systemic chronic inflammation|DDF
35464431|student_A|gut microbiota-induced systemic chronic inflammation|DDF|affect|chronic diseases|DDF
35464431|student_A|NF|DDF|affect|gut microbiota-induced systemic chronic inflammation|DDF
35464431|student_A|GM|microbiome|is linked to|neurodegeneration|DDF
35464431|student_A|gut microbiota|microbiome|is linked to|AD|DDF
35464431|student_A|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
35464431|student_A|brain aging|DDF|affect|gut microbiota-induced systemic chronic inflammation|DDF
35464431|student_A|Systemic Chronic Inflammation|DDF|affect|Neuroinflammation|DDF
35464431|student_A|GM|microbiome|is linked to|aging|DDF
35464431|student_A|NF|DDF|affect|GM-SCI|DDF
35464431|student_A|GM|microbiome|is linked to|ND|DDF
35464431|student_A|chronic diseases|DDF|affect|GM-SCI|DDF
35464431|student_A|GM|microbiome|is linked to|inflammatory or "leaky" IB|DDF
35464431|student_A|ND|DDF|affect|GM-SCI|DDF
35464431|student_A|gut microbiota|microbiome|is linked to|brain cognition|DDF
35464431|student_A|gut microbiota|microbiome|is linked to|neurodegenerative diseases|DDF
35464431|student_A|Aging|DDF|affect|Systemic Chronic Inflammation|DDF
35464431|student_A|GM|microbiome|is linked to|brain pathophysiology|DDF
35464431|student_A|GM|microbiome|is linked to|neuroinflammation|DDF
35464431|student_A|gut microbiota|microbiome|is linked to|multiple sclerosis|DDF
35464431|student_A|gut microbiota|microbiome|is linked to|MS|DDF
35464431|student_A|brain aging|DDF|affect|GM-SCI|DDF
35464431|student_A|GM dysbiosis|DDF|target|mice|animal
35464431|student_A|GM dysbiosis|DDF|target|rats|animal
35464431|student_A|GM|microbiome|is linked to|brain aging|DDF
35464431|student_A|gut microbiota|microbiome|is linked to|PD|DDF
35464431|student_A|GM|microbiome|is linked to|NF|DDF
32894625|student_A|Helicobacter pylori (HP) infection|DDF|affect|worse motor function|DDF
32894625|student_A|PD|DDF|target|patients|human
34835406|student_A|probiotics|dietary supplement|impact|gut microbiota|microbiome
34835406|student_A|gut microbiota|microbiome|is linked to|neurodegeneration|DDF
34835406|student_A|human gut microbiota|microbiome|is linked to|neurodegeneration|DDF
34835406|student_A|probiotics|dietary supplement|impact|human gut microbiota|microbiome
34835406|student_A|human gut microbiota|microbiome|is linked to|imbalance|DDF
34835406|student_A|gut microbiota|microbiome|is linked to|imbalance|DDF
34835406|student_A|gut microbiota|microbiome|is linked to|Neurodegenerative Disease|DDF
34835406|student_A|human gut microbiota|microbiome|is linked to|Neurodegenerative Disease|DDF
34835406|student_A|human gut microbiota|microbiome|is linked to|neurodegenerative diseases|DDF
34835406|student_A|gut microbiota|microbiome|is linked to|neurodegenerative diseases|DDF
34835406|student_A|human gut microbiota|microbiome|used by|FMT|biomedical technique
34835406|student_A|gut microbiota|microbiome|used by|FMT|biomedical technique
36569929|student_A|cerebral toxoplasmosis|DDF|affect|chronic brain inflammation processes|DDF
36569929|student_A|gut microbiota|microbiome|is linked to|Alzheimer's disease|DDF
36569929|student_A|neuroschistosomiasis|DDF|affect|chronic brain inflammation processes|DDF
36569929|student_A|gut microbiota|microbiome|is linked to|Parasite infections|DDF
36569929|student_A|gut microbiota|microbiome|is linked to|Parkinson's|DDF
36569929|student_A|parasite infections|DDF|change abundance|gut microbiota|microbiome
36569929|student_A|gut microbiota|microbiome|is linked to|central nervous system inflammation|DDF
36569929|student_A|bacterial metabolites|chemical|influence|central nervous system inflammation|DDF
36569929|student_A|gut microbiota|microbiome|is linked to|parasite infections|DDF
36569929|student_A|cerebral malaria|DDF|affect|chronic brain inflammation processes|DDF
36569929|student_A|gut microbiota|microbiome|is linked to|neurodegenerative diseases|DDF
36569929|student_A|human African trypanosomiasis|DDF|affect|chronic brain inflammation processes|DDF
36569929|student_A|parasite infections|DDF|affect|neuropathophysiological processes|DDF
36569929|student_A|gut microbiota|microbiome|is linked to|neuroinflammation|DDF
36569929|student_A|neurocysticercosis|DDF|affect|chronic brain inflammation processes|DDF
36569929|student_A|parasitic diseases|DDF|affect|chronic brain inflammation processes|DDF
35041424|student_A|Gut Microbiota|microbiome|is linked to|Anxiety|DDF
35041424|student_A|population's diet|food|influence|mental disorders|DDF
35041424|student_A|Gut Microbiota|microbiome|is linked to|Depression|DDF
37490970|student_A|disrupted microbiome|microbiome|is linked to|glioma|DDF
37490970|student_A|Firmicutes/Bacteroidetes ratio|bacteria|influence|primary open-angle glaucoma|DDF
37490970|student_A|glaucoma|DDF|target|patients|human
37490970|student_A|disrupted microbiome|microbiome|is linked to|multiple sclerosis|DDF
37490970|student_A|microbiome|microbiome|is linked to|neurodegenerative diseases|DDF
37490970|student_A|Gut Microbiota|microbiome|is linked to|Glaucoma Progression|DDF
37490970|student_A|glutathione|chemical|influence|primary open-angle glaucoma|DDF
37490970|student_A|disrupted microbiome|microbiome|is linked to|Parkinson disease|DDF
37490970|student_A|Gut Microbiota|microbiome|is linked to|Retinal Diseases|DDF
37490970|student_A|taurocholic acid|chemical|influence|primary open-angle glaucoma|DDF
37490970|student_A|microbial composition|microbiome|located in|patients|human
37490970|student_A|disrupted microbiome|microbiome|is linked to|Alzheimer disease|DDF
37490970|student_A|disrupted microbiome|microbiome|is linked to|central nervous system diseases|DDF
35844606|student_B|gut microbes|microbiome|is linked to|ischemic stroke|DDF
35844606|student_B|gut microbes|microbiome|is linked to|neurological illnesses|DDF
35844606|student_B|microbiota|microbiome|is linked to|autoimmune diseases|DDF
35844606|student_B|gut microbes|microbiome|is linked to|Alzheimer's disease|DDF
35844606|student_B|gut microbes|microbiome|is linked to|Parkinson's disease|DDF
35844606|student_B|microbiota|microbiome|is linked to|neurological disorders|DDF
35844606|student_B|microbiota|microbiome|located in|gastrointestinal tract|anatomical location
33935107|student_A|Short-chain fatty acids|chemical|produced by|gut microbiota|microbiome
35879588|student_A|paraprobiotics|dietary supplement|influence|behavioural and neurobiological abnormalities|DDF
35879588|student_A|prebiotics|dietary supplement|influence|behavioural and neurobiological abnormalities|DDF
35879588|student_A|paraprobiotics|dietary supplement|influence|age-associated neurodegenerative diseases|DDF
35879588|student_A|microbiota|microbiome|is linked to|horizontal gene transfer|DDF
35879588|student_A|behavioural and neurobiological abnormalities|DDF|target|elderly patients|human
35879588|student_A|Alzheimer's and Parkinson's disease|DDF|target|elderly people|human
35879588|student_A|microbiota|microbiome|is linked to|translocation|DDF
35879588|student_A|Neurodegenerative diseases|DDF|target|elderly people|human
35879588|student_A|probiotics|dietary supplement|influence|behavioural and neurobiological abnormalities|DDF
35879588|student_A|microbiota|microbiome|is linked to|sepsis|DDF
35879588|student_A|gut microbiota|microbiome|located in|aged population|human
35879588|student_A|gut microbiota|microbiome|is linked to|age-related CNS disorders|DDF
32244373|student_B|neurodegenerative diseases|DDF|affect|host liver metabolism|DDF
32244373|student_B|polyphenolic compounds|chemical|impact|gut microbiota|microbiome
32244373|student_B|Prosaic Foods|food|influence|Alzheimer Disease|DDF
32244373|student_B|prosaic foods|food|influence|neurodegenerative diseases|DDF
39339804|student_B|oral microbiota|microbiome|compared to|gut microbiota|microbiome
39339804|student_B|diet|food|impact|oral microbiota|microbiome
39339804|student_B|oral microbiota|microbiome|located in|oral cavity|anatomical location
39339804|student_B|oral pathogens|bacteria|part of|microbial diversity|microbiome
39339804|student_B|gastrointestinal problems|DDF|affect|periodontitis|DDF
39339804|student_B|oral microbiota|microbiome|compared to|microbial community|microbiome
39339804|student_B|microbial community|microbiome|located in|humans|human
39339804|student_B|fermentable carbohydrates|dietary supplement|impact|oral pathogens|bacteria
39339804|student_B|gut microbiota|microbiome|located in|gastrointestinal tract|anatomical location
39339804|student_B|oral diseases|DDF|affect|gastrointestinal problems|DDF
39339804|student_B|oral microbiota|microbiome|located in|humans|human
39339804|student_B|microbial diversity|microbiome|located in|gut|anatomical location
39339804|student_B|microbial diversity|microbiome|located in|oral cavity|anatomical location
39339804|student_B|diets/dietary components|food|impact|microbial diversity|microbiome
39339804|student_B|fermentable carbohydrates|dietary supplement|impact|microbial diversity|microbiome
39339804|student_B|Diet|food|impact|microbial diversity|microbiome
39339804|student_B|diets/dietary components|food|impact|oral pathogens|bacteria
38776563|student_A|Dysbiosis|DDF|affect|mental health disorders|DDF
38776563|student_A|mental diseases|DDF|target|world's population|human
38776563|student_A|gut microbiome|microbiome|is linked to|psychiatric conditions|DDF
38776563|student_A|Gut microbiota|microbiome|located in|human gut|anatomical location
38776563|student_A|imbalance in the gut microbiota|DDF|affect|mental health disorders|DDF
38776563|student_A|Gut microbiota|microbiome|located in|gastrointestinal tract|anatomical location
38776563|student_A|gut microbiota|microbiome|is linked to|mental health-related illnesses|DDF
38776563|student_A|imbalance in the gut microbiota|DDF|affect|psychiatric illnesses|DDF
38776563|student_A|Dysbiosis|DDF|affect|psychiatric illnesses|DDF
38776563|student_A|gut microbiota|microbiome|is linked to|psychiatric disorders|DDF
38776563|student_A|Gut microbiota|microbiome|is linked to|mental illnesses|DDF
39106786|student_A|gut microbiota|microbiome|is linked to|MDD|DDF
39106786|student_A|Gut microbiota|microbiome|is linked to|major depression disorder|DDF
39106786|student_A|gut microbiota|microbiome|is linked to|neuropsychiatric diseases|DDF
39106786|student_A|gut microbiota|microbiome|is linked to|major depression disorder|DDF
39106786|student_A|Gut microbiota|microbiome|is linked to|PD|DDF
39106786|student_A|Gut microbiota|microbiome|is linked to|MDD|DDF
39106786|student_A|Gut microbiota|microbiome|is linked to|anxiety|DDF
39106786|student_A|Gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
39106786|student_A|Gut microbiota|microbiome|is linked to|addiction|DDF
39106786|student_A|gut microbiota|microbiome|is linked to|anxiety|DDF
39106786|student_A|gut microbiota|microbiome|is linked to|addiction|DDF
39106786|student_A|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
39106786|student_A|gut microbiota|microbiome|is linked to|PD|DDF
39106786|student_A|Gut microbiota|microbiome|is linked to|neuropsychiatric diseases|DDF
33549028|student_A|gut microbiota|microbiome|located in|human intestine|anatomical location
33549028|student_A|gut microbiota|microbiome|is linked to|neuropsychiatric diseases|DDF
33549028|student_A|gut microbiota|microbiome|is linked to|neuropsychiatric disorders|DDF
32247371|student_A|dysbiotic microbiota|DDF|target|PD patients|human
32247371|student_A|medication|drug|change effect|dysbiotic microbiota|DDF
32247371|student_A|neurodegenerative disorders|DDF|target|human subjects|human
32247371|student_A|gut microbiota|microbiome|is linked to|PD clinical features|DDF
32247371|student_A|gut microbiota|microbiome|is linked to|alpha-synuclein (α-syn) pathology|DDF
32247371|student_A|gut microbiota|microbiome|is linked to|neurodegenerative disorders|DDF
32247371|student_A|neuroinflammation|DDF|target|PD patients|human
32247371|student_A|medication|drug|change effect|PD|DDF
32247371|student_A|Levodopa|drug|change effect|PD|DDF
32247371|student_A|gut microbiome|microbiome|is linked to|Parkinson's disease|DDF
32247371|student_A|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
32247371|student_A|microbiota|microbiome|is linked to|neuroinflammation|DDF
32247371|student_A|PD|DDF|target|PD patients|human
32247371|student_A|Levodopa|drug|change effect|dysbiotic microbiota|DDF
32247371|student_A|gut microbiota|microbiome|is linked to|PD|DDF
32247371|student_A|dysbiosis|DDF|target|PD patients|human
32247371|student_A|gut microbiota|microbiome|located in|healthy subjects|human
32247371|student_A|gut microbiota|microbiome|located in|human subjects|human
39089603|student_A|Enhanced cerebral blood flow similarity|DDF|affect|chronic insomnia|DDF
39089603|student_A|CI|DDF|target|patients|human
39089603|student_A|Lactobacillales|bacteria|influence|increased CBF similarities|DDF
39089603|student_A|gut microbiota|microbiome|used by|cognitive test|biomedical technique
39089603|student_A|increased CBF similarities|DDF|affect|sleep behaviors|DDF
39089603|student_A|Negativicutes|bacteria|influence|increased CBF similarities|DDF
39089603|student_A|gut microbiota|microbiome|used by|clinical assessment|biomedical technique
39089603|student_A|gut microbiota|microbiome|used by|multimodal MRI|biomedical technique
39089603|student_A|gut microbiota|microbiome|is linked to|Chronic insomnia|DDF
39089603|student_A|gut microbiota|microbiome|used by|sleep behavior recording|biomedical technique
39089603|student_A|enhanced cerebral blood flow (CBF) similarities|DDF|affect|CI|DDF
39089603|student_A|gut microbiota|microbiome|is linked to|increased CBF similarities|DDF
39089603|student_A|gut microbiota|microbiome|is linked to|CI|DDF
34402617|student_A|Human Microbiome|microbiome|used by|Microbial Community Analysis|biomedical technique
34402617|student_A|human gut microbiota|microbiome|used by|GEMs|biomedical technique
33390888|student_A|caffeine|dietary supplement|influence|PD|DDF
33390888|student_A|caffeine|dietary supplement|influence|dopaminergic neurodegeneration|DDF
33390888|student_A|istradefylline|drug|change effect|PD|DDF
33390888|student_A|Caffeine|dietary supplement|influence|Parkinson's Disease|DDF
33390888|student_A|caffeine consumption|dietary supplement|influence|PD|DDF
33138351|student_A|gut microbiota|microbiome|is linked to|dementia|DDF
33138351|student_A|gut microbiota|microbiome|is linked to|dysbiosis|DDF
33138351|student_A|microbiota|microbiome|is linked to|human diseases|DDF
33138351|student_A|bacterial amyloid|chemical|influence|neurological disorders|DDF
33138351|student_A|gut microbiota|microbiome|is linked to|neurodegenerative diseases|DDF
33138351|student_A|gut microbiota|microbiome|is linked to|cancer|DDF
33138351|student_A|gut microbiota|microbiome|is linked to|obesity|DDF
33138351|student_A|gut microbiota|microbiome|is linked to|social behavior|DDF
38848976|student_B|gut microbiota|microbiome|used by|Network pharmacology|biomedical technique
38848976|student_B|Coprococcus|bacteria|part of|gut microbiota|microbiome
38848976|student_B|(R)-3-(4-Hydroxyphenyl)lactate|chemical|change expression|hub-genes|gene
38848976|student_B|Coprococcus|bacteria|change expression|PTGS2|gene
38848976|student_B|gut microbiota|microbiome|change expression|PTGS2|gene
38848976|student_B|gut microbiota|microbiome|change expression|hub-genes|gene
38848976|student_B|Coprococcus|bacteria|change expression|MMP9|gene
38848976|student_B|Subdoligranulum|bacteria|change expression|hub-genes|gene
38848976|student_B|Coprococcus|bacteria|change expression|hub-genes|gene
38848976|student_B|gut microbiota|microbiome|is linked to|depression|DDF
38848976|student_B|3-Indolepropionic acid|chemical|change expression|hub-genes|gene
38848976|student_B|Subdoligranulum|bacteria|change expression|PTGS2|gene
38848976|student_B|Subdoligranulum|bacteria|change expression|MMP9|gene
38848976|student_B|antidepressants|drug|change effect|Depression|DDF
38848976|student_B|gut microbiota|microbiome|change expression|MMP9|gene
38848976|student_B|Subdoligranulum|bacteria|part of|gut microbiota|microbiome
38848976|student_B|gut microbiota|microbiome|used by|molecular dynamics simulation|biomedical technique
39364125|student_B|gut microbiome|microbiome|is linked to|depression|DDF
39364125|student_B|depression|DDF|change abundance|Bifidobacteriaceae|bacteria
39364125|student_B|microbiomes|microbiome|located in|individuals|human
39364125|student_B|depression|DDF|change abundance|bacterial taxa|bacteria
39364125|student_B|depression|DDF|change abundance|Streptococcaceae|bacteria
39364125|student_B|depression|DDF|change abundance|Veillonellaceae|bacteria
39364125|student_B|gut microbiota|microbiome|located in|human|human
39364125|student_B|depression|DDF|change abundance|microbiomes|microbiome
39364125|student_B|gut microbiome|microbiome|is linked to|mental health|DDF
39364125|student_B|gut microbiome|microbiome|located in|gut-brain|anatomical location
39364125|student_B|gut microbiome|microbiome|located in|human|human
39364125|student_B|coronavirus disease 2019|DDF|affect|Depression|DDF
39364125|student_B|COVID-19|DDF|affect|Depression|DDF
39364125|student_B|depression|DDF|target|individuals|human
39364125|student_B|depressive symptom severity scores|DDF|change abundance|gut microbiota|microbiome
39364125|student_B|gut microbiome|microbiome|located in|participants|human
39337263|student_A|Ethanol Exposure|DDF|affect|Microbiota-Induced Immune Dysregulation|DDF
39337263|student_A|microbiota|microbiome|is linked to|disease|DDF
39337263|student_A|lasting effects|DDF|affect|susceptibility to psychiatric disorders|DDF
39337263|student_A|Prenatal Stress|DDF|affect|Psychiatric Risks|DDF
39337263|student_A|maternal gut microbiota dysbiosis|DDF|affect|chronic inflammation|DDF
39337263|student_A|risk of depression|DDF|target|offspring|human
39337263|student_A|maternal gut microbiota dysbiosis|DDF|affect|combined effects|DDF
39337263|student_A|chronic inflammation|DDF|affect|risk of depression|DDF
39337263|student_A|microbiota|microbiome|is linked to|host health|DDF
39337263|student_A|Prenatal Stress|DDF|affect|Microbiota-Induced Immune Dysregulation|DDF
39337263|student_A|lasting effects|DDF|affect|inflammation response|DDF
39337263|student_A|disturbances|DDF|change abundance|maternal microbiota|microbiome
39337263|student_A|immune system dysfunction|DDF|affect|risk of depression|DDF
39337263|student_A|Prenatal Stress|DDF|affect|Ethanol Exposure|DDF
39337263|student_A|Changes|DDF|change abundance|maternal gut microbiota|microbiome
39337263|student_A|ethanol exposure|DDF|change abundance|maternal gut microbiota|microbiome
39337263|student_A|Ethanol Exposure|DDF|affect|Psychiatric Risks|DDF
39337263|student_A|prenatal maternal stress|DDF|affect|susceptibility to depression|DDF
39337263|student_A|maternal gut microbiota dysbiosis|DDF|affect|immune system dysfunction|DDF
39337263|student_A|lasting effects|DDF|affect|offspring's health|DDF
39337263|student_A|prenatal maternal stress|DDF|change abundance|maternal and offspring microbiota|microbiome
39337263|student_A|stress|DDF|change abundance|maternal gut microbiota|microbiome
39337263|student_A|prenatal ethanol exposure|DDF|change abundance|maternal and offspring microbiota|microbiome
35245613|student_A|intestinal microbes|bacteria|influence|PD|DDF
35245613|student_A|gut microbiota|microbiome|is linked to|PD|DDF
35245613|student_A|PD|DDF|strike|brain|anatomical location
35245613|student_A|intestinal microbiota|microbiome|is linked to|PD|DDF
35245613|student_A|PD|DDF|strike|gut|anatomical location
35245613|student_A|PD|DDF|target|patients|human
35367961|student_A|gut microbiota|microbiome|is linked to|Alzheimer's disease|DDF
35367961|student_A|gut microbiota|microbiome|is linked to|cognitive impairment|DDF
35367961|student_A|gut microbiota|microbiome|is linked to|cognitive disorders|DDF
35367961|student_A|Gut Microbiota|microbiome|is linked to|Alzheimer's Disease|DDF
35444255|student_B|microbial-derived neuroactive metabolites|chemical|produced by|gut microbiota|microbiome
35444255|student_B|gamma-aminobutyric acid|chemical|produced by|gut microbiota|microbiome
35444255|student_B|BD|DDF|change abundance|gut microbiota|microbiome
35444255|student_B|bipolar depression|DDF|change abundance|gut microbiome|microbiome
35444255|student_B|gut microbiota|microbiome|is linked to|BD|DDF
35444255|student_B|serum metabolome|chemical|produced by|gut microbiota|microbiome
35444255|student_B|Citrobacter freundii|bacteria|part of|gut microbiota|microbiome
35444255|student_B|short-chain fatty acids|chemical|produced by|gut microbiota|microbiome
35444255|student_B|unmedicated patients with depressed bipolar disorder|human|used by|faecal metagenomic, serum metabolomics and neuroimaging studies|biomedical technique
35444255|student_B|Phascolarctobacterium spp.|bacteria|part of|gut microbiota|microbiome
35444255|student_B|Flavobacterium spp.|bacteria|part of|gut microbiota|microbiome
35444255|student_B|kynurenic acid|chemical|produced by|gut microbiota|microbiome
35444255|student_B|BD|DDF|target|unmedicated patients with depressed bipolar disorder|human
35444255|student_B|Enterobacter spp.|bacteria|part of|gut microbiota|microbiome
35444255|student_B|Yersinia spp.|bacteria|part of|gut microbiota|microbiome
35444255|student_B|multiple B-vitamins|chemical|produced by|gut microbiota|microbiome
35444255|student_B|Akkermansia muciniphila|bacteria|part of|gut microbiota|microbiome
35444255|student_B|Yersinia aleksiciae|bacteria|part of|gut microbiota|microbiome
35444255|student_B|aberrant cognitive function, emotion regulation, and interoception|DDF|target|unmedicated patients with depressed bipolar disorder|human
35444255|student_B|Citrobacter werkmanii|bacteria|part of|gut microbiota|microbiome
35444255|student_B|Citrobacter spp.|bacteria|part of|gut microbiota|microbiome
35444255|student_B|gut microbiome|microbiome|used by|Multi-omics analyses|biomedical technique
35444255|student_B|Yersinia frederiksenii|bacteria|part of|gut microbiota|microbiome
35444255|student_B|Enterobacter cloacae|bacteria|part of|gut microbiota|microbiome
35444255|student_B|Enterobacter kobei|bacteria|part of|gut microbiota|microbiome
38057970|student_A|PD|DDF|target|participants|human
38057970|student_A|Parkinson's disease|DDF|target|patients|human
31968211|student_A|gut microbiota|microbiome|is linked to|gastrointestinal diseases|DDF
31968211|student_A|gut microbiota|microbiome|is linked to|neurological and gastrointestinal diseases|DDF
31968211|student_A|patient's gastrointestinal tract|anatomical location|located in|FMT recipients|human
31968211|student_A|gut microbiota|microbiome|located in|FMT recipients|human
31968211|student_A|gut microbiota|microbiome|is linked to|immunological response|DDF
31968211|student_A|gut microbiota|microbiome|is linked to|diabetes|DDF
31968211|student_A|gut microbiota|microbiome|is linked to|weight gain|DDF
31968211|student_A|gut microbiota|microbiome|located in|healthy donor|human
31968211|student_A|gut microbiota|microbiome|located in|patient's gastrointestinal tract|anatomical location
31968211|student_A|gut microbiota|microbiome|is linked to|cancer|DDF
31968211|student_A|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
31968211|student_A|gut microbiota|microbiome|is linked to|metabolic syndrome|DDF
34358037|student_A|Gut Microbiota|microbiome|is linked to|Neuroinflammation|DDF
34358037|student_A|dysbiosis|DDF|affect|CNS pathologies|DDF
34358037|student_A|commensal and pathogenic gut bacteria|bacteria|influence|CNS pathologies|DDF
34358037|student_A|dysregulation of systemic homeostasis|DDF|affect|CNS pathologies|DDF
34358037|student_A|gut microbiota|microbiome|is linked to|neuroinflammation|DDF
36235622|student_A|microbiota-based probiotic dietary supplementation|dietary supplement|influence|Alzheimer's and Parkinson's diseases|DDF
36235622|student_A|probiotic bacteria|bacteria|influence|neurodegeneration|DDF
36235622|student_A|microbiota-based probiotic dietary supplementation|dietary supplement|influence|dementia|DDF
36235622|student_A|microbiota-based probiotic dietary supplementation|dietary supplement|influence|neurodegeneration|DDF
36235622|student_A|probiotic bacteria|bacteria|influence|systemic inflammation|DDF
36235622|student_A|probiotic bacteria|bacteria|influence|neuroinflammation|DDF
36235622|student_A|dysbiosis|DDF|affect|human neurodegenerative and brain-related diseases|DDF
35207483|student_B|novel pharmacological targets|drug|change effect|major depressive disorder|DDF
35207483|student_B|fatty acids|dietary supplement|influence|depressive symptoms|DDF
35207483|student_B|clinically available antidepressants|drug|change effect|depressive symptoms|DDF
35207483|student_B|antidepressant|drug|change effect|depressive symptoms|DDF
35207483|student_B|ketamine|drug|change effect|major depressive disorder|DDF
35207483|student_B|Novel Pharmacological Approaches|drug|change effect|Depression|DDF
35207483|student_B|plants|dietary supplement|influence|depressive symptoms|DDF
35207483|student_B|Monoamine-based antidepressants|drug|change effect|major depressive disorder|DDF
35207483|student_B|analogues|drug|change effect|major depressive disorder|DDF
35207483|student_B|novel pharmaceutical approaches|drug|change effect|depressive symptoms|DDF
35207483|student_B|natural products|dietary supplement|influence|depressive symptoms|DDF
35207483|student_B|therapeutic|drug|change effect|inflammation|DDF
35207483|student_B|herbs|dietary supplement|influence|depressive symptoms|DDF
35207483|student_B|antidepressants|drug|change effect|major depressive disorder|DDF
31931152|student_A|neurodegeneration|DDF|target|individuals diagnosed with PD|human
31931152|student_A|Parkinson's disease|DDF|target|individuals diagnosed with PD|human
31931152|student_A|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
31931152|student_A|dietary and/or therapeutic interventions|dietary supplement|influence|PD|DDF
31931152|student_A|gut microbiota|microbiome|is linked to|immune-driven pathogenesis|DDF
31931152|student_A|gut microbiota|microbiome|is linked to|PD|DDF
31931152|student_A|PD|DDF|target|individuals diagnosed with PD|human
39360531|student_A|RA|DDF|target|patients|human
39360531|student_A|flavonoids|chemical|influence|RA|DDF
39360531|student_A|autoimmune disease|DDF|target|patients|human
39360531|student_A|alkaloids|chemical|influence|RA|DDF
39360531|student_A|terpenoids|chemical|influence|RA|DDF
39386896|student_B|gut microbiota|microbiome|is linked to|schizophrenia|DDF
39386896|student_B|gut microbiota|microbiome|located in|gut-brain|anatomical location
39386896|student_B|schizophrenia|DDF|target|patients|human
39386896|student_B|gut microbiota|microbiome|used by|LC-MS|biomedical technique
39386896|student_B|gut microbial|microbiome|is linked to|schizophrenia|DDF
39386896|student_B|schizophrenia|DDF|change abundance|bacterial species|bacteria
39386896|student_B|gut microbiota|microbiome|used by|Liquid chromatography-mass spectrometry|biomedical technique
39386896|student_B|schizophrenia|DDF|target|individuals|human
39386896|student_B|amino acid|chemical|located in|central nervous system|anatomical location
39386896|student_B|gut microbiota|microbiome|located in|patients|human
39386896|student_B|lipid|chemical|located in|central nervous system|anatomical location
33338469|student_B|bacterial endotoxin|chemical|influence|progressive neurodegeneration|DDF
33338469|student_B|α-syn|chemical|interact|bacterial lipid components|chemical
33338469|student_B|lipid metabolites|chemical|interact|α-syn|chemical
33338469|student_B|Parkinson's disease|DDF|strike|gastrointestinal tract|anatomical location
33338469|student_B|LPS|chemical|influence|progressive neurodegeneration|DDF
33338469|student_B|Gram-negative bacteria|bacteria|interact|LPS|chemical
33338469|student_B|Gram-negative bacteria|bacteria|interact|Lipopolysaccharide|chemical
33338469|student_B|Lipopolysaccharide|chemical|influence|progressive neurodegeneration|DDF
33338469|student_B|α-syn|chemical|part of|homeostatic protein components|chemical
33338469|student_B|bacterial endotoxin|chemical|interact|Lipopolysaccharide|chemical
33338469|student_B|amyloidogenesis|DDF|strike|gut|anatomical location
33338469|student_B|lipid metabolites|chemical|interact|α-synuclein|chemical
33338469|student_B|bacterial endotoxin|chemical|impact|Gram-negative bacteria|bacteria
33338469|student_B|bacterial lipid components|chemical|interact|LPS|chemical
33338469|student_B|α-synuclein|chemical|part of|homeostatic protein components|chemical
33338469|student_B|bacterial endotoxin|chemical|interact|LPS|chemical
33338469|student_B|lipid contents|chemical|influence|α-syn amyloidogenesis|DDF
33338469|student_B|Gram-negative bacteria|bacteria|influence|progressive neurodegeneration|DDF
33338469|student_B|neurodegenerative diseases|DDF|strike|second brain|anatomical location
33338469|student_B|PD|DDF|strike|gastrointestinal tract|anatomical location
33338469|student_B|lipid metabolites|chemical|interact|homeostatic protein components|chemical
35603160|student_A|intestinal permeability|DDF|target|CS patients|human
35603160|student_A|Escherichia-Shigella|bacteria|part of|intestinal microbiota|microbiome
35603160|student_A|gut dysbiosis|DDF|affect|systemic inflammation|DDF
35603160|student_A|CS patients|human|used by|16S rRNA sequencing|biomedical technique
35603160|student_A|LPS|chemical|influence|systemic inflammation|DDF
35603160|student_A|Gut Dysbiosis|DDF|affect|Systemic Inflammatory Response|DDF
35603160|student_A|LBP|chemical|influence|systemic inflammation|DDF
35603160|student_A|LPS-binding protein|chemical|influence|systemic inflammation|DDF
35603160|student_A|gastrointestinal (GI) dysfunction|DDF|target|CS patients|human
35603160|student_A|Streptococcus|bacteria|part of|intestinal microbiota|microbiome
35603160|student_A|plasma C-reactive protein|chemical|influence|systemic inflammation|DDF
35603160|student_A|gut dysbiosis|DDF|target|CS patients|human
35603160|student_A|Lactobacillus|bacteria|part of|intestinal microbiota|microbiome
35603160|student_A|Gut Dysbiosis|DDF|affect|Cryptogenic Stroke|DDF
35603160|student_A|CRP|chemical|influence|systemic inflammation|DDF
35603160|student_A|systemic inflammation|DDF|change abundance|Klebsilla|bacteria
35603160|student_A|Lactobacillaceae|bacteria|part of|intestinal microbiota|microbiome
35603160|student_A|gut dysbiosis|DDF|affect|CS|DDF
35603160|student_A|lipopolysaccharide|chemical|influence|systemic inflammation|DDF
35603160|student_A|NCs|human|used by|16S rRNA sequencing|biomedical technique
35603160|student_A|systemic inflammation|DDF|target|CS patients|human
35603160|student_A|Enterobacteriaceae|bacteria|part of|intestinal microbiota|microbiome
35603160|student_A|gut inflammation|DDF|target|CS patients|human
35603160|student_A|Klebsilla|bacteria|part of|intestinal microbiota|microbiome
35603160|student_A|Streptococcaceae|bacteria|part of|intestinal microbiota|microbiome
39027446|student_A|Dialister|bacteria|interact|bacteria|bacteria
39027446|student_A|Coprococcus|bacteria|interact|bacteria|bacteria
39027446|student_A|gut microbiota alterations|DDF|affect|depressive symptoms|DDF
39027446|student_A|Probiotic bacteria|bacteria|influence|depressive behavior|DDF
39027446|student_A|defensins|chemical|part of|antimicrobial proteins|chemical
39027446|student_A|Exposure to stressors|DDF|change abundance|bacteria|bacteria
39027446|student_A|neurotransmitters|chemical|interact|essential metabolites|chemical
39027446|student_A|Oscillibacter|bacteria|interact|bacteria|bacteria
39027446|student_A|Psychotropics|drug|change effect|mental health benefits|DDF
39027446|student_A|disturbances|DDF|interact|metabolites|chemical
39027446|student_A|Psychotropics|drug|change effect|antidepressant effects|DDF
39027446|student_A|probiotics|dietary supplement|influence|gut microbiota alterations|DDF
39027446|student_A|short-chain fatty acids (SCFAs)|chemical|part of|essential metabolites|chemical
39027446|student_A|catalysidins|chemical|part of|antimicrobial proteins|chemical
39027446|student_A|type C lectins|chemical|part of|antimicrobial proteins|chemical
39027446|student_A|Bacteroides|bacteria|interact|bacteria|bacteria
39027446|student_A|essential metabolites|chemical|produced by|gut microbiome|microbiome
39027446|student_A|prebiotics|dietary supplement|influence|gut microbiota alterations|DDF
39027446|student_A|tryptophan metabolites|chemical|part of|essential metabolites|chemical
39027446|student_A|depression|DDF|target|people|human
39027446|student_A|disturbances|DDF|change abundance|gut bacterial community|microbiome
39027446|student_A|Clostridium|bacteria|interact|bacteria|bacteria
39027446|student_A|depression|DDF|affect|ratio of intestinal-derived molecules|DDF
39027446|student_A|gut microbiota|microbiome|is linked to|major depressive disorder|DDF
38735387|student_A|inflammatory bowel diseases|DDF|affect|psychiatric Disorders|DDF
38735387|student_A|genus Roseburia|bacteria|change expression|rs11751561|gene
38735387|student_A|anti-inflammatory drugs|drug|change effect|Psychiatric disorders|DDF
38735387|student_A|inflammatory bowel diseases|DDF|affect|Psychiatric disorders|DDF
38735387|student_A|genus Roseburia|bacteria|change expression|shared genetic variant|gene
38735387|student_A|anti-inflammatory drugs|drug|change effect|psychiatric disorders|DDF
38735387|student_A|anti-inflammatory drugs|drug|change effect|psychiatric Disorders|DDF
36362150|student_A|mucosal immunity|DDF|change abundance|gut microbiota|microbiome
36362150|student_A|altered immunological conditions|DDF|change abundance|gut microbiota|microbiome
36362150|student_A|gut-associated microbes|bacteria|influence|myalgic encephalomyelitis|DDF
36362150|student_A|gut-associated microbes|bacteria|influence|Alzheimer's disease|DDF
36362150|student_A|Mucosal Immunity|DDF|affect|Neuroimmune Disease|DDF
36362150|student_A|mucosal immunity|DDF|change abundance|microbiota|microbiome
36362150|student_A|small molecules|chemical|located in|gut|anatomical location
36362150|student_A|gut-associated microbes|bacteria|influence|Parkinson's disease|DDF
36362150|student_A|small molecules|chemical|located in|vagus nerves|anatomical location
36362150|student_A|altered immunological conditions|DDF|affect|neuroimmune diseases|DDF
36362150|student_A|gut microbiota|microbiome|is linked to|neuroimmune diseases|DDF
36362150|student_A|gut-associated microbes|bacteria|influence|autism|DDF
38863592|student_A|anxiety|DDF|target|men|human
38863592|student_A|intestinal microbiota|microbiome|located in|host|human
38863592|student_A|probiotics|dietary supplement|influence|anxiety|DDF
38863592|student_A|diet|food|impact|gut microbiota|microbiome
38863592|student_A|prebiotic and probiotic food|food|impact|intestinal microbiota|microbiome
38863592|student_A|anxiety|DDF|target|women|human
38863592|student_A|prebiotics|dietary supplement|influence|anxiety|DDF
38863592|student_A|prebiotic food|food|influence|anxiety|DDF
35715396|student_A|Prevotella-enriched microbiome|microbiome|located in|exclusion group|human
35715396|student_A|anxiety-related physical symptoms|DDF|target|exclusion group|human
35715396|student_A|Faecalibacterium spp.|bacteria|located in|exclusion group|human
35715396|student_A|gut microbiota|microbiome|used by|bioinformatics|biomedical technique
35715396|student_A|gut microbiota|microbiome|used by|16 S rRNA gene sequencing|biomedical technique
35508109|student_B|Human microbiota|microbiome|located in|mice|animal
35508109|student_B|Drosophila|animal|used by|RNAi-mediated knockdown|biomedical technique
35508109|student_B|Proline supplementation|dietary supplement|influence|depression|DDF
35508109|student_B|depression|DDF|target|mice|animal
35508109|student_B|Drosophila|animal|used by|mono-association|biomedical technique
35508109|student_B|proline consumption|dietary supplement|influence|depression|DDF
35508109|student_B|Human microbiota|microbiome|change expression|GABA-, proline-, and extracellular matrix-related prefrontal cortex genes|gene
35342048|student_A|secondary bile acids|chemical|impact|gut microbiota|microbiome
35342048|student_A|microbial metabolites|chemical|impact|gut microbiota|microbiome
35342048|student_A|HA|chemical|impact|gut microbiota|microbiome
35342048|student_A|Gut microbiota|microbiome|used by|shotgun metagenomic sequencing|biomedical technique
35342048|student_A|Hippuric acid|chemical|impact|gut microbiota|microbiome
35342048|student_A|Parkinson's Disease|DDF|target|Patients|human
35342048|student_A|indole derivatives|chemical|impact|gut microbiota|microbiome
35342048|student_A|PD|DDF|change abundance|gut microbiota|microbiome
35342048|student_A|PD|DDF|target|patients|human
31654753|student_A|aging|DDF|affect|Defective mitochondrial homeostasis|DDF
31654753|student_A|gut microbiota|microbiome|is linked to|neurodegenerative diseases|DDF
31654753|student_A|gut microbiota|microbiome|is linked to|PD|DDF
38959280|student_A|sexual or gender minority|DDF|target|cisgender heterosexual|human
38959280|student_A|gut microbiome|microbiome|is linked to|SGM|DDF
38959280|student_A|Nail|anatomical location|located in|cisgender-heterosexual|human
38959280|student_A|saliva|anatomical location|located in|cisgender-heterosexual|human
38959280|student_A|SGM|DDF|target|young adults|human
36593694|student_B|gut microbiome|microbiome|is linked to|Parkinson disease|DDF
36593694|student_B|PD|DDF|change abundance|Roseburia|bacteria
36593694|student_B|Gut microbiota dysbiosis|DDF|change abundance|taxa|bacteria
36593694|student_B|Gut microbiota dysbiosis|DDF|affect|Parkinson disease|DDF
36593694|student_B|gut microbiota|microbiome|is linked to|Parkinson disease|DDF
36593694|student_B|butyrate-producing taxa|bacteria|interact|pathogenic metabolites|chemical
36593694|student_B|intestinal inflammation|DDF|strike|gut mucosal layer|anatomical location
36593694|student_B|PD|DDF|change abundance|Bifidobacterium|bacteria
36593694|student_B|PD|DDF|is a|heterogeneous pathology|DDF
36593694|student_B|Parkinson disease|DDF|change abundance|gut microbiota|microbiome
36593694|student_B|Parkinson disease|DDF|is a|heterogeneous pathology|DDF
36593694|student_B|Akkermansia|bacteria|part of|PD-associated microbiota|microbiome
36593694|student_B|Parkinson disease|DDF|change abundance|Roseburia|bacteria
36593694|student_B|PD|DDF|change abundance|gut microbiome|microbiome
36593694|student_B|taxa|bacteria|influence|PD|DDF
36593694|student_B|Parkinson disease|DDF|change abundance|Bifidobacterium|bacteria
36593694|student_B|Roseburia|bacteria|part of|PD-associated microbiota|microbiome
36593694|student_B|Faecalibacterium|bacteria|part of|PD-associated microbiota|microbiome
36593694|student_B|taxa|bacteria|influence|Parkinson disease|DDF
36593694|student_B|PD|DDF|change abundance|Akkermansia|bacteria
36593694|student_B|Bifidobacterium|bacteria|part of|PD-associated microbiota|microbiome
36593694|student_B|butyrate-producing taxa|bacteria|interact|Akkermansia|bacteria
36593694|student_B|Parkinson disease|DDF|change abundance|Akkermansia|bacteria
36593694|student_B|PD-associated microbiota|microbiome|is linked to|intestinal inflammation|DDF
36593694|student_B|Parkinson disease|DDF|change abundance|gut microbiome|microbiome
36593694|student_B|PD|DDF|change abundance|Faecalibacterium|bacteria
36593694|student_B|pathogenic metabolites|chemical|located in|enteric nervous system|anatomical location
36593694|student_B|gut microbiome|microbiome|is linked to|PD|DDF
36593694|student_B|gut microbiota|microbiome|is linked to|PD|DDF
36593694|student_B|PD|DDF|change abundance|gut microbiota|microbiome
36593694|student_B|Parkinson disease|DDF|change abundance|Faecalibacterium|bacteria
39029984|student_A|CBD|chemical|impact|gut microbiota|microbiome
39029984|student_A|Autism Spectrum Disorder|DDF|affect|restricted and repetitive patterns of behavior|DDF
39029984|student_A|CBD|chemical|influence|specific ASD symptoms and comorbidities|DDF
39029984|student_A|CBD|drug|change effect|potential therapeutic effects|DDF
39029984|student_A|CBD|drug|change effect|low induction of side effects|DDF
39029984|student_A|specific ASD symptoms and comorbidities|DDF|target|humans|human
39029984|student_A|CBD|drug|change effect|central symptoms and comorbidities of ASD|DDF
39029984|student_A|ASD|DDF|affect|restricted and repetitive patterns of behavior|DDF
39029984|student_A|Cannabidiol|drug|change effect|potential therapeutic effects|DDF
39029984|student_A|CBD|drug|change effect|Autism Spectrum Disorder|DDF
39029984|student_A|CBD|chemical|influence|social and behavioral processing|DDF
39029984|student_A|ASD|DDF|affect|persistent deficits in social communication and interaction|DDF
39029984|student_A|Autism Spectrum Disorder|DDF|affect|persistent deficits in social communication and interaction|DDF
39029984|student_A|gut microbiota|microbiome|located in|gut|anatomical location
34768765|student_A|zoonotic <i>Helicobacter</i> species|bacteria|located in|non-human primates|animal
34768765|student_A|idiopathic PD patients|human|used by|gastric biopsies|biomedical technique
34768765|student_A|zoonotic <i>Helicobacter</i> species|bacteria|located in|humans|human
34768765|student_A|stomach|anatomical location|located in|pigs|animal
34768765|student_A|control patients|human|used by|gastric biopsies|biomedical technique
34768765|student_A|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
34768765|student_A|loss of dopaminergic neurons|DDF|target|<i>H. suis/</i>6-OHDA groups|human
34768765|student_A|brain tissue|anatomical location|located in|<i>H. suis</i>-infected 6-OHDA mice|animal
34768765|student_A|stomach|anatomical location|located in|non-human primates|animal
34768765|student_A|short- or long-term <i>H. suis</i> infection|DDF|target|mice|animal
34768765|student_A|gastric <i>H. suis</i>|bacteria|influence|PD pathology|DDF
34768765|student_A|gastric <i>H. suis</i>|bacteria|influence|oxidative stress|DDF
34768765|student_A|6-OHDA|drug|change effect|loss of dopaminergic neurons|DDF
34768765|student_A|gastric <i>H. suis</i>|bacteria|influence|neuroprotective effect|DDF
34768765|student_A|Gastric <i>Helicobacter suis</i> Infection|DDF|affect|Neurotoxicity|DDF
34768765|student_A|zoonotic <i>Helicobacter</i> species|bacteria|located in|pigs|animal
34768765|student_A|gut microbiota|microbiome|is linked to|PD|DDF
34768765|student_A|6-OHDA|drug|change effect|short- or long-term <i>H. suis</i> infection|DDF
34768765|student_A|loss of dopaminergic neurons|DDF|target|control/6-OHDA groups|human
38815661|student_B|gut microbiota|microbiome|is linked to|mood disorder|DDF
38815661|student_B|Hungatella|bacteria|part of|microbial genera|microbiome
38815661|student_B|Ruminococcus torques|bacteria|part of|microbial genera|microbiome
38815661|student_B|gut microbiota|microbiome|located in|individuals|human
38815661|student_B|Gut microbiota composition|microbiome|is linked to|psychiatric disorders|DDF
38815661|student_B|gut microbiota|microbiome|is linked to|autism spectrum disorder|DDF
38815661|student_B|gut microbiota composition|microbiome|is linked to|stress-related|DDF
38815661|student_B|gut microbiota|microbiome|located in|participants|human
38815661|student_B|mood disorder|DDF|target|individuals|human
38815661|student_B|Oscillibacter|bacteria|part of|microbial genera|microbiome
38815661|student_B|autism spectrum disorder|DDF|target|individuals|human
38815661|student_B|gut microbiota|microbiome|is linked to|substance use disorder|DDF
38815661|student_B|gut microbiota|microbiome|located in|unaffected individuals|human
38815661|student_B|Clostridium sensu stricto 1|bacteria|part of|microbial genera|microbiome
38815661|student_B|gut microbiota composition|microbiome|located in|patients|human
38815661|student_B|gut microbiota composition|microbiome|is linked to|neurodevelopmental disorders|DDF
38815661|student_B|Flavonifractor|bacteria|part of|microbial genera|microbiome
38815661|student_B|gut microbiota composition|microbiome|used by|Research Domain Criteria (RDoC) domains|biomedical technique
38815661|student_B|substance use disorder|DDF|target|individuals|human
38815661|student_B|psychiatric comorbidity|DDF|target|patients|human
38815661|student_B|gut microbiota|microbiome|located in|patients|human
38815661|student_B|gut microbiota|microbiome|located in|psychiatrically unaffected individuals|human
38815661|student_B|microbial composition|microbiome|is linked to|psychiatric disorders|DDF
38815661|student_B|anxiety disorder|DDF|target|individuals|human
38815661|student_B|microbial genera|microbiome|used by|RDoC's negative valence|biomedical technique
38815661|student_B|attention deficit/hyperactivity disorder|DDF|target|individuals|human
38815661|student_B|CHKCI001|bacteria|part of|microbial genera|microbiome
38815661|student_B|stress-related|DDF|target|patients|human
38815661|student_B|gut microbiota|microbiome|is linked to|anxiety disorder|DDF
38815661|student_B|gut microbiota|microbiome|is linked to|attention deficit/hyperactivity disorder|DDF
38815661|student_B|neurodevelopmental disorders|DDF|target|patients|human
38815661|student_B|gut microbiota|microbiome|is linked to|psychiatric comorbidity|DDF
38815661|student_B|Sporobacter|bacteria|part of|microbial genera|microbiome
38815661|student_B|gut microbiota composition|microbiome|is linked to|psychiatric comorbidity|DDF
38815661|student_B|Sellimonas|bacteria|part of|microbial genera|microbiome
38827186|student_A|Gut microbiota|microbiome|is linked to|psychiatric disorders|DDF
38827186|student_A|gut microbiota|microbiome|is linked to|neuropsychiatric diseases|DDF
38827186|student_A|gut microbiota|microbiome|is linked to|mental health|DDF
38827186|student_A|Gut microbiota|microbiome|is linked to|psychiatric conditions|DDF
38827186|student_A|gut microbiota|microbiome|is linked to|mental illnesses|DDF
38869657|student_B|Neurotransmitters|chemical|impact|gut microbiota composition|microbiome
38869657|student_B|Bifidobacterium breve 207-1|bacteria|located in|healthy adults|human
38869657|student_B|high-dose B. breve 207-1|drug|administered|healthy adults|human
38869657|student_B|Bifidobacterium breve 207-1|bacteria|interact|hormones|chemical
38869657|student_B|short-chain fatty acids|chemical|produced by|gut microbiota|microbiome
38869657|student_B|207-1|drug|impact|probiotics groups|microbiome
38869657|student_B|SCFAs|chemical|produced by|gut microbiota|microbiome
38869657|student_B|placebo|drug|administered|healthy adults|human
38869657|student_B|GABA|chemical|impact|probiotic groups|microbiome
38869657|student_B|HPA axis hormones|chemical|impact|probiotic groups|microbiome
38869657|student_B|constipation|DDF|target|healthy adults|human
38869657|student_B|acetic and propionic acids|chemical|produced by|gut microbiota|microbiome
38869657|student_B|gut microbiota|microbiome|located in|LD group|human
38869657|student_B|Bifidobacterium breve 207-1|bacteria|interact|specific neurotransmitters|chemical
38869657|student_B|specific neurotransmitters|chemical|located in|healthy adults|human
38869657|student_B|hormones|chemical|located in|healthy adults|human
38869657|student_B|207-1|drug|impact|probiotic groups|microbiome
38869657|student_B|207-1|drug|impact|gut microbiota|microbiome
38869657|student_B|overweight|DDF|target|healthy adults|human
38869657|student_B|low-dose B. breve 207-1|drug|administered|healthy adults|human
38869657|student_B|gut microbiota composition|microbiome|used by|gas chromatography-mass spectrometry|biomedical technique
38869657|student_B|γ-aminobutyric acid|chemical|impact|probiotic groups|microbiome
38869657|student_B|207-1|drug|administered|healthy adults|human
38869657|student_B|GABA|chemical|impact|gut microbiota composition|microbiome
38869657|student_B|insomnia|DDF|target|healthy adults|human
38869657|student_B|gut microbiota composition|microbiome|used by|GC-MS|biomedical technique
38869657|student_B|gut microbiota|microbiome|located in|HD group|human
38869657|student_B|serum hormones|chemical|impact|gut microbiota composition|microbiome
38869657|student_B|high mental stress|DDF|target|healthy adults|human
38869657|student_B|γ-aminobutyric acid|chemical|impact|gut microbiota composition|microbiome
38869657|student_B|gut microbiota composition|microbiome|used by|16 S rRNA sequencing|biomedical technique
39417049|student_A|gut microbiota|microbiome|is linked to|insomnia|DDF
39417049|student_A|insomnia|DDF|change abundance|gut microbiota|microbiome
35713539|student_A|high stress|DDF|target|males|human
35713539|student_A|mental health|DDF|target|asymptomatic individuals|human
35713539|student_A|high stress|DDF|target|females|human
34982206|student_A|tetracyclines|drug|change effect|Alzheimer's and Parkinson's disease|DDF
34982206|student_A|doxycycline|drug|administered|AD and PD patients|human
34982206|student_A|tetracycline compounds|chemical|influence|AD/PD pathology|DDF
34982206|student_A|tetracycline antibiotic agents|drug|change effect|bacterial resistance|DDF
34982206|student_A|tetracycline compounds|chemical|located in|AD/PD patients|human
34982206|student_A|minocycline|drug|administered|AD and PD patients|human
35779628|student_A|(S)-ketamine|drug|administered|humans|human
35779628|student_A|(R)-ketamine|drug|change effect|PD|DDF
35779628|student_A|(R)-ketamine|drug|change effect|dementias|DDF
35779628|student_A|(R,S)-ketamine|drug|change effect|depression|DDF
35779628|student_A|Depression|DDF|affect|dementias|DDF
35779628|student_A|(R,S)-ketamine|drug|administered|rodents|animal
35779628|student_A|(R)-ketamine|drug|change effect|stroke|DDF
35779628|student_A|(R,S)-ketamine|drug|administered|humans|human
35779628|student_A|Depression|DDF|affect|stroke|DDF
35779628|student_A|(R)-ketamine|drug|administered|rodents|animal
35779628|student_A|(R)-ketamine|drug|change effect|MS|DDF
35779628|student_A|(R)-ketamine|drug|change effect|neurological disorders|DDF
35779628|student_A|(R)-ketamine|drug|change effect|multiple sclerosis|DDF
35779628|student_A|(S)-ketamine|drug|administered|rodents|animal
35779628|student_A|(R)-ketamine|drug|change effect|AD|DDF
35779628|student_A|(R)-ketamine|drug|administered|humans|human
36039924|student_A|healthy diet|dietary supplement|influence|Chronic noncommunicable diseases|DDF
36039924|student_A|Mediterranean diet|dietary supplement|influence|atherosclerosis progression|DDF
36039924|student_A|Mediterranean diet|dietary supplement|influence|morbidity|DDF
36039924|student_A|Mediterranean diet|dietary supplement|influence|diabetes|DDF
36039924|student_A|Mediterranean diet|dietary supplement|influence|cancers|DDF
36039924|student_A|Mediterranean diet|dietary supplement|influence|systemic inflammation|DDF
36039924|student_A|Mediterranean diet|dietary supplement|influence|cardiovascular disease|DDF
36039924|student_A|Mediterranean diet|dietary supplement|influence|chronic noncommunicable diseases|DDF
35103734|student_A|chicoric acid|chemical|impact|gut microbiota|microbiome
35103734|student_A|TLR4|chemical|influence|gut inflammation|DDF
35103734|student_A|proinflammatory cytokines|chemical|located in|colon|anatomical location
35103734|student_A|MyD88|chemical|influence|neuroinflammation|DDF
35103734|student_A|IL-1β|chemical|located in|colon|anatomical location
35103734|student_A|Parkinson's disease|DDF|is a|neurodegenerative disorder|DDF
35103734|student_A|CA|chemical|influence|viruses|DDF
35103734|student_A|chicoric acid|chemical|influence|Parkinson's disease|DDF
35103734|student_A|Chicoric acid|chemical|influence|viruses|DDF
35103734|student_A|Firmicutes|bacteria|part of|gut microbiota|microbiome
35103734|student_A|CA|chemical|influence|neuroinflammation|DDF
35103734|student_A|proinflammatory cytokines|chemical|located in|striatum|anatomical location
35103734|student_A|Bacteroidetes|bacteria|part of|gut microbiota|microbiome
35103734|student_A|CA|chemical|influence|MPTP-induced microbial dysbiosis|DDF
35103734|student_A|proinflammatory cytokines|chemical|located in|serum|anatomical location
35103734|student_A|NF-κB|chemical|influence|gut inflammation|DDF
35103734|student_A|CA|chemical|part of|polyphenolic acid|chemical
35103734|student_A|TNF-α|chemical|located in|colon|anatomical location
35103734|student_A|Lactobacillus|bacteria|part of|gut microbiota|microbiome
35103734|student_A|Chicoric acid|chemical|part of|polyphenolic acid|chemical
35103734|student_A|TLR4|chemical|influence|neuroinflammation|DDF
35103734|student_A|IL-1β|chemical|located in|serum|anatomical location
35103734|student_A|CA|chemical|interact|TNF-α|chemical
35103734|student_A|CA|chemical|located in|MPTP-induced PD mice|animal
35103734|student_A|CA|chemical|influence|inflammation|DDF
35103734|student_A|MyD88|chemical|influence|gut inflammation|DDF
35103734|student_A|CA|chemical|located in|colonic epithelial|anatomical location
35103734|student_A|Ruminiclostridium|bacteria|part of|gut microbiota|microbiome
35103734|student_A|CA|chemical|influence|obesity|DDF
35103734|student_A|CA|chemical|impact|gut microbiota|microbiome
35103734|student_A|PD|DDF|is a|neurodegenerative disorder|DDF
35103734|student_A|TNF-α|chemical|located in|serum|anatomical location
35103734|student_A|IL-1β|chemical|located in|striatum|anatomical location
35103734|student_A|Chicoric acid|chemical|influence|inflammation|DDF
35103734|student_A|TNF-α|chemical|located in|striatum|anatomical location
35103734|student_A|CA|chemical|interact|IL-1β|chemical
35103734|student_A|CA|chemical|influence|gut inflammation|DDF
35103734|student_A|Chicoric acid|chemical|influence|obesity|DDF
35103734|student_A|NF-κB|chemical|influence|neuroinflammation|DDF
35103734|student_A|chicoric acid|chemical|change expression|TLR4|gene
35103734|student_A|CA|chemical|interact|SCFA|chemical
35103734|student_A|Parabacteroide|bacteria|part of|gut microbiota|microbiome
35103734|student_A|CA|chemical|interact|proinflammatory cytokines|chemical
35831877|student_B|gut microbiota|microbiome|is linked to|sepsis|DDF
35831877|student_B|impairment of the intestinal barrier|DDF|change abundance|gut microbiota|microbiome
35044528|student_B|gut microbiota|microbiome|is linked to|brain health and function|DDF
35044528|student_B|gut microbiota|microbiome|is linked to|cognitive or brain function|DDF
35044528|student_B|gut microbiota|microbiome|is linked to|memory, learning, anxiety, stress, neurodevelopmental and neurodegenerative disorders|DDF
38857554|student_A|SGS|dietary supplement|influence|depression|DDF
38857554|student_A|prefrontal cortex|anatomical location|located in|HI/R-injured mice|animal
38857554|student_A|SGS|dietary supplement|influence|splenomegaly|DDF
38857554|student_A|metabolites|chemical|influence|HI/R|DDF
38857554|student_A|depression-like behaviors|DDF|target|mice|animal
38857554|student_A|vegetables|dietary supplement|influence|depression|DDF
38857554|student_A|SGS|dietary supplement|influence|depression-like behaviors|DDF
38857554|student_A|Dietary sulforaphane glucosinolate|dietary supplement|influence|depression-like behaviors|DDF
38857554|student_A|sulforaphane glucosinolate|dietary supplement|influence|depression-like behaviors|DDF
38857554|student_A|broccoli|dietary supplement|influence|depression|DDF
38857554|student_A|SGS|dietary supplement|influence|systemic inflammation|DDF
38857554|student_A|Depression|DDF|target|patients|human
38857554|student_A|depression|DDF|target|patients|human
31829756|student_A|gut neuropeptides|chemical|influence|PD|DDF
31829756|student_A|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
31829756|student_A|neuropeptides|chemical|influence|PD|DDF
31829756|student_A|neuropeptides|chemical|influence|Parkinson's disease|DDF
31829756|student_A|gut microbiota|microbiome|is linked to|PD|DDF
31829756|student_A|dysregulation of the main neuroendocrine axes coordinated by the hypothalamus|DDF|affect|disruptions at the peripheral level|DDF
31829756|student_A|gut neuropeptides|chemical|influence|Parkinson's disease|DDF
32844199|student_A|Parkinson's disease patients|human|used by|real-time PCR|biomedical technique
32844199|student_A|healthy spouses|human|used by|shotgun metagenomic sequencing|biomedical technique
32844199|student_A|volunteer Chinese patients|human|used by|shotgun metagenomic sequencing|biomedical technique
32844199|student_A|Parkinson's disease patients|human|used by|quantitative PCR|biomedical technique
32844199|student_A|healthy controls|human|used by|quantitative PCR|biomedical technique
32844199|student_A|gut microbiome|microbiome|change expression|gene set|gene
32844199|student_A|control subjects|human|used by|real-time PCR|biomedical technique
32844199|student_A|couples|human|used by|quantitative PCR|biomedical technique
32844199|student_A|Parkinson's disease|DDF|target|healthy spouses|human
32844199|student_A|Parkinson's disease|DDF|target|patients|human
32844199|student_A|multiple system atrophy|DDF|target|patients|human
32844199|student_A|gut microbiome|microbiome|is linked to|Parkinson's disease|DDF
32844199|student_A|Alzheimer's disease|DDF|target|patients|human
32844199|student_A|independent group of 78 patients|human|used by|quantitative PCR|biomedical technique
32844199|student_A|Parkinson's disease|DDF|target|independent group of 78 patients|human
32844199|student_A|Parkinson's disease|DDF|target|volunteer Chinese patients|human
32844199|student_A|healthy control subjects|human|used by|quantitative PCR|biomedical technique
32844199|student_A|patients|human|used by|real-time PCR|biomedical technique
39476179|student_A|probiotics|dietary supplement|impact|gut microbiota|microbiome
39476179|student_A|obesity|DDF|change abundance|gut microbiota|microbiome
39476179|student_A|gut microbiome|microbiome|is linked to|obesity|DDF
39476179|student_A|antibiotics|drug|impact|gut microbiota|microbiome
39476179|student_A|gut microbiota|microbiome|is linked to|depressive symptoms|DDF
39476179|student_A|gut microbiota|microbiome|is linked to|depression|DDF
39476179|student_A|gut microbiome|microbiome|is linked to|comorbidities|DDF
39476179|student_A|gut microbiota|microbiome|is linked to|weight disorders|DDF
39476179|student_A|antidiabetic drugs|drug|impact|gut microbiota|microbiome
39476179|student_A|gut microbiota|microbiome|is linked to|obesity|DDF
39476179|student_A|antidepressants|drug|impact|gut microbiota|microbiome
38908788|student_A|CKD|DDF|change abundance|gut microbiota|microbiome
38908788|student_A|CKD|DDF|target|participants aged 55-75 years|human
38908788|student_A|CKD|DDF|target|Participants|human
38908788|student_A|CKD|DDF|target|Group 1|human
38908788|student_A|CKD|DDF|change abundance|Lachnospira|bacteria
38908788|student_A|gut microbiota|microbiome|located in|older populations|human
38908788|student_A|Gut microbiota|microbiome|is linked to|chronic kidney disease|DDF
38908788|student_A|Fecal microbiota|microbiome|used by|16S sequencing|biomedical technique
38908788|student_A|CKD|DDF|target|participants|human
38908788|student_A|Chronic kidney disease|DDF|target|elderly|human
38908788|student_A|CKD|DDF|target|older populations|human
38908788|student_A|gut microbiota|microbiome|is linked to|CKD|DDF
38908788|student_A|CKD|DDF|target|Group 2|human
38908788|student_A|eGFR-CysC|chemical|influence|CKD|DDF
38908788|student_A|CKD|DDF|target|elderly|human
32827699|student_A|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|chemical|influence|Parkinsonism|DDF
32827699|student_A|Frisingicoccus|bacteria|influence|anxiety|DDF
32827699|student_A|gut microbiota|microbiome|used by|16S rRNA sequence analysis|biomedical technique
32827699|student_A|substantia nigra|anatomical location|located in|PD mice|animal
32827699|student_A|acupuncture-treated mice|animal|used by|16S rRNA sequence analysis|biomedical technique
32827699|student_A|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
32827699|student_A|Phocea|bacteria|influence|anxiety|DDF
32827699|student_A|striatum|anatomical location|located in|PD mice|animal
32827699|student_A|Holdemania|bacteria|influence|anxiety|DDF
32827699|student_A|gut microbial dysbiosis|DDF|target|PD mice|animal
32827699|student_A|neuroinflammation|DDF|target|PD mice|animal
32827699|student_A|Butyricimonas|bacteria|influence|anxiety|DDF
32827699|student_A|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|chemical|influence|gut microbial dysbiosis|DDF
32827699|student_A|acupoints GB34|anatomical location|located in|PD mice|animal
32827699|student_A|genera|bacteria|influence|anxiety|DDF
32827699|student_A|Gracilibacter|bacteria|influence|anxiety|DDF
32827699|student_A|gut microbiota|microbiome|is linked to|PD|DDF
32827699|student_A|Aestuariispira|bacteria|influence|anxiety|DDF
32827699|student_A|PD mice|animal|used by|16S rRNA sequence analysis|biomedical technique
32827699|student_A|ST36|anatomical location|located in|PD mice|animal
32827699|student_A|comorbid anxiety|DDF|target|PD mice|animal
38892645|student_A|mood|DDF|target|athletes|human
38892645|student_A|severe GI symptoms|DDF|target|well-trained athletes|human
38892645|student_A|gut microbiota metrics|DDF|target|groups|human
38892645|student_A|GI issues|DDF|target|NGI|human
38892645|student_A|GI issues|DDF|target|non-GI group|human
38892645|student_A|gastrointestinal (GI) symptoms|DDF|target|well-trained athletes|human
38892645|student_A|multi-ingredient fermented whey supplement|dietary supplement|administered|GI complaints group|human
38892645|student_A|multi-ingredient fermented whey supplement|dietary supplement|influence|wellbeing|DDF
38892645|student_A|Gut Microbiota|microbiome|located in|Trained Recreative and Competitive Athletes|human
38892645|student_A|physical (PHQ) and mental wellbeing|DDF|target|athletes|human
38892645|student_A|GI issues|DDF|target|athletes|human
38892645|student_A|self-reported symptoms|DDF|target|athletes|human
38892645|student_A|GI symptoms|DDF|target|athletes|human
38892645|student_A|wellbeing|DDF|target|athletes|human
38892645|student_A|GI issues|DDF|target|GI group|human
38892645|student_A|sleep quality|DDF|target|athletes|human
38892645|student_A|gastrointestinal (GI) symptoms|DDF|affect|general physical and mental wellbeing|DDF
38892645|student_A|GI complaints|DDF|target|well-trained athletes|human
38892645|student_A|multi-ingredient supplements|dietary supplement|influence|GI complaints|DDF
38892645|student_A|GI Complaints|DDF|target|Trained Recreative and Competitive Athletes|human
38892645|student_A|multi-ingredient supplements|dietary supplement|influence|gut health-related markers|DDF
38892645|student_A|multi-ingredient fermented whey supplement|dietary supplement|impact|gut microbiota|microbiome
38892645|student_A|GI issues|DDF|target|GI-B|human
38892645|student_A|severe GI complaints|DDF|target|GI group|human
38892645|student_A|Self-Reported Gastrointestinal Symptoms|DDF|target|Trained Recreative and Competitive Athletes|human
38892645|student_A|multi-ingredient fermented whey supplement|dietary supplement|influence|self-reported GI symptoms|DDF
38892645|student_A|General Physical and Mental Wellbeing|DDF|target|Trained Recreative and Competitive Athletes|human
38892645|student_A|severe GI complaints|DDF|target|GI-S|human
36408101|student_B|gut microbiota|microbiome|located in|gastrointestinal tract|anatomical location
36408101|student_B|Specific amino acids|chemical|influence|PD|DDF
35600818|student_B|Rats|animal|used by|Absolute Bacterial Quantification-Combined Approach|biomedical technique
35600818|student_B|TPG|drug|impact|Negativicutes|bacteria
35600818|student_B|Tianqi Pingchan Granule|drug|change effect|Parkinson's disease|DDF
35600818|student_B|TPG|drug|impact|Selenomonadales|bacteria
35600818|student_B|PD|DDF|change abundance|Selenomonadales|bacteria
35600818|student_B|PD rats|animal|used by|16S rRNA sequence analysis|biomedical technique
35600818|student_B|PD|DDF|change abundance|Negativicutes|bacteria
35600818|student_B|6-OHDA-Induced Parkinson's Disease|DDF|target|Rats|animal
35600818|student_B|TPG|drug|change effect|glia-mediated neuroinflammation|DDF
35600818|student_B|PD rats|animal|used by|<i>in vivo</i> experiment-combined approach|biomedical technique
35600818|student_B|Tianqi Pingchan Granule|drug|change effect|6-OHDA-Induced Parkinson's Disease|DDF
35600818|student_B|TPG|drug|impact|Mycoplasmatales|bacteria
35600818|student_B|TPG|drug|impact|Mollicutes|bacteria
35600818|student_B|Tianqi Pingchan Granule|drug|change effect|neurodegenerative disease|DDF
35600818|student_B|PD|DDF|change abundance|Mollicutes|bacteria
35600818|student_B|TPG|drug|impact|Enterobacteriales|bacteria
35600818|student_B|PD|DDF|change abundance|Mycoplasmatales|bacteria
35600818|student_B|PD|DDF|target|PD rats|animal
35600818|student_B|PD|DDF|change abundance|Enterobacteriales|bacteria
35600818|student_B|TPG|drug|impact|gut microbiota|microbiome
35600818|student_B|gut microbiota|microbiome|is linked to|PD|DDF
36421902|student_B|misfolded α-synuclein|chemical|influence|PD|DDF
36421902|student_B|PD|DDF|target|patients|human
36421902|student_B|hyposmia|DDF|target|PD patients|human
36421902|student_B|microbial agents|microbiome|is linked to|PD|DDF
36421902|student_B|gastrointestinal dysfunctions|DDF|target|PD patients|human
36421902|student_B|PD patients|human|used by|seed amplification assays|biomedical technique
36421902|student_B|intestinal microbiota|microbiome|is linked to|PD|DDF
36421902|student_B|remarkable olfactory deficits|DDF|target|patients|human
36421902|student_B|dysbiosis|DDF|interact|misfolded α-synuclein|chemical
36421902|student_B|hyposalivation|DDF|target|PD patients|human
36421902|student_B|dysphagia|DDF|target|PD patients|human
31684843|student_A|MeDiet|food|influence|memory and cognition impairment|DDF
31684843|student_A|MeDiet|food|influence|Parkinson disease|DDF
31684843|student_A|Malnutrition|DDF|affect|Parkinson disease|DDF
31684843|student_A|malnutrition|DDF|affect|cognitive decline|DDF
31684843|student_A|Malnutrition|DDF|affect|gut-microbiota-brain axis dysfunction|DDF
31684843|student_A|malnutrition|DDF|affect|Parkinson disease|DDF
31684843|student_A|MeDiet|food|influence|AD|DDF
31684843|student_A|calorie-controlled diets|food|influence|Alzheimer's disease|DDF
31684843|student_A|calorie-controlled diets|food|influence|cognitive decline|DDF
31684843|student_A|calorie-controlled diets|food|influence|PD|DDF
31684843|student_A|malnutrition|DDF|affect|gut-microbiota-brain axis dysfunction|DDF
31684843|student_A|Mediterranean diet|food|influence|memory and cognition impairment|DDF
31684843|student_A|calorie-controlled diets|food|influence|Parkinson disease|DDF
31684843|student_A|EPA|dietary supplement|influence|memory and cognition impairment|DDF
31684843|student_A|DHA|dietary supplement|influence|memory and cognition impairment|DDF
31684843|student_A|Neurodegenerative diseases|DDF|affect|progressive functional loss of neurons|DDF
31684843|student_A|vitamins|dietary supplement|influence|memory and cognition impairment|DDF
31684843|student_A|Omega-3 and -6|dietary supplement|influence|neuron degeneration|DDF
31684843|student_A|MeDiet|food|influence|Alzheimer's disease|DDF
31684843|student_A|calorie-controlled diets|food|influence|AD|DDF
31684843|student_A|MeDiet|food|influence|cognitive decline|DDF
31684843|student_A|MeDiet|food|influence|PD|DDF
31684843|student_A|insulin resistance|DDF|affect|cognitive decline|DDF
31684843|student_A|neurodegenerative diseases|DDF|affect|progressive functional loss of neurons|DDF
31684843|student_A|insulin resistance|DDF|affect|Parkinson disease|DDF
31684843|student_A|Malnutrition|DDF|affect|cognitive decline|DDF
34566874|student_B|motor fluctuations|DDF|target|patients|human
34566874|student_B|dyskinesia|DDF|target|patients|human
34566874|student_B|levodopa|drug|change effect|neurodegenerative disorder|DDF
34566874|student_B|levodopa|drug|change effect|Parkinson's disease|DDF
34566874|student_B|gut microbiota|microbiome|located in|patients|human
34566874|student_B|levodopa-induced dyskinesia|DDF|target|patients|human
34566874|student_B|PD|DDF|target|patients|human
35453597|student_B|SCI|DDF|change abundance|microbiota composition|microbiome
35453597|student_B|specific brain areas|anatomical location|located in|SCI patients|human
35453597|student_B|psychological stress|DDF|target|SCI patients|human
35453597|student_B|Modulator|drug|change effect|Psychological Stress|DDF
35453597|student_B|microbiota composition|microbiome|is linked to|depression|DDF
35453597|student_B|SCIs|DDF|target|SCI patients|human
35453597|student_B|novel therapeutic strategies|drug|change effect|gut dysbiosis|DDF
35453597|student_B|Spinal cord injuries|DDF|target|SCI patients|human
35453597|student_B|psychological stress-related symptoms|DDF|target|SCI patients|human
35453597|student_B|novel therapeutic strategies|drug|change effect|psychological stress|DDF
35453597|student_B|depression|DDF|target|SCI patients|human
35453597|student_B|depression-like symptoms|DDF|target|SCI patients|human
35453597|student_B|gut dysbiosis|DDF|target|SCI patients|human
35453597|student_B|imbalance|DDF|change abundance|microbiota composition|microbiome
35453597|student_B|novel therapeutic strategies|drug|change effect|SCIs|DDF
35453597|student_B|mental health depletion|DDF|target|SCI patients|human
35453597|student_B|anxiety|DDF|target|SCI patients|human
35822696|student_A|Desulfovibrio|bacteria|influence|PD therapy|DDF
35822696|student_A|Helicobacter pylori|bacteria|influence|PD therapy|DDF
35822696|student_A|Enterococcus faecalis|bacteria|influence|PD therapy|DDF
35822696|student_A|gut bacteria|bacteria|influence|PD therapy|DDF
35822696|student_A|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
35822696|student_A|gut microbiota|microbiome|is linked to|PD|DDF
35822696|student_A|Parkinson's disease|DDF|change abundance|gut microbiota|microbiome
32035595|student_B|Dietary polyphenols|dietary supplement|influence|brain disorders|DDF
32035595|student_B|Dietary polyphenols|dietary supplement|influence|oxidative stress|DDF
32035595|student_B|food bioactive compounds|chemical|influence|depression|DDF
32035595|student_B|Polyphenols|chemical|influence|brain disorders|DDF
32035595|student_B|food bioactive compounds|chemical|influence|Down's syndrome|DDF
32035595|student_B|nutraceuticals|dietary supplement|influence|brain disorders|DDF
32035595|student_B|food bioactive compounds|chemical|influence|Alzheimer's disease|DDF
32035595|student_B|food bioactive compounds|chemical|influence|Parkinson's disease|DDF
32035595|student_B|Dietary polyphenols|dietary supplement|influence|neurodegeneration|DDF
32035595|student_B|food bioactive compounds|chemical|influence|Autism spectrum disorder|DDF
32035595|student_B|Dietary polyphenols|dietary supplement|influence|inflammation|DDF
32035595|student_B|food bioactive compounds|chemical|influence|psychiatric disorders|DDF
32035595|student_B|food bioactive compounds|chemical|influence|brain diseases|DDF
32035595|student_B|food bioactive compounds|chemical|influence|anxiety|DDF
32035595|student_B|Dietary polyphenols|dietary supplement|influence|chronic disorders|DDF
32035595|student_B|dietary polyphenols|chemical|influence|brain disorders|DDF
35349746|student_A|neurodegenerative diseases|DDF|affect|cognition abilities|DDF
35349746|student_A|Gut microbiota|microbiome|located in|microglia|anatomical location
36686268|student_A|Verrucomicrobiaceae|bacteria|influence|PD|DDF
36686268|student_A|Scardovia_inopinata|bacteria|influence|PD|DDF
36686268|student_A|Christensenellaceae|bacteria|influence|PD|DDF
36686268|student_A|Prevotellaceae|bacteria|influence|PD|DDF
36686268|student_A|Lachnospiraceae|bacteria|influence|PD|DDF
36686268|student_A|Bifidobacterium_dentium|bacteria|influence|PD|DDF
36686268|student_A|Scardovia_wiggsiae|bacteria|influence|PD|DDF
36686268|student_A|Bifidobacteriaceae|bacteria|influence|PD|DDF
36686268|student_A|Ruminococcaceae|bacteria|influence|PD|DDF
36686268|student_A|Bifidobacteriaceae|bacteria|influence|Parkinson's disease|DDF
36686268|student_A|gut microbiota|microbiome|is linked to|PD|DDF
39303815|student_B|chronic restraint stress|DDF|target|mice|animal
39303815|student_B|CRS|DDF|target|mice|animal
39303815|student_B|metformin|drug|change effect|depressive syndromes|DDF
39303815|student_B|depression-like behaviors|DDF|target|mice|animal
39303815|student_B|5-hydroxytryptamine|chemical|located in|brain|anatomical location
39303815|student_B|5-hydroxytryptamine|chemical|located in|gut|anatomical location
39303815|student_B|tryptophan|chemical|impact|gut microbiome|microbiome
39303815|student_B|bile acid metabolites|chemical|produced by|gut microbiome|microbiome
39303815|student_B|dysbiotic gut microbiome|microbiome|is linked to|chronic restraint stress|DDF
39303815|student_B|mice|animal|used by|oral administration|biomedical technique
39303815|student_B|metformin|drug|impact|Akkermansia muciniphila|bacteria
39303815|student_B|metformin|drug|impact|A. muciniphila|bacteria
39303815|student_B|bile acids|chemical|produced by|gut microbiota|microbiome
39303815|student_B|Metformin|drug|change effect|depression-Like behaviors|DDF
39303815|student_B|metformin|drug|change effect|depression-like behaviors|DDF
39303815|student_B|depression-Like behaviors|DDF|target|mice|animal
32934117|student_A|Gut Microbiota|microbiome|is linked to|Parkinson's Disease|DDF
32934117|student_A|microbiota modifications|DDF|interact|fecal metabolites|chemical
32934117|student_A|controls|human|used by|next-generation sequencing approach|biomedical technique
32934117|student_A|<i>Lachnospiraceae</i> family|bacteria|influence|Parkinson's disease|DDF
32934117|student_A|gut microbes|microbiome|is linked to|altered homeostasis|DDF
32934117|student_A|Parkinson's disease|DDF|interact|misfolded alpha-synuclein|chemical
32934117|student_A|Parkinson's disease|DDF|target|patients|human
32934117|student_A|gut dysregulation|DDF|affect|Parkinson's disease|DDF
32934117|student_A|Pseudobutyrivibrio|bacteria|influence|Parkinson's disease|DDF
32934117|student_A|<i>Lachnospiraceae</i> family|bacteria|influence|altered metabolism rates|DDF
32934117|student_A|several bacterial metabolites|chemical|produced by|gut microbes|microbiome
32934117|student_A|Blautia|bacteria|influence|Parkinson's disease|DDF
32934117|student_A|Butyrivibrio|bacteria|influence|Parkinson's disease|DDF
32934117|student_A|several bacterial metabolites|chemical|influence|altered homeostasis|DDF
32934117|student_A|Butyrivibrio|bacteria|influence|altered metabolism rates|DDF
32934117|student_A|fecal metabolites|chemical|produced by|gut microbiota|microbiome
32934117|student_A|Parkinson's disease|DDF|target|Italian patients|human
32934117|student_A|Blautia|bacteria|influence|altered metabolism rates|DDF
32934117|student_A|Pseudobutyrivibrio|bacteria|influence|altered metabolism rates|DDF
32934117|student_A|Coprococcus|bacteria|influence|Parkinson's disease|DDF
32934117|student_A|Italian patients|human|used by|next-generation sequencing approach|biomedical technique
32934117|student_A|Coprococcus|bacteria|influence|altered metabolism rates|DDF
34682763|student_A|gut flora|microbiome|is linked to|multiple sclerosis|DDF
34682763|student_A|Proteobacteria|bacteria|part of|gut microorganisms|microbiome
34682763|student_A|antibiotics|drug|impact|gut microorganisms|microbiome
34682763|student_A|Firmicutes|bacteria|part of|gut microorganisms|microbiome
34682763|student_A|gut flora|microbiome|is linked to|neurologic and neuropsychological disorders|DDF
34682763|student_A|Actinomyces|bacteria|part of|gut microorganisms|microbiome
34682763|student_A|gut flora|microbiome|is linked to|autism spectrum disorder|DDF
34682763|student_A|Fusobacteria|bacteria|part of|gut microorganisms|microbiome
34682763|student_A|Verucomicrobia|bacteria|part of|gut microorganisms|microbiome
34682763|student_A|gut flora|microbiome|is linked to|Parkinson's and Alzheimer's disease|DDF
34682763|student_A|gut flora|microbiome|is linked to|amyotrophic lateral sclerosis|DDF
34682763|student_A|Bacteroides|bacteria|part of|gut microorganisms|microbiome
34682763|student_A|diet|dietary supplement|impact|gut microorganisms|microbiome
32323181|student_A|gut flora|microbiome|is linked to|neurodegenerative disease|DDF
32323181|student_A|gut flora|microbiome|is linked to|CNS pathology|DDF
32323181|student_A|Gut Microbiota|microbiome|is linked to|Neurologic Diseases and Injuries|DDF
32323181|student_A|gut flora|microbiome|is linked to|dysbiosis|DDF
32323181|student_A|gut flora|microbiome|is linked to|physiologic response to traumatic injury|DDF
32323181|student_A|gut flora|microbiome|is linked to|bacterial translocation|DDF
32323181|student_A|gut flora|microbiome|located in|human gut|anatomical location
32323181|student_A|gut flora|microbiome|is linked to|gut flora dysbiosis|DDF
32323181|student_A|gut flora|microbiome|is linked to|developmental disorders|DDF
32323181|student_A|gut flora dysbiosis|DDF|affect|autoimmune disease|DDF
32323181|student_A|gut flora dysbiosis|DDF|affect|developmental disorders|DDF
32323181|student_A|gut flora dysbiosis|DDF|affect|physiologic response to traumatic injury|DDF
32323181|student_A|gut flora|microbiome|is linked to|systemic inflammation|DDF
32323181|student_A|microbial by-products|chemical|produced by|gut flora|microbiome
32323181|student_A|gut flora dysbiosis|DDF|affect|neurodegenerative disease|DDF
32323181|student_A|bacterial flora|microbiome|located in|human gut|anatomical location
32323181|student_A|gut flora|microbiome|is linked to|autoimmune disease|DDF
35299696|student_A|gut microbiota|microbiome|is linked to|depression|DDF
35299696|student_A|gut microbiota|microbiome|is linked to|anxiety|DDF
39458509|student_A|low-FODMAP diet|dietary supplement|influence|depression|DDF
39458509|student_A|Gut Microbiota|microbiome|is linked to|Anxiety|DDF
39458509|student_A|Mediterranean diet|dietary supplement|influence|psychopathology|DDF
39458509|student_A|Low FODMAP diet|dietary supplement|influence|Psychopathology|DDF
39458509|student_A|Low FODMAP diet|dietary supplement|influence|Irritable Bowel Syndrome|DDF
39458509|student_A|IBS|DDF|change abundance|gut microbiota|microbiome
39458509|student_A|IBS|DDF|change abundance|GM|microbiome
39458509|student_A|Gut Microbiota|microbiome|is linked to|Depression|DDF
39458509|student_A|Mediterranean Diet|dietary supplement|influence|Psychopathology|DDF
39458509|student_A|Mediterranean Diet|dietary supplement|influence|Irritable Bowel Syndrome|DDF
39458509|student_A|Mediterranean Diet|dietary supplement|influence|Anxiety|DDF
39458509|student_A|Mediterranean Diet|dietary supplement|influence|Depression|DDF
39458509|student_A|Low FODMAP diet|dietary supplement|influence|Depression|DDF
39458509|student_A|Low FODMAP diet|dietary supplement|influence|Anxiety|DDF
39458509|student_A|low-FODMAP diet|dietary supplement|influence|IBS|DDF
39458509|student_A|Mediterranean Diet|dietary supplement|impact|Gut Microbiota|microbiome
39458509|student_A|low-FODMAP diet|dietary supplement|influence|psychopathology|DDF
39458509|student_A|Gut Microbiota|microbiome|is linked to|Psychopathology|DDF
39458509|student_A|Low FODMAP diet|dietary supplement|impact|Gut Microbiota|microbiome
39458509|student_A|low-FODMAP diet|dietary supplement|influence|anxiety|DDF
39458509|student_A|low-FODMAP diet|dietary supplement|influence|intestinal bowel syndrome|DDF
39458509|student_A|Gut Microbiota|microbiome|is linked to|Irritable Bowel Syndrome|DDF
32357258|student_A|gut microbiota alterations|DDF|affect|Parkinson's disease|DDF
32357258|student_A|Significant microbiota taxonomic differences|DDF|target|Parkinson's patients|human
32357258|student_A|reduced colonic transit time|DDF|affect|Parkinson's disease|DDF
32357258|student_A|Parkinson's microbiota|microbiome|is linked to|reduced carbohydrate fermentation and butyrate synthesis capacity|DDF
32357258|student_A|p-cresol|chemical|produced by|Parkinson's microbiota|microbiome
32357258|student_A|phenylacetylglutamine|chemical|produced by|Parkinson's microbiota|microbiome
32357258|student_A|Parkinson's microbiota|microbiome|is linked to|Compositional and metabolic alterations|DDF
32357258|student_A|intestinal microbes|microbiome|is linked to|gastrointestinal disturbances|DDF
32357258|student_A|Participants|human|used by|untargeted metabolomics|biomedical technique
32357258|student_A|Parkinson's microbiota|microbiome|is linked to|increased proteolytic fermentation|DDF
32357258|student_A|elevated proteolytic metabolites|chemical|influence|constipation|DDF
32357258|student_A|constipation|DDF|interact|systemic microbial metabolites|chemical
32357258|student_A|deleterious amino acid metabolites|chemical|produced by|Parkinson's microbiota|microbiome
32357258|student_A|constipation|DDF|target|patients|human
32357258|student_A|systemic microbial metabolites|chemical|influence|Parkinson's disease|DDF
32357258|student_A|Participants|human|used by|microbiota sequencing|biomedical technique
32357258|student_A|altered bacterial metabolism|DDF|affect|reduced gut health|DDF
32357258|student_A|gastrointestinal comorbidities|DDF|affect|Parkinson's disease|DDF
32357258|student_A|gastrointestinal disturbances|DDF|target|patients|human
35076270|student_A|neurodegenerative disorder|DDF|change abundance|microbiota composition|microbiome
35076270|student_A|PD medication|drug|change effect|PD|DDF
35076270|student_A|levodopa|drug|change expression|tyrosine decarboxylase enzymes|gene
35076270|student_A|human PD|DDF|change abundance|microbiota|microbiome
31340904|student_A|bacteria|bacteria|influence|inflammation|DDF
31340904|student_A|gut microbiota|microbiome|is linked to|neurological diseases|DDF
31340904|student_A|neurological diseases|DDF|affect|aetiopathogenesis|DDF
31340904|student_A|gut microbiota|microbiome|is linked to|Alzheimer disease|DDF
31340904|student_A|short-chain fatty acids|chemical|impact|bacteria|bacteria
31340904|student_A|probiotics|dietary supplement|influence|neurological diseases|DDF
31340904|student_A|viruses|microbiome|is linked to|neurological diseases|DDF
31340904|student_A|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
31340904|student_A|gut microbiota|microbiome|is linked to|amyotrophic lateral sclerosis|DDF
31340904|student_A|gut microbiota|microbiome|is linked to|neuromyelitis optica|DDF
31340904|student_A|fungi|bacteria|influence|neurological diseases|DDF
31340904|student_A|microbiota|microbiome|is linked to|neurological diseases|DDF
31340904|student_A|gut microbiota|microbiome|is linked to|multiple sclerosis|DDF
35959396|student_A|P. gingivalis|bacteria|influence|PD|DDF
35959396|student_A|Porphyromonas gingivalis|bacteria|influence|Parkinson's disease|DDF
35959396|student_A|Porphyromonas gingivalis|bacteria|influence|cognitive impairment|DDF
35959396|student_A|P. gingivalis|bacteria|influence|neurodegeneration|DDF
35959396|student_A|P. gingivalis|bacteria|interact|α-Syn|chemical
35959396|student_A|P. gingivalis|bacteria|influence|AD|DDF
35959396|student_A|P. gingivalis|bacteria|interact|Aβ|chemical
35959396|student_A|P. gingivalis|bacteria|influence|neuroinflammation|DDF
36145184|student_B|uncontrolled intake of refined carbohydrates|dietary supplement|influence|metabolic disease|DDF
36145184|student_B|uncontrolled intake of refined carbohydrates|dietary supplement|influence|metabolic syndrome|DDF
36145184|student_B|sugar intake|dietary supplement|influence|metabolic disease|DDF
36145184|student_B|carbohydrates|chemical|impact|gut microorganisms|microbiome
36145184|student_B|fiber|chemical|impact|gut microorganisms|microbiome
36145184|student_B|simple carbohydrates and refined carbohydrates|chemical|influence|alertness|DDF
36145184|student_B|abusive consumption of refined, simple, and low-quality carbohydrates|dietary supplement|influence|main Western diseases of the 21st century|DDF
36145184|student_B|simple carbohydrates and refined carbohydrates|chemical|influence|tiredness|DDF
38968876|student_A|Parabacteroides distasonis|bacteria|part of|gut microbiome|microbiome
38968876|student_A|MDD|DDF|change abundance|beneficial symbionts|microbiome
38968876|student_A|MDD|DDF|change abundance|gut microbiome|microbiome
38968876|student_A|Faecalobacterium|bacteria|part of|gut microbiome|microbiome
38968876|student_A|Dorea|bacteria|part of|gut microbiome|microbiome
38968876|student_A|major depression|DDF|change abundance|gut microbiome|microbiome
32325848|student_B|Lachnospiraceae|bacteria|located in|PD patients|human
32325848|student_B|Gut Microbiota|microbiome|is linked to|Parkinson's Disease|DDF
32325848|student_B|<i>Verrucomicrobiaceae</i> families|bacteria|located in|PD patients|human
32325848|student_B|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
32325848|student_B|gut microbiota|microbiome|is linked to|PD|DDF
39163908|student_B|probiotic formulation|dietary supplement|impact|Levilactobacillus brevis P30021|bacteria
39163908|student_B|acetylcholine|chemical|impact|microbiota|microbiome
39163908|student_B|GABA|chemical|impact|microbiota|microbiome
39163908|student_B|probiotic|dietary supplement|influence|mental health|DDF
39163908|student_B|probiotic|dietary supplement|impact|gut microbiota|microbiome
39163908|student_B|Lactiplantibacillus|bacteria|part of|gut microbiota|microbiome
39163908|student_B|L.brevis|bacteria|part of|gut microbiota|microbiome
39163908|student_B|adults|human|used by|CogState Battery test|biomedical technique
39163908|student_B|probiotic formulation|dietary supplement|impact|Lactiplantibacillus plantarum P30025|bacteria
39163908|student_B|psychobiotic bacteria|bacteria|influence|stressed-related disorders|DDF
39163908|student_B|probiotic|dietary supplement|influence|depression|DDF
39163908|student_B|probiotic formulation|dietary supplement|influence|depressive symptoms|DDF
39163908|student_B|choline|chemical|impact|microbiota|microbiome
39163908|student_B|glutamate|chemical|impact|microbiota|microbiome
35067061|student_B|<i>L. plantarum</i> DP189|bacteria|interact|GSH-Px|chemical
35067061|student_B|<i>Lactobacillus plantarum</i> DP189|bacteria|influence|Gut Microbiota Disorder|DDF
35067061|student_B|<i>L. plantarum</i> DP189|bacteria|interact|α-SYN|chemical
35067061|student_B|<i>L. plantarum</i> DP189|bacteria|change expression|Nrf2|gene
35067061|student_B|<i>Lactobacillus plantarum</i> DP189|bacteria|interact|α-synuclein (α-SYN) aggregates|chemical
35067061|student_B|<i>L. plantarum</i> DP189|bacteria|interact|interleukin-10|chemical
35067061|student_B|<i>L. plantarum</i> DP189|bacteria|interact|interleukin-1β|chemical
35067061|student_B|<i>L. plantarum</i> DP189|bacteria|change expression|ARE|gene
35067061|student_B|α-SYN Aggravation|DDF|target|MPTP-Induced Parkinson's Disease Mice|animal
35067061|student_B|<i>L. plantarum</i> DP189|bacteria|interact|reactive oxygen species|chemical
35067061|student_B|Proteobacteria|bacteria|part of|gut microbiota|microbiome
35067061|student_B|<i>L. plantarum</i> DP189|bacteria|interact|interleukin-6|chemical
35067061|student_B|<i>Lactobacillus plantarum</i> DP189|bacteria|influence|Oxidative Damage|DDF
35067061|student_B|gut microbiota|microbiome|located in|PD mice|animal
35067061|student_B|<i>L. plantarum</i> DP189|bacteria|interact|malondialdehyde|chemical
35067061|student_B|<i>L. plantarum</i> DP189|bacteria|interact|SOD|chemical
35067061|student_B|<i>L. plantarum</i> DP189|bacteria|interact|TNF-α|chemical
35067061|student_B|<i>L. plantarum</i> DP189|bacteria|influence|oxidative stress|DDF
35067061|student_B|Prevotella|bacteria|part of|gut microbiota|microbiome
35067061|student_B|SN|anatomical location|located in|PD mice|animal
35067061|student_B|<i>L. plantarum</i> DP189|bacteria|interact|superoxide dismutase|chemical
35067061|student_B|<i>L. plantarum</i> DP189|bacteria|change expression|nuclear factor erythroid 2-related factor|gene
35067061|student_B|<i>L. plantarum</i> DP189|bacteria|interact|ROS|chemical
35067061|student_B|<i>L. plantarum</i> DP189|bacteria|interact|IL-10|chemical
35067061|student_B|<i>L. plantarum</i> DP189|bacteria|interact|IL-1β|chemical
35067061|student_B|Lactobacillus|bacteria|part of|gut microbiota|microbiome
35067061|student_B|<i>L. plantarum</i> DP189|bacteria|influence|neurodegeneration|DDF
35067061|student_B|substantia nigra|anatomical location|located in|Parkinson's disease (PD) mice|animal
35067061|student_B|<i>Lactobacillus plantarum</i> DP189|bacteria|influence|Inflammation|DDF
35067061|student_B|<i>L. plantarum</i> DP189|bacteria|interact|tumor necrosis factor-α|chemical
35067061|student_B|pathogenic bacteria|bacteria|part of|gut microbiota|microbiome
35067061|student_B|<i>L. plantarum</i> DP189|bacteria|interact|IL-6|chemical
35067061|student_B|<i>L. plantarum</i> DP189|bacteria|change expression|PGC-1α|gene
35067061|student_B|<i>L. plantarum</i> DP189|bacteria|interact|MDA|chemical
35067061|student_B|SN|anatomical location|located in|Parkinson's disease (PD) mice|animal
35067061|student_B|<i>L. plantarum</i> DP189|bacteria|part of|gut microbiota|microbiome
35067061|student_B|<i>Lactobacillus plantarum</i> DP189|bacteria|influence|α-SYN Aggravation|DDF
35067061|student_B|probiotics|bacteria|part of|gut microbiota|microbiome
35067061|student_B|<i>L. plantarum</i> DP189|bacteria|interact|glutathione peroxide|chemical
35067061|student_B|Actinobacteria|bacteria|part of|gut microbiota|microbiome
32161568|student_B|PD-MCI|DDF|change abundance|Ruminococcus|bacteria
32161568|student_B|patients|human|used by|gas chromatography-mass spectrometry|biomedical technique
32161568|student_B|Ruminococcaceae|bacteria|located in|PD-MCI group|human
32161568|student_B|short-chain fatty acids|chemical|located in|patients|human
32161568|student_B|PD-MCI|DDF|change abundance|Porphyromonadaceae family|bacteria
32161568|student_B|healthy spouses|human|used by|gas chromatography-mass spectrometry|biomedical technique
32161568|student_B|PD-NC|DDF|target|patients|human
32161568|student_B|fecal microbial diversities|DDF|affect|PD-NC|DDF
32161568|student_B|Odoribacter|bacteria|located in|PD-MCI group|human
32161568|student_B|PD-MCI|DDF|target|patients|human
32161568|student_B|Alistipes|bacteria|located in|PD-MCI group|human
32161568|student_B|Gut bacteria|bacteria|influence|PD|DDF
32161568|student_B|Gut Microbiota|microbiome|is linked to|Mild Cognitive Impairment|DDF
32161568|student_B|gut microbiota|microbiome|located in|patients|human
32161568|student_B|gut microbiota|microbiome|located in|HC|human
32161568|student_B|altered gut microbiota|DDF|target|patients|human
32161568|student_B|PD|DDF|target|patients|human
32161568|student_B|Ruminococcus|bacteria|located in|PD-MCI group|human
32161568|student_B|mild cognitive impairment|DDF|target|patients|human
32161568|student_B|fecal microbiota|microbiome|is linked to|PD|DDF
32161568|student_B|patients|human|used by|16S ribosomal RNA sequencing|biomedical technique
32161568|student_B|PD-MCI|DDF|change abundance|Blautia|bacteria
32161568|student_B|Gut bacteria|bacteria|influence|Parkinson's disease|DDF
32161568|student_B|gut microbiota|microbiome|located in|healthy controls|human
32161568|student_B|Barnesiella|bacteria|located in|PD-MCI group|human
32161568|student_B|healthy spouses|human|used by|16S ribosomal RNA sequencing|biomedical technique
32161568|student_B|fecal microbial diversities|DDF|affect|PD-MCI|DDF
32161568|student_B|fecal microbial diversities|DDF|target|patients|human
32161568|student_B|fecal microbiota|microbiome|is linked to|cognitive impairment|DDF
32161568|student_B|Butyricimonas|bacteria|located in|PD-MCI group|human
32161568|student_B|Blautia|bacteria|located in|PD-MCI group|human
32161568|student_B|short-chain fatty acids|chemical|located in|healthy spouses|human
32161568|student_B|Rikenellaceae|bacteria|located in|PD-MCI group|human
33499229|student_A|gut microbiota|microbiome|is linked to|akinetic-rigid features|DDF
33499229|student_A|Gut Microbiota|microbiome|is linked to|TD|DDF
33499229|student_A|Gut Microbiota|microbiome|is linked to|Parkinson's Disease|DDF
33499229|student_A|non-TD|DDF|change abundance|Coprococcus|bacteria
33499229|student_A|Lachnospira|bacteria|part of|Gut Microbiota|microbiome
33499229|student_A|non-tremor dominant|DDF|change abundance|Serratia|bacteria
33499229|student_A|Gut Microbiota|microbiome|is linked to|non-TD|DDF
33499229|student_A|PD|DDF|change abundance|Serratia|bacteria
33499229|student_A|non-tremor dominant|DDF|change abundance|Enterobacteriaceae|bacteria
33499229|student_A|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
33499229|student_A|gut microbiota|microbiome|is linked to|motor deficits|DDF
33499229|student_A|glucuronic acid|chemical|produced by|Gut Microbiota|microbiome
33499229|student_A|PD|DDF|change abundance|Enterobacteriaceae|bacteria
33499229|student_A|Parkinson's disease|DDF|change abundance|Blautia|bacteria
33499229|student_A|Gut Microbiota|microbiome|is linked to|akinetic-rigid features|DDF
33499229|student_A|Serratia|bacteria|part of|gut microbiota|microbiome
33499229|student_A|gut microbiota|microbiome|is linked to|non-TD|DDF
33499229|student_A|PD|DDF|target|PD patients|human
33499229|student_A|gut microbiota|microbiome|is linked to|TD|DDF
33499229|student_A|non-tremor dominant|DDF|change abundance|Lachnospira|bacteria
33499229|student_A|Enterobacteriaceae|bacteria|part of|gut microbiota|microbiome
33499229|student_A|Gut Microbiota|microbiome|located in|PD patients|human
33499229|student_A|nicotinic acid|chemical|produced by|gut microbiota|microbiome
33499229|student_A|PD|DDF|change abundance|Lachnospira|bacteria
33499229|student_A|gut microbiota|microbiome|is linked to|AR|DDF
33499229|student_A|gut microbiota|microbiome|is linked to|PD|DDF
33499229|student_A|non-TD|DDF|change abundance|Lachnospiraceae|bacteria
33499229|student_A|gut microbiota|microbiome|is linked to|tremor dominant|DDF
33499229|student_A|Escherichia|bacteria|part of|gut microbiota|microbiome
33499229|student_A|Parkinson's disease|DDF|change abundance|Serratia|bacteria
33499229|student_A|non-tremor dominant|DDF|target|PD patients|human
33499229|student_A|Blautia|bacteria|part of|Gut Microbiota|microbiome
33499229|student_A|non-TD|DDF|change abundance|Blautia|bacteria
33499229|student_A|Gut Microbiota|microbiome|is linked to|AR|DDF
33499229|student_A|Lachnospiraceae|bacteria|part of|Gut Microbiota|microbiome
33499229|student_A|nicotinic acid|chemical|produced by|Gut Microbiota|microbiome
33499229|student_A|glucuronic acid|chemical|produced by|gut microbiota|microbiome
33499229|student_A|gut microbiota|microbiome|is linked to|non-tremor dominant|DDF
33499229|student_A|non-TD|DDF|target|PD patients|human
33499229|student_A|gut microbiota|microbiome|is linked to|clinically heterogenic disorder|DDF
33499229|student_A|tremor dominant|DDF|target|PD patients|human
33499229|student_A|non-tremor dominant|DDF|change abundance|Coprococcus|bacteria
33499229|student_A|gut microbiota|microbiome|located in|PD patients|human
33499229|student_A|Parkinson's disease|DDF|change abundance|Escherichia|bacteria
33499229|student_A|TD|DDF|target|PD patients|human
33499229|student_A|PD|DDF|change abundance|Coprococcus|bacteria
33499229|student_A|akinetic-rigid features|DDF|target|PD patients|human
33499229|student_A|motor deficits|DDF|target|PD patients|human
33499229|student_A|cadaverine|chemical|produced by|Gut Microbiota|microbiome
33499229|student_A|Gut Microbiota|microbiome|is linked to|non-tremor dominant|DDF
33499229|student_A|Lachnospira|bacteria|part of|gut microbiota|microbiome
33499229|student_A|non-TD|DDF|change abundance|Escherichia|bacteria
33499229|student_A|Parkinson's disease|DDF|change abundance|Enterobacteriaceae|bacteria
33499229|student_A|non-tremor dominant|DDF|change abundance|Lachnospiraceae|bacteria
33499229|student_A|Coprococcus|bacteria|part of|Gut Microbiota|microbiome
33499229|student_A|PD|DDF|change abundance|Lachnospiraceae|bacteria
33499229|student_A|Parkinson's disease|DDF|target|PD patients|human
33499229|student_A|Serratia|bacteria|part of|Gut Microbiota|microbiome
33499229|student_A|non-tremor dominant|DDF|change abundance|Escherichia|bacteria
33499229|student_A|Parkinson's disease|DDF|change abundance|Lachnospira|bacteria
33499229|student_A|Gut Microbiota|microbiome|is linked to|motor deficits|DDF
33499229|student_A|Enterobacteriaceae|bacteria|part of|Gut Microbiota|microbiome
33499229|student_A|non-TD|DDF|change abundance|Serratia|bacteria
33499229|student_A|non-tremor dominant|DDF|change abundance|Blautia|bacteria
33499229|student_A|PD|DDF|change abundance|Blautia|bacteria
33499229|student_A|non-TD|DDF|change abundance|Enterobacteriaceae|bacteria
33499229|student_A|Escherichia|bacteria|part of|Gut Microbiota|microbiome
33499229|student_A|AR|DDF|target|PD patients|human
33499229|student_A|non-TD|DDF|change abundance|Lachnospira|bacteria
33499229|student_A|Gut Microbiota|microbiome|is linked to|tremor dominant|DDF
33499229|student_A|Blautia|bacteria|part of|gut microbiota|microbiome
33499229|student_A|Parkinson's Disease|DDF|target|PD patients|human
33499229|student_A|Gut Microbiota|microbiome|is linked to|PD|DDF
33499229|student_A|Lachnospiraceae|bacteria|part of|gut microbiota|microbiome
33499229|student_A|Coprococcus|bacteria|part of|gut microbiota|microbiome
33499229|student_A|Parkinson's disease|DDF|change abundance|Coprococcus|bacteria
33499229|student_A|gut microbiota|microbiome|is linked to|Parkinson's Disease|DDF
33499229|student_A|cadaverine|chemical|produced by|gut microbiota|microbiome
33499229|student_A|clinically heterogenic disorder|DDF|target|PD patients|human
33499229|student_A|PD|DDF|change abundance|Escherichia|bacteria
33499229|student_A|Gut Microbiota|microbiome|is linked to|Parkinson's disease|DDF
33499229|student_A|Gut Microbiota|microbiome|is linked to|clinically heterogenic disorder|DDF
35491707|student_A|Withania somnifera|dietary supplement|influence|neurodegenerative diseases|DDF
35491707|student_A|W. somnifera|dietary supplement|influence|gut-dysbiosis|DDF
35491707|student_A|W. somnifera|dietary supplement|influence|neurodegenerative diseases|DDF
35491707|student_A|dysbiosis|DDF|change abundance|gut microbiota|microbiome
34907601|student_B|calorie-dense foods|dietary supplement|influence|obesity|DDF
34907601|student_B|WD pellets|dietary supplement|impact|gut microbiota|microbiome
34907601|student_B|obesity|DDF|target|generations|human
34907601|student_B|epigenetic inheritance|DDF|target|F1|animal
34907601|student_B|physiological alterations|DDF|target|F1|animal
34907601|student_B|disease susceptibility|DDF|target|offspring|human
34907601|student_B|Western diet|dietary supplement|impact|gut microbiota|microbiome
34907601|student_B|impaired glycemic control|DDF|target|fathers|animal
34907601|student_B|Western-style diet|dietary supplement|influence|physiological alterations|DDF
34907601|student_B|highly processed|dietary supplement|influence|disease susceptibility|DDF
34907601|student_B|increased body weight|DDF|target|fathers|animal
34907601|student_B|calorie-dense foods|dietary supplement|influence|disease susceptibility|DDF
34907601|student_B|highly processed|dietary supplement|influence|overweight|DDF
34907601|student_B|food|dietary supplement|impact|gut microbiota|microbiome
34907601|student_B|gut microbiota|microbiome|located in|offspring|animal
34907601|student_B|calorie-dense foods|dietary supplement|influence|overweight|DDF
34907601|student_B|overweight|DDF|target|generations|human
34907601|student_B|highly processed|dietary supplement|influence|metabolic dysfunction|DDF
34907601|student_B|WD|dietary supplement|change expression|phenotypic changes|gene
34907601|student_B|impaired glycemic control|DDF|target|F0 males|animal
34907601|student_B|calorie-dense foods|dietary supplement|influence|metabolic dysfunction|DDF
34907601|student_B|highly processed|dietary supplement|influence|obesity|DDF
34907601|student_B|Western diet|dietary supplement|influence|stress reactivity|DDF
34907601|student_B|increased body weight|DDF|target|F0 males|animal
34907601|student_B|physiological alterations|DDF|target|offspring|animal
34907601|student_B|behavioral despair|DDF|target|offspring|animal
34907601|student_B|gut microbiota|microbiome|used by|16S microbiome profiling|biomedical technique
34907601|student_B|higher body weights|DDF|target|pups|animal
34907601|student_B|gut microbiota|microbiome|located in|F1|animal
34907601|student_B|behavioral despair|DDF|target|F1|animal
34907601|student_B|epigenetic inheritance|DDF|target|offspring|animal
34907601|student_B|Actinobacteria|bacteria|part of|gut microbiota|microbiome
38756585|student_B|GBM|DDF|change abundance|Ruminococcus 2|bacteria
38756585|student_B|GBM|DDF|change abundance|Bacteroides vulgatus|bacteria
38756585|student_B|GBM|DDF|change abundance|Escherichia-Shigella|bacteria
38756585|student_B|GBM|DDF|change abundance|Parasutterella|bacteria
38756585|student_B|GBM|DDF|change abundance|Enterobacteriaceae|bacteria
38756585|student_B|GBM|DDF|change abundance|Prevotella_9|bacteria
38756585|student_B|gut microbial dysbiosis|DDF|target|patients|human
38756585|student_B|GBM|DDF|change abundance|Bacteroides|bacteria
38756585|student_B|GBM|DDF|change abundance|Lachnospiraceae|bacteria
38756585|student_B|GBM|DDF|change abundance|Firmicutes|bacteria
38756585|student_B|GBM|DDF|change abundance|Rikenellaceae|bacteria
38756585|student_B|GBM|DDF|change abundance|Faecalibacterium|bacteria
38756585|student_B|GBM|DDF|change abundance|Bacteroidaceae|bacteria
38756585|student_B|GBM|DDF|target|patients|human
38756585|student_B|individuals|human|used by|high-throughput sequencing|biomedical technique
38756585|student_B|gut microbial dysbiosis|DDF|affect|glioblastoma brain tumour|DDF
38756585|student_B|GBM|DDF|change abundance|Proteobacteria|bacteria
38756585|student_B|GBM|DDF|change abundance|Prevotellaceae|bacteria
38756585|student_B|GBM|DDF|change abundance|Escherichia coli|bacteria
38756585|student_B|GBM|DDF|change abundance|Veillonellaceae|bacteria
34025392|student_A|mitochondrial dysfunction|DDF|affect|PD pathophysiology|DDF
34025392|student_A|PD|DDF|affect|progressive impairment of motor and non-motor functions|DDF
34025392|student_A|probiotic|dietary supplement|influence|energy metabolism|DDF
34025392|student_A|mitochondrial dysfunction|DDF|affect|energy metabolism|DDF
34025392|student_A|mitochondria function|DDF|affect|energy metabolism|DDF
34025392|student_A|muscle mass|DDF|target|PD rats|animal
34025392|student_A|AP-32 supplement|dietary supplement|influence|motor function|DDF
34025392|student_A|mitochondrial activities|DDF|strike|muscle|anatomical location
34025392|student_A|AP-32 supplement|dietary supplement|influence|muscle mass|DDF
34025392|student_A|mitochondrial activities|DDF|strike|brain|anatomical location
34025392|student_A|progressive impairment of motor and non-motor functions|DDF|target|aging people|human
34025392|student_A|Probiotic Supplementation|dietary supplement|influence|Energy Metabolism|DDF
34025392|student_A|mitochondrial function|DDF|strike|muscles|anatomical location
34025392|student_A|Parkinson's disease|DDF|affect|progressive impairment of motor and non-motor functions|DDF
34025392|student_A|Probiotic Supplementation|dietary supplement|influence|6-OHDA-Induced Motor Deficit|DDF
34025392|student_A|motor function|DDF|target|PD rats|animal
34025392|student_A|mitochondrial function|DDF|affect|6-OHDA-induced motor deficit|DDF
34025392|student_A|mitochondrial function|DDF|strike|brain|anatomical location
34025392|student_A|probiotic AP-32 and A-RM supplementations|dietary supplement|influence|energy metabolism|DDF
34025392|student_A|probiotic|dietary supplement|influence|host energy metabolism|DDF
34025392|student_A|neurodegenerative disease|DDF|affect|progressive impairment of motor and non-motor functions|DDF
34025392|student_A|probiotic|dietary supplement|influence|gut microbiota dysbiosis|DDF
31552496|student_A|"abnormal" microbiota|microbiome|is linked to|ASD|DDF
31552496|student_A|pre- or probiotics|dietary supplement|impact|gut microbiota|microbiome
31552496|student_A|bacteria-derived products|chemical|influence|pain perception|DDF
31552496|student_A|gut microbiota|microbiome|is linked to|dysbiosis|DDF
31552496|student_A|"abnormal" microbiota|microbiome|is linked to|neurological diseases|DDF
31552496|student_A|"abnormal" microbiota|microbiome|is linked to|Parkinson's disease|DDF
31552496|student_A|host receptor-targeted drugs|drug|change effect|well-being|DDF
31552496|student_A|novel microbial ligands|chemical|influence|well-being|DDF
31552496|student_A|"abnormal" microbiota|microbiome|is linked to|autism spectrum disorder|DDF
31552496|student_A|novel microbial ligands|chemical|influence|chronic pain management|DDF
31552496|student_A|gut microbiota|microbiome|is linked to|painful gastrointestinal disorders|DDF
31552496|student_A|host receptor-targeted drugs|drug|change effect|chronic pain management|DDF
31552496|student_A|"abnormal" microbiota|microbiome|is linked to|Alzheimer's|DDF
31552496|student_A|gut microbiota|microbiome|is linked to|afferent sensory neurons function and pain|DDF
35849305|student_A|Psychobiotics|bacteria|influence|anorexia nervosa|DDF
35849305|student_A|Psychobiotics|bacteria|influence|CNS disorders|DDF
35849305|student_A|functional foods containing psychotropic strains|dietary supplement|influence|mental health|DDF
35849305|student_A|Psychobiotics|bacteria|influence|multiple sclerosis|DDF
35849305|student_A|Psychobiotics|bacteria|influence|Parkinson's disease|DDF
35849305|student_A|Psychobiotics containing nutrients|dietary supplement|impact|microbiota|microbiome
35849305|student_A|Nervous system disorders|DDF|target|people|human
35849305|student_A|Psychobiotics containing nutrients|dietary supplement|influence|central nervous system (CNS) disorders|DDF
35849305|student_A|Psychobiotics|bacteria|influence|autism spectrum disorders|DDF
35849305|student_A|Psychobiotics|bacteria|influence|neurological disorders|DDF
35849305|student_A|Psychobiotics|bacteria|influence|insomnia|DDF
35849305|student_A|Psychobiotics|bacteria|influence|depression|DDF
35849305|student_A|Gut Microbiota|microbiome|is linked to|Neurological Disorders|DDF
35849305|student_A|probiotic strains|bacteria|influence|CNS disorders|DDF
35849305|student_A|Psychobiotics|bacteria|influence|diabetic neuropathy|DDF
38732060|student_A|probiotics|dietary supplement|impact|gut microbiota|microbiome
38732060|student_A|prebiotics|dietary supplement|influence|obesity|DDF
38732060|student_A|human gut microbiota|microbiome|located in|gastrointestinal tract|anatomical location
38732060|student_A|probiotics|dietary supplement|impact|human gut microbiota|microbiome
38732060|student_A|Prebiotics|dietary supplement|impact|Gut Microbiota|microbiome
38732060|student_A|probiotics|dietary supplement|impact|Gut Microbiota|microbiome
38732060|student_A|Prebiotics|dietary supplement|influence|inflammatory bowel disease|DDF
38732060|student_A|prebiotics|dietary supplement|impact|human gut microbiota|microbiome
38732060|student_A|prebiotics|dietary supplement|impact|Gut Microbiota|microbiome
38732060|student_A|Prebiotics|dietary supplement|administered|host|human
38732060|student_A|Prebiotics|dietary supplement|impact|human gut microbiota|microbiome
38732060|student_A|prebiotics|dietary supplement|influence|inflammatory bowel disease|DDF
38732060|student_A|Prebiotics|dietary supplement|influence|obesity|DDF
38732060|student_A|Prebiotics|dietary supplement|impact|gut microbiota|microbiome
38732060|student_A|prebiotics|dietary supplement|impact|gut microbiota|microbiome
35399732|student_B|Escherichia coli|bacteria|influence|euthyroid thyroid cancer|DDF
35399732|student_B|gut microbial dysbiosis|DDF|target|euthyroid thyroid cancer patients|human
35399732|student_B|gut microbial taxa|microbiome|located in|euthyroid thyroid cancer patients|human
35399732|student_B|Thyroid cancer|DDF|target|humans|human
34274348|student_A|microbes|microbiome|located in|liver|anatomical location
34274348|student_A|bioactive factors|chemical|impact|microbes|microbiome
34274348|student_A|microbiota|microbiome|located in|enteric nervous system|anatomical location
34274348|student_A|microbes|microbiome|located in|adipose tissue|anatomical location
34274348|student_A|microbes|microbiome|located in|brain|anatomical location
34274348|student_A|microbes|microbiome|located in|tissue|anatomical location
34274348|student_A|gaseous factors|chemical|impact|gut microbiota|microbiome
34274348|student_A|short-chain fatty acids|chemical|produced by|gut microbiota|microbiome
34274348|student_A|gut microbiota|microbiome|located in|brain|anatomical location
39317918|student_A|Gut Microbiota|microbiome|located in|intestinal epithelial surface|anatomical location
39317918|student_A|GM|microbiome|located in|intestinal epithelial surface|anatomical location
32247376|student_A|gut microbiota|microbiome|is linked to|synucleinopathies|DDF
32247376|student_A|neurodegeneration|DDF|affect|synucleinopathies|DDF
36613486|student_B|oxidative brain injury|DDF|target|PD patients|human
36613486|student_B|gut microbiota|microbiome|located in|PD-affected patients|human
36613486|student_B|affected brain regions|anatomical location|located in|PD patients|human
36613486|student_B|chronic neuroinflammation|DDF|target|PD patients|human
36613486|student_B|anti- or pro-inflammatory metabolites|chemical|produced by|microbiota|microbiome
38889540|student_B|chronic pain|DDF|change abundance|gut microbiota|microbiome
38889540|student_B|gastrointestinal dysfunction|DDF|target|patients|human
38889540|student_B|obesity|DDF|target|patients|human
38889540|student_B|Chronic stress|DDF|target|patients|human
38889540|student_B|gut-brain axis diseases|DDF|target|patients|human
38889540|student_B|neurological diseases|DDF|target|patients|human
38889540|student_B|chronic stress|DDF|target|patients|human
38889540|student_B|mood disorders|DDF|target|patients|human
38889540|student_B|vitamins|dietary supplement|impact|microbiota|microbiome
38889540|student_B|microbiota|microbiome|located in|patients|human
38889540|student_B|chronic pain|DDF|target|patients|human
38889540|student_B|chronic stress|DDF|change abundance|gut microbiota|microbiome
38889540|student_B|brain|anatomical location|located in|patients|human
38889540|student_B|gut|anatomical location|located in|patients|human
38889540|student_B|amino acids|dietary supplement|impact|microbiota|microbiome
38889540|student_B|minerals|dietary supplement|impact|microbiota|microbiome
36421473|student_A|beneficial bacteria|bacteria|part of|gut microbiota|microbiome
36421473|student_A|antioxidants|chemical|influence|oxidative stress|DDF
36421473|student_A|Gut Microbiota|microbiome|is linked to|Neurodegenerative Diseases|DDF
36421473|student_A|gut microbiota|microbiome|is linked to|oxidative stress-mediated neurodegenerative diseases|DDF
36421473|student_A|oxidants|chemical|influence|oxidative stress|DDF
36421473|student_A|gut microbiota|microbiome|is linked to|neurodegenerative diseases|DDF
36421473|student_A|gut microbiota|microbiome|located in|brain|anatomical location
33860738|student_A|gastrointestinal symptoms|DDF|target|PD patients|human
33860738|student_A|gastrointestinal disorders|DDF|target|patients with PD|human
33860738|student_A|Gastrointestinal disorders|DDF|affect|Parkinson disease|DDF
39378456|student_A|antibiotics|drug|impact|microbiome|microbiome
39378456|student_A|probiotics|dietary supplement|influence|psychiatric disorders|DDF
39378456|student_A|Gut Microbiota|microbiome|is linked to|major depressive disorder|DDF
39378456|student_A|diet|dietary supplement|impact|microbiome|microbiome
39378456|student_A|gut microbiome|microbiome|is linked to|major depressive disorder|DDF
39378456|student_A|probiotics|dietary supplement|influence|psychiatric conditions|DDF
39378456|student_A|psychobiotics|dietary supplement|influence|psychiatric conditions|DDF
39378456|student_A|psychobiotics|dietary supplement|influence|psychiatric disorders|DDF
39125364|student_A|anxiety|DDF|target|non-depressed groups|human
39125364|student_A|gut microbiome|microbiome|is linked to|neuropsychiatric disease|DDF
39125364|student_A|fiber intake|dietary supplement|administered|non-depressed groups|human
39125364|student_A|maternal fiber intake|dietary supplement|influence|perinatal depression and anxiety|DDF
39125364|student_A|Maternal Fiber Intake|dietary supplement|influence|Perinatal Depression|DDF
39125364|student_A|antenatal diet|dietary supplement|influence|maternal mental health disorders|DDF
39125364|student_A|fiber intake|dietary supplement|influence|maternal mental health disorders|DDF
39125364|student_A|fiber|dietary supplement|influence|perinatal depression and anxiety|DDF
39125364|student_A|fiber intake|dietary supplement|influence|depression|DDF
39125364|student_A|depression|DDF|target|non-depressed groups|human
39125364|student_A|Maternal Fiber Intake|dietary supplement|influence|Anxiety|DDF
39125364|student_A|depression|DDF|target|depressed and non-depressed groups|human
39125364|student_A|anxiety|DDF|target|depressed and non-depressed groups|human
39125364|student_A|fiber intake|dietary supplement|influence|anxiety|DDF
39125364|student_A|fiber|dietary supplement|influence|PDA|DDF
39125364|student_A|fiber intake|dietary supplement|administered|depressed and non-depressed groups|human
39125364|student_A|maternal fiber intake|dietary supplement|influence|PDA|DDF
35711580|student_B|glucose|chemical|located in|human body|anatomical location
35711580|student_B|lipid|chemical|located in|human body|anatomical location
35711580|student_B|schizophrenia|DDF|target|patients|human
35711580|student_B|subjects|human|used by|16S rRNA sequence|biomedical technique
35711580|student_B|Prevotella-Enterotype|microbiome|located in|Schizophrenia Patients|human
35711580|student_B|gut microbes|microbiome|located in|controls|human
35711580|student_B|obesity|DDF|target|people|human
35711580|student_B|enterotype-P|microbiome|located in|health controls|human
35711580|student_B|enterotype-P|microbiome|located in|controls|human
35711580|student_B|gut microbes|microbiome|located in|patients|human
35711580|student_B|microbiota|microbiome|located in|subjects|human
35711580|student_B|enterotype-P|microbiome|located in|patients|human
35711580|student_B|gut microbiota|microbiome|is linked to|obesity|DDF
35711580|student_B|gut microbiota|microbiome|located in|patients|human
35711580|student_B|enterotype-P|microbiome|located in|patients' group|human
35711580|student_B|enterotype-P|microbiome|located in|subjects|human
35711580|student_B|schizophrenia|DDF|target|people|human
35742813|student_B|6-OHDA|drug|change effect|PD|DDF
35742813|student_B|gut microbiota|microbiome|is linked to|PD|DDF
35742813|student_B|ceftriaxone|drug|change effect|PD|DDF
35742813|student_B|6-OHDA|drug|change expression|Bcl-2/Bax|gene
35742813|student_B|post-biotic sodium butyrate|dietary supplement|influence|PD|DDF
35742813|student_B|systemic|anatomical location|located in|mice|animal
35742813|student_B|colon|anatomical location|located in|mice|animal
35742813|student_B|6-OHDA|drug|change expression|tyrosine hydroxylase|gene
35742813|student_B|CFX|drug|administered|mice|animal
37389240|student_A|SIBO|DDF|affect|fibromyalgia|DDF
37389240|student_A|SIBO|DDF|affect|functional abdominal bloating|DDF
37389240|student_A|SIBO|DDF|affect|diverticular and celiac diseases|DDF
37389240|student_A|SIBO|DDF|affect|acromegaly|DDF
37389240|student_A|SIBO|DDF|affect|diseases|DDF
37389240|student_A|SIBO|DDF|affect|hyperlipidemia|DDF
37389240|student_A|SIBO|DDF|affect|functional diarrhea|DDF
37389240|student_A|SIBO|DDF|affect|gallstone disease|DDF
37389240|student_A|SIBO|DDF|affect|functional dyspepsia|DDF
37389240|student_A|SIBO|DDF|affect|cirrhosis|DDF
37389240|student_A|SIBO|DDF|affect|functional constipation|DDF
37389240|student_A|SIBO|DDF|change abundance|bacteria|bacteria
37389240|student_A|SIBO|DDF|affect|short bowel syndrome|DDF
37389240|student_A|SIBO|DDF|affect|MAFLD|DDF
37389240|student_A|SIBO|DDF|affect|gastroparesis|DDF
37389240|student_A|SIBO|DDF|affect|systemic sclerosis|DDF
37389240|student_A|SIBO|DDF|affect|multiple sclerosis|DDF
37389240|student_A|SIBO|DDF|affect|primary biliary cholangitis|DDF
37389240|student_A|SIBO|DDF|affect|pancreatitis|DDF
37389240|student_A|SIBO|DDF|affect|spondylarthropathy|DDF
37389240|student_A|SIBO|DDF|affect|asthma|DDF
37389240|student_A|Small intestinal bacterial overgrowth|DDF|strike|small intestine|anatomical location
37389240|student_A|SIBO|DDF|affect|lactase deficiency|DDF
37389240|student_A|SIBO|DDF|affect|chronic intestinal pseudo-obstruction|DDF
37389240|student_A|SIBO|DDF|affect|hypothyroidism|DDF
37389240|student_A|SIBO|DDF|affect|heart failure|DDF
37389240|student_A|SIBO|DDF|affect|metabolic-associated fatty liver disease|DDF
37389240|student_A|SIBO|DDF|target|patients|human
37389240|student_A|SIBO|DDF|affect|cystic fibrosis|DDF
36359864|student_A|Rifaximin|drug|interact|occludin|chemical
36359864|student_A|occludin|chemical|influence|systemic inflammation|DDF
36359864|student_A|Rifaximin|drug|interact|interleukin-6|chemical
36359864|student_A|Rifaximin|drug|impact|gut microbiota|microbiome
36359864|student_A|rifaximin|drug|impact|Flavonifractor|microbiome
36359864|student_A|Rifaximin|drug|impact|Gut Microbiota|microbiome
36359864|student_A|rifaximin|drug|change effect|inflammation status|DDF
36359864|student_A|Rifaximin|drug|impact|Prevotellaceae UCG-001|bacteria
36359864|student_A|tumor necrosis factor-α|chemical|influence|systemic inflammation|DDF
36359864|student_A|rifaximin|drug|change effect|PD|DDF
36359864|student_A|rifaximin|drug|administered|patients|human
36359864|student_A|gut microbiota|microbiome|located in|Patients|human
36359864|student_A|Rifaximin|drug|change effect|Parkinson's Disease|DDF
36359864|student_A|PD|DDF|target|patients|human
36359864|student_A|rifaximin|drug|administered|transgenic PD mice|animal
36359864|student_A|Rifaximin|drug|interact|tumor necrosis factor-α|chemical
36359864|student_A|Rifaximin|drug|change effect|Inflammation|DDF
36359864|student_A|gut microbiota|microbiome|located in|transgenic PD mice|animal
36359864|student_A|gut microbiota|microbiome|is linked to|gut-derived inflammation|DDF
36359864|student_A|rifaximin|drug|impact|gut microbiota|microbiome
36359864|student_A|interleukin-1β|chemical|influence|systemic inflammation|DDF
36359864|student_A|rifaximin|drug|change effect|neuroprotective effect|DDF
36359864|student_A|Rifaximin|drug|impact|Bacteroides|bacteria
36359864|student_A|interleukin-6|chemical|influence|systemic inflammation|DDF
36359864|student_A|plasma proinflammatory cytokine|chemical|interact|baseline plasma interleukin-1α|chemical
36359864|student_A|Rifaximin|drug|impact|Muribaculum|bacteria
36359864|student_A|Rifaximin|drug|interact|claudin-5|chemical
36359864|student_A|claudin-5|chemical|influence|systemic inflammation|DDF
36359864|student_A|Rifaximin|drug|impact|Lachnospiraceae UCG-001|bacteria
36359864|student_A|Rifaximin|drug|interact|interleukin-1β|chemical
35016506|student_A|coffee|food|influence|motor deficits|DDF
35016506|student_A|coffee|food|change expression|antiapoptotic protein Bcl-2|gene
35016506|student_A|coffee|food|influence|PD|DDF
35016506|student_A|coffee|food|change expression|BBB tight junction protein occludin|gene
35016506|student_A|coffee|food|change expression|cytochrome c|gene
35016506|student_A|coffee|food|influence|TH neuron loss|DDF
35016506|student_A|coffee|food|change expression|cleaved caspase-3|gene
35016506|student_A|Neurodegeneration|DDF|target|Mice|animal
35016506|student_A|Coffee|food|influence|MPTP-Induced Motor Deficits|DDF
35016506|student_A|coffee|food|change expression|astrocyte activation marker GFAP|gene
35016506|student_A|gut microbiota|microbiome|is linked to|pathogenesis|DDF
35016506|student_A|coffee|food|influence|MPTP-induced gut microbiota dysbiosis|DDF
35016506|student_A|coffee|food|influence|Parkinson disease|DDF
35016506|student_A|MPTP-Induced Motor Deficits|DDF|target|Mice|animal
35016506|student_A|coffee|food|change expression|Bax|gene
35016506|student_A|Coffee|food|influence|Neurodegeneration|DDF
35016506|student_A|coffee|food|change expression|α-syn|gene
33148438|student_A|Cb|dietary supplement|influence|dopaminergic neuron loss|DDF
33148438|student_A|dysbiosis of gut microbiota|DDF|target|MPTP-induced mice|animal
33148438|student_A|1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine|chemical|located in|Male C57BL/6 mice|animal
33148438|student_A|MPTP|chemical|located in|Male C57BL/6 mice|animal
33148438|student_A|motor deficits|DDF|target|MPTP-induced mice|animal
33148438|student_A|Male C57BL/6 mice|animal|used by|beam walking teat|biomedical technique
33148438|student_A|probiotic Clostridium butyricum|dietary supplement|influence|PD|DDF
33148438|student_A|Male C57BL/6 mice|animal|used by|pole test|biomedical technique
33148438|student_A|Cb|dietary supplement|influence|PD|DDF
33148438|student_A|Cb|dietary supplement|influence|microglia activation|DDF
33148438|student_A|Cb|dietary supplement|influence|synaptic dysfunction|DDF
33148438|student_A|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
33148438|student_A|Male C57BL/6 mice|animal|used by|16S rRNA sequencing analysis|biomedical technique
33148438|student_A|dopaminergic neuron loss|DDF|target|Male C57BL/6 mice|animal
33148438|student_A|gut microbiota|microbiome|used by|16S rRNA sequencing analysis|biomedical technique
33148438|student_A|Probiotic Clostridium butyricum|dietary supplement|influence|Parkinson's disease|DDF
33148438|student_A|Probiotic Clostridium butyricum|dietary supplement|influence|motor deficits|DDF
33148438|student_A|dopaminergic neuron loss|DDF|target|MPTP-induced mice|animal
33148438|student_A|probiotic Clostridium butyricum|dietary supplement|influence|Parkinson's disease|DDF
33148438|student_A|Male C57BL/6 mice|animal|used by|open field test|biomedical technique
33148438|student_A|Cb|dietary supplement|influence|motor deficits|DDF
33148438|student_A|microglia activation|DDF|target|MPTP-induced mice|animal
33148438|student_A|synaptic dysfunction|DDF|target|MPTP-induced mice|animal
33148438|student_A|Male C57BL/6 mice|animal|used by|forced swimming test|biomedical technique
33148438|student_A|Cb|dietary supplement|influence|Parkinson's disease|DDF
33148438|student_A|microglia activation|DDF|target|Male C57BL/6 mice|animal
33148438|student_A|gut microbiota|microbiome|is linked to|PD|DDF
38803488|student_A|inflammatory proteins|chemical|influence|COVID-19|DDF
38803488|student_A|order Bifidobacteriales|bacteria|change expression|CCL2|gene
38803488|student_A|family Bifidobacteriaceae|bacteria|change expression|CCL2|gene
38803488|student_A|human gut microbiota|microbiome|is linked to|COVID-19|DDF
35115853|student_A|SD|DDF|change abundance|gut microbiota|microbiome
35115853|student_A|gut microbiota|microbiome|located in|SD rats|animal
34347266|student_B|MPTP|chemical|influence|PD|DDF
34347266|student_B|PD|DDF|target|mice|animal
34347266|student_B|gut microbiota|microbiome|is linked to|PD|DDF
34347266|student_B|SN|anatomical location|located in|mice|animal
34347266|student_B|substantia nigra pars compacta|anatomical location|located in|mice|animal
37529095|student_A|Streptococcaceae|bacteria|located in|PD mice|animal
37529095|student_A|ncultured_Erysipelotrichales_bacterium|bacteria|located in|AET mice|animal
37529095|student_A|Actinobacteria|bacteria|located in|PD mice|animal
37529095|student_A|Streptococcus|bacteria|located in|PD mice|animal
37529095|student_A|Bacilli|bacteria|located in|AET mice|animal
37529095|student_A|Lysinibacillus|bacteria|located in|PD mice|animal
37529095|student_A|Lactococcus|bacteria|located in|AET mice|animal
37529095|student_A|Firmicutes|bacteria|located in|PD mice|animal
37529095|student_A|Lactobacillaceae|bacteria|located in|AET mice|animal
37529095|student_A|Bacteroidetes|bacteria|located in|PD mice|animal
37529095|student_A|Lactobacillaceae|bacteria|located in|PD mice|animal
37529095|student_A|Prevotellaceae_UCG-001|bacteria|located in|PD mice|animal
37529095|student_A|Lactococcus|bacteria|located in|PD mice|animal
37529095|student_A|gut microbial dysbiosis|DDF|affect|PD|DDF
37529095|student_A|Lactobacillus|bacteria|located in|AET mice|animal
37529095|student_A|Lactobacillus_gasseri|bacteria|located in|AET mice|animal
37529095|student_A|Lactobacillales|bacteria|located in|AET mice|animal
37529095|student_A|Pelomonas|bacteria|located in|PD mice|animal
37529095|student_A|Lactobacillus|bacteria|located in|PD mice|animal
37529095|student_A|gut microbial dysbiosis|DDF|affect|Parkinson's disease|DDF
35422756|student_A|prominent inflammatory component|DDF|affect|illness|DDF
35422756|student_A|Pro-inflammatory bacteria|bacteria|part of|PD gut microbiota|microbiome
35422756|student_A|bacterial antigen|chemical|influence|sub-mucosal inflammation|DDF
35422756|student_A|systemic inflammation|DDF|strike|CNS|anatomical location
35422756|student_A|systemic exposure|DDF|interact|bacterial endotoxin lipopolysaccharide|chemical
35422756|student_A|bacterial antigen|chemical|located in|gut epithelium|anatomical location
34954497|student_A|Lactobacillaceae Lactobacillus|bacteria|part of|gut microbiota|microbiome
34954497|student_A|gut microbiota|microbiome|located in|Parkinson's disease patients|human
34954497|student_A|gut microbiota|microbiome|is linked to|motor complications|DDF
34954497|student_A|gut microbiota|microbiome|located in|PD patients|human
34954497|student_A|Lachnospiraceae Blautia|bacteria|part of|gut microbiota|microbiome
34954497|student_A|dyskinesia|DDF|target|patients|human
34954497|student_A|Lachnospiraceae Lactobacillus|bacteria|part of|gut microbiota|microbiome
34954497|student_A|PD|DDF|target|patients|human
34954497|student_A|motor complications|DDF|target|PD patients|human
37346870|student_A|neurological diseases|DDF|target|humans|human
37346870|student_A|multiple sclerosis|DDF|target|humans|human
37346870|student_A|autism spectrum disorder|DDF|target|humans|human
37346870|student_A|Gut Microbiota|microbiome|is linked to|Neuropsychiatric Disorders|DDF
37346870|student_A|Alzheimer's disease|DDF|target|humans|human
37346870|student_A|Parkinson disease|DDF|target|humans|human
37346870|student_A|stroke|DDF|target|humans|human
37346870|student_A|depression|DDF|target|humans|human
37346870|student_A|neurological diseases|DDF|target|animals|animal
37346870|student_A|gut microbiota|microbiome|is linked to|nervous system diseases|DDF
36558531|student_A|polyphenols|chemical|interact|glycosylation|chemical
36558531|student_A|beneficial bacteria|bacteria|influence|NND|DDF
36558531|student_A|beneficial bacteria|bacteria|interact|neurotransmitters|chemical
36558531|student_A|polyphenols|chemical|interact|intestinal enzymes|chemical
36558531|student_A|Polyphenols|chemical|produced by|intestinal microbiota|microbiome
36558531|student_A|beneficial bacteria|bacteria|interact|hormones|chemical
36558531|student_A|beneficial bacteria|bacteria|interact|short-chain fatty acids|chemical
36558531|student_A|Gut Microbiota|microbiome|is linked to|Neurodegenerative Diseases|DDF
36558531|student_A|beneficial bacteria|bacteria|interact|SCFAs|chemical
36558531|student_A|polyphenols|chemical|influence|NND|DDF
36558531|student_A|Polyphenols|chemical|influence|Neurodegenerative Diseases|DDF
36558531|student_A|polyphenols|chemical|interact|polymers|chemical
36558531|student_A|Polyphenols|chemical|influence|neurodegenerative diseases|DDF
36558531|student_A|Polyphenols|chemical|impact|beneficial bacteria|bacteria
36558531|student_A|Polyphenols|chemical|interact|antioxidants|chemical
36558531|student_A|Polyphenols|chemical|influence|intestinal microbiota disorders|DDF
36558531|student_A|Polyphenols|chemical|influence|NND|DDF
36558531|student_A|polyphenols|chemical|produced by|intestinal microbiota|microbiome
33633723|student_A|Parkinson's disease|DDF|target|patients|human
33633723|student_A|H. pylori|bacteria|influence|neurological disorders|DDF
33633723|student_A|H. suis|bacteria|influence|neurological disorders|DDF
33633723|student_A|Gut microbiota|microbiome|located in|brain|anatomical location
33633723|student_A|gut microbiota|microbiome|is linked to|neurological disorders|DDF
33633723|student_A|H. suis|bacteria|located in|patients|human
33633723|student_A|Helicobacter|bacteria|influence|Neurological Disorders|DDF
36934020|student_B|PD|DDF|strike|periphery of the body|anatomical location
36934020|student_B|Parkinson's disease|DDF|change abundance|short-chain fatty acid-producing bacteria|bacteria
36934020|student_B|Parkinson's disease|DDF|affect|intestinal permeability|DDF
36934020|student_B|bacterial amyloid proteins|chemical|interact|α-synuclein|chemical
36934020|student_B|dopaminergic treatments|chemical|impact|short-chain fatty acid-producing bacteria|bacteria
36934020|student_B|PD|DDF|affect|intestinal permeability|DDF
36934020|student_B|Parkinson's disease|DDF|strike|periphery of the body|anatomical location
36934020|student_B|PD|DDF|affect|local and systemic inflammation|DDF
36934020|student_B|dopaminergic treatments|chemical|influence|PD|DDF
36934020|student_B|gut microbiota|microbiome|used by|intestinal decontamination|biomedical technique
36934020|student_B|microorganisms|bacteria|located in|host|animal
36934020|student_B|local and systemic inflammation|DDF|affect|Parkinson's disease|DDF
36934020|student_B|dopaminergic treatments|chemical|influence|Parkinson's disease|DDF
36934020|student_B|PD|DDF|change abundance|short-chain fatty acid-producing bacteria|bacteria
35433746|student_A|Gut microbiota|microbiome|is linked to|depression|DDF
35433746|student_A|Gut microbiota|microbiome|is linked to|dementia|DDF
35433746|student_A|probiotic formulations|dietary supplement|influence|neuropsychiatric-associated affections|DDF
35433746|student_A|Gut microbiota|microbiome|is linked to|bipolar disorder|DDF
35433746|student_A|Gut Microbiota|microbiome|is linked to|Neurological and Psychiatric Disorders|DDF
35433746|student_A|Gut microbiota|microbiome|is linked to|anxiety|DDF
35433746|student_A|Gut microbiota|microbiome|is linked to|autism|DDF
35433746|student_A|Gut microbiota|microbiome|is linked to|schizophrenia|DDF
35433746|student_A|Gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
35433746|student_A|Gut microbiota|microbiome|is linked to|Alzheimer's disease|DDF
35433746|student_A|Gut microbiota|microbiome|is linked to|multiple sclerosis|DDF
35433746|student_A|Gut microbiota|microbiome|is linked to|epilepsy|DDF
35433746|student_A|gut microbiota|microbiome|is linked to|neuropsychiatric illnesses|DDF
35433746|student_A|gut microbiota|microbiome|located in|brain|anatomical location
35433746|student_A|Gut microbiota|microbiome|is linked to|neurological and psychiatric disorders|DDF
31606537|student_A|realgar|chemical|influence|neurological disorders|DDF
31606537|student_A|Cinnabar|chemical|influence|neurological disorders|DDF
31606537|student_A|As<sub>4</sub>S<sub>4</sub>|chemical|influence|loss of DA neurons|DDF
31606537|student_A|DA neuron loss|DDF|target|rat|animal
31606537|student_A|Hua-Feng-Dan|drug|impact|Verrucomicrobiaceae|bacteria
31606537|student_A|cinnabar|chemical|influence|DA neuron loss|DDF
31606537|student_A|cinnabar|chemical|influence|LPS plus ROT induced neurotoxicity|DDF
31606537|student_A|As<sub>4</sub>S<sub>4</sub>|chemical|influence|LPS plus rotenone-induced neurotoxicity|DDF
31606537|student_A|HFD|drug|change effect|LPS plus ROT induced neurotoxicity|DDF
31606537|student_A|HgS|chemical|influence|loss of DA neurons|DDF
31606537|student_A|Cinnabar|chemical|influence|loss of DA neurons|DDF
31606537|student_A|LPS plus ROT induced neurotoxicity|DDF|target|rat|animal
31606537|student_A|Verrucomicrobiaceae|bacteria|part of|gut microbiome|microbiome
31606537|student_A|HgS|chemical|influence|behavioral dysfunction|DDF
31606537|student_A|As<sub>4</sub>S<sub>4</sub>|chemical|influence|behavioral dysfunction|DDF
31606537|student_A|HFD|drug|impact|Enterobacteeriaceae|bacteria
31606537|student_A|Hua-Feng-Dan|drug|change effect|neurodegenerative diseases|DDF
31606537|student_A|HFD-reduced|drug|change effect|LPS plus rotenone-induced neurotoxicity|DDF
31606537|student_A|neurological disorders|DDF|target|rats|animal
31606537|student_A|cinnabar|chemical|influence|disturbance of gut microbiota|DDF
31606537|student_A|HFD|drug|change effect|disturbance of gut microbiota|DDF
31606537|student_A|HFD-original|drug|impact|Lactobacteriaceae|bacteria
31606537|student_A|realgar|chemical|influence|neurodegenerative diseases|DDF
31606537|student_A|HgS|chemical|influence|neurodegenerative diseases|DDF
31606537|student_A|HFD-original|drug|impact|gut microbiome|microbiome
31606537|student_A|Cinnabar|chemical|influence|LPS plus ROT induced neurotoxicity|DDF
31606537|student_A|Hua-Feng-Dan|drug|change effect|LPS plus ROT induced neurotoxicity|DDF
31606537|student_A|Cinnabar|chemical|impact|gut microbiome|microbiome
31606537|student_A|LPS|chemical|impact|Enterobacteeriaceae|bacteria
31606537|student_A|HFD-original|drug|change effect|LPS plus rotenone-induced neurotoxicity|DDF
31606537|student_A|neurological disorders|DDF|target|rat|animal
31606537|student_A|Lipopolysaccharide|chemical|impact|Lactobacteriaceae|bacteria
31606537|student_A|Hua-Feng-Dan|drug|impact|gut microbiome|microbiome
31606537|student_A|HFD-original|drug|impact|Verrucomicrobiaceae|bacteria
31606537|student_A|Verrucomicrobiaceae|bacteria|part of|gut microbiota|microbiome
31606537|student_A|cinnabar|chemical|impact|gut microbiome|microbiome
31606537|student_A|HFD-reduced|drug|impact|Enterobacteeriaceae|bacteria
31606537|student_A|HFD-original|drug|change effect|disturbance of gut microbiota|DDF
31606537|student_A|Behavioral dysfunction|DDF|target|rat|animal
31606537|student_A|LPS plus ROT induced neurotoxicity|DDF|target|Rats|animal
31606537|student_A|Lipopolysaccharide|chemical|impact|Verrucomicrobiaceae|bacteria
31606537|student_A|HFD-reduced|drug|change effect|behavioral dysfunction|DDF
31606537|student_A|HFD-reduced|drug|change effect|DA neuron loss|DDF
31606537|student_A|HFD-original|drug|impact|gut microbiota|microbiome
31606537|student_A|Hua-Feng-Dan|drug|change effect|disturbance of gut microbiota|DDF
31606537|student_A|Lactobacteriaceae|bacteria|part of|gut microbiota|microbiome
31606537|student_A|HFD-reduced|drug|change effect|neurological disorders|DDF
31606537|student_A|Cinnabar|chemical|impact|gut microbiota|microbiome
31606537|student_A|HFD-reduced|drug|impact|gut microbiome|microbiome
31606537|student_A|realgar|chemical|influence|disturbance of gut microbiota|DDF
31606537|student_A|HFD|drug|change effect|loss of DA neurons|DDF
31606537|student_A|Hua-Feng-Dan|drug|impact|gut microbiota|microbiome
31606537|student_A|cinnabar|chemical|impact|gut microbiota|microbiome
31606537|student_A|ROT|chemical|impact|Enterobacteeriaceae|bacteria
31606537|student_A|As<sub>4</sub>S<sub>4</sub>|chemical|influence|neurodegenerative diseases|DDF
31606537|student_A|As<sub>4</sub>S<sub>4</sub>|chemical|impact|gut microbiome|microbiome
31606537|student_A|HFD-reduced|drug|impact|Verrucomicrobiaceae|bacteria
31606537|student_A|neurological disorders|DDF|target|Rats|animal
31606537|student_A|cinnabar|chemical|influence|behavioral dysfunction|DDF
31606537|student_A|HFD|drug|change effect|behavioral dysfunction|DDF
31606537|student_A|HgS|chemical|impact|gut microbiome|microbiome
31606537|student_A|realgar|chemical|influence|LPS plus ROT induced neurotoxicity|DDF
31606537|student_A|HgS|chemical|influence|LPS plus ROT induced neurotoxicity|DDF
31606537|student_A|As<sub>4</sub>S<sub>4</sub>|chemical|influence|DA neuron loss|DDF
31606537|student_A|HFD-original|drug|change effect|loss of DA neurons|DDF
31606537|student_A|Behavioral dysfunction|DDF|target|Rats|animal
31606537|student_A|LPS plus ROT induced neurotoxicity|DDF|target|rats|animal
31606537|student_A|HgS|chemical|influence|neurological disorders|DDF
31606537|student_A|As<sub>4</sub>S<sub>4</sub>|chemical|influence|neurological disorders|DDF
31606537|student_A|Hua-Feng-Dan|drug|impact|Lactobacteriaceae|bacteria
31606537|student_A|disturbance of gut microbiota|DDF|target|rat|animal
31606537|student_A|neurodegenerative diseases|DDF|target|rats|animal
31606537|student_A|HFD-reduced|drug|change effect|neurodegenerative diseases|DDF
31606537|student_A|LPS plus rotenone-induced neurotoxicity|DDF|target|Rats|animal
31606537|student_A|ROT|chemical|impact|Verrucomicrobiaceae|bacteria
31606537|student_A|HgS|chemical|impact|gut microbiota|microbiome
31606537|student_A|HFD-original|drug|change effect|behavioral dysfunction|DDF
31606537|student_A|Hua-Feng-Dan|drug|change effect|LPS plus rotenone-induced neurotoxicity|DDF
31606537|student_A|rotenone|chemical|impact|Lactobacteriaceae|bacteria
31606537|student_A|HFD-original|drug|impact|Enterobacteeriaceae|bacteria
31606537|student_A|cinnabar|chemical|influence|loss of DA neurons|DDF
31606537|student_A|HFD-reduced|drug|change effect|LPS plus ROT induced neurotoxicity|DDF
31606537|student_A|cinnabar|chemical|influence|LPS plus rotenone-induced neurotoxicity|DDF
31606537|student_A|As<sub>4</sub>S<sub>4</sub>|chemical|influence|disturbance of gut microbiota|DDF
31606537|student_A|HFD|drug|change effect|LPS plus rotenone-induced neurotoxicity|DDF
31606537|student_A|LPS plus rotenone-induced neurotoxicity|DDF|target|rat|animal
31606537|student_A|HFD-reduced|drug|impact|Lactobacteriaceae|bacteria
31606537|student_A|LPS|chemical|impact|Verrucomicrobiaceae|bacteria
31606537|student_A|rotenone|chemical|impact|Verrucomicrobiaceae|bacteria
31606537|student_A|realgar|chemical|influence|behavioral dysfunction|DDF
31606537|student_A|HFD|drug|impact|gut microbiota|microbiome
31606537|student_A|Cinnabar|chemical|influence|behavioral dysfunction|DDF
31606537|student_A|HFD-original|drug|change effect|DA neuron loss|DDF
31606537|student_A|Enterobacteeriaceae|bacteria|part of|gut microbiota|microbiome
31606537|student_A|Cinnabar|chemical|influence|disturbance of gut microbiota|DDF
31606537|student_A|Behavioral dysfunction|DDF|target|rats|animal
31606537|student_A|realgar|chemical|impact|gut microbiota|microbiome
31606537|student_A|DA neuron loss|DDF|target|rats|animal
31606537|student_A|As<sub>4</sub>S<sub>4</sub>|chemical|influence|LPS plus ROT induced neurotoxicity|DDF
31606537|student_A|disturbance of gut microbiota|DDF|target|Rats|animal
31606537|student_A|Hua-Feng-Dan|drug|change effect|DA neuron loss|DDF
31606537|student_A|HFD-reduced|drug|change effect|disturbance of gut microbiota|DDF
31606537|student_A|ROT|chemical|impact|Lactobacteriaceae|bacteria
31606537|student_A|HFD|drug|impact|Lactobacteriaceae|bacteria
31606537|student_A|HFD-reduced|drug|impact|gut microbiota|microbiome
31606537|student_A|HFD|drug|impact|gut microbiome|microbiome
31606537|student_A|HFD|drug|change effect|DA neuron loss|DDF
31606537|student_A|neurodegenerative diseases|DDF|target|Rats|animal
31606537|student_A|cinnabar|chemical|influence|neurological disorders|DDF
31606537|student_A|realgar|chemical|influence|loss of DA neurons|DDF
31606537|student_A|Enterobacteeriaceae|bacteria|part of|gut microbiome|microbiome
31606537|student_A|HFD|drug|change effect|neurological disorders|DDF
31606537|student_A|Hua-Feng-Dan|drug|change effect|loss of DA neurons|DDF
31606537|student_A|realgar|chemical|impact|gut microbiome|microbiome
31606537|student_A|realgar|chemical|influence|LPS plus rotenone-induced neurotoxicity|DDF
31606537|student_A|HgS|chemical|influence|LPS plus rotenone-induced neurotoxicity|DDF
31606537|student_A|HFD-original|drug|change effect|neurodegenerative diseases|DDF
31606537|student_A|As<sub>4</sub>S<sub>4</sub>|chemical|impact|gut microbiota|microbiome
31606537|student_A|HFD|drug|impact|Verrucomicrobiaceae|bacteria
31606537|student_A|Cinnabar|chemical|influence|LPS plus rotenone-induced neurotoxicity|DDF
31606537|student_A|LPS|chemical|impact|Lactobacteriaceae|bacteria
31606537|student_A|HgS|chemical|influence|disturbance of gut microbiota|DDF
31606537|student_A|neurodegenerative diseases|DDF|target|rat|animal
31606537|student_A|Hua-Feng-Dan|drug|change effect|behavioral dysfunction|DDF
31606537|student_A|Lipopolysaccharide|chemical|impact|Enterobacteeriaceae|bacteria
31606537|student_A|HFD-original|drug|change effect|LPS plus ROT induced neurotoxicity|DDF
31606537|student_A|disturbance of gut microbiota|DDF|target|rats|animal
31606537|student_A|Hua-Feng-Dan|drug|impact|Enterobacteeriaceae|bacteria
31606537|student_A|HFD-original|drug|change effect|neurological disorders|DDF
31606537|student_A|HFD-reduced|drug|change effect|loss of DA neurons|DDF
31606537|student_A|Lactobacteriaceae|bacteria|part of|gut microbiome|microbiome
31606537|student_A|Cinnabar|chemical|influence|neurodegenerative diseases|DDF
31606537|student_A|LPS plus rotenone-induced neurotoxicity|DDF|target|rats|animal
31606537|student_A|DA neuron loss|DDF|target|Rats|animal
31606537|student_A|rotenone|chemical|impact|Enterobacteeriaceae|bacteria
31606537|student_A|Hua-Feng-Dan|drug|change effect|neurological disorders|DDF
31606537|student_A|HgS|chemical|influence|DA neuron loss|DDF
31606537|student_A|cinnabar|chemical|influence|neurodegenerative diseases|DDF
31606537|student_A|realgar|chemical|influence|DA neuron loss|DDF
31606537|student_A|HFD|drug|change effect|neurodegenerative diseases|DDF
31606537|student_A|Cinnabar|chemical|influence|DA neuron loss|DDF
38892525|student_B|volatile organic compounds|chemical|produced by|gut microbiota|microbiome
38892525|student_B|low FODMAP diet|food|influence|IBS|DDF
38892525|student_B|gut microbiota|microbiome|is linked to|IBS symptom|DDF
38892525|student_B|MED-LFD|food|influence|IBS symptom|DDF
38892525|student_B|branched and short-chain fatty acids|chemical|produced by|gut microbiota|microbiome
38892525|student_B|Mediterranean Low Fodmap Diet|food|impact|Gut Microbiota|microbiome
38892525|student_B|Mediterranean Low Fodmap Diet|food|influence|Irritable Bowel Syndrome Symptoms|DDF
38892525|student_B|low FODMAP diet|food|influence|Irritable bowel syndrome|DDF
38892525|student_B|Mediterranean diet|food|influence|IBS symptoms|DDF
38892525|student_B|Mediterranean diet|food|influence|chronic low-grade inflammation-related diseases|DDF
38892525|student_B|Mediterranean diet|food|impact|gut microbiota|microbiome
35631301|student_B|bone|anatomical location|located in|humans|human
35631301|student_B|cognitive decline|DDF|target|humans|human
35631301|student_B|phenolic compounds|chemical|influence|chronic human diseases|DDF
35631301|student_B|vegetables|dietary supplement|influence|chronic human diseases|DDF
35631301|student_B|Anthocyanins|chemical|impact|gut microbiota|microbiome
35631301|student_B|gastrointestinal tract|anatomical location|located in|humans|human
35631301|student_B|Dark-coloured fruits|dietary supplement|influence|chronic human diseases|DDF
35631301|student_B|Anthocyanins|chemical|influence|inflammation|DDF
35631301|student_B|liver|anatomical location|located in|humans|human
35631301|student_B|lipid|chemical|located in|liver|anatomical location
35631301|student_B|therapeutic potential|drug|change effect|chronic human diseases|DDF
35631301|student_B|Anthocyanins|chemical|influence|oxidative stress|DDF
35631301|student_B|cereals|dietary supplement|influence|chronic human diseases|DDF
35631301|student_B|anthocyanins|chemical|influence|chronic human diseases|DDF
35631301|student_B|Anthocyanins|chemical|influence|Chronic Diseases|DDF
35631301|student_B|obesity|DDF|target|humans|human
35631301|student_B|kidneys|anatomical location|located in|humans|human
35631301|student_B|lipid|chemical|produced by|gut microbiota|microbiome
35631301|student_B|lipid|chemical|located in|gastrointestinal tract|anatomical location
35631301|student_B|gut microbiota|microbiome|located in|humans|human
35631301|student_B|chronic human diseases|DDF|target|humans|human
35631301|student_B|organs|anatomical location|located in|humans|human
35631301|student_B|glucose|chemical|produced by|gut microbiota|microbiome
35631301|student_B|glucose|chemical|located in|liver|anatomical location
38972900|student_A|gut microbiota dysbiosis|DDF|affect|anxiety-like behaviour|DDF
38972900|student_A|gut microbiota dysbiosis|DDF|affect|anxiety-like disorder|DDF
38972900|student_A|anxiety-like behaviour|DDF|target|mice|animal
38972900|student_A|anxiety-like disorder|DDF|target|mice|animal
38972900|student_A|anxiety disorders|DDF|target|mice|animal
38972900|student_A|anxiety-like disorder|DDF|target|male mice|animal
38972900|student_A|anxiety disorders|DDF|target|male mice|animal
38972900|student_A|anxiety-like behaviour|DDF|target|male mice|animal
31837645|student_A|Western diet|food|influence|low-grade systemic inflammatory and oxidative changes|DDF
31837645|student_A|vegetables|food|influence|chronic metabolic diseases|DDF
31837645|student_A|Western diet|food|influence|neurodegenerative diseases|DDF
31837645|student_A|Western diet|food|impact|gut microbiota|microbiome
31837645|student_A|ultra-processed foods|food|influence|chronic metabolic diseases|DDF
31837645|student_A|fiber|dietary supplement|influence|chronic metabolic diseases|DDF
31837645|student_A|ultra-processed diet|food|impact|gut microbiota|microbiome
31837645|student_A|ultra-processed foods|food|influence|cognitive decline|DDF
31837645|student_A|vegetables|food|impact|gut microbiota|microbiome
31837645|student_A|fiber|dietary supplement|impact|gut microbiota|microbiome
31837645|student_A|Western diet|food|influence|NDs|DDF
31837645|student_A|ultra-processed foods|food|influence|dysregulation of the microbiota|DDF
31837645|student_A|dysregulation of the microbiota|DDF|affect|cognitive decline|DDF
31837645|student_A|gut microbiota|microbiome|is linked to|neurodegenerative diseases|DDF
31837645|student_A|ultra-processed foods|food|influence|low-grade systemic inflammatory and oxidative changes|DDF
31837645|student_A|gut microbiota|microbiome|located in|gut|anatomical location
31837645|student_A|Western diet|food|influence|cognitive decline|DDF
31837645|student_A|ultra-processed diet|food|influence|neurodegenerative diseases|DDF
31837645|student_A|ultra-processed foods|food|impact|gut microbiota|microbiome
31837645|student_A|gut microbiota|microbiome|is linked to|chronic metabolic diseases|DDF
31837645|student_A|ultra-processed foods|food|influence|neurodegenerative diseases|DDF
31837645|student_A|ultra-processed foods|food|influence|NDs|DDF
31837645|student_A|Western diet|food|influence|dysregulation of the microbiota|DDF
36183483|student_A|fecal microbiota|microbiome|located in|presenior population|human
36183483|student_A|gut microbiota|microbiome|located in|older population|human
36183483|student_A|Peptostreptococcaceae|bacteria|part of|gut microbiota|microbiome
36183483|student_A|bacteria|bacteria|part of|gut microbiota|microbiome
36183483|student_A|gut microbiota|microbiome|used by|16S RNA gene sequencing|biomedical technique
36183483|student_A|gut microbiota|microbiome|located in|presenior population|human
36183483|student_A|bacterial taxa|bacteria|part of|gut microbiota|microbiome
36183483|student_A|Actinobacteria|bacteria|part of|gut microbiota|microbiome
35243260|student_A|mucin|chemical|located in|mice|animal
35243260|student_A|gut microbiota|microbiome|is linked to|neurodegenerative disorders|DDF
39195546|student_A|Vagal Tone|DDF|target|Adults|human
39195546|student_A|sugar regions|chemical|produced by|gut microbiota|microbiome
39195546|student_A|glutamine|chemical|produced by|gut microbiota|microbiome
39195546|student_A|brain|anatomical location|located in|participants|human
39195546|student_A|acetone|chemical|produced by|gut microbiota|microbiome
39195546|student_A|acetoacetate|chemical|located in|symptomatic and LVT groups|human
39195546|student_A|high vagal tone|DDF|interact|propionate|chemical
39195546|student_A|Depression Symptoms|DDF|target|Adults|human
39195546|student_A|propionate|chemical|produced by|gut microbiota|microbiome
39195546|student_A|valerate|chemical|produced by|gut microbiota|microbiome
39195546|student_A|acetate|chemical|produced by|gut microbiota|microbiome
39195546|student_A|Anxiety|DDF|target|Adults|human
39195546|student_A|high vagal tone|DDF|interact|valerate|chemical
39195546|student_A|Firmicutes phylum|bacteria|located in|groups|human
39195546|student_A|high vagal tone|DDF|interact|glutamate|chemical
39195546|student_A|vagus nerve|anatomical location|located in|participants|human
39195546|student_A|gut microbiota|microbiome|located in|young, healthy adults|human
39195546|student_A|acetoacetate|chemical|produced by|gut microbiota|microbiome
39195546|student_A|Gut Microbiota|microbiome|located in|Adults|human
39195546|student_A|high and low vagal tone|DDF|target|participants|human
39195546|student_A|valine|chemical|produced by|gut microbiota|microbiome
39195546|student_A|brain|anatomical location|located in|young, healthy adults|human
39195546|student_A|butyrate|chemical|produced by|gut microbiota|microbiome
39195546|student_A|gut microbiota|microbiome|located in|brain|anatomical location
39195546|student_A|Vagal Tone|DDF|change abundance|Gut Microbiota|microbiome
39195546|student_A|high vagal tone|DDF|interact|acetate|chemical
39195546|student_A|glutamate|chemical|produced by|gut microbiota|microbiome
39195546|student_A|high vagal tone|DDF|interact|butyrate|chemical
38944290|student_B|SND|DDF|change abundance|Fluviimonas_pallidilutea|bacteria
38944290|student_B|depression-like behaviors|DDF|target|knock-out mice|animal
38944290|student_B|SND|DDF|change abundance|Parvibacter_caecicola|bacteria
38944290|student_B|splenic nerve|anatomical location|located in|mice|animal
38944290|student_B|spleen-gut-brain|anatomical location|located in|knock-out mice|animal
38944290|student_B|depression-like behaviors|DDF|target|mice|animal
38944290|student_B|SND|DDF|change abundance|gut microbiota|microbiome
38944290|student_B|SND|DDF|change abundance|Maribacter_arcticus|bacteria
38944290|student_B|gut microbiota|microbiome|located in|mice|animal
38944290|student_B|gut microbiota|microbiome|change expression|Chrna7|gene
38944290|student_B|systemic inflammation|DDF|target|mice|animal
38944290|student_B|spleen nerve|anatomical location|located in|mice|animal
32926778|student_A|gut microbiota|microbiome|is linked to|gut microbiota dysbiosis|DDF
32926778|student_A|Parasutterella|bacteria|part of|microbiota|microbiome
32926778|student_A|Parkinson's Disease|DDF|target|Mouse|animal
32926778|student_A|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|chemical|interact|apoptotic protein Bim|chemical
32926778|student_A|Rikenellaceae|bacteria|part of|microbiota|microbiome
32926778|student_A|Coriobacteriaceae|bacteria|part of|microbiota|microbiome
32926778|student_A|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|chemical|interact|cleaved caspase-3|chemical
32926778|student_A|Parabacteroides|bacteria|part of|microbiota|microbiome
32926778|student_A|MPTP|chemical|interact|apoptotic protein Bim|chemical
32926778|student_A|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
32926778|student_A|Ruminococcus|bacteria|part of|microbiota|microbiome
32926778|student_A|Lachnospiraceae|bacteria|part of|microbiota|microbiome
32926778|student_A|MPTP|chemical|interact|cleaved caspase-3|chemical
32926778|student_A|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|chemical|interact|α-synuclein|chemical
32926778|student_A|microbiota|microbiome|located in|MPTP-treated mice|animal
32926778|student_A|Lactobacillaceae|bacteria|part of|microbiota|microbiome
32926778|student_A|Flavonifractor|bacteria|part of|microbiota|microbiome
32926778|student_A|MPTP|chemical|interact|α-synuclein|chemical
32926778|student_A|1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine|chemical|influence|Parkinson's Disease|DDF
32926778|student_A|gut microbiota|microbiome|is linked to|PD|DDF
39121264|student_A|psychobiotics|chemical|impact|microbiota|microbiome
36478577|student_B|Western diet|dietary supplement|influence|dysbiosis|DDF
36478577|student_B|foods|dietary supplement|impact|microbiota|microbiome
36478577|student_B|Western diet|dietary supplement|impact|microbiota|microbiome
36478577|student_B|meals|dietary supplement|impact|microbiota|microbiome
36478577|student_B|chocolate biscuit|dietary supplement|impact|microbiota|microbiome
36478577|student_B|festive cinematic diets|dietary supplement|impact|gut microbiota|microbiome
36478577|student_B|polyphenols|chemical|impact|microbiota|microbiome
36478577|student_B|Meals|dietary supplement|impact|microbiota|microbiome
36478577|student_B|dysbiosis|DDF|change abundance|microbiota|microbiome
36478577|student_B|festive foods|dietary supplement|impact|microbiota|microbiome
36478577|student_B|microbiota-enhancing|dietary supplement|impact|microbiota|microbiome
36478577|student_B|fibre|dietary supplement|impact|microbiota|microbiome
36478577|student_B|high sugar|dietary supplement|impact|microbiota|microbiome
36478577|student_B|fat|dietary supplement|impact|microbiota|microbiome
36478577|student_B|microbiota-detrimental food|dietary supplement|impact|microbiota|microbiome
36478577|student_B|beneficial proteins|dietary supplement|impact|microbiota|microbiome
34996385|student_A|Short-chain fatty acids|chemical|produced by|gut microbiota|microbiome
34996385|student_A|tizanidine|drug|interact|propionic acid|chemical
34996385|student_A|trihexyphenidyl|drug|interact|propionic acid|chemical
34996385|student_A|Parkinson's disease|DDF|is a|enteric nervous system dysfunction|DDF
34996385|student_A|healthy controls|human|used by|gas chromatography-mass spectrometer|biomedical technique
34996385|student_A|PD patients|human|used by|gas chromatography-mass spectrometer|biomedical technique
34996385|student_A|SCFAs|chemical|produced by|gut microbiota|microbiome
32871960|student_A|PD|DDF|target|colonic FMT group|human
32871960|student_A|Parkinson's disease|DDF|target|colonic FMT group|human
32871960|student_A|gut microbiota|microbiome|used by|FMT via nasal-jejunal tube|biomedical technique
32871960|student_A|gut microbiota|microbiome|located in|colonic FMT group|human
32871960|student_A|Parkinson's disease|DDF|target|patients|human
32871960|student_A|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
32871960|student_A|gut microbiota|microbiome|located in|patients|human
32871960|student_A|gut microbiota|microbiome|used by|FMT via colonoscopy|biomedical technique
32871960|student_A|gut microbiota|microbiome|used by|nasointestinal FMT|biomedical technique
32871960|student_A|PD|DDF|target|patients|human
32871960|student_A|Parkinson's disease|DDF|target|PD patients|human
32871960|student_A|Parkinson's disease|DDF|target|Colonic FMT group|human
32871960|student_A|Parkinson's disease|DDF|target|nasointestinal FMT group|human
32871960|student_A|gut microbiota|microbiome|is linked to|neurodegenerative diseases|DDF
32871960|student_A|gut microbiota|microbiome|located in|PD patients|human
32871960|student_A|PD|DDF|target|PD patients|human
32871960|student_A|gut microbiota|microbiome|located in|Colonic FMT group|human
32871960|student_A|gut microbiota|microbiome|located in|nasointestinal FMT group|human
32871960|student_A|PD|DDF|target|Colonic FMT group|human
32871960|student_A|PD|DDF|target|nasointestinal FMT group|human
32871960|student_A|gut microbiota|microbiome|is linked to|PD|DDF
39021622|student_A|baseline gut microbial profiles|microbiome|located in|patients|human
39021622|student_A|gut microbiome|microbiome|is linked to|antidepressant resistance|DDF
39021622|student_A|gut microbiome|microbiome|located in|healthy individuals|human
39021622|student_A|probiotics|dietary supplement|influence|treatment for depression|DDF
39021622|student_A|gut microbiota|microbiome|is linked to|depression|DDF
39021622|student_A|gut microbiome|microbiome|located in|blood-brain barrier|anatomical location
39021622|student_A|gut microbiota|microbiome|is linked to|treatment of depression|DDF
39021622|student_A|baseline gut microbiota|microbiome|located in|remission and non-remission groups|human
39021622|student_A|gut microbiota|microbiome|located in|patients|human
39021622|student_A|Baseline gut microbiota profiles|microbiome|located in|patients|human
39021622|student_A|depression|DDF|target|patients|human
34996879|student_A|propionate|chemical|located in|controls|human
34996879|student_A|SCFAs-producing gut bacteria|bacteria|interact|SCFAs|chemical
34996879|student_A|acetate|chemical|located in|controls|human
34996879|student_A|gut metabolite SCFAs|chemical|located in|controls|human
34996879|student_A|SCFAs|chemical|located in|healthy controls|human
34996879|student_A|fecal SCFAs|chemical|influence|PD|DDF
34996879|student_A|SCFAs-producing gut bacteria|bacteria|located in|healthy controls|human
34996879|student_A|SCFA subtypes|chemical|influence|PD|DDF
34996879|student_A|propionate|chemical|located in|patients|human
34996879|student_A|Short-chain fatty acids|chemical|influence|PD|DDF
34996879|student_A|Ruminococcus sp AM07-15|bacteria|located in|PD patient group|human
34996879|student_A|gut metabolite SCFAs|chemical|located in|patients|human
34996879|student_A|Short-Chain Fatty Acids|chemical|impact|Gut Microbiota|microbiome
34996879|student_A|SCFAs|chemical|influence|PD|DDF
34996879|student_A|acetate|chemical|located in|patients|human
34996879|student_A|Short-chain fatty acids|chemical|influence|Parkinson disease|DDF
34996879|student_A|butyrate|chemical|influence|PD|DDF
34996879|student_A|SCFAs|chemical|located in|PD patient group|human
34996879|student_A|plasma SCFAs|chemical|influence|PD|DDF
34996879|student_A|SCFAs|chemical|influence|Parkinson disease|DDF
34996879|student_A|Parkinson Disease|DDF|change abundance|Gut Microbiota|microbiome
34996879|student_A|butyrate|chemical|located in|controls|human
34996879|student_A|gut metabolite SCFAs|chemical|influence|PD|DDF
34996879|student_A|PD|DDF|target|patients|human
34996879|student_A|Gut microbiota|microbiome|used by|metagenomic shotgun sequencing|biomedical technique
34996879|student_A|butyrate|chemical|located in|patients|human
34996879|student_A|gut microbial metabolites|chemical|influence|PD|DDF
34996879|student_A|gut microbial metabolites|chemical|influence|Parkinson disease|DDF
34996879|student_A|proinflammatory microbes|bacteria|located in|PD patient group|human
34996879|student_A|propionic acid|chemical|located in|PD patient group|human
34996879|student_A|propionate|chemical|influence|PD|DDF
34996879|student_A|Parkinson Disease|DDF|target|Patients|human
34996879|student_A|Parkinson disease|DDF|target|patients|human
34996879|student_A|acetate|chemical|influence|PD|DDF
34996879|student_A|Clostridiales bacterium NK3B98|bacteria|located in|PD patient group|human
35600753|student_B|GMB|microbiome|is linked to|SCZ|DDF
35600753|student_B|SCZ|DDF|target|SCZ patients|human
35600753|student_B|GMB composition changes|microbiome|is linked to|metabolic perturbations|DDF
35600753|student_B|metabolic comorbidities|DDF|target|Patients|human
35600753|student_B|gut microbiota|microbiome|is linked to|SCZ|DDF
35600753|student_B|GMB|microbiome|located in|SCZ patients|human
35600753|student_B|gut microbiota|microbiome|is linked to|mental illnesses|DDF
35600753|student_B|GMB|microbiome|is linked to|depression|DDF
35600753|student_B|APs|drug|impact|GMB|microbiome
35600753|student_B|prebiotic/probiotic formulations|dietary supplement|influence|SCZ symptoms|DDF
35600753|student_B|SCZ|DDF|target|Patients|human
35600753|student_B|GMB|microbiome|located in|mice|animal
35600753|student_B|SCZ|DDF|target|mice|animal
35600753|student_B|APs|drug|change effect|metabolic adverse effects|DDF
35600753|student_B|antipsychotic-induced|drug|change effect|metabolic alterations|DDF
35600753|student_B|AP-induced|drug|change effect|metabolic alterations|DDF
35600753|student_B|diabetes mellitus|DDF|target|Patients|human
35600753|student_B|gut microbiota|microbiome|is linked to|depression|DDF
35600753|student_B|obesity|DDF|target|Patients|human
35600753|student_B|probiotic formulations|dietary supplement|influence|SCZ|DDF
35600753|student_B|AP-induced|drug|change effect|metabolic perturbations|DDF
35600753|student_B|mental disorder|DDF|target|Patients|human
35600753|student_B|therapeutic benefits|drug|change effect|SCZ|DDF
35600753|student_B|Gut microbiome|microbiome|is linked to|schizophrenia|DDF
35600753|student_B|Antipsychotics|drug|change effect|SCZ|DDF
35600753|student_B|APs|drug|change effect|SCZ|DDF
35600753|student_B|APs|drug|change effect|metabolic alterations|DDF
35600753|student_B|prebiotic/probiotic formulations|dietary supplement|influence|metabolic alterations|DDF
35600753|student_B|Antipsychotics|drug|change effect|metabolic perturbations|DDF
35600753|student_B|GMB|microbiome|is linked to|SCZ symptomatology|DDF
35600753|student_B|GMB composition changes|microbiome|is linked to|SCZ|DDF
35600753|student_B|Schizophrenia|DDF|target|Patients|human
35600753|student_B|GMB|microbiome|is linked to|bipolar disorder|DDF
35600753|student_B|GMB|microbiome|is linked to|metabolic adverse effects|DDF
35600753|student_B|GMB|microbiome|is linked to|mental illnesses|DDF
35600753|student_B|APs|drug|change effect|metabolic perturbations|DDF
35600753|student_B|prebiotic|dietary supplement|influence|SCZ|DDF
35600753|student_B|gut microbiota|microbiome|is linked to|bipolar disorder|DDF
35600753|student_B|GMB|microbiome|is linked to|metabolic alterations|DDF
35127723|student_A|MPTP|drug|change effect|neuroinflammation|DDF
35127723|student_A|MPTP|drug|change effect|locomotor deficits|DDF
35127723|student_A|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|drug|change effect|neuroinflammation|DDF
35127723|student_A|PD|DDF|affect|loss of neurons|DDF
35127723|student_A|progressive neurological disorder|DDF|affect|impaired movement|DDF
35127723|student_A|loss of neurons|DDF|affect|impaired movement|DDF
35127723|student_A|dopamine|chemical|located in|striatum|anatomical location
35127723|student_A|5-hydroxytryptamine|chemical|located in|colon|anatomical location
35127723|student_A|PD|DDF|affect|impaired movement|DDF
35127723|student_A|progressive neurological disorder|DDF|affect|loss of neurons|DDF
35127723|student_A|Parkinson's disease|DDF|affect|impaired movement|DDF
35127723|student_A|Parkinson's disease|DDF|affect|loss of neurons|DDF
35127723|student_A|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|drug|change effect|locomotor deficits|DDF
36088985|student_A|LPS|chemical|influence|depression|DDF
36088985|student_A|antagomiR-149|chemical|influence|LPS-induced depression-like behavior|DDF
36088985|student_A|new antidepressant (R)-ketamine|drug|change effect|depression|DDF
36088985|student_A|PFC|anatomical location|located in|male mice|animal
36088985|student_A|prefrontal cortex|anatomical location|located in|male mice|animal
36088985|student_A|PFC|anatomical location|located in|LPS-treated mice|animal
36088985|student_A|(R)-ketamine|drug|impact|gut microbiota|microbiome
36088985|student_A|gut microbiota|microbiome|located in|LPS-treated mice|animal
36088985|student_A|miR-149|chemical|influence|LPS-induced depression-like behavior|DDF
36088985|student_A|depression|DDF|target|male mice|animal
36078738|student_A|vaccine|drug|change effect|psychiatric problems|DDF
36078738|student_A|Psychobiotics|dietary supplement|influence|COVID-19 Pandemic|DDF
36078738|student_A|probiotics|dietary supplement|impact|Bifidobacterium|bacteria
36078738|student_A|probiotics|dietary supplement|impact|commensal gut microbiota|microbiome
36078738|student_A|Psychobiotics|dietary supplement|impact|Lactobacillus|bacteria
36078738|student_A|gut microbiota|microbiome|located in|gastrointestinal tract|anatomical location
36078738|student_A|psychobiotic|dietary supplement|influence|COVID-19|DDF
36078738|student_A|gut microbiota|microbiome|located in|brain|anatomical location
36078738|student_A|probiotics|dietary supplement|impact|Lactobacillus|bacteria
36078738|student_A|Psychobiotics|dietary supplement|impact|commensal gut microbiota|microbiome
38748594|student_A|gut dysbiosis|DDF|target|C-section infants|human
38748594|student_A|maternal-infant microbiota|microbiome|located in|C-section infants|human
38748594|student_A|maternal-infant microbiota|microbiome|is linked to|gut dysbiosis|DDF
35654260|student_B|neurodegenerative disorders|DDF|target|patients|human
35654260|student_B|depression|DDF|target|patients|human
35654260|student_B|gut microbiota|microbiome|located in|patients|human
35654260|student_B|psychiatric symptom|DDF|target|patients|human
35654260|student_B|cardiovascular diseases|DDF|target|patients|human
35654260|student_B|microbes-derived compounds|chemical|influence|neurodegenerative disorders|DDF
35654260|student_B|gut microbiota|microbiome|is linked to|neurodegenerative disorders|DDF
35654260|student_B|physical disorders|DDF|target|patients|human
35654260|student_B|pain|DDF|target|patients|human
35654260|student_B|brain|anatomical location|located in|patients|human
35654260|student_B|psychiatric|DDF|target|patients|human
35654260|student_B|peripheral organs|anatomical location|located in|patients|human
35654260|student_B|gut microbiota|microbiome|is linked to|psychiatric disorders|DDF
35654260|student_B|microbes-derived compounds|chemical|influence|psychiatric disorders|DDF
35654260|student_B|brain diseases|DDF|target|patients|human
35654260|student_B|dysbiosis|DDF|change abundance|gut microbiota|microbiome
35432038|student_A|oral microbiome|microbiome|is linked to|NPDs|DDF
35432038|student_A|NPDs|DDF|change abundance|gut microbiota|microbiome
35432038|student_A|oral microbiota|microbiome|is linked to|neuroinflammation|DDF
35432038|student_A|oral microbiota|microbiome|located in|brain|anatomical location
35432038|student_A|gut microbiota|microbiome|located in|brain|anatomical location
38847603|student_B|prebiotics|dietary supplement|influence|intestinal barrier integrity|DDF
38847603|student_B|dietary fiber pectins|dietary supplement|influence|intestinal barrier integrity|DDF
38847603|student_B|prebiotics|dietary supplement|influence|immune function|DDF
38847603|student_B|dietary fiber pectins|dietary supplement|influence|immune function|DDF
38847603|student_B|dietary fiber intake|dietary supplement|influence|diseases|DDF
38847603|student_B|prebiotics|dietary supplement|influence|gut health|DDF
38847603|student_B|prebiotics|dietary supplement|impact|microbiota|microbiome
38847603|student_B|gut microbiota|microbiome|located in|adults|human
38847603|student_B|dietary fiber intake|dietary supplement|influence|weight management|DDF
38847603|student_B|gut microbiota|microbiome|located in|infants|human
38847603|student_B|Dietary fiber pectins|dietary supplement|influence|gut health|DDF
38847603|student_B|dietary fiber pectins|dietary supplement|influence|gut health|DDF
38847603|student_B|dietary fiber pectins|dietary supplement|impact|gut microbiota|microbiome
38847603|student_B|prebiotics|dietary supplement|impact|gut microbiota|microbiome
38847603|student_B|prebiotics|dietary supplement|influence|metabolic health|DDF
38847603|student_B|prebiotics|dietary supplement|influence|weight management|DDF
38847603|student_B|dietary fiber pectins|dietary supplement|influence|metabolic health|DDF
38847603|student_B|Dietary fiber pectins|dietary supplement|impact|gut microbiota|microbiome
38847603|student_B|dietary fiber intake|dietary supplement|influence|digestive health|DDF
38847603|student_B|prebiotics|dietary supplement|influence|diseases|DDF
38847603|student_B|gut microbiota|microbiome|is linked to|mental health|DDF
38847603|student_B|dietary fiber intake|dietary supplement|influence|mental health|DDF
38847603|student_B|prebiotics|dietary supplement|influence|intestinal inflammatory diseases|DDF
38847603|student_B|prebiotics|dietary supplement|influence|digestive health|DDF
38847603|student_B|Dietary fiber pectins|dietary supplement|influence|intestinal inflammatory diseases|DDF
38847603|student_B|dietary fiber pectins|dietary supplement|influence|mental health|DDF
38847603|student_B|prebiotics|dietary supplement|influence|mental health|DDF
38847603|student_B|gut microbiota|microbiome|is linked to|immune function|DDF
38847603|student_B|dietary fiber intake|dietary supplement|influence|immune function|DDF
38847603|student_B|pectin|chemical|impact|microbiota|microbiome
38847603|student_B|dietary fiber pectins|dietary supplement|influence|digestive health|DDF
35317694|student_B|fermented foods|dietary supplement|influence|Parkinson's disease|DDF
35317694|student_B|fermented foods|dietary supplement|influence|cardiovascular|DDF
35317694|student_B|fermented foods|dietary supplement|influence|obesity|DDF
35317694|student_B|fermented foods|dietary supplement|influence|chronic diseases|DDF
35317694|student_B|Fermented foods|dietary supplement|impact|Lactobacilli|bacteria
35317694|student_B|fermented foods|dietary supplement|influence|Alzheimer's disease|DDF
35317694|student_B|fermented foods|dietary supplement|influence|stroke|DDF
35317694|student_B|fermented foods|dietary supplement|influence|multiple sclerosis disease|DDF
35317694|student_B|fermented foods|dietary supplement|impact|gut microbiota|microbiome
35317694|student_B|fermented foods|dietary supplement|influence|gastrointestinal diseases|DDF
35317694|student_B|fermented foods|dietary supplement|impact|microbiota|microbiome
35317694|student_B|fermented foods|dietary supplement|influence|diabetes|DDF
35317694|student_B|microbiota|microbiome|is linked to|neurological diseases|DDF
35317694|student_B|Fermented foods|dietary supplement|impact|Lactic acid bacteria|bacteria
35317694|student_B|Fermented foods|dietary supplement|impact|Bifidobacteria|bacteria
35317694|student_B|fermented foods|dietary supplement|influence|neurological diseases|DDF
36001607|student_A|dysbiosis|DDF|affect|cancer|DDF
36001607|student_A|desaminotyrosine|chemical|impact|gut microbiota|microbiome
36001607|student_A|dysbiosis|DDF|affect|neurodegenerative disease|DDF
36001607|student_A|gut microbiota|microbiome|used by|Metabologenomic approach|biomedical technique
36001607|student_A|dysbiosis|DDF|affect|gut inflammation|DDF
36001607|student_A|dihydro-3-coumaric acid|chemical|impact|gut microbiota|microbiome
35981631|student_A|gut microbiota|microbiome|used by|metabolomics analysis|biomedical technique
35981631|student_A|mice|animal|used by|antibiotic-induced microbiome depletion|biomedical technique
35981631|student_A|ABX|drug|impact|gut microbiota|microbiome
35981631|student_A|Enterococusfaecalis|bacteria|part of|gut microbiota|microbiome
35981631|student_A|gut microbiota|microbiome|located in|water + LPS group|animal
35981631|student_A|short-chain fatty acids|chemical|produced by|gut microbiota|microbiome
35981631|student_A|gut microbiota|microbiome|located in|ABX + LPS group|animal
35981631|student_A|LPS|chemical|influence|ALI|DDF
35981631|student_A|Clostriumtertium|bacteria|part of|gut microbiota|microbiome
35981631|student_A|IL-6|chemical|impact|gut microbiota|microbiome
35981631|student_A|ABX|drug|change effect|ALI|DDF
35981631|student_A|antibiotic cocktail|drug|change effect|ALI|DDF
35981631|student_A|gut microbiota|microbiome|used by|16s rRNA analysis|biomedical technique
35981631|student_A|ALI|DDF|target|mice|animal
35981631|student_A|Bacteroidescaecimyris|bacteria|part of|gut microbiota|microbiome
35981631|student_A|plasma metabolites|chemical|produced by|gut microbiota|microbiome
35981631|student_A|LPS|chemical|impact|gut microbiota|microbiome
35981631|student_A|gut microbiota|microbiome|used by|Untargeted metabolomics analysis|biomedical technique
35981631|student_A|interleukin-6|chemical|impact|gut microbiota|microbiome
36158270|student_A|Roseburia_inulinivorans|bacteria|part of|GM|microbiome
36158270|student_A|gut microbiota|microbiome|located in|subjects|human
36158270|student_A|GM dysbiosis|DDF|change abundance|GM|microbiome
36158270|student_A|Prevotellaceae|bacteria|part of|GM|microbiome
36158270|student_A|Proteobacteria|bacteria|part of|GM|microbiome
36158270|student_A|Firmicutes|bacteria|part of|GM|microbiome
36158270|student_A|Roseburia|bacteria|part of|GM|microbiome
36158270|student_A|dyslipidemia|DDF|target|Chinese population|human
36158270|student_A|GM|microbiome|located in|Chinese population|human
36158270|student_A|Bacteroidetes|bacteria|part of|GM|microbiome
36158270|student_A|GM|microbiome|located in|females|human
36158270|student_A|Lactobacillus_salivarius|bacteria|part of|GM|microbiome
36158270|student_A|GM|microbiome|is linked to|dyslipidemia|DDF
36158270|student_A|Lactobacillus|bacteria|part of|GM|microbiome
36158270|student_A|Lactobacillaceae|bacteria|part of|GM|microbiome
36158270|student_A|Coriobacteriales|bacteria|part of|GM|microbiome
36158270|student_A|GM|microbiome|used by|sequencing analyses|biomedical technique
36158270|student_A|gut microbiota|microbiome|is linked to|dyslipidemia|DDF
36158270|student_A|GM|microbiome|located in|males|human
36158270|student_A|unidentified_Ruminococcaceae|bacteria|part of|GM|microbiome
36158270|student_A|dyslipidemia|DDF|target|subjects|human
36158270|student_A|GM|microbiome|used by|16S rRNA gene sequencing|biomedical technique
36158270|student_A|Coriobacteriia|bacteria|part of|GM|microbiome
36619768|student_A|neurological symptoms|DDF|target|COVID-19 recovered patients|human
36619768|student_A|viral infections|DDF|change abundance|gut microbiota|microbiome
36619768|student_A|COVID-19|DDF|target|patients|human
36619768|student_A|gut dysbiosis|DDF|affect|Guillain-Barre syndrome|DDF
36619768|student_A|repurposed medications|drug|change effect|gut dysbiosis|DDF
36619768|student_A|long-term neurological symptoms|DDF|target|patients|human
36619768|student_A|gut dysbiosis|DDF|affect|long-term neurological disorders|DDF
36619768|student_A|impaired gut microbiota|microbiome|is linked to|neurological disorders|DDF
36619768|student_A|SARS-CoV-2|DDF|change abundance|gut microbiota|microbiome
36619768|student_A|intestinal microbiota disorders|DDF|target|patients|human
35135531|student_B|SZ patients|human|used by|Fecal metabolome analysis|biomedical technique
35135531|student_B|protein fermentation|chemical|impact|intestinal microbiome|microbiome
35135531|student_B|carbohydrate fermentation|chemical|impact|intestinal microbiome|microbiome
35135531|student_B|nutrition|dietary supplement|influence|SZ|DDF
35135531|student_B|protein fermentation|chemical|influence|schizophrenia|DDF
35135531|student_B|gut|anatomical location|located in|SZ patients|human
35135531|student_B|nutrition|dietary supplement|influence|schizophrenia|DDF
35135531|student_B|SZ patients|human|used by|metagenome analysis|biomedical technique
35135531|student_B|intestinal microbiome|microbiome|located in|SZ patients|human
35135531|student_B|dysbiosis|DDF|change abundance|intestinal microbiome|microbiome
35135531|student_B|microbiota-targeted therapeutics|drug|change effect|SZ|DDF
35135531|student_B|dysbiosis|DDF|target|SZ patients|human
35135531|student_B|nutrition care|dietary supplement|influence|SZ|DDF
35135531|student_B|Protein synthesis|chemical|change expression|metagenome|gene
35135531|student_B|aberrant macronutrient|dietary supplement|impact|gut microbes|microbiome
35135531|student_B|nutrition|dietary supplement|influence|mental illness|DDF
35135531|student_B|SZ patients|human|used by|sequencing|biomedical technique
35135531|student_B|Protein synthesis|chemical|change expression|aminoacyl-tRNA transferases|gene
35135531|student_B|psychiatric symptoms|DDF|target|SZ patients|human
35135531|student_B|protein synthesis|chemical|impact|intestinal microbiome|microbiome
35135531|student_B|SZ patients|human|used by|metagenome analysis|biomedical technique
35135531|student_B|gut microbes|microbiome|is linked to|SZ|DDF
35135531|student_B|SZ patients|human|used by|measurement|biomedical technique
35135531|student_B|dysbiosis|DDF|change abundance|intestinal microbiota|microbiome
36959989|student_A|Bifidobacterium longum|bacteria|influence|children's neurodevelopmental disorders|DDF
36959989|student_A|L. Planetarium 128|bacteria|influence|children's neurodevelopmental disorders|DDF
36959989|student_A|Non-communicable diseases|DDF|target|age-groups|human
36959989|student_A|mental health issues|DDF|affect|Non-communicable diseases|DDF
36959989|student_A|therapeutic agents|drug|change effect|infectious diseases|DDF
36959989|student_A|gut microbiota|microbiome|is linked to|neurodevelopmental disorders|DDF
36959989|student_A|therapeutic agents|drug|change effect|hemato-oncological conditions|DDF
36959989|student_A|Paracasei 37|bacteria|influence|ADHD|DDF
36959989|student_A|gut microbiota|microbiome|is linked to|autism spectrum disorders|DDF
36959989|student_A|L. reuteri DSM 17938|bacteria|influence|ADHD|DDF
36959989|student_A|L. reuteri DSM 17938|bacteria|influence|ASD|DDF
36959989|student_A|gut microbiota|microbiome|is linked to|neurodegenerative diseases|DDF
36959989|student_A|Bifidobacterium longum|bacteria|influence|ADHD|DDF
36959989|student_A|gut microbiota|microbiome|is linked to|ADHD|DDF
36959989|student_A|L. Planetarium 128|bacteria|influence|ADHD|DDF
36959989|student_A|human gut microbiome|microbiome|located in|human brain|anatomical location
36959989|student_A|Paracasei 37|bacteria|influence|ASD|DDF
36959989|student_A|NCDs|DDF|target|age-groups|human
36959989|student_A|L. reuteri DSM 17938|bacteria|influence|children's neurodevelopmental disorders|DDF
36959989|student_A|gut microbiota|microbiome|is linked to|attention-deficit hyperactivity disorder|DDF
36959989|student_A|Paracasei 37|bacteria|influence|children's neurodevelopmental disorders|DDF
36959989|student_A|gut microbiota|microbiome|is linked to|ASD|DDF
36959989|student_A|Bifidobacterium longum|bacteria|influence|ASD|DDF
36959989|student_A|L. Planetarium 128|bacteria|influence|ASD|DDF
36959989|student_A|therapeutic agents|drug|change effect|neurodevelopmental and neurodegenerative disorders|DDF
36959989|student_A|Probiotics|dietary supplement|influence|Pediatric Neurodevelopmental Disorders|DDF
33362788|student_A|stress|DDF|interact|pro-inflammatory cytokines|chemical
33362788|student_A|intestinal microbial metabolites|chemical|influence|neuropsychiatric disorders|DDF
33362788|student_A|intestinal microbial metabolites|chemical|influence|multiple sclerosis|DDF
33362788|student_A|stress|DDF|interact|interleukin-18|chemical
33362788|student_A|stress|DDF|interact|interleukin-1β|chemical
33362788|student_A|intestinal microbial metabolites|chemical|influence|Alzheimer's and Parkinson's diseases|DDF
34938619|student_A|gut dysbiosis|DDF|affect|neuropsychiatric manifestations|DDF
34938619|student_A|Gut dysbiosis|DDF|affect|inflammatory bowel disease|DDF
35272713|student_B|antibiotics|drug|impact|microbiome|microbiome
35272713|student_B|gut microbiota|microbiome|is linked to|Alzheimer's disease|DDF
35272713|student_B|microbiota|microbiome|located in|SOD1 mice|animal
35272713|student_B|antibiotics|drug|change effect|multiple sclerosis|DDF
35272713|student_B|gut microbiota|microbiome|is linked to|amyotrophic lateral sclerosis|DDF
35272713|student_B|antibiotics|drug|change expression|homeostatic genes|gene
35272713|student_B|Akkermansia|bacteria|part of|microbiome|microbiome
35272713|student_B|butyrate-producing bacteria|bacteria|part of|microbiome|microbiome
35272713|student_B|antibiotics|drug|impact|butyrate-producing bacteria|bacteria
35272713|student_B|microbiota|microbiome|is linked to|neurodegenerative|DDF
35272713|student_B|neurologic disease|DDF|target|SOD1 mice|animal
35272713|student_B|amyotrophic lateral sclerosis|DDF|target|SOD1 mice|animal
35272713|student_B|antibiotics|drug|change expression|neurodegenerative disease genes|gene
35272713|student_B|antibiotics|drug|impact|Akkermansia|bacteria
35272713|student_B|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
35272713|student_B|antibiotics|drug|change effect|Alzheimer's disease|DDF
35272713|student_B|gut microbiota|microbiome|is linked to|neurologic disease|DDF
35272713|student_B|Parkinson's disease|DDF|target|SOD1 mice|animal
35272713|student_B|Alzheimer's disease|DDF|target|SOD1 mice|animal
35272713|student_B|neurodegenerative|DDF|target|SOD1 mice|animal
35272713|student_B|multiple sclerosis|DDF|target|SOD1 mice|animal
35272713|student_B|microbiota|microbiome|is linked to|amyotrophic lateral sclerosis|DDF
35272713|student_B|antibiotics|drug|change effect|amyotrophic lateral sclerosis|DDF
35272713|student_B|gut microbiota|microbiome|is linked to|multiple sclerosis|DDF
35272713|student_B|antibiotics|drug|change effect|Parkinson's disease|DDF
35889175|student_A|Bisphenol A|chemical|influence|neurological and overall mental health|DDF
35889175|student_A|Environmental Pollutants|chemical|impact|Gut Microbiome|microbiome
35889175|student_A|microbiome|microbiome|is linked to|brain health|DDF
35889175|student_A|environmental pollutants|chemical|influence|neurological and overall mental health|DDF
35889175|student_A|pollutants|chemical|impact|intestinal microbiota|microbiome
35889175|student_A|particulate matter|chemical|influence|neurological and overall mental health|DDF
35889175|student_A|pollutants|chemical|influence|psychiatric or neurological disorders|DDF
35889175|student_A|phthalates|chemical|influence|neurological and overall mental health|DDF
35889175|student_A|microbiome|microbiome|is linked to|gut dysbiosis|DDF
35889175|student_A|Environmental Pollutants|chemical|influence|Mental Health|DDF
35889175|student_A|heavy metals|chemical|influence|neurological and overall mental health|DDF
36551872|student_A|gut microbiota|microbiome|is linked to|Alzheimer's disease|DDF
36551872|student_A|gut microbiota|microbiome|is linked to|neurodegenerative conditions|DDF
36551872|student_A|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
36551872|student_A|pro-inflammatory cytokines|chemical|influence|chronic neuroinflammatory diseases|DDF
36551872|student_A|oxidative stress|DDF|affect|chronic neuroinflammatory diseases|DDF
36551872|student_A|Probiotic treatment|dietary supplement|impact|gut microbioma|microbiome
32103766|student_A|human microbiome|microbiome|located in|gut|anatomical location
32103766|student_A|oral and nasal microbiota|microbiome|is linked to|PD|DDF
32103766|student_A|human microbiome|microbiome|located in|controls|human
32103766|student_A|significantly altered bacterial taxa|bacteria|part of|gut microbiota|microbiome
32103766|student_A|human microbiome|microbiome|located in|mucosal interfaces|anatomical location
32103766|student_A|gut microbiota|microbiome|located in|PD patients|human
32103766|student_A|human microbiome|microbiome|located in|PD patients|human
32103766|student_A|gut microbiota|microbiome|located in|matched controls|human
32103766|student_A|gut microbiota|microbiome|is linked to|PD|DDF
32103766|student_A|Gut, oral and nasal microbiota|microbiome|is linked to|Parkinson's disease|DDF
32103766|student_A|human microbiome|microbiome|located in|nose|anatomical location
32103766|student_A|human microbiome|microbiome|located in|mouth|anatomical location
33617267|student_A|trehalose|chemical|influence|learning retrieval|DDF
33617267|student_A|lactulose|chemical|influence|neuroprotective effects|DDF
33617267|student_A|trehalose|chemical|influence|neuroprotective effects|DDF
33617267|student_A|lactulose|chemical|influence|AD|DDF
33617267|student_A|lactulose|chemical|influence|neuroprotective effect|DDF
33617267|student_A|Lactulose|chemical|impact|human gut microbiota|microbiome
33617267|student_A|lactulose|chemical|change expression|synaptic protein expression level|gene
33617267|student_A|trehalose|chemical|change expression|synaptic protein expression level|gene
33617267|student_A|lactulose|chemical|influence|short-term memory|DDF
33617267|student_A|prebiotic|dietary supplement|impact|human gut microbiota|microbiome
33617267|student_A|Lactulose|chemical|located in|mice|animal
33617267|student_A|mice|animal|used by|bilateral intrahippocampal CA1 injection|biomedical technique
33617267|student_A|trehalose|chemical|influence|neuroinflammation|DDF
33617267|student_A|trehalose|chemical|influence|short-term memory|DDF
33617267|student_A|trehalose analogs|chemical|influence|neuroprotective effect|DDF
33617267|student_A|melibiose|chemical|influence|neuroprotective effect|DDF
33617267|student_A|lactulose|chemical|influence|neuroinflammation|DDF
33617267|student_A|trehalose|chemical|located in|mice|animal
33617267|student_A|preventive and/or therapeutic disaccharide|dietary supplement|influence|AD|DDF
33617267|student_A|lactulose|chemical|influence|learning retrieval|DDF
36093196|student_B|ω-3 fatty acids|dietary supplement|influence|maternal depression and anxiety|DDF
36093196|student_B|iron|dietary supplement|influence|maternal depression and anxiety|DDF
36093196|student_B|Probiotics|dietary supplement|impact|gut microbiota|microbiome
36093196|student_B|nutrition|dietary supplement|influence|perinatal depression|DDF
36093196|student_B|probiotics|dietary supplement|influence|perinatal depression|DDF
36093196|student_B|nutritional and dietary interventions|dietary supplement|influence|maternal depression and anxiety|DDF
36093196|student_B|fiber|dietary supplement|influence|maternal depression and anxiety|DDF
36093196|student_B|vitamin D|dietary supplement|influence|maternal depression and anxiety|DDF
36093196|student_B|Perinatal depression|DDF|target|women during pregnancy (prenatal) and after childbirth (postnatal)|human
36093196|student_B|Probiotics|dietary supplement|influence|perinatal mood disorders|DDF
36093196|student_B|gut microbiota|microbiome|located in|women during pregnancy (prenatal) and after childbirth (postnatal)|human
36334596|student_B|gut microbiota|microbiome|located in|luminal side|anatomical location
39287570|student_A|microbiota|microbiome|located in|Participants|human
39287570|student_A|postpartum mental health disturbances|DDF|target|women|human
39287570|student_A|Stool microbiota|microbiome|used by|16S ribosomal RNA gene sequencing|biomedical technique
39287570|student_A|postpartum mental health issues|DDF|target|women|human
38582194|student_A|Inflammatory, neurodegenerative and psychiatric disorders|DDF|target|people|human
38582194|student_A|microbiota|microbiome|is linked to|reduced mental and physical health|DDF
38582194|student_A|microbiota|microbiome|is linked to|psychiatric disorders|DDF
36358286|student_A|Bifidobacterium|bacteria|part of|gut microbiota|microbiome
36358286|student_A|Adult Female Mice|animal|used by|Long-Term Moderate Static Magnetic Field Exposure|biomedical technique
36358286|student_A|C57BL/6J adult female mice|animal|used by|behavioral tests|biomedical technique
36358286|student_A|anxiety|DDF|target|adult female mice|animal
36358286|student_A|Ralstonia|bacteria|part of|gut microbiota|microbiome
36358286|student_A|C57BL/6J adult female mice|animal|used by|open field and elevated plus test|biomedical technique
36358286|student_A|Yaniella|bacteria|influence|anxiety|DDF
36358286|student_A|sham group|animal|used by|behavioral tests|biomedical technique
36358286|student_A|gut microbiota|microbiome|is linked to|anxiety|DDF
36358286|student_A|upward and downward 150 mT SMF groups|animal|used by|open field and elevated plus test|biomedical technique
36358286|student_A|upward and downward 150 mT SMF groups|animal|used by|behavioral tests|biomedical technique
36358286|student_A|gut microbiota|microbiome|located in|mice|animal
36358286|student_A|Yaniella|bacteria|part of|gut microbiota|microbiome
36358286|student_A|Clostridium|bacteria|part of|gut microbiota|microbiome
36358286|student_A|Bifidobacterium|bacteria|influence|anxiety|DDF
36358286|student_A|Clostridium|bacteria|influence|anxiety|DDF
36358286|student_A|sham group|animal|used by|open field and elevated plus test|biomedical technique
36358286|student_A|Ralstonia|bacteria|influence|anxiety|DDF
32226375|student_B|gut microbiota|microbiome|is linked to|PD|DDF
39375215|student_A|gut microbiota|microbiome|is linked to|depression|DDF
39375215|student_A|Gut microbiota|microbiome|is linked to|depression|DDF
37798034|student_A|human donors|human|used by|FMT|biomedical technique
37798034|student_A|Parkinson's disease|DDF|target|patients|human
37798034|student_A|patients|human|used by|donor-FMT pilot study|biomedical technique
37798034|student_A|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
37798034|student_A|levodopa|drug|change effect|idiopathic PD|DDF
35650236|student_B|gut microbiota|microbiome|used by|Hoehn & Yahr (HY) stages|biomedical technique
35650236|student_B|short-chain fatty acid|chemical|produced by|gut microbiota|microbiome
35650236|student_B|mucin-degrading genus Akkermansia|bacteria|influence|PD|DDF
35650236|student_B|Parkinson's disease|DDF|target|patients|human
35650236|student_B|Blautia|bacteria|influence|PD|DDF
35650236|student_B|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
35650236|student_B|Fusicatenibacter|bacteria|influence|PD|DDF
35650236|student_B|Faecalibacterium|bacteria|influence|PD|DDF
34911958|student_A|pramipexole|drug|change effect|gastrointestinal symptoms|DDF
34911958|student_A|entacapone|drug|change effect|gastrointestinal symptoms|DDF
34911958|student_A|anti-PD medication|drug|change effect|gastrointestinal symptoms|DDF
34911958|student_A|rasagiline|drug|change effect|gastrointestinal symptoms|DDF
34911958|student_A|anti-PD medication|drug|interact|bacterial TDC|chemical
34911958|student_A|ropinirole|drug|change effect|gastrointestinal symptoms|DDF
34911958|student_A|Gut bacterial tyrosine decarboxylase|chemical|influence|Parkinsons disease|DDF
34911958|student_A|levodopa|drug|change effect|Parkinson's disease|DDF
34911958|student_A|anti-PD medications|drug|change effect|gastrointestinal symptoms|DDF
34911958|student_A|tyrosine decarboxylating (TDC) bacteria|bacteria|interact|levodopa|drug
34911958|student_A|levodopa|drug|change effect|PD|DDF
35799798|student_B|NSSI|DDF|target|adolescents|human
35799798|student_B|gut microbiota|microbiome|used by|16S rDNA gene sequencing method|biomedical technique
35799798|student_B|gut microbiota|microbiome|located in|adolescents|human
35799798|student_B|non-suicidal self-injury|DDF|target|adolescents|human
35799798|student_B|depression|DDF|target|adolescents|human
39392025|student_A|Borrelia Burgdorferi|bacteria|influence|OCD|DDF
39392025|student_A|bacteria|bacteria|influence|infectious diseases|DDF
39392025|student_A|bacteria|bacteria|influence|OCD|DDF
34750307|student_A|synbiotics|dietary supplement|influence|mental health|DDF
34750307|student_A|microbiota|microbiome|is linked to|brain disorders|DDF
34750307|student_A|prebiotics|dietary supplement|influence|mental health|DDF
34750307|student_A|gut microbiota|microbiome|is linked to|mental health|DDF
34750307|student_A|microbiota|microbiome|is linked to|mental health|DDF
34750307|student_A|diet|dietary supplement|influence|mental health|DDF
34750307|student_A|probiotics|dietary supplement|influence|mental health|DDF
36355135|student_A|gut microbiota|microbiome|is linked to|neurodegenerative disorders|DDF
36355135|student_A|commensal gut microbiota|microbiome|located in|brain|anatomical location
36355135|student_A|Gut Microbiota|microbiome|is linked to|Neurodegenerative Disorders|DDF
36355135|student_A|gut microbiota|microbiome|is linked to|intractable diseases|DDF
34719435|student_A|antibiotics|drug|change effect|Parkinson's disease|DDF
34719435|student_A|anti-infective agents|drug|change effect|oxidative stress|DDF
34719435|student_A|infective pathogens|bacteria|influence|influenza virus|DDF
34719435|student_A|anti-infective agents|drug|change effect|neuroinflammation|DDF
34719435|student_A|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
34719435|student_A|infective pathogens|bacteria|influence|Parkinson's disease|DDF
34719435|student_A|Anti-Infective Agents|drug|change effect|Parkinson's Disease|DDF
34719435|student_A|pleiotropic agents|drug|change effect|Parkinson's disease|DDF
34719435|student_A|infective pathogens|bacteria|influence|hepatitis C virus|DDF
33470765|student_A|propionate|chemical|located in|intestinal epithelial barrier|anatomical location
33470765|student_A|gut microbiota metabolite propionate|chemical|influence|intestinal epithelial barrier dysfunction-mediated Parkinson's disease|DDF
33470765|student_A|intestinal epithelial barrier|anatomical location|located in|mice|animal
33470765|student_A|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson's disease|DDF|target|mice|animal
36226922|student_A|MPTP|chemical|impact|norank_f_Muribaculaceae|bacteria
36226922|student_A|MPTP|chemical|influence|PD|DDF
36226922|student_A|Fucosylated Chondroitin Sulfate|chemical|influence|Gut Dysbiosis|DDF
36226922|student_A|fCS-<i>Ib</i>|dietary supplement|influence|PD|DDF
36226922|student_A|MPTP|chemical|located in|SN|anatomical location
36226922|student_A|MPTP|chemical|impact|Staphylococcus|bacteria
39199404|student_B|stress-induced injurious behaviors|DDF|target|chickens|animal
39199404|student_B|gut microbiota|microbiome|is linked to|mental disorders|DDF
39199404|student_B|MGB|microbiome|is linked to|social stress-induced injurious behaviors|DDF
39199404|student_B|Injurious Behavior|DDF|target|Chicken|animal
39199404|student_B|neuropsychiatric disorders|DDF|target|humans|human
39199404|student_B|neurotoxic compounds|chemical|influence|neuropsychiatric disorders|DDF
39199404|student_B|MGB|microbiome|is linked to|neuropsychiatric disorders|DDF
39199404|student_B|microbiota-gut-brain|microbiome|is linked to|neuropsychiatric disorders|DDF
39199404|student_B|gut microbiota|microbiome|located in|chickens|animal
39199404|student_B|mental disorders|DDF|target|individuals|human
39199404|student_B|neurotoxic compounds|chemical|influence|neuronal injury|DDF
39199404|student_B|neuropsychiatric disorders|DDF|target|animals|animal
39199404|student_B|social stress-induced injurious behaviors|DDF|target|chickens|animal
39199404|student_B|neurotoxic compounds|chemical|influence|neuroinflammation|DDF
35829770|student_A|gut microbiota|microbiome|is linked to|gut dysbiosis|DDF
35829770|student_A|nicotinamide|chemical|produced by|gut microbiota|microbiome
35829770|student_A|alanine betaine|chemical|produced by|gut microbiota|microbiome
35829770|student_A|Parkinson's disease|DDF|is a|neurodegenerative disease|DDF
34948234|student_A|gut microbiota dysbiosis|DDF|affect|Cancers|DDF
34948234|student_A|cancer|DDF|target|human host|human
34948234|student_A|gut microbiota|microbiome|is linked to|Alzheimer's disease|DDF
34948234|student_A|Human Gut Microbiota|microbiome|is linked to|gut microbiota dysbiosis|DDF
34948234|student_A|gut microbiota|microbiome|is linked to|metabolic syndrome|DDF
34948234|student_A|dysbiosis|DDF|affect|metabolic diseases|DDF
34948234|student_A|human gut microbiota|microbiome|is linked to|multiple sclerosis|DDF
34948234|student_A|Human Gut Microbiota|microbiome|is linked to|Hashimoto's thyroidis|DDF
34948234|student_A|gut microbiota|microbiome|is linked to|nervous system disturbances|DDF
34948234|student_A|gut microbiota|microbiome|is linked to|type 2 diabetes mellitus|DDF
34948234|student_A|dysbiosis|DDF|affect|Graves' disease|DDF
34948234|student_A|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
34948234|student_A|Human Gut Microbiota|microbiome|is linked to|metabolic diseases|DDF
34948234|student_A|Human Gut Microbiota|microbiome|is linked to|Graves' disease|DDF
34948234|student_A|Parkinson's disease|DDF|target|human host|human
34948234|student_A|human gut microbiota|microbiome|is linked to|cancer|DDF
34948234|student_A|dysbiosis|DDF|affect|multiple sclerosis|DDF
34948234|student_A|human gut microbiota|microbiome|is linked to|Hashimoto's thyroidis|DDF
34948234|student_A|metabolites|chemical|produced by|microbiota|microbiome
34948234|student_A|gut microbiota dysbiosis|DDF|affect|nervous system disturbances|DDF
34948234|student_A|gut microbiota dysbiosis|DDF|affect|type 2 diabetes mellitus|DDF
34948234|student_A|Human Gut Microbiota|microbiome|located in|human host|human
34948234|student_A|Human Gut Microbiota|microbiome|is linked to|multiple sclerosis|DDF
34948234|student_A|microbiota|microbiome|is linked to|depression|DDF
34948234|student_A|Graves' disease|DDF|target|human host|human
34948234|student_A|type 2 diabetes mellitus|DDF|target|human host|human
34948234|student_A|microbiota|microbiome|is linked to|nervous system disturbances|DDF
34948234|student_A|human gut microbiota|microbiome|is linked to|type 2 diabetes mellitus|DDF
34948234|student_A|dysbiosis|DDF|affect|Hashimoto's thyroidis|DDF
34948234|student_A|metabolites|chemical|produced by|human gut microbiota|microbiome
34948234|student_A|Human Gut Microbiota|microbiome|is linked to|cancer|DDF
34948234|student_A|nervous system disturbances|DDF|target|human host|human
34948234|student_A|human gut microbiota|microbiome|located in|human host|human
34948234|student_A|microbiota|microbiome|is linked to|Cancers|DDF
34948234|student_A|microbiota|microbiome|is linked to|dysbiosis|DDF
34948234|student_A|dysbiosis|DDF|target|human host|human
34948234|student_A|gut microbiota|microbiome|is linked to|Graves' disease|DDF
34948234|student_A|Human Gut Microbiota|microbiome|is linked to|Parkinson's disease|DDF
34948234|student_A|gut microbiota|microbiome|is linked to|depression|DDF
34948234|student_A|dysbiosis|DDF|affect|Cancers|DDF
34948234|student_A|Human Gut Microbiota|microbiome|is linked to|type 2 diabetes mellitus|DDF
34948234|student_A|Hashimoto's thyroidis|DDF|target|human host|human
34948234|student_A|microbiota|microbiome|is linked to|gut microbiota dysbiosis|DDF
34948234|student_A|human gut microbiota|microbiome|is linked to|Alzheimer's disease|DDF
34948234|student_A|Alzheimer's disease|DDF|target|human host|human
34948234|student_A|metabolic diseases|DDF|target|human host|human
34948234|student_A|dysbiosis|DDF|affect|cancer|DDF
34948234|student_A|gut microbiota|microbiome|is linked to|dysbiosis|DDF
34948234|student_A|microbiota|microbiome|is linked to|metabolic diseases|DDF
34948234|student_A|microbiota|microbiome|is linked to|metabolic syndrome|DDF
34948234|student_A|human gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
34948234|student_A|metabolites|chemical|located in|intestines|anatomical location
34948234|student_A|human gut microbiota|microbiome|is linked to|depression|DDF
34948234|student_A|gut microbiota dysbiosis|DDF|affect|multiple sclerosis|DDF
34948234|student_A|Human Gut Microbiota|microbiome|is linked to|Alzheimer's disease|DDF
34948234|student_A|gut microbiota|microbiome|is linked to|gut microbiota dysbiosis|DDF
34948234|student_A|intestines|anatomical location|located in|human host|human
34948234|student_A|microbiota|microbiome|is linked to|multiple sclerosis|DDF
34948234|student_A|dysbiosis|DDF|affect|type 2 diabetes mellitus|DDF
34948234|student_A|metabolites|chemical|produced by|Human Gut Microbiota|microbiome
34948234|student_A|Cancers|DDF|target|human host|human
34948234|student_A|gut microbiota|microbiome|is linked to|metabolic diseases|DDF
34948234|student_A|gut microbiota dysbiosis|DDF|affect|Hashimoto's thyroidis|DDF
34948234|student_A|human gut microbiota|microbiome|is linked to|Cancers|DDF
34948234|student_A|Human Gut Microbiota|microbiome|is linked to|depression|DDF
34948234|student_A|microbiota|microbiome|is linked to|Hashimoto's thyroidis|DDF
34948234|student_A|Human Gut Microbiota|microbiome|is linked to|nervous system disturbances|DDF
34948234|student_A|gut microbiota dysbiosis|DDF|affect|Graves' disease|DDF
34948234|student_A|metabolites|chemical|produced by|gut microbiota|microbiome
34948234|student_A|gut microbiota|microbiome|is linked to|multiple sclerosis|DDF
34948234|student_A|gut microbiota dysbiosis|DDF|affect|metabolic diseases|DDF
34948234|student_A|microbiota|microbiome|is linked to|Graves' disease|DDF
34948234|student_A|human gut microbiota|microbiome|is linked to|nervous system disturbances|DDF
34948234|student_A|Human Gut Microbiota|microbiome|is linked to|Cancers|DDF
34948234|student_A|Human Gut Microbiota|microbiome|is linked to|dysbiosis|DDF
34948234|student_A|microbiota|microbiome|located in|human host|human
34948234|student_A|gut microbiota|microbiome|is linked to|Hashimoto's thyroidis|DDF
34948234|student_A|gut microbiota dysbiosis|DDF|affect|cancer|DDF
34948234|student_A|dysbiosis|DDF|affect|nervous system disturbances|DDF
34948234|student_A|human gut microbiota|microbiome|is linked to|dysbiosis|DDF
34948234|student_A|microbiota|microbiome|is linked to|cancer|DDF
34948234|student_A|Human Gut Microbiota|microbiome|is linked to|metabolic syndrome|DDF
34948234|student_A|microbiota|microbiome|located in|intestines|anatomical location
34948234|student_A|microbiota|microbiome|is linked to|Alzheimer's disease|DDF
34948234|student_A|gut microbiota dysbiosis|DDF|target|human host|human
34948234|student_A|human gut microbiota|microbiome|is linked to|gut microbiota dysbiosis|DDF
34948234|student_A|gut microbiota|microbiome|is linked to|Cancers|DDF
34948234|student_A|gut microbiota|microbiome|located in|human host|human
34948234|student_A|multiple sclerosis|DDF|target|human host|human
34948234|student_A|metabolic syndrome|DDF|target|human host|human
34948234|student_A|depression|DDF|target|human host|human
34948234|student_A|microbiota|microbiome|is linked to|type 2 diabetes mellitus|DDF
34948234|student_A|microbiota|microbiome|is linked to|Parkinson's disease|DDF
34948234|student_A|human gut microbiota|microbiome|is linked to|metabolic diseases|DDF
34948234|student_A|human gut microbiota|microbiome|is linked to|metabolic syndrome|DDF
34948234|student_A|gut microbiota|microbiome|is linked to|cancer|DDF
34948234|student_A|human gut microbiota|microbiome|is linked to|Graves' disease|DDF
33404072|student_A|commensal bacteria|bacteria|influence|Alzheimer's disease|DDF
33404072|student_A|gut microbiota|microbiome|is linked to|extraintestinal disorders|DDF
33404072|student_A|gut microbiota|microbiome|is linked to|neurodevelopmental and neurodegenerative disorders|DDF
33404072|student_A|commensal bacteria|bacteria|influence|neurological disorders|DDF
33404072|student_A|commensal bacteria|bacteria|influence|multiple sclerosis|DDF
33404072|student_A|commensal bacteria|bacteria|influence|Parkinson's disease|DDF
33404072|student_A|commensal bacteria|bacteria|part of|gut microbiota|microbiome
33291597|student_A|unhealthy nutrition|DDF|affect|Neurodegenerative diseases|DDF
33291597|student_A|probiotics|dietary supplement|influence|diseases of the central nervous system|DDF
33291597|student_A|Adiponectin|chemical|influence|Neurodegenerative diseases|DDF
33291597|student_A|Adiponectin|chemical|influence|Parkinson's disease|DDF
33291597|student_A|unhealthy nutrition|DDF|affect|neurodegenerative diseases|DDF
33291597|student_A|unhealthy nutrition|DDF|change abundance|gut microbiota|microbiome
33291597|student_A|chronic and selective process of neuron cell death|DDF|affect|Alzheimer's disease|DDF
33291597|student_A|prebiotics|dietary supplement|influence|Alzheimer's disease|DDF
33291597|student_A|probiotics|dietary supplement|influence|Parkinson's disease|DDF
33291597|student_A|polyphenols|dietary supplement|influence|neuroinflammation|DDF
33291597|student_A|probiotics|dietary supplement|influence|metabolic and inflammatory diseases|DDF
33291597|student_A|chronic and selective process of neuron cell death|DDF|affect|diseases of the central nervous system|DDF
33291597|student_A|Adiponectin|chemical|located in|adipose tissue|anatomical location
33291597|student_A|polyphenols|dietary supplement|influence|Alzheimer's disease|DDF
33291597|student_A|chronic and selective process of neuron cell death|DDF|affect|Neurodegenerative Diseases|DDF
33291597|student_A|probiotics|dietary supplement|influence|Neurodegenerative diseases|DDF
33291597|student_A|prebiotics|dietary supplement|influence|Neurodegenerative Diseases|DDF
33291597|student_A|Adiponectin|chemical|influence|neurodegenerative diseases|DDF
33291597|student_A|Adiponectin|chemical|impact|gut microbiota|microbiome
33291597|student_A|prebiotics|dietary supplement|influence|immune diseases|DDF
33291597|student_A|unhealthy nutrition|DDF|affect|Neurodegenerative Diseases|DDF
33291597|student_A|polyphenols|dietary supplement|influence|diseases of the central nervous system|DDF
33291597|student_A|polyphenols|dietary supplement|influence|Neurodegenerative Diseases|DDF
33291597|student_A|probiotics|dietary supplement|influence|neurodegenerative diseases|DDF
33291597|student_A|prebiotics|dietary supplement|influence|obesity|DDF
33291597|student_A|unhealthy nutrition|DDF|affect|metabolic and inflammatory diseases|DDF
33291597|student_A|prebiotics|dietary supplement|influence|diseases of the central nervous system|DDF
33291597|student_A|probiotics|dietary supplement|influence|neuroinflammation|DDF
33291597|student_A|polyphenols|dietary supplement|influence|immune diseases|DDF
33291597|student_A|unhealthy nutrition|DDF|affect|Alzheimer's disease|DDF
33291597|student_A|polyphenols|dietary supplement|influence|obesity|DDF
33291597|student_A|Adiponectin|chemical|influence|Neurodegenerative Diseases|DDF
33291597|student_A|chronic and selective process of neuron cell death|DDF|affect|Neurodegenerative diseases|DDF
33291597|student_A|unhealthy nutrition|DDF|affect|obesity|DDF
33291597|student_A|chronic and selective process of neuron cell death|DDF|affect|Parkinson's disease|DDF
33291597|student_A|unhealthy nutrition|DDF|affect|diseases of the central nervous system|DDF
33291597|student_A|prebiotics|dietary supplement|influence|Parkinson's disease|DDF
33291597|student_A|probiotics|dietary supplement|influence|Neurodegenerative Diseases|DDF
33291597|student_A|Adiponectin|chemical|influence|Alzheimer's disease|DDF
33291597|student_A|prebiotics|dietary supplement|influence|metabolic and inflammatory diseases|DDF
33291597|student_A|polyphenols|dietary supplement|influence|Parkinson's disease|DDF
33291597|student_A|chronic and selective process of neuron cell death|DDF|affect|neurodegenerative diseases|DDF
33291597|student_A|prebiotics|dietary supplement|influence|neurodegenerative diseases|DDF
33291597|student_A|prebiotics|dietary supplement|influence|Neurodegenerative diseases|DDF
33291597|student_A|Adiponectin|chemical|influence|immune diseases|DDF
33291597|student_A|probiotics|dietary supplement|influence|Alzheimer's disease|DDF
33291597|student_A|polyphenols|dietary supplement|influence|metabolic and inflammatory diseases|DDF
33291597|student_A|unhealthy nutrition|DDF|affect|Parkinson's disease|DDF
33291597|student_A|probiotics|dietary supplement|influence|immune diseases|DDF
33291597|student_A|Adiponectin|chemical|influence|diseases of the central nervous system|DDF
33291597|student_A|polyphenols|dietary supplement|influence|neurodegenerative diseases|DDF
33291597|student_A|polyphenols|dietary supplement|influence|Neurodegenerative diseases|DDF
33291597|student_A|adipokine|chemical|located in|adipose tissue|anatomical location
33291597|student_A|neurodegenerative diseases|DDF|affect|unhealthy nutrition|DDF
33291597|student_A|prebiotics|dietary supplement|influence|neuroinflammation|DDF
33291597|student_A|probiotics|dietary supplement|influence|obesity|DDF
38892694|student_B|Bifidobacterium|bacteria|part of|gut microbiota|microbiome
38892694|student_B|Blautia|bacteria|part of|gut microbiota|microbiome
38892694|student_B|gut metabolome|chemical|produced by|gut microbiota|microbiome
38892694|student_B|upregulated lipid metabolites|chemical|produced by|gut microbiota|microbiome
38892694|student_B|Gut Microbiota|microbiome|located in|Participants|human
38892694|student_B|Collinsella|bacteria|part of|gut microbiota|microbiome
38892694|student_B|chronic psychological stress|DDF|target|participants|human
38892694|student_B|Metabolites|chemical|produced by|Gut Microbiota|microbiome
38892694|student_B|metabolome|chemical|produced by|gut microbiota|microbiome
38892694|student_B|gut microbiota|microbiome|located in|participants|human
38892694|student_B|metabolites|chemical|produced by|gut microbiota|microbiome
38892694|student_B|Faecalibacterium|bacteria|part of|gut microbiota|microbiome
38892694|student_B|circadian rhythm disorders|DDF|target|participants|human
38892694|student_B|Bacteroides|bacteria|part of|gut microbiota|microbiome
38892694|student_B|psychobiotics|drug|impact|gut microbiota|microbiome
39015337|student_A|vaginal microbiome|microbiome|is linked to|mental health parameters|DDF
39015337|student_A|high levels of stress and depressive symptoms|DDF|target|women|human
39015337|student_A|findings|DDF|target|healthy young women|human
39015337|student_A|depressive symptoms|DDF|target|healthy women|human
39015337|student_A|mental illness|DDF|target|populations|human
39015337|student_A|gut microbiome|microbiome|located in|populations|human
39015337|student_A|psychiatric diagnoses|DDF|target|young women|human
39015337|student_A|gut microbiota|microbiome|is linked to|psychological symptoms|DDF
39015337|student_A|elevated depressive symptoms|DDF|target|women|human
39015337|student_A|Blautia|bacteria|located in|Women with high perceived stress|human
39015337|student_A|stress|DDF|target|healthy women|human
39015337|student_A|gut microbiome|microbiome|is linked to|future psychiatric interventions|DDF
39015337|student_A|gut and vaginal microbiome|microbiome|used by|Shotgun metagenomic profiling|biomedical technique
39015337|student_A|symptoms of stress and depression|DDF|target|cohort of healthy women|human
39015337|student_A|Escherichia|bacteria|located in|Women with high perceived stress|human
39015337|student_A|Shigella|bacteria|located in|Women with high perceived stress|human
39015337|student_A|cohort of healthy women|human|used by|Investigations|biomedical technique
39015337|student_A|Vaginosis symptoms|DDF|target|women|human
32739365|student_A|Lactobacillus plantarum PS128|dietary supplement|influence|neurodegenerative progression|DDF
32739365|student_A|Parkinson's disease|DDF|target|PD-model mice|animal
32739365|student_A|PS128|dietary supplement|influence|MPTP-induced oxidative stress|DDF
32739365|student_A|PS128|dietary supplement|influence|neuroinflammation|DDF
32739365|student_A|PS128|dietary supplement|influence|motor deficits|DDF
32739365|student_A|PS128|dietary supplement|influence|neurodegenerative processes|DDF
32739365|student_A|PD|DDF|target|PD-model mice|animal
32739365|student_A|PS128|dietary supplement|impact|gut microbiota|microbiome
32739365|student_A|psychobiotics|dietary supplement|influence|PD|DDF
32739365|student_A|Lactobacillus plantarum PS128|dietary supplement|influence|abnormal behaviors|DDF
32739365|student_A|PS128|dietary supplement|influence|abnormal behaviors|DDF
32739365|student_A|striatum|anatomical location|located in|PD-model mice|animal
32739365|student_A|PS128|dietary supplement|influence|MPTP-induced motor deficits|DDF
36191590|student_A|Lachnospiraceae|bacteria|located in|patients|human
36191590|student_A|AN|DDF|target|patients|human
36191590|student_A|anorexia nervosa|DDF|target|patients|human
36191590|student_A|gut microbiota|microbiome|is linked to|anorexia nervosa|DDF
36191590|student_A|gut microbiota|microbiome|located in|patients|human
36191590|student_A|gut microbiota|microbiome|used by|Microbial diversity analysis|biomedical technique
36191590|student_A|gut microbiota|microbiome|is linked to|AN|DDF
39033825|student_A|gut microbiota|microbiome|change expression|Core antibiotic resistance genes|gene
39033825|student_A|Weissella|bacteria|change expression|ARGs|gene
39033825|student_A|Weissella_cibaria|bacteria|part of|gut microbiota|microbiome
39033825|student_A|Lactobacillus|bacteria|change expression|ARGs|gene
39033825|student_A|Lactobacillus_plantaru|bacteria|part of|gut microbiota|microbiome
39033825|student_A|Eggerthella|bacteria|change expression|ARGs|gene
39033825|student_A|gut microbiota|microbiome|is linked to|major depressive disorder|DDF
39033825|student_A|gut microbiota|microbiome|is linked to|depression|DDF
39033825|student_A|gut microbiota|microbiome|change expression|antibiotic resistance genes|gene
39033825|student_A|gut microbiota|microbiome|change expression|ARGs|gene
34386321|student_A|oral drugs|drug|impact|gut microbiota|microbiome
34386321|student_A|gut microbiota|microbiome|located in|gastrointestinal tract|anatomical location
34386321|student_A|oral drugs|drug|impact|symbiotic gut microbiota|microbiome
34386321|student_A|symbiotic gut microbiota|microbiome|located in|gastrointestinal tract|anatomical location
33106549|student_A|Bacteroidetes|bacteria|part of|altered gut microbiota|microbiome
33106549|student_A|Huntington's disease|DDF|affect|weight loss|DDF
33106549|student_A|progressive, multifaceted neurodegenerative disease|DDF|affect|gut problems|DDF
33106549|student_A|HD|DDF|affect|gut problems|DDF
33106549|student_A|HD|DDF|affect|increased intestinal permeability|DDF
33106549|student_A|occludin|chemical|influence|increased gut permeability|DDF
33106549|student_A|dysbiosis|DDF|target|R6/2 mice|animal
33106549|student_A|increased intestinal permeability-leaky gut syndrome|DDF|target|Parkinson's disease patients|human
33106549|student_A|HD|DDF|affect|weight loss|DDF
33106549|student_A|progressive, multifaceted neurodegenerative disease|DDF|affect|weight loss|DDF
33106549|student_A|Firmicutes|bacteria|part of|altered gut microbiota|microbiome
33106549|student_A|tight junction proteins|chemical|influence|increased gut permeability|DDF
33106549|student_A|zonula occludens|chemical|influence|increased gut permeability|DDF
33106549|student_A|increased intestinal permeability|DDF|target|R6/2 mice|animal
33106549|student_A|altered gut microbiota|microbiome|located in|R6/2 mice|animal
33106549|student_A|Huntington's disease|DDF|affect|gut problems|DDF
36455673|student_B|brain-derived neurotrophic factor|chemical|impact|intestinal flora|microbiome
36455673|student_B|MPTP|chemical|influence|intestinal pathology|DDF
36455673|student_B|microbial disorders|DDF|affect|PD|DDF
36455673|student_B|MPTP|chemical|interact|dopamine|chemical
36455673|student_B|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|chemical|influence|Parkinson's disease|DDF
36455673|student_B|Parkinson's disease|DDF|target|mice|animal
36455673|student_B|intestinal flora|microbiome|located in|mice|animal
36455673|student_B|PD|DDF|target|mice|animal
36455673|student_B|MPTP|chemical|influence|Parkinson's disease|DDF
36455673|student_B|intestinal inflammation|DDF|change abundance|intestinal flora|microbiome
36455673|student_B|microbial disorders|DDF|affect|Parkinson's disease|DDF
36455673|student_B|PD|DDF|is a|neurodegenerative disease|DDF
36455673|student_B|intestinal inflammatory factors|chemical|impact|intestinal flora|microbiome
36455673|student_B|intestinal mucosal barrier condition|DDF|change abundance|intestinal flora|microbiome
36455673|student_B|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|chemical|influence|PD|DDF
36455673|student_B|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|chemical|interact|DA|chemical
36455673|student_B|Parkinson's disease|DDF|change abundance|intestinal flora|microbiome
36455673|student_B|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|chemical|interact|dopamine|chemical
36455673|student_B|MPTP|chemical|influence|PD|DDF
36455673|student_B|dopamine|chemical|located in|striatum|anatomical location
36455673|student_B|dopaminergic neurons|chemical|impact|intestinal flora|microbiome
36455673|student_B|DA|chemical|located in|striatum|anatomical location
36455673|student_B|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|chemical|influence|intestinal pathology|DDF
36455673|student_B|intestinal flora|microbiome|is linked to|intestinal mucosal barrier condition|DDF
36455673|student_B|brain-derived neurotrophic factor|chemical|located in|striatum|anatomical location
36455673|student_B|Parkinson's disease|DDF|is a|neurodegenerative disease|DDF
36455673|student_B|PD|DDF|change abundance|intestinal flora|microbiome
36455673|student_B|MPTP|chemical|interact|DA|chemical
35225349|student_A|physical therapists|human|used by|exercise regimens|biomedical technique
35225349|student_A|dysregulations|DDF|change abundance|gut microbiota|microbiome
35225349|student_A|PD|DDF|affect|peripheral dysregulations|DDF
35225349|student_A|individuals|human|used by|exercise regimens|biomedical technique
35225349|student_A|PD|DDF|target|individuals|human
35225349|student_A|PD|DDF|target|people|human
35225349|student_A|PD|DDF|target|People|human
35225349|student_A|individuals|human|used by|exercise|biomedical technique
35225349|student_A|Parkinson disease|DDF|strike|central nervous system|anatomical location
35225349|student_A|PD|DDF|change abundance|reduced microbial diversity|bacteria
35225349|student_A|people|human|used by|therapeutic exercises|biomedical technique
35225349|student_A|gut microbiota|microbiome|located in|non-PD populations|human
35225349|student_A|gut microbiota|microbiome|is linked to|PD|DDF
35225349|student_A|peripheral dysregulations|DDF|change abundance|gut microbiota|microbiome
35225349|student_A|Physical therapists|human|used by|therapeutic exercises|biomedical technique
35225349|student_A|gut microbiota|microbiome|is linked to|pathology|DDF
35225349|student_A|PD|DDF|strike|central nervous system|anatomical location
35225349|student_A|gut microbiota|microbiome|is linked to|PD symptoms|DDF
35897024|student_A|Chronic gut inflammation|DDF|target|human PD patients|human
39217732|student_A|severe depression|DDF|target|patients|human
39217732|student_A|Depression|DDF|change abundance|Firmicutes phylum|bacteria
39217732|student_A|beneficial bacteria|bacteria|part of|gut microbiota|microbiome
39217732|student_A|Depression|DDF|change abundance|Actinobacteria spp.|bacteria
39217732|student_A|Bifidobacterium spp.|bacteria|part of|gut microbiota|microbiome
39217732|student_A|Actinobacteria spp.|bacteria|part of|gut microbiota|microbiome
39217732|student_A|gut microbiota|microbiome|is linked to|depression|DDF
39217732|student_A|Depression|DDF|change abundance|Fusobacterium spp.|bacteria
39217732|student_A|Depression|DDF|change abundance|Bacteroidetes phylum|bacteria
39217732|student_A|Bacteroidetes phylum|bacteria|part of|gut microbiota|microbiome
39217732|student_A|Lactobacillus spp.|bacteria|part of|gut microbiota|microbiome
39217732|student_A|Fusobacterium spp.|bacteria|part of|gut microbiota|microbiome
39217732|student_A|Firmicutes phylum|bacteria|part of|gut microbiota|microbiome
39217732|student_A|Depression|DDF|change abundance|Lactobacillus spp.|bacteria
39217732|student_A|Depression|DDF|change abundance|Bifidobacterium spp.|bacteria
39217732|student_A|potentially pathogenic bacteria|bacteria|part of|gut microbiota|microbiome
36742204|student_A|Symprove™|dietary supplement|influence|PD|DDF
36742204|student_A|Symprove™|dietary supplement|influence|gastrointestinal diseases|DDF
36742204|student_A|GM|microbiome|is linked to|PD symptoms|DDF
36742204|student_A|probiotics|dietary supplement|influence|neurodegeneration|DDF
36742204|student_A|microbiota|microbiome|is linked to|PD|DDF
36742204|student_A|Symprove™|dietary supplement|influence|neurodegeneration|DDF
36742204|student_A|Symprove™|dietary supplement|influence|neuroinflammation|DDF
36742204|student_A|neuroinflammation|DDF|strike|brain|anatomical location
36742204|student_A|Symprove™|dietary supplement|influence|early-stage PD|DDF
36742204|student_A|gut microbiota|microbiome|is linked to|PD|DDF
36742204|student_A|probiotics|dietary supplement|influence|PD|DDF
36742204|student_A|GM|microbiome|is linked to|PD|DDF
36742204|student_A|neurodegeneration|DDF|strike|brain|anatomical location
36742204|student_A|gut microbiota|microbiome|is linked to|PD symptoms|DDF
35445772|student_A|Turicibacteraceae|bacteria|interact|TLCA|chemical
35445772|student_A|Turicibacteraceae|bacteria|interact|glycodeoxycholic acid|chemical
35445772|student_A|Turicibacterales|bacteria|interact|TLCA|chemical
35445772|student_A|Turicibacter|bacteria|interact|TLCA|chemical
35445772|student_A|Turicibacter|bacteria|interact|GLCA|chemical
35445772|student_A|Turicibacterales|bacteria|interact|taurodeoxycholic acid|chemical
35445772|student_A|Turicibacteraceae|bacteria|interact|GLCA|chemical
35445772|student_A|Turicibacterales|bacteria|interact|glycodeoxycholic acid|chemical
35445772|student_A|Turicibacterales|bacteria|interact|GLCA|chemical
35445772|student_A|Gut microbiota|microbiome|is linked to|major depressive disorder|DDF
35445772|student_A|Turicibacter|bacteria|interact|taurodeoxycholic acid|chemical
35445772|student_A|Turicibacter|bacteria|interact|glycodeoxycholic acid|chemical
35445772|student_A|bile acids|chemical|influence|major depressive disorder|DDF
35445772|student_A|Turicibacteraceae|bacteria|interact|taurodeoxycholic acid|chemical
33400024|student_A|α-synuclein|chemical|located in|brain|anatomical location
33400024|student_A|microbes|bacteria|influence|dysbiosis|DDF
33400024|student_A|toxicants|chemical|influence|dysbiosis|DDF
33400024|student_A|endogenous or exogenous chemicals|chemical|influence|dysbiosis|DDF
33400024|student_A|Constipation|DDF|target|PD patients|human
33400024|student_A|gut bacteria|bacteria|influence|Constipation|DDF
36140263|student_B|Major depressive disorder|DDF|change abundance|Ruthenibacterium lactatiformans|bacteria
36140263|student_B|glutamine|chemical|produced by|GM|microbiome
36140263|student_B|GM|microbiome|located in|MDD patients|human
36140263|student_B|MDD|DDF|change abundance|Escherichia coli|bacteria
36140263|student_B|Roseburia intestinalis|bacteria|part of|GM|microbiome
36140263|student_B|glutamate|chemical|produced by|GM|microbiome
36140263|student_B|conjugated linoleic acids|chemical|produced by|GM|microbiome
36140263|student_B|GM|microbiome|is linked to|MDD|DDF
36140263|student_B|Major depressive disorder|DDF|change abundance|Escherichia coli|bacteria
36140263|student_B|key enzymes|chemical|change expression|bacterial genes|gene
36140263|student_B|GM|microbiome|located in|healthy volunteers|human
36140263|student_B|acetic|chemical|produced by|GM|microbiome
36140263|student_B|Major Depressive Disorder|DDF|change abundance|Human Gut Microbiota|microbiome
36140263|student_B|GM|microbiome|change expression|bacterial genes|gene
36140263|student_B|MDD|DDF|change abundance|Roseburia hominis|bacteria
36140263|student_B|melatonin|chemical|produced by|GM|microbiome
36140263|student_B|Ruthenibacterium lactatiformans|bacteria|part of|GM|microbiome
36140263|student_B|Roseburia hominis|bacteria|part of|GM|microbiome
36140263|student_B|spermidine|chemical|produced by|GM|microbiome
36140263|student_B|gut microbiota|microbiome|is linked to|MDD|DDF
36140263|student_B|healthy volunteers|human|used by|Comparative taxonomic analysis|biomedical technique
36140263|student_B|MDD patients|human|used by|16S rRNA sequencing|biomedical technique
36140263|student_B|gut microbiota|microbiome|is linked to|Major depressive disorder|DDF
36140263|student_B|asparagine|chemical|produced by|GM|microbiome
36140263|student_B|Faecalibacterium prausntizii|bacteria|part of|GM|microbiome
36140263|student_B|Major depressive disorder|DDF|change abundance|Roseburia hominis|bacteria
36140263|student_B|GM|microbiome|is linked to|Major depressive disorder|DDF
36140263|student_B|MDD|DDF|change abundance|Roseburia intestinalis|bacteria
36140263|student_B|Escherichia coli|bacteria|part of|GM|microbiome
36140263|student_B|GM|microbiome|used by|16S rRNA sequencing|biomedical technique
36140263|student_B|butyric|chemical|produced by|GM|microbiome
36140263|student_B|MDD|DDF|change abundance|Faecalibacterium prausnitzii|bacteria
36140263|student_B|Faecalibacterium prausnitzii|bacteria|part of|GM|microbiome
36140263|student_B|Major depressive disorder|DDF|change abundance|Roseburia intestinalis|bacteria
36140263|student_B|Major depressive disorder|DDF|change abundance|Faecalibacterium prausnitzii|bacteria
36140263|student_B|MDD patients|human|used by|Comparative taxonomic analysis|biomedical technique
36140263|student_B|MDD|DDF|change abundance|Ruthenibacterium lactatiformans|bacteria
36140263|student_B|arginine|chemical|produced by|GM|microbiome
36140263|student_B|GM|microbiome|used by|Comparative taxonomic analysis|biomedical technique
36558405|student_A|Gut dysbiosis|DDF|change abundance|gut microbiota|microbiome
36558405|student_A|active AN|DDF|change abundance|specific SCFA-producing bacteria|bacteria
36558405|student_A|active AN|DDF|change abundance|gut microbiota|microbiome
36558405|student_A|SCFA|chemical|produced by|gut microbiota|microbiome
36558405|student_A|acetic-, butyric-, formic-, isobutyric-, isovaleric-, propionic-, and succinic acid|chemical|produced by|gut microbiota|microbiome
36558405|student_A|AN|DDF|target|individuals|human
36558405|student_A|active AN|DDF|target|females|human
36558405|student_A|short-chain fatty acids|chemical|produced by|gut microbiota|microbiome
36558405|student_A|gut microbiota|microbiome|located in|brain|anatomical location
36558405|student_A|specific SCFA-producing bacteria|bacteria|part of|gut microbiota|microbiome
36558405|student_A|gut microbiota|microbiome|is linked to|AN|DDF
35684340|student_A|commensal microorganisms|bacteria|part of|gut microbiota|microbiome
35684340|student_A|gut microbiota|microbiome|is linked to|Amyotrophic Lateral Sclerosis|DDF
35684340|student_A|gut microbiota|microbiome|is linked to|Alzheimer's disease|DDF
35684340|student_A|synbiotics|dietary supplement|influence|neurological illnesses|DDF
35684340|student_A|boron reagents|chemical|influence|dysbiosis|DDF
35684340|student_A|gut microbiota|microbiome|is linked to|Multiple Sclerosis|DDF
35684340|student_A|prebiotics|dietary supplement|influence|neurological illnesses|DDF
35684340|student_A|probiotics|dietary supplement|influence|neurological illnesses|DDF
35684340|student_A|gut microbiota|microbiome|is linked to|stress|DDF
35684340|student_A|gut microbiota|microbiome|is linked to|neurodevelopmental and neurodegenerative disorders|DDF
35684340|student_A|boron|chemical|influence|neurodegenerative diseases|DDF
35684340|student_A|gut microbiota|microbiome|is linked to|anxiety|DDF
35684340|student_A|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
35684340|student_A|gut microbiota|microbiome|located in|gut|anatomical location
35684340|student_A|gut microbiota|microbiome|is linked to|Autism Spectrum Disorder|DDF
35924055|student_A|OPA|chemical|change expression|apoptosis-related genes|gene
35924055|student_A|OPA|chemical|influence|dysbiosis of gut microbiota|DDF
35924055|student_A|OPA|chemical|located in|P. Americana|animal
35924055|student_A|<i>Periplaneta Americana</i> oligosaccharides|chemical|located in|Periplaneta Americana|animal
35924055|student_A|Oligosaccharides|chemical|located in|Periplaneta Americana|animal
35924055|student_A|PD|DDF|strike|brain|anatomical location
35924055|student_A|<i>Periplaneta Americana</i> oligosaccharides|chemical|located in|P. Americana|animal
35924055|student_A|OPA|chemical|located in|Periplaneta Americana|animal
35035709|student_A|gut microbiota|microbiome|is linked to|constipation|DDF
35035709|student_A|microbial population|microbiome|used by|16S rRNA sequencing|biomedical technique
35035709|student_A|constipated PD patients|human|used by|16S rRNA sequencing|biomedical technique
35035709|student_A|constipation|DDF|change abundance|gut microbiota|microbiome
35035709|student_A|gut microbiota|microbiome|is linked to|PD|DDF
35035709|student_A|non-constipated PD (NC-PD) patients|human|used by|16S rRNA sequencing|biomedical technique
35035709|student_A|Parkinson's disease|DDF|target|middle-aged and elderly populations|human
32916966|student_A|gut microbiota|microbiome|is linked to|pathologies|DDF
32916966|student_A|gut microbiota|microbiome|is linked to|microbial dysbiosis|DDF
32916966|student_A|gut microbiota|microbiome|is linked to|atherosclerosis|DDF
32916966|student_A|gut microbiota|microbiome|is linked to|Dysbiosis|DDF
32916966|student_A|gut microbiota|microbiome|is linked to|metabolic diseases|DDF
32916966|student_A|gut microbiota|microbiome|is linked to|obesity|DDF
32916966|student_A|gut microbiota|microbiome|is linked to|Metabolic Disease|DDF
32916966|student_A|gut microbiota|microbiome|is linked to|type 2 diabetes|DDF
36881358|student_A|Bifidobacteriaceae|bacteria|located in|Parkinson's subjects|human
36881358|student_A|parkinsonism|DDF|change abundance|gut microbiota|microbiome
36881358|student_A|Verrucomicrobiaceae|bacteria|located in|Parkinson's subjects|human
36881358|student_A|Parkinson's disease|DDF|target|patients|human
36881358|student_A|Parkinson's disease|DDF|change abundance|pathogens|bacteria
36881358|student_A|gut microorganisms|bacteria|influence|PD|DDF
36881358|student_A|pathogens|bacteria|part of|gut microbiota|microbiome
36881358|student_A|Christensenellaceae|bacteria|located in|Parkinson's subjects|human
36881358|student_A|small intestinal bacterial overgrowth|DDF|target|Parkinson's subjects|human
36881358|student_A|parkinsonism|DDF|change abundance|pathogens|bacteria
38879123|student_A|Veillonella atypica|bacteria|influence|SDS or BDI-II scores|DDF
38879123|student_A|incident subthreshold depression|DDF|target|Chinese young adults|human
38879123|student_A|gut microbiota|microbiome|is linked to|SD|DDF
38879123|student_A|SD|DDF|target|individuals|human
38879123|student_A|gut microbiota|microbiome|is linked to|incident SD|DDF
38879123|student_A|subthreshold depression|DDF|target|young adults|human
38879123|student_A|SD|DDF|target|young adults|human
38879123|student_A|gut microbiota|microbiome|is linked to|findings|DDF
38875919|student_A|gut microbiota|microbiome|is linked to|depression|DDF
38875919|student_A|gut microbiota|microbiome|located in|individuals|human
38875919|student_A|depression|DDF|target|Korean population|human
36432461|student_A|Nutritional interventions|dietary supplement|influence|mental health decline|DDF
36432461|student_A|Poorer mental health|DDF|target|undergraduate students|human
36432461|student_A|walnut consumption|dietary supplement|influence|mental health|DDF
36432461|student_A|academic stress|DDF|target|male participants|human
36432461|student_A|Walnuts|food|influence|Mental Health|DDF
36432461|student_A|gut microbial diversity|microbiome|located in|females|human
36432461|student_A|academic stress|DDF|target|university students|human
36432461|student_A|walnut consumption|dietary supplement|influence|academic stress|DDF
36432461|student_A|academic stress|DDF|target|undergraduate students|human
36432461|student_A|gut microbial diversity|microbiome|is linked to|Academic stress|DDF
36432461|student_A|walnut consumption|dietary supplement|impact|gut microbial diversity|microbiome
36432461|student_A|Academic stress|DDF|target|females|human
33719004|student_B|CD4|chemical|located in|ileum|anatomical location
33719004|student_B|casein|chemical|influence|PD|DDF
33719004|student_B|Iba-1|chemical|located in|midbrain|anatomical location
33719004|student_B|Casein|chemical|influence|Nigrostriatal Disease|DDF
33719004|student_B|casein|chemical|influence|intestinal pathologic injury|DDF
33719004|student_B|CD4|chemical|located in|midbrain|anatomical location
33719004|student_B|intestinal pathologic injury|DDF|target|MPTP mice|animal
33719004|student_B|TH|chemical|located in|ileum|anatomical location
33719004|student_B|intestinal dysbacteriosis|DDF|target|MPTP mice|animal
33719004|student_B|dopamine|chemical|located in|striatum|anatomical location
33719004|student_B|TH|chemical|located in|midbrain|anatomical location
33719004|student_B|dyskinesia|DDF|target|mice|animal
33719004|student_B|IL-22|chemical|located in|ileum|anatomical location
33719004|student_B|Iba-1|chemical|located in|ileum|anatomical location
33719004|student_B|IL-22|chemical|located in|midbrain|anatomical location
33719004|student_B|casein|chemical|influence|intestinal dysbacteriosis|DDF
33719004|student_B|intestinal dysbacteriosis|DDF|interact|casein|chemical
33719004|student_B|PD|DDF|change abundance|gut microbiota|microbiome
34829716|student_A|probiotics|dietary supplement|impact|gut microbiota|microbiome
34829716|student_A|New Actor Kefir|food|influence|Neurodegenerative Diseases|DDF
36120376|student_A|hippocampus|anatomical location|located in|mice|animal
36120376|student_A|Nef|drug|impact|Lactobacillus|bacteria
36120376|student_A|depression-prone mice|animal|used by|swimming tests|biomedical technique
36120376|student_A|Lactobacillus|bacteria|part of|intestinal microbiota|microbiome
36120376|student_A|hippocampus|anatomical location|located in|depressed mice|animal
36120376|student_A|Nef|drug|change effect|chronic stress-induced depression|DDF
36120376|student_A|intestinal microbiota|microbiome|located in|depressed mice|animal
36120376|student_A|Neferine|drug|change effect|chronic stress-induced depression|DDF
36048886|student_A|mental health|DDF|target|children|human
36048886|student_A|mental disorders|DDF|target|adolescents|human
36048886|student_A|Mental Health|DDF|target|Children|human
36048886|student_A|Mental Health|DDF|target|Adolescents|human
36048886|student_A|mental disorders|DDF|target|children|human
36048886|student_A|Microbiota|microbiome|located in|Children|human
36048886|student_A|gut microbiota|microbiome|located in|children|human
36048886|student_A|diet|dietary supplement|administered|children|human
36048886|student_A|Microbiota|microbiome|located in|Adolescents|human
38983862|student_A|cognitive impairments|DDF|affect|diverse symptoms|DDF
38983862|student_A|gut|anatomical location|located in|healthy donor|human
38983862|student_A|depressive symptoms|DDF|target|patient|human
38983862|student_A|depression|DDF|target|patients|human
38983862|student_A|mood disturbances|DDF|affect|diverse symptoms|DDF
38983862|student_A|healthy donor|human|used by|FMT|biomedical technique
38983862|student_A|dysbiosis|DDF|target|patient|human
38983862|student_A|gut microbiota|microbiome|is linked to|emotional and neural regulation|DDF
38983862|student_A|neuropsychiatric outcomes|DDF|target|patient|human
38983862|student_A|healthy donor|human|used by|infusion of fecal matter|biomedical technique
38983862|student_A|Depression|DDF|affect|diverse symptoms|DDF
38983862|student_A|gut|anatomical location|located in|patient|human
36126853|student_B|gut microbiota|microbiome|is linked to|Neuroinflammation|DDF
36126853|student_B|microbial community|microbiome|located in|mice|animal
33557583|student_A|gut microbiome|microbiome|change expression|rRNA|gene
33557583|student_A|gut microbiota|microbiome|used by|Electroacupuncture|biomedical technique
33557583|student_A|gut microbiota|microbiome|used by|EA|biomedical technique
33557583|student_A|pro-inflammatory and anti-inflammatory cytokines|chemical|change expression|mRNA|gene
33185912|student_A|LCIG|drug|administered|LCIG group|human
33185912|student_A|gut microbiota|microbiome|is linked to|Parkinson disease|DDF
33185912|student_A|LD-carbidopa intestinal gel|drug|impact|GM|microbiome
33185912|student_A|LCIG|drug|impact|GM|microbiome
33185912|student_A|levodopa|drug|change effect|Parkinson disease|DDF
33185912|student_A|LCIG group|human|used by|gas chromatography mass spectrometry|biomedical technique
33185912|student_A|gut inflammation|DDF|target|LCIG group|human
33185912|student_A|levodopa|drug|impact|GM|microbiome
33185912|student_A|LCIG|drug|change effect|inflammatory intestinal microenvironment|DDF
33185912|student_A|levodopa-carbidopa intrajejunal gel|drug|change effect|Parkinson disease|DDF
33185912|student_A|PD|DDF|target|patients|human
33185912|student_A|patients|human|used by|next-generation sequencing|biomedical technique
33185912|student_A|LD|drug|impact|GM|microbiome
33185912|student_A|LD|drug|change effect|inflammatory intestinal microenvironment|DDF
33185912|student_A|LD group|human|used by|gas chromatography mass spectrometry|biomedical technique
33185912|student_A|Naïve group|human|used by|gas chromatography mass spectrometry|biomedical technique
33185912|student_A|gut inflammation|DDF|target|LD group|human
33185912|student_A|LD|drug|administered|LD group|human
33185912|student_A|gut microbiota|microbiome|is linked to|PD|DDF
33185912|student_A|GM|microbiome|is linked to|PD|DDF
33185912|student_A|GM|microbiome|is linked to|Parkinson disease|DDF
39313515|student_A|oral astilbin|chemical|influence|APAP-induced ALI|DDF
39313515|student_A|astilbin|chemical|influence|APAP-induced ALI|DDF
39313515|student_A|HT|chemical|influence|oxidative stress|DDF
39313515|student_A|astilbin|chemical|interact|hydroxytyrosol|chemical
39313515|student_A|acetaminophen-induced acute liver injury|DDF|target|mice|animal
39313515|student_A|HT|chemical|influence|APAP-induced ALI|DDF
39313515|student_A|astilbin|chemical|impact|GM|microbiome
39313515|student_A|Acetaminophen (APAP) overdose-induced acute liver injury|DDF|affect|extensive oxidative stress|DDF
39313515|student_A|astilbin|chemical|influence|acetaminophen-induced acute liver injury|DDF
39313515|student_A|APAP|drug|change effect|ALI|DDF
39313515|student_A|ALI|DDF|affect|extensive oxidative stress|DDF
39313515|student_A|astilbin|chemical|impact|gut microbiota|microbiome
39313515|student_A|astilbin|chemical|interact|HT|chemical
39313515|student_A|astilbin|chemical|located in|intestine|anatomical location
39313515|student_A|oral astilbin|chemical|impact|GM|microbiome
35677440|student_A|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
35677440|student_A|gut microbiota|microbiome|is linked to|Alzheimer's disease|DDF
35677440|student_A|gut microbiota|microbiome|is linked to|neurocognitive and mental disorders|DDF
35677440|student_A|alterations in the gut microbial composition|DDF|target|patients with BD|human
34440599|student_A|Gut microbiota|microbiome|located in|gastrointestinal (GI) tract|anatomical location
34440599|student_A|dementia|DDF|target|old population|human
34440599|student_A|Gut Microbiota|microbiome|is linked to|Aging Related Neurodegenerative Disorders|DDF
34440599|student_A|gut microbiota|microbiome|is linked to|aging related neurodegeneration|DDF
33352217|student_A|gut microbes|microbiome|is linked to|neurodegenerative disorders|DDF
33352217|student_A|gut microbes|microbiome|is linked to|disease conditions|DDF
33352217|student_A|gut microbes|microbiome|is linked to|human diseases|DDF
33352217|student_A|Human gut microbiota|microbiome|is linked to|neurodegenerative diseases|DDF
33352217|student_A|microorganisms|microbiome|compared to|Human gut microbiota|microbiome
33352217|student_A|gut microbes|microbiome|is linked to|Multiple sclerosis|DDF
33352217|student_A|gut microbes|microbiome|is linked to|Alzheimer's disease|DDF
33352217|student_A|gut microbes|microbiome|is linked to|Parkinson's disease|DDF
33352217|student_A|Human gut microbiota|microbiome|is linked to|human diseases|DDF
33352217|student_A|Human gut microbiota|microbiome|is linked to|disease conditions|DDF
33352217|student_A|Human gut microbes|microbiome|is linked to|human diseases|DDF
35565888|student_A|neurotransmitters|chemical|impact|gut microbiota|microbiome
35565888|student_A|gut microbiota|microbiome|located in|central nervous system|anatomical location
35565888|student_A|gut microbiota|microbiome|is linked to|depression|DDF
35565888|student_A|gut microbiota|microbiome|is linked to|mental health|DDF
35565888|student_A|gut peptides|chemical|produced by|gut microbiota|microbiome
35565888|student_A|gut microbiota|microbiome|is linked to|depressive disorder|DDF
35852145|student_A|Gut Microbiota|microbiome|located in|Monozygotic Twins Discordant|human
35852145|student_A|Bifidobacterium pseudocatenulatum|bacteria|interact|bacterial taxa|bacteria
35852145|student_A|gut microbiota|microbiome|located in|Parkinson's disease patients|human
35852145|student_A|monozygotic twin|human|used by|Fecal samples|biomedical technique
35852145|student_A|primary bile acid biosynthesis|chemical|impact|bacterial taxa|bacteria
35852145|student_A|Gut Microbiota|microbiome|is linked to|Parkinson's Disease|DDF
35852145|student_A|Bifidobacterium catenulatum|bacteria|interact|bacterial taxa|bacteria
35852145|student_A|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
35852145|student_A|Bacteroides pectinophilus|bacteria|interact|bacterial taxa|bacteria
36200207|student_A|Parkinson's disease|DDF|interact|alpha-synuclein|chemical
36200207|student_A|misfolded protein alpha-synuclein|chemical|influence|PD|DDF
36200207|student_A|PD|DDF|affect|dopaminergic neuron loss|DDF
36200207|student_A|Probiotics|dietary supplement|influence|Parkinson's Disease|DDF
36200207|student_A|Probiotics|dietary supplement|influence|PD|DDF
36200207|student_A|gut-microbiota|microbiome|is linked to|PD|DDF
36200207|student_A|Probiotics|dietary supplement|impact|gut microbiota|microbiome
36200207|student_A|Probiotics|dietary supplement|influence|neurological diseases|DDF
36200207|student_A|gamma-Aminobutyric acid|chemical|impact|gut microbiota|microbiome
36200207|student_A|PD|DDF|interact|alpha-synuclein|chemical
36200207|student_A|Parkinson's disease|DDF|affect|dopaminergic neuron loss|DDF
36200207|student_A|misfolded protein alpha-synuclein|chemical|located in|olfactory bulb|anatomical location
36200207|student_A|misfolded protein alpha-synuclein|chemical|located in|gut|anatomical location
36200207|student_A|probiotics|dietary supplement|impact|gut microbial flora|microbiome
36200207|student_A|misfolded protein alpha-synuclein|chemical|located in|vagus nerve|anatomical location
36200207|student_A|gut microbiota|microbiome|located in|small intestine|anatomical location
36200207|student_A|gut microbiota|microbiome|located in|brain|anatomical location
36200207|student_A|microbiota|microbiome|is linked to|neurodegeneration|DDF
37798868|student_A|Erythrocytic α-Synuclein|chemical|influence|Parkinson's Disease|DDF
37798868|student_A|Gut Microbiome|microbiome|is linked to|Parkinson's Disease|DDF
37798868|student_A|butyrate|chemical|impact|GIT microbiome|microbiome
37798868|student_A|short-chain fatty acids|chemical|produced by|gut microbiota|microbiome
37798868|student_A|microbiota|microbiome|used by|radioactive labeling|biomedical technique
